# num of genes	num of total genes	Log of odds ratio	P-value	Adjusted p-value	GO term ID	GO term name	GO type
5	5	3.3218233202	-	9.94e-06	GO:1900015	regulation of cytokine production involved in inflammatory response	BP
5	5	3.3218233202	-	9.94e-06	GO:0071681	cellular response to indole-3-methanol	BP
4	4	3.3218233202	-	9.96e-05	GO:0035791	platelet-derived growth factor receptor-beta signaling pathway	BP
4	4	3.3218233202	-	9.96e-05	GO:0051098	regulation of binding	BP
3	3	3.3218233202	-	9.98e-04	GO:1903243	negative regulation of cardiac muscle hypertrophy in response to stress	BP
3	3	3.3218233202	-	9.98e-04	GO:0001827	inner cell mass cell fate commitment	BP
3	3	3.3218233202	-	9.98e-04	GO:0070141	response to UV-A	BP
3	3	3.3218233202	-	9.98e-04	GO:0006549	isoleucine metabolic process	BP
3	3	3.3218233202	-	9.98e-04	GO:0000255	allantoin metabolic process	BP
3	3	3.3218233202	-	9.98e-04	GO:0019724	B cell mediated immunity	BP
3	3	3.3218233202	-	9.98e-04	GO:0002902	regulation of B cell apoptotic process	BP
3	3	3.3218233202	-	9.98e-04	GO:0021781	glial cell fate commitment	BP
3	3	3.3218233202	-	9.98e-04	GO:1990785	response to water-immersion restraint stress	BP
3	3	3.3218233202	-	9.98e-04	GO:2000973	regulation of pro-B cell differentiation	BP
3	3	3.3218233202	-	9.98e-04	GO:1902174	positive regulation of keratinocyte apoptotic process	BP
3	3	3.3218233202	-	9.98e-04	GO:0007176	regulation of epidermal growth factor-activated receptor activity	BP
3	3	3.3218233202	-	9.98e-04	GO:0061198	fungiform papilla formation	BP
3	3	3.3218233202	-	9.98e-04	GO:0033003	regulation of mast cell activation	BP
3	3	3.3218233202	-	9.98e-04	GO:0042512	negative regulation of tyrosine phosphorylation of Stat1 protein	BP
3	3	3.3218233202	-	9.98e-04	GO:0030801	positive regulation of cyclic nucleotide metabolic process	BP
3	3	3.3218233202	-	9.98e-04	GO:0038145	macrophage colony-stimulating factor signaling pathway	BP
3	3	3.3218233202	-	9.98e-04	GO:0021697	cerebellar cortex formation	BP
3	3	3.3218233202	-	9.98e-04	GO:0031281	positive regulation of cyclase activity	BP
2	2	3.3218233202	-	9.99e-03	GO:0030832	regulation of actin filament length	BP
2	2	3.3218233202	-	9.99e-03	GO:0001865	NK T cell differentiation	BP
2	2	3.3218233202	-	9.99e-03	GO:0060667	branch elongation involved in salivary gland morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:0060661	submandibular salivary gland formation	BP
2	2	3.3218233202	-	9.99e-03	GO:0071221	cellular response to bacterial lipopeptide	BP
2	2	3.3218233202	-	9.99e-03	GO:0060595	fibroblast growth factor receptor signaling pathway involved in mammary gland specification	BP
2	2	3.3218233202	-	9.99e-03	GO:0098868	bone growth	BP
2	2	3.3218233202	-	9.99e-03	GO:0009785	blue light signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0010652	positive regulation of cell communication by chemical coupling	BP
2	2	3.3218233202	-	9.99e-03	GO:2000077	negative regulation of type B pancreatic cell development	BP
2	2	3.3218233202	-	9.99e-03	GO:0035747	natural killer cell chemotaxis	BP
2	2	3.3218233202	-	9.99e-03	GO:0060512	prostate gland morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:1902746	regulation of lens fiber cell differentiation	BP
2	2	3.3218233202	-	9.99e-03	GO:2000402	negative regulation of lymphocyte migration	BP
2	2	3.3218233202	-	9.99e-03	GO:0032959	inositol trisphosphate biosynthetic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0022898	regulation of transmembrane transporter activity	BP
2	2	3.3218233202	-	9.99e-03	GO:0045066	regulatory T cell differentiation	BP
2	2	3.3218233202	-	9.99e-03	GO:0060915	mesenchymal cell differentiation involved in lung development	BP
2	2	3.3218233202	-	9.99e-03	GO:0034391	regulation of smooth muscle cell apoptotic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0032425	positive regulation of mismatch repair	BP
2	2	3.3218233202	-	9.99e-03	GO:0033277	abortive mitotic cell cycle	BP
2	2	3.3218233202	-	9.99e-03	GO:0072604	interleukin-6 secretion	BP
2	2	3.3218233202	-	9.99e-03	GO:0019049	evasion or tolerance of host defenses by virus	BP
2	2	3.3218233202	-	9.99e-03	GO:0038162	erythropoietin-mediated signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0090218	positive regulation of lipid kinase activity	BP
2	2	3.3218233202	-	9.99e-03	GO:0007057	spindle assembly involved in female meiosis I	BP
2	2	3.3218233202	-	9.99e-03	GO:0032817	regulation of natural killer cell proliferation	BP
2	2	3.3218233202	-	9.99e-03	GO:1903894	regulation of IRE1-mediated unfolded protein response	BP
2	2	3.3218233202	-	9.99e-03	GO:1901558	response to metformin	BP
2	2	3.3218233202	-	9.99e-03	GO:0070352	positive regulation of white fat cell proliferation	BP
2	2	3.3218233202	-	9.99e-03	GO:0002638	negative regulation of immunoglobulin production	BP
2	2	3.3218233202	-	9.99e-03	GO:0072156	distal tubule morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:0036493	positive regulation of translation in response to endoplasmic reticulum stress	BP
2	2	3.3218233202	-	9.99e-03	GO:0032615	interleukin-12 production	BP
2	2	3.3218233202	-	9.99e-03	GO:0071338	positive regulation of hair follicle cell proliferation	BP
2	2	3.3218233202	-	9.99e-03	GO:0048513	animal organ development	BP
2	2	3.3218233202	-	9.99e-03	GO:0035408	histone H3-T6 phosphorylation	BP
2	2	3.3218233202	-	9.99e-03	GO:0061308	cardiac neural crest cell development involved in heart development	BP
2	2	3.3218233202	-	9.99e-03	GO:0031959	mineralocorticoid receptor signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0010868	negative regulation of triglyceride biosynthetic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0060168	positive regulation of adenosine receptor signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0038179	neurotrophin signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0005986	sucrose biosynthetic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0048340	paraxial mesoderm morphogenesis	BP
2	2	3.3218233202	-	9.99e-03	GO:1990051	activation of protein kinase C activity	BP
2	2	3.3218233202	-	9.99e-03	GO:0002327	immature B cell differentiation	BP
2	2	3.3218233202	-	9.99e-03	GO:0050906	detection of stimulus involved in sensory perception	BP
2	2	3.3218233202	-	9.99e-03	GO:1902728	positive regulation of growth factor dependent skeletal muscle satellite cell proliferation	BP
2	2	3.3218233202	-	9.99e-03	GO:0038188	cholecystokinin signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0060390	regulation of SMAD protein import into nucleus	BP
2	2	3.3218233202	-	9.99e-03	GO:1902202	regulation of hepatocyte growth factor receptor signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0050794	regulation of cellular process	BP
2	2	3.3218233202	-	9.99e-03	GO:1901299	negative regulation of hydrogen peroxide-mediated programmed cell death	BP
2	2	3.3218233202	-	9.99e-03	GO:0035607	fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development	BP
2	2	3.3218233202	-	9.99e-03	GO:0006925	inflammatory cell apoptotic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0032878	regulation of establishment or maintenance of cell polarity	BP
2	2	3.3218233202	-	9.99e-03	GO:0038109	Kit signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0010559	regulation of glycoprotein biosynthetic process	BP
2	2	3.3218233202	-	9.99e-03	GO:0048378	regulation of lateral mesodermal cell fate specification	BP
2	2	3.3218233202	-	9.99e-03	GO:0060615	mammary gland bud formation	BP
2	2	3.3218233202	-	9.99e-03	GO:0043366	beta selection	BP
2	2	3.3218233202	-	9.99e-03	GO:2000278	regulation of DNA biosynthetic process	BP
2	2	3.3218233202	-	9.99e-03	GO:2000681	negative regulation of rubidium ion transport	BP
2	2	3.3218233202	-	9.99e-03	GO:0035728	response to hepatocyte growth factor	BP
2	2	3.3218233202	-	9.99e-03	GO:0003365	establishment of cell polarity involved in ameboidal cell migration	BP
2	2	3.3218233202	-	9.99e-03	GO:0002752	cell surface pattern recognition receptor signaling pathway	BP
2	2	3.3218233202	-	9.99e-03	GO:0086098	angiotensin-activated signaling pathway involved in heart process	BP
2	2	3.3218233202	-	9.99e-03	GO:0010966	regulation of phosphate transport	BP
2	2	3.3218233202	-	9.99e-03	GO:0060529	squamous basal epithelial stem cell differentiation involved in prostate gland acinus development	BP
1	1	3.3218233202	-	1.00e-01	GO:0060268	negative regulation of respiratory burst	BP
1	1	3.3218233202	-	1.00e-01	GO:1902212	negative regulation of prolactin signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0099641	anterograde axonal protein transport	BP
1	1	3.3218233202	-	1.00e-01	GO:1902215	negative regulation of interleukin-4-mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0010752	regulation of cGMP-mediated signaling	BP
1	1	3.3218233202	-	1.00e-01	GO:0010758	regulation of macrophage chemotaxis	BP
1	1	3.3218233202	-	1.00e-01	GO:0039650	suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0002333	transitional one stage B cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0046671	negative regulation of retinal cell programmed cell death	BP
1	1	3.3218233202	-	1.00e-01	GO:0007344	pronuclear fusion	BP
1	1	3.3218233202	-	1.00e-01	GO:0071351	cellular response to interleukin-18	BP
1	1	3.3218233202	-	1.00e-01	GO:2000646	positive regulation of receptor catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0048532	anatomical structure arrangement	BP
1	1	3.3218233202	-	1.00e-01	GO:1902396	protein localization to bicellular tight junction	BP
1	1	3.3218233202	-	1.00e-01	GO:0021814	cell motility involved in cerebral cortex radial glia guided migration	BP
1	1	3.3218233202	-	1.00e-01	GO:0046824	positive regulation of nucleocytoplasmic transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0070179	D-serine biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0061326	renal tubule development	BP
1	1	3.3218233202	-	1.00e-01	GO:0061324	canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1903286	regulation of potassium ion import	BP
1	1	3.3218233202	-	1.00e-01	GO:0060496	mesenchymal-epithelial cell signaling involved in lung development	BP
1	1	3.3218233202	-	1.00e-01	GO:0002371	dendritic cell cytokine production	BP
1	1	3.3218233202	-	1.00e-01	GO:2000850	negative regulation of glucocorticoid secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0050857	positive regulation of antigen receptor-mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0046587	positive regulation of calcium-dependent cell-cell adhesion	BP
1	1	3.3218233202	-	1.00e-01	GO:0046631	alpha-beta T cell activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0030167	proteoglycan catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:2001229	negative regulation of response to gamma radiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0086055	Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling	BP
1	1	3.3218233202	-	1.00e-01	GO:0086054	bundle of His cell to Purkinje myocyte communication by electrical coupling	BP
1	1	3.3218233202	-	1.00e-01	GO:0010522	regulation of calcium ion transport into cytosol	BP
1	1	3.3218233202	-	1.00e-01	GO:0035790	platelet-derived growth factor receptor-alpha signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0001980	regulation of systemic arterial blood pressure by ischemic conditions	BP
1	1	3.3218233202	-	1.00e-01	GO:0003171	atrioventricular valve development	BP
1	1	3.3218233202	-	1.00e-01	GO:0003174	mitral valve development	BP
1	1	3.3218233202	-	1.00e-01	GO:0097254	renal tubular secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0061365	positive regulation of triglyceride lipase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0061360	optic chiasma development	BP
1	1	3.3218233202	-	1.00e-01	GO:1903249	negative regulation of citrulline biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0061582	intestinal epithelial cell migration	BP
1	1	3.3218233202	-	1.00e-01	GO:0099563	modification of synaptic structure	BP
1	1	3.3218233202	-	1.00e-01	GO:0046544	development of secondary male sexual characteristics	BP
1	1	3.3218233202	-	1.00e-01	GO:0035229	positive regulation of glutamate-cysteine ligase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:1903906	regulation of plasma membrane raft polarization	BP
1	1	3.3218233202	-	1.00e-01	GO:1903903	regulation of establishment of T cell polarity	BP
1	1	3.3218233202	-	1.00e-01	GO:1903909	regulation of receptor clustering	BP
1	1	3.3218233202	-	1.00e-01	GO:1904213	negative regulation of iodide transmembrane transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0038154	interleukin-11-mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0070447	positive regulation of oligodendrocyte progenitor proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0098906	regulation of Purkinje myocyte action potential	BP
1	1	3.3218233202	-	1.00e-01	GO:0098902	regulation of membrane depolarization during action potential	BP
1	1	3.3218233202	-	1.00e-01	GO:0003284	septum primum development	BP
1	1	3.3218233202	-	1.00e-01	GO:0032361	pyridoxal phosphate catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	BP
1	1	3.3218233202	-	1.00e-01	GO:1904206	positive regulation of skeletal muscle hypertrophy	BP
1	1	3.3218233202	-	1.00e-01	GO:0030322	stabilization of membrane potential	BP
1	1	3.3218233202	-	1.00e-01	GO:0033184	positive regulation of histone ubiquitination	BP
1	1	3.3218233202	-	1.00e-01	GO:0010021	amylopectin biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0032773	positive regulation of monophenol monooxygenase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0043610	regulation of carbohydrate utilization	BP
1	1	3.3218233202	-	1.00e-01	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	1	3.3218233202	-	1.00e-01	GO:0071228	cellular response to tumor cell	BP
1	1	3.3218233202	-	1.00e-01	GO:1904075	positive regulation of trophectodermal cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0034346	positive regulation of type III interferon production	BP
1	1	3.3218233202	-	1.00e-01	GO:0002663	positive regulation of B cell tolerance induction	BP
1	1	3.3218233202	-	1.00e-01	GO:1903205	regulation of hydrogen peroxide-induced cell death	BP
1	1	3.3218233202	-	1.00e-01	GO:0014005	microglia development	BP
1	1	3.3218233202	-	1.00e-01	GO:1905314	semi-lunar valve development	BP
1	1	3.3218233202	-	1.00e-01	GO:1905313	transforming growth factor beta receptor signaling pathway involved in heart development	BP
1	1	3.3218233202	-	1.00e-01	GO:0071418	cellular response to amine stimulus	BP
1	1	3.3218233202	-	1.00e-01	GO:2000761	positive regulation of N-terminal peptidyl-lysine acetylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061736	engulfment of target by autophagosome	BP
1	1	3.3218233202	-	1.00e-01	GO:1990859	cellular response to endothelin	BP
1	1	3.3218233202	-	1.00e-01	GO:0093001	glycolysis from storage polysaccharide through glucose-1-phosphate	BP
1	1	3.3218233202	-	1.00e-01	GO:0002840	regulation of T cell mediated immune response to tumor cell	BP
1	1	3.3218233202	-	1.00e-01	GO:0021686	cerebellar granular layer maturation	BP
1	1	3.3218233202	-	1.00e-01	GO:0021682	nerve maturation	BP
1	1	3.3218233202	-	1.00e-01	GO:0045728	respiratory burst after phagocytosis	BP
1	1	3.3218233202	-	1.00e-01	GO:0035711	T-helper 1 cell activation	BP
1	1	3.3218233202	-	1.00e-01	GO:1903434	negative regulation of constitutive secretory pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0070640	vitamin D3 metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:2000486	negative regulation of glutamine transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0032738	positive regulation of interleukin-15 production	BP
1	1	3.3218233202	-	1.00e-01	GO:0051446	positive regulation of meiotic cell cycle	BP
1	1	3.3218233202	-	1.00e-01	GO:0002625	regulation of T cell antigen processing and presentation	BP
1	1	3.3218233202	-	1.00e-01	GO:0043371	negative regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0043375	CD8-positive, alpha-beta T cell lineage commitment	BP
1	1	3.3218233202	-	1.00e-01	GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0042774	plasma membrane ATP synthesis coupled electron transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0090648	response to environmental enrichment	BP
1	1	3.3218233202	-	1.00e-01	GO:0032072	regulation of restriction endodeoxyribonuclease activity	BP
1	1	3.3218233202	-	1.00e-01	GO:1904404	response to formaldehyde	BP
1	1	3.3218233202	-	1.00e-01	GO:0045818	negative regulation of glycogen catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0090096	positive regulation of metanephric cap mesenchymal cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0060817	inactivation of paternal X chromosome	BP
1	1	3.3218233202	-	1.00e-01	GO:0006780	uroporphyrinogen III biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0000097	sulfur amino acid biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0060552	positive regulation of fructose 1,6-bisphosphate metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0060550	positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:1904828	positive regulation of hydrogen sulfide biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0033028	myeloid cell apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0046327	glycerol biosynthetic process from pyruvate	BP
1	1	3.3218233202	-	1.00e-01	GO:1990774	tumor necrosis factor secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0070489	T cell aggregation	BP
1	1	3.3218233202	-	1.00e-01	GO:1900133	regulation of renin secretion into blood stream	BP
1	1	3.3218233202	-	1.00e-01	GO:0051695	actin filament uncapping	BP
1	1	3.3218233202	-	1.00e-01	GO:1904793	regulation of euchromatin binding	BP
1	1	3.3218233202	-	1.00e-01	GO:1904651	positive regulation of fat cell apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1902228	positive regulation of macrophage colony-stimulating factor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0051249	regulation of lymphocyte activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0010768	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	1	3.3218233202	-	1.00e-01	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	BP
1	1	3.3218233202	-	1.00e-01	GO:0010481	epidermal cell division	BP
1	1	3.3218233202	-	1.00e-01	GO:0043969	histone H2B acetylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0051796	negative regulation of timing of catagen	BP
1	1	3.3218233202	-	1.00e-01	GO:0021998	neural plate mediolateral regionalization	BP
1	1	3.3218233202	-	1.00e-01	GO:0034972	histone H3-R26 methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0071301	cellular response to vitamin B1	BP
1	1	3.3218233202	-	1.00e-01	GO:0006117	acetaldehyde metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0098736	negative regulation of the force of heart contraction	BP
1	1	3.3218233202	-	1.00e-01	GO:0003270	Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0006582	melanin metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0050677	positive regulation of urothelial cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0032423	regulation of mismatch repair	BP
1	1	3.3218233202	-	1.00e-01	GO:1902068	regulation of sphingolipid mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0036399	TCR signalosome assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:1905045	negative regulation of Schwann cell proliferation involved in axon regeneration	BP
1	1	3.3218233202	-	1.00e-01	GO:0019089	transmission of virus	BP
1	1	3.3218233202	-	1.00e-01	GO:2000655	negative regulation of cellular response to testosterone stimulus	BP
1	1	3.3218233202	-	1.00e-01	GO:2000657	negative regulation of apolipoprotein binding	BP
1	1	3.3218233202	-	1.00e-01	GO:0014896	muscle hypertrophy	BP
1	1	3.3218233202	-	1.00e-01	GO:0043402	glucocorticoid mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0070572	positive regulation of neuron projection regeneration	BP
1	1	3.3218233202	-	1.00e-01	GO:2000514	regulation of CD4-positive, alpha-beta T cell activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0032667	regulation of interleukin-23 production	BP
1	1	3.3218233202	-	1.00e-01	GO:0072431	signal transduction involved in mitotic G1 DNA damage checkpoint	BP
1	1	3.3218233202	-	1.00e-01	GO:1904591	positive regulation of protein import	BP
1	1	3.3218233202	-	1.00e-01	GO:0035665	TIRAP-dependent toll-like receptor 4 signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1990402	embryonic liver development	BP
1	1	3.3218233202	-	1.00e-01	GO:0030826	regulation of cGMP biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1990349	gap junction-mediated intercellular transport	BP
1	1	3.3218233202	-	1.00e-01	GO:1901187	regulation of ephrin receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0072302	negative regulation of metanephric glomerular mesangial cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0072386	plus-end-directed organelle transport along microtubule	BP
1	1	3.3218233202	-	1.00e-01	GO:0072308	negative regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0019043	establishment of viral latency	BP
1	1	3.3218233202	-	1.00e-01	GO:0007440	foregut morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0034477	U6 snRNA 3'-end processing	BP
1	1	3.3218233202	-	1.00e-01	GO:0002502	peptide antigen assembly with MHC class I protein complex	BP
1	1	3.3218233202	-	1.00e-01	GO:0010534	regulation of activation of JAK2 kinase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0035789	metanephric mesenchymal cell migration	BP
1	1	3.3218233202	-	1.00e-01	GO:0035437	maintenance of protein localization in endoplasmic reticulum	BP
1	1	3.3218233202	-	1.00e-01	GO:1903755	positive regulation of SUMO transferase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0051171	regulation of nitrogen compound metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0044330	canonical Wnt signaling pathway involved in positive regulation of wound healing	BP
1	1	3.3218233202	-	1.00e-01	GO:0044337	canonical Wnt signaling pathway involved in positive regulation of apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0051282	regulation of sequestering of calcium ion	BP
1	1	3.3218233202	-	1.00e-01	GO:0070104	negative regulation of interleukin-6-mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1904000	positive regulation of eating behavior	BP
1	1	3.3218233202	-	1.00e-01	GO:0014038	regulation of Schwann cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:1903911	positive regulation of receptor clustering	BP
1	1	3.3218233202	-	1.00e-01	GO:0043060	meiotic metaphase I plate congression	BP
1	1	3.3218233202	-	1.00e-01	GO:0043062	extracellular structure organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0072340	cellular lactam catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0048352	paraxial mesoderm structural organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0032814	regulation of natural killer cell activation	BP
1	1	3.3218233202	-	1.00e-01	GO:1990029	vasomotion	BP
1	1	3.3218233202	-	1.00e-01	GO:2000591	positive regulation of metanephric mesenchymal cell migration	BP
1	1	3.3218233202	-	1.00e-01	GO:2000597	positive regulation of optic nerve formation	BP
1	1	3.3218233202	-	1.00e-01	GO:0035744	T-helper 1 cell cytokine production	BP
1	1	3.3218233202	-	1.00e-01	GO:0046725	negative regulation by virus of viral protein levels in host cell	BP
1	1	3.3218233202	-	1.00e-01	GO:0002676	regulation of chronic inflammatory response	BP
1	1	3.3218233202	-	1.00e-01	GO:1903897	regulation of PERK-mediated unfolded protein response	BP
1	1	3.3218233202	-	1.00e-01	GO:1903891	regulation of ATF6-mediated unfolded protein response	BP
1	1	3.3218233202	-	1.00e-01	GO:0060283	negative regulation of oocyte development	BP
1	1	3.3218233202	-	1.00e-01	GO:2000753	positive regulation of glucosylceramide catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:2000755	positive regulation of sphingomyelin catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0048611	embryonic ectodermal digestive tract development	BP
1	1	3.3218233202	-	1.00e-01	GO:0072262	metanephric glomerular mesangial cell proliferation involved in metanephros development	BP
1	1	3.3218233202	-	1.00e-01	GO:0060587	regulation of lipoprotein lipid oxidation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061185	negative regulation of dermatome development	BP
1	1	3.3218233202	-	1.00e-01	GO:0061181	regulation of chondrocyte development	BP
1	1	3.3218233202	-	1.00e-01	GO:0052405	negative regulation by host of symbiont molecular function	BP
1	1	3.3218233202	-	1.00e-01	GO:1905285	fibrous ring of heart morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:1990264	peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0061519	macrophage homeostasis	BP
1	1	3.3218233202	-	1.00e-01	GO:0038002	endocrine signaling	BP
1	1	3.3218233202	-	1.00e-01	GO:1904414	positive regulation of cardiac ventricle development	BP
1	1	3.3218233202	-	1.00e-01	GO:0060035	notochord cell development	BP
1	1	3.3218233202	-	1.00e-01	GO:0097501	stress response to metal ion	BP
1	1	3.3218233202	-	1.00e-01	GO:0090085	regulation of protein deubiquitination	BP
1	1	3.3218233202	-	1.00e-01	GO:0033320	UDP-D-xylose biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1904353	regulation of telomere capping	BP
1	1	3.3218233202	-	1.00e-01	GO:0061026	cardiac muscle tissue regeneration	BP
1	1	3.3218233202	-	1.00e-01	GO:1903387	positive regulation of homophilic cell adhesion	BP
1	1	3.3218233202	-	1.00e-01	GO:0001544	initiation of primordial ovarian follicle growth	BP
1	1	3.3218233202	-	1.00e-01	GO:0036323	vascular endothelial growth factor receptor-1 signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1903465	positive regulation of mitotic cell cycle DNA replication	BP
1	1	3.3218233202	-	1.00e-01	GO:0042488	positive regulation of odontogenesis of dentin-containing tooth	BP
1	1	3.3218233202	-	1.00e-01	GO:1905176	positive regulation of vascular smooth muscle cell dedifferentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:2000981	negative regulation of inner ear receptor cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061550	cranial ganglion development	BP
1	1	3.3218233202	-	1.00e-01	GO:0060981	cell migration involved in coronary angiogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0046318	negative regulation of glucosylceramide biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0048753	pigment granule organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0060709	glycogen cell differentiation involved in embryonic placenta development	BP
1	1	3.3218233202	-	1.00e-01	GO:0019481	L-alanine catabolic process, by transamination	BP
1	1	3.3218233202	-	1.00e-01	GO:0021933	radial glia guided migration of cerebellar granule cell	BP
1	1	3.3218233202	-	1.00e-01	GO:1904317	cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine	BP
1	1	3.3218233202	-	1.00e-01	GO:0010948	negative regulation of cell cycle process	BP
1	1	3.3218233202	-	1.00e-01	GO:2001286	regulation of caveolin-mediated endocytosis	BP
1	1	3.3218233202	-	1.00e-01	GO:0048691	positive regulation of axon extension involved in regeneration	BP
1	1	3.3218233202	-	1.00e-01	GO:0061044	negative regulation of vascular wound healing	BP
1	1	3.3218233202	-	1.00e-01	GO:1905208	negative regulation of cardiocyte differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0042991	transcription factor import into nucleus	BP
1	1	3.3218233202	-	1.00e-01	GO:0090367	negative regulation of mRNA modification	BP
1	1	3.3218233202	-	1.00e-01	GO:1902233	negative regulation of positive thymic T cell selection	BP
1	1	3.3218233202	-	1.00e-01	GO:2000351	regulation of endothelial cell apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0051257	meiotic spindle midzone assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:1904501	positive regulation of chromatin-mediated maintenance of transcription	BP
1	1	3.3218233202	-	1.00e-01	GO:0042527	negative regulation of tyrosine phosphorylation of Stat6 protein	BP
1	1	3.3218233202	-	1.00e-01	GO:0003409	optic cup structural organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0001710	mesodermal cell fate commitment	BP
1	1	3.3218233202	-	1.00e-01	GO:0052066	entry of symbiont into host cell by promotion of host phagocytosis	BP
1	1	3.3218233202	-	1.00e-01	GO:2000830	positive regulation of parathyroid hormone secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:1900163	positive regulation of phospholipid scramblase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0010905	negative regulation of UDP-glucose catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0046657	folic acid catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0051665	membrane raft localization	BP
1	1	3.3218233202	-	1.00e-01	GO:0009817	defense response to fungus, incompatible interaction	BP
1	1	3.3218233202	-	1.00e-01	GO:1902910	positive regulation of melanosome transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0032928	regulation of superoxide anion generation	BP
1	1	3.3218233202	-	1.00e-01	GO:0016999	antibiotic metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0046098	guanine metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0060901	regulation of hair cycle by canonical Wnt signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0060904	regulation of protein folding in endoplasmic reticulum	BP
1	1	3.3218233202	-	1.00e-01	GO:0006343	establishment of chromatin silencing	BP
1	1	3.3218233202	-	1.00e-01	GO:1903514	calcium ion transport from endoplasmic reticulum to cytosol	BP
1	1	3.3218233202	-	1.00e-01	GO:0060127	prolactin secreting cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0002316	follicular B cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:2001031	positive regulation of cellular glucuronidation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901340	negative regulation of store-operated calcium channel activity	BP
1	1	3.3218233202	-	1.00e-01	GO:1900082	negative regulation of arginine catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1900085	negative regulation of peptidyl-tyrosine autophosphorylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0045938	positive regulation of circadian sleep/wake cycle, sleep	BP
1	1	3.3218233202	-	1.00e-01	GO:0014889	muscle atrophy	BP
1	1	3.3218233202	-	1.00e-01	GO:0035409	histone H3-Y41 phosphorylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0072428	signal transduction involved in intra-S DNA damage checkpoint	BP
1	1	3.3218233202	-	1.00e-01	GO:0097274	urea homeostasis	BP
1	1	3.3218233202	-	1.00e-01	GO:0007499	ectoderm and mesoderm interaction	BP
1	1	3.3218233202	-	1.00e-01	GO:0100057	regulation of phenotypic switching by transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:1903926	cellular response to bisphenol A	BP
1	1	3.3218233202	-	1.00e-01	GO:0042659	regulation of cell fate specification	BP
1	1	3.3218233202	-	1.00e-01	GO:0032848	negative regulation of cellular pH reduction	BP
1	1	3.3218233202	-	1.00e-01	GO:0019056	modulation by virus of host transcription	BP
1	1	3.3218233202	-	1.00e-01	GO:0098968	neurotransmitter receptor transport postsynaptic membrane to endosome	BP
1	1	3.3218233202	-	1.00e-01	GO:2000097	regulation of smooth muscle cell-matrix adhesion	BP
1	1	3.3218233202	-	1.00e-01	GO:0001840	neural plate development	BP
1	1	3.3218233202	-	1.00e-01	GO:1905064	negative regulation of vascular smooth muscle cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061115	lung proximal/distal axis specification	BP
1	1	3.3218233202	-	1.00e-01	GO:1903760	regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization	BP
1	1	3.3218233202	-	1.00e-01	GO:1903764	regulation of potassium ion export across plasma membrane	BP
1	1	3.3218233202	-	1.00e-01	GO:0044329	canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion	BP
1	1	3.3218233202	-	1.00e-01	GO:0044328	canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration	BP
1	1	3.3218233202	-	1.00e-01	GO:0071247	cellular response to chromate	BP
1	1	3.3218233202	-	1.00e-01	GO:0060436	bronchiole morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0010823	negative regulation of mitochondrion organization	BP
1	1	3.3218233202	-	1.00e-01	GO:1905337	positive regulation of aggrephagy	BP
1	1	3.3218233202	-	1.00e-01	GO:0061753	substrate localization to autophagosome	BP
1	1	3.3218233202	-	1.00e-01	GO:0031275	regulation of lateral pseudopodium assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0060879	semicircular canal fusion	BP
1	1	3.3218233202	-	1.00e-01	GO:0002863	positive regulation of inflammatory response to antigenic stimulus	BP
1	1	3.3218233202	-	1.00e-01	GO:1904197	positive regulation of granulosa cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904193	negative regulation of cholangiocyte apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0072255	metanephric glomerular mesangial cell development	BP
1	1	3.3218233202	-	1.00e-01	GO:0050674	urothelial cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904227	negative regulation of glycogen synthase activity, transferring glucose-1-phosphate	BP
1	1	3.3218233202	-	1.00e-01	GO:0060601	lateral sprouting from an epithelium	BP
1	1	3.3218233202	-	1.00e-01	GO:0070662	mast cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0070667	negative regulation of mast cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904056	positive regulation of cholangiocyte proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0051463	negative regulation of cortisol secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:0071206	establishment of protein localization to juxtaparanode region of axon	BP
1	1	3.3218233202	-	1.00e-01	GO:0060479	lung cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:1901563	response to camptothecin	BP
1	1	3.3218233202	-	1.00e-01	GO:1901976	regulation of cell cycle checkpoint	BP
1	1	3.3218233202	-	1.00e-01	GO:0035733	hepatic stellate cell activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0031034	myosin filament assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:1903452	positive regulation of G1 to G0 transition	BP
1	1	3.3218233202	-	1.00e-01	GO:0070194	synaptonemal complex disassembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0007037	vacuolar phosphate transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0003311	pancreatic D cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0051541	elastin metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0019101	female somatic sex determination	BP
1	1	3.3218233202	-	1.00e-01	GO:0019102	male somatic sex determination	BP
1	1	3.3218233202	-	1.00e-01	GO:0042321	negative regulation of circadian sleep/wake cycle, sleep	BP
1	1	3.3218233202	-	1.00e-01	GO:1903393	positive regulation of adherens junction organization	BP
1	1	3.3218233202	-	1.00e-01	GO:1903644	regulation of chaperone-mediated protein folding	BP
1	1	3.3218233202	-	1.00e-01	GO:0060768	regulation of epithelial cell proliferation involved in prostate gland development	BP
1	1	3.3218233202	-	1.00e-01	GO:0060578	superior vena cava morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0002761	regulation of myeloid leukocyte differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0002769	natural killer cell inhibitory signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:2000425	regulation of apoptotic cell clearance	BP
1	1	3.3218233202	-	1.00e-01	GO:0043315	positive regulation of neutrophil degranulation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904639	cellular response to resveratrol	BP
1	1	3.3218233202	-	1.00e-01	GO:1904631	response to glucoside	BP
1	1	3.3218233202	-	1.00e-01	GO:1904635	positive regulation of glomerular visceral epithelial cell apoptotic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0097326	melanocyte adhesion	BP
1	1	3.3218233202	-	1.00e-01	GO:2001113	negative regulation of cellular response to hepatocyte growth factor stimulus	BP
1	1	3.3218233202	-	1.00e-01	GO:1904306	positive regulation of gastro-intestinal system smooth muscle contraction	BP
1	1	3.3218233202	-	1.00e-01	GO:1904303	positive regulation of maternal process involved in parturition	BP
1	1	3.3218233202	-	1.00e-01	GO:1904300	positive regulation of transcytosis	BP
1	1	3.3218233202	-	1.00e-01	GO:1903689	regulation of wound healing, spreading of epidermal cells	BP
1	1	3.3218233202	-	1.00e-01	GO:2001145	negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:1905689	positive regulation of diacylglycerol kinase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0002721	regulation of B cell cytokine production	BP
1	1	3.3218233202	-	1.00e-01	GO:0035112	genitalia morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0043299	leukocyte degranulation	BP
1	1	3.3218233202	-	1.00e-01	GO:1902947	regulation of tau-protein kinase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0090104	pancreatic epsilon cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0044111	development involved in symbiotic interaction	BP
1	1	3.3218233202	-	1.00e-01	GO:0003252	negative regulation of cell proliferation involved in heart valve morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0003251	positive regulation of cell proliferation involved in heart valve morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:1902206	negative regulation of interleukin-2-mediated signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1902203	negative regulation of hepatocyte growth factor receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0010743	regulation of macrophage derived foam cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904531	positive regulation of actin filament binding	BP
1	1	3.3218233202	-	1.00e-01	GO:0007403	glial cell fate determination	BP
1	1	3.3218233202	-	1.00e-01	GO:2000118	regulation of sodium-dependent phosphate transport	BP
1	1	3.3218233202	-	1.00e-01	GO:2000119	negative regulation of sodium-dependent phosphate transport	BP
1	1	3.3218233202	-	1.00e-01	GO:2000808	negative regulation of synaptic vesicle clustering	BP
1	1	3.3218233202	-	1.00e-01	GO:0050793	regulation of developmental process	BP
1	1	3.3218233202	-	1.00e-01	GO:0021515	cell differentiation in spinal cord	BP
1	1	3.3218233202	-	1.00e-01	GO:0044708	single-organism behavior	BP
1	1	3.3218233202	-	1.00e-01	GO:2000639	negative regulation of SREBP signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0099040	ceramide translocation	BP
1	1	3.3218233202	-	1.00e-01	GO:0003213	cardiac right atrium morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0070512	positive regulation of histone H4-K20 methylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0001100	negative regulation of exit from mitosis	BP
1	1	3.3218233202	-	1.00e-01	GO:0001971	negative regulation of activation of membrane attack complex	BP
1	1	3.3218233202	-	1.00e-01	GO:0035604	fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow	BP
1	1	3.3218233202	-	1.00e-01	GO:0035602	fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow	BP
1	1	3.3218233202	-	1.00e-01	GO:0035603	fibroblast growth factor receptor signaling pathway involved in hemopoiesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0034127	regulation of MyD88-independent toll-like receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1900402	regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:0050865	regulation of cell activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0002152	bile acid conjugation	BP
1	1	3.3218233202	-	1.00e-01	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
1	1	3.3218233202	-	1.00e-01	GO:1901723	negative regulation of cell proliferation involved in kidney development	BP
1	1	3.3218233202	-	1.00e-01	GO:0086044	atrial cardiac muscle cell to AV node cell communication by electrical coupling	BP
1	1	3.3218233202	-	1.00e-01	GO:2000536	negative regulation of entry of bacterium into host cell	BP
1	1	3.3218233202	-	1.00e-01	GO:0097090	presynaptic membrane organization	BP
1	1	3.3218233202	-	1.00e-01	GO:1904025	positive regulation of glucose catabolic process to lactate via pyruvate	BP
1	1	3.3218233202	-	1.00e-01	GO:0035644	phosphoanandamide dephosphorylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0002695	negative regulation of leukocyte activation	BP
1	1	3.3218233202	-	1.00e-01	GO:0002344	B cell affinity maturation	BP
1	1	3.3218233202	-	1.00e-01	GO:0072434	signal transduction involved in mitotic G2 DNA damage checkpoint	BP
1	1	3.3218233202	-	1.00e-01	GO:0052547	regulation of peptidase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:2000739	regulation of mesenchymal stem cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0071441	negative regulation of histone H3-K14 acetylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0061767	negative regulation of lung blood pressure	BP
1	1	3.3218233202	-	1.00e-01	GO:0043000	Golgi to plasma membrane CFTR protein transport	BP
1	1	3.3218233202	-	1.00e-01	GO:1904597	negative regulation of connective tissue replacement involved in inflammatory response wound healing	BP
1	1	3.3218233202	-	1.00e-01	GO:0072362	regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:0072365	regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	3.3218233202	-	1.00e-01	GO:0090025	regulation of monocyte chemotaxis	BP
1	1	3.3218233202	-	1.00e-01	GO:0090237	regulation of arachidonic acid secretion	BP
1	1	3.3218233202	-	1.00e-01	GO:1902988	neurofibrillary tangle assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0006713	glucocorticoid catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0098974	postsynaptic actin cytoskeleton organization	BP
1	1	3.3218233202	-	1.00e-01	GO:0003294	atrial ventricular junction remodeling	BP
1	1	3.3218233202	-	1.00e-01	GO:0002066	columnar/cuboidal epithelial cell development	BP
1	1	3.3218233202	-	1.00e-01	GO:0010034	response to acetate	BP
1	1	3.3218233202	-	1.00e-01	GO:0036060	slit diaphragm assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0071873	response to norepinephrine	BP
1	1	3.3218233202	-	1.00e-01	GO:0071250	cellular response to nitrite	BP
1	1	3.3218233202	-	1.00e-01	GO:0071258	cellular response to gravity	BP
1	1	3.3218233202	-	1.00e-01	GO:0060405	regulation of penile erection	BP
1	1	3.3218233202	-	1.00e-01	GO:0060400	negative regulation of growth hormone receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1904685	positive regulation of metalloendopeptidase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0002651	positive regulation of tolerance induction to self antigen	BP
1	1	3.3218233202	-	1.00e-01	GO:1902165	regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
1	1	3.3218233202	-	1.00e-01	GO:1905305	negative regulation of cardiac myofibril assembly	BP
1	1	3.3218233202	-	1.00e-01	GO:0100002	negative regulation of protein kinase activity by protein phosphorylation	BP
1	1	3.3218233202	-	1.00e-01	GO:0032298	positive regulation of DNA-dependent DNA replication initiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0060843	venous endothelial cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0098930	axonal transport	BP
1	1	3.3218233202	-	1.00e-01	GO:0031658	negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
1	1	3.3218233202	-	1.00e-01	GO:0001835	blastocyst hatching	BP
1	1	3.3218233202	-	1.00e-01	GO:0032960	regulation of inositol trisphosphate biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0045713	low-density lipoprotein particle receptor biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1904238	pericyte cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904237	positive regulation of substrate-dependent cell migration, cell attachment to substrate	BP
1	1	3.3218233202	-	1.00e-01	GO:0097017	renal protein absorption	BP
1	1	3.3218233202	-	1.00e-01	GO:0035491	positive regulation of leukotriene production involved in inflammatory response	BP
1	1	3.3218233202	-	1.00e-01	GO:0060611	mammary gland fat development	BP
1	1	3.3218233202	-	1.00e-01	GO:0042976	activation of Janus kinase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0071211	protein targeting to vacuole involved in autophagy	BP
1	1	3.3218233202	-	1.00e-01	GO:0042703	menstruation	BP
1	1	3.3218233202	-	1.00e-01	GO:0044029	hypomethylation of CpG island	BP
1	1	3.3218233202	-	1.00e-01	GO:0060806	negative regulation of cell differentiation involved in embryonic placenta development	BP
1	1	3.3218233202	-	1.00e-01	GO:0061040	female gonad morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0009441	glycolate metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1903676	positive regulation of cap-dependent translational initiation	BP
1	1	3.3218233202	-	1.00e-01	GO:1904141	positive regulation of microglial cell migration	BP
1	1	3.3218233202	-	1.00e-01	GO:0048241	epinephrine transport	BP
1	1	3.3218233202	-	1.00e-01	GO:1900383	regulation of synaptic plasticity by receptor localization to synapse	BP
1	1	3.3218233202	-	1.00e-01	GO:1904604	negative regulation of advanced glycation end-product receptor activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0006043	glucosamine catabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0060014	granulosa cell differentiation	BP
1	1	3.3218233202	-	1.00e-01	GO:0090219	negative regulation of lipid kinase activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0045175	basal protein localization	BP
1	1	3.3218233202	-	1.00e-01	GO:2000184	positive regulation of progesterone biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:2000230	negative regulation of pancreatic stellate cell proliferation	BP
1	1	3.3218233202	-	1.00e-01	GO:0060751	branch elongation involved in mammary gland duct branching	BP
1	1	3.3218233202	-	1.00e-01	GO:0050760	negative regulation of thymidylate synthase biosynthetic process	BP
1	1	3.3218233202	-	1.00e-01	GO:0051389	inactivation of MAPKK activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0046958	nonassociative learning	BP
1	1	3.3218233202	-	1.00e-01	GO:0006991	response to sterol depletion	BP
1	1	3.3218233202	-	1.00e-01	GO:0032535	regulation of cellular component size	BP
1	1	3.3218233202	-	1.00e-01	GO:0002758	innate immune response-activating signal transduction	BP
1	1	3.3218233202	-	1.00e-01	GO:0060694	regulation of cholesterol transporter activity	BP
1	1	3.3218233202	-	1.00e-01	GO:0098761	cellular response to interleukin-7	BP
1	1	3.3218233202	-	1.00e-01	GO:0044140	negative regulation of growth of symbiont on or near host surface	BP
1	1	3.3218233202	-	1.00e-01	GO:0007063	regulation of sister chromatid cohesion	BP
1	1	3.3218233202	-	1.00e-01	GO:0071298	cellular response to L-ascorbic acid	BP
1	1	3.3218233202	-	1.00e-01	GO:0010232	vascular transport	BP
1	1	3.3218233202	-	1.00e-01	GO:1901860	positive regulation of mitochondrial DNA metabolic process	BP
1	1	3.3218233202	-	1.00e-01	GO:1901863	positive regulation of muscle tissue development	BP
1	1	3.3218233202	-	1.00e-01	GO:0021763	subthalamic nucleus development	BP
1	1	3.3218233202	-	1.00e-01	GO:0042501	serine phosphorylation of STAT protein	BP
1	1	3.3218233202	-	1.00e-01	GO:0036119	response to platelet-derived growth factor	BP
1	1	3.3218233202	-	1.00e-01	GO:0097117	guanylate kinase-associated protein clustering	BP
1	1	3.3218233202	-	1.00e-01	GO:1900148	negative regulation of Schwann cell migration	BP
1	1	3.3218233202	-	1.00e-01	GO:1902548	negative regulation of cellular response to vascular endothelial growth factor stimulus	BP
1	1	3.3218233202	-	1.00e-01	GO:0038195	urokinase plasminogen activator signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:0060520	activation of prostate induction by androgen receptor signaling pathway	BP
1	1	3.3218233202	-	1.00e-01	GO:1905223	epicardium morphogenesis	BP
1	1	3.3218233202	-	1.00e-01	GO:0032637	interleukin-8 production	BP
1	1	3.3218233202	-	1.00e-01	GO:0032633	interleukin-4 production	BP
8	8	3.3218233202	-	9.82e-09	GO:0030235	nitric-oxide synthase regulator activity	MF
7	7	3.3218233202	-	9.87e-08	GO:0004679	AMP-activated protein kinase activity	MF
4	4	3.3218233202	-	9.96e-05	GO:0050815	phosphoserine binding	MF
4	4	3.3218233202	-	9.96e-05	GO:0043125	ErbB-3 class receptor binding	MF
3	3	3.3218233202	-	9.98e-04	GO:0004992	platelet activating factor receptor activity	MF
3	3	3.3218233202	-	9.98e-04	GO:0050816	phosphothreonine binding	MF
3	3	3.3218233202	-	9.98e-04	GO:0045309	protein phosphorylated amino acid binding	MF
3	3	3.3218233202	-	9.98e-04	GO:0031800	type 3 metabotropic glutamate receptor binding	MF
3	3	3.3218233202	-	9.98e-04	GO:0031997	N-terminal myristoylation domain binding	MF
3	3	3.3218233202	-	9.98e-04	GO:0008426	protein kinase C inhibitor activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0004951	cholecystokinin receptor activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0038052	RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0047322	[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0008269	JAK pathway signal transduction adaptor activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0005011	macrophage colony-stimulating factor receptor activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0005019	platelet-derived growth factor beta-receptor activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0034212	peptide N-acetyltransferase activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0042610	CD8 receptor binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0086075	gap junction channel activity involved in cardiac conduction electrical coupling	MF
2	2	3.3218233202	-	9.99e-03	GO:0035403	histone kinase activity (H3-T6 specific)	MF
2	2	3.3218233202	-	9.99e-03	GO:0031701	angiotensin receptor binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0010465	nerve growth factor receptor activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0042132	fructose 1,6-bisphosphate 1-phosphatase activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0009882	blue light photoreceptor activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0031762	follicle-stimulating hormone receptor binding	MF
2	2	3.3218233202	-	9.99e-03	GO:0097199	cysteine-type endopeptidase activity involved in apoptotic signaling pathway	MF
2	2	3.3218233202	-	9.99e-03	GO:0050405	[acetyl-CoA carboxylase] kinase activity	MF
2	2	3.3218233202	-	9.99e-03	GO:0031691	alpha-1A adrenergic receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:1990450	linear polyubiquitin binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0004852	uroporphyrinogen-III synthase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0008545	JUN kinase kinase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0001093	TFIIB-class transcription factor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0051916	granulocyte colony-stimulating factor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0004586	ornithine decarboxylase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0035226	glutamate-cysteine ligase catalytic subunit binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0000016	lactase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0016248	channel inhibitor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004955	prostaglandin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0038051	glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0061733	peptide-lysine-N-acetyltransferase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0015439	heme-transporting ATPase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0032138	single base insertion or deletion binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0001011	transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting	MF
1	1	3.3218233202	-	1.00e-01	GO:0005020	stem cell factor receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0035033	histone deacetylase regulator activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004508	steroid 17-alpha-monooxygenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0046904	calcium oxalate binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0052817	very long chain acyl-CoA hydrolase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0052816	long-chain acyl-CoA hydrolase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047305	(R)-3-amino-2-methylpropionate-pyruvate transaminase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0070856	myosin VI light chain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0004676	3-phosphoinositide-dependent protein kinase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0018114	threonine racemase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0032427	GBD domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0002135	CTP binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0086063	voltage-gated sodium channel activity involved in SA node cell action potential	MF
1	1	3.3218233202	-	1.00e-01	GO:0086060	voltage-gated sodium channel activity involved in AV node cell action potential	MF
1	1	3.3218233202	-	1.00e-01	GO:0086061	voltage-gated sodium channel activity involved in bundle of His cell action potential	MF
1	1	3.3218233202	-	1.00e-01	GO:0044377	RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending	MF
1	1	3.3218233202	-	1.00e-01	GO:0061609	fructose-1-phosphate aldolase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0060175	brain-derived neurotrophic factor-activated receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0043028	cysteine-type endopeptidase regulator activity involved in apoptotic process	MF
1	1	3.3218233202	-	1.00e-01	GO:0001087	transcription factor activity, TFIIB-class binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0030549	acetylcholine receptor activator activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0030379	neurotensin receptor activity, non-G-protein coupled	MF
1	1	3.3218233202	-	1.00e-01	GO:0030378	serine racemase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0030377	urokinase plasminogen activator receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004900	erythropoietin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0001626	nociceptin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005199	structural constituent of cell wall	MF
1	1	3.3218233202	-	1.00e-01	GO:0000250	lanosterol synthase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005017	platelet-derived growth factor-activated receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005018	platelet-derived growth factor alpha-receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0038049	transcription factor activity, ligand-activated RNA polymerase II transcription factor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0030272	5-formyltetrahydrofolate cyclo-ligase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0050462	N-acetylneuraminate synthase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0036327	VEGF-B-activated receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0050429	calcium-dependent phospholipase C activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047444	N-acylneuraminate-9-phosphate synthase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047442	17-alpha-hydroxyprogesterone aldolase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0031859	platelet activating factor receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0015929	hexosaminidase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0030616	transforming growth factor beta receptor, common-partner cytoplasmic mediator activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0061656	SUMO conjugating enzyme activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0036458	hepatocyte growth factor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0086079	gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling	MF
1	1	3.3218233202	-	1.00e-01	GO:0086078	gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling	MF
1	1	3.3218233202	-	1.00e-01	GO:0086076	gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling	MF
1	1	3.3218233202	-	1.00e-01	GO:0099038	ceramide-translocating ATPase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0035401	histone kinase activity (H3-Y41 specific)	MF
1	1	3.3218233202	-	1.00e-01	GO:0031896	V2 vasopressin receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0001846	opsonin binding	MF
1	1	3.3218233202	-	1.00e-01	GO:1903763	gap junction channel activity involved in cell communication by electrical coupling	MF
1	1	3.3218233202	-	1.00e-01	GO:0036326	VEGF-A-activated receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004728	signal transducer, downstream of receptor, with protein tyrosine phosphatase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0019970	interleukin-11 binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0070320	inward rectifier potassium channel inhibitor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0017172	cysteine dioxygenase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005009	insulin-activated receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005008	hepatocyte growth factor-activated receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0009020	tRNA (guanosine-2'-O-)-methyltransferase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0004883	glucocorticoid receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0051427	hormone receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0070974	POU domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0070976	TIR domain binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0036332	placental growth factor-activated receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0042131	thiamine phosphate phosphatase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0042497	triacyl lipopeptide binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0015126	canalicular bile acid transmembrane transporter activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0030412	formimidoyltetrahydrofolate cyclodeaminase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0036487	nitric-oxide synthase inhibitor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0032561	guanyl ribonucleotide binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0050038	L-xylulose reductase (NADP+) activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0016430	tRNA (adenine-N6-)-methyltransferase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0052666	tRNA (cytosine-2'-O-)-methyltransferase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005133	interferon-gamma receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0008721	D-serine ammonia-lyase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0048040	UDP-glucuronate decarboxylase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0043423	3-phosphoinositide-dependent protein kinase binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0035605	peptidyl-cysteine S-nitrosylase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0008554	sodium-exporting ATPase activity, phosphorylative mechanism	MF
1	1	3.3218233202	-	1.00e-01	GO:0004921	interleukin-11 receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0046817	chemokine receptor antagonist activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0050379	UDP-glucuronate 5'-epimerase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:1904599	advanced glycation end-product binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0031741	type B gastrin/cholecystokinin receptor binding	MF
1	1	3.3218233202	-	1.00e-01	GO:0098973	structural constituent of postsynaptic actin cytoskeleton	MF
1	1	3.3218233202	-	1.00e-01	GO:0015054	gastrin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0005030	neurotrophin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0038021	leptin receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047464	heparosan-N-sulfate-glucuronate 5-epimerase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0017082	mineralocorticoid receptor activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0030407	formimidoyltransferase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0030409	glutamate formimidoyltransferase activity	MF
1	1	3.3218233202	-	1.00e-01	GO:0047963	glycine N-choloyltransferase activity	MF
10	11	3.18431979645	-	9.72e-10	GO:0043560	insulin receptor substrate binding	MF
42	47	3.1595518913	-	3.65e-11	GO:0038083	peptidyl-tyrosine autophosphorylation	BP
8	9	3.15189831876	-	8.06e-08	GO:0010863	positive regulation of phospholipase C activity	BP
8	9	3.15189831876	-	8.06e-08	GO:0004716	signal transducer, downstream of receptor, with protein tyrosine kinase activity	MF
7	8	3.12917824226	-	7.21e-07	GO:0007172	signal complex assembly	BP
7	8	3.12917824226	-	7.21e-07	GO:0060396	growth hormone receptor signaling pathway	BP
11	13	3.0808152207	-	6.22e-10	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	BP
10	12	3.05878891437	-	5.31e-09	GO:0035635	entry of bacterium into host cell	BP
5	6	3.05878891437	-	5.47e-05	GO:0099565	chemical synaptic transmission, postsynaptic	BP
5	6	3.05878891437	-	5.47e-05	GO:0038202	TORC1 signaling	BP
5	6	3.05878891437	-	5.47e-05	GO:0033210	leptin-mediated signaling pathway	BP
5	6	3.05878891437	-	5.47e-05	GO:0010742	macrophage derived foam cell differentiation	BP
5	6	3.05878891437	-	5.47e-05	GO:0060440	trachea formation	BP
5	6	3.05878891437	-	5.47e-05	GO:0005168	neurotrophin TRKA receptor binding	MF
13	16	3.02226303834	-	8.23e-12	GO:0005159	insulin-like growth factor receptor binding	MF
4	5	2.99989522531	-	4.58e-04	GO:0019530	taurine metabolic process	BP
4	5	2.99989522531	-	4.58e-04	GO:0003161	cardiac conduction system development	BP
4	5	2.99989522531	-	4.58e-04	GO:0048639	positive regulation of developmental growth	BP
4	5	2.99989522531	-	4.58e-04	GO:0030284	estrogen receptor activity	MF
4	5	2.99989522531	-	4.58e-04	GO:0035004	phosphatidylinositol 3-kinase activity	MF
6	8	2.90678582092	-	6.34e-06	GO:0060020	Bergmann glial cell differentiation	BP
3	4	2.90678582092	-	9.98e-04	GO:0050855	regulation of B cell receptor signaling pathway	BP
3	4	2.90678582092	-	9.98e-04	GO:0070317	negative regulation of G0 to G1 transition	BP
3	4	2.90678582092	-	9.98e-04	GO:2000757	negative regulation of peptidyl-lysine acetylation	BP
3	4	2.90678582092	-	9.98e-04	GO:1904058	positive regulation of sensory perception of pain	BP
3	4	2.90678582092	-	3.69e-03	GO:0090400	stress-induced premature senescence	BP
3	4	2.90678582092	-	3.69e-03	GO:0071801	regulation of podosome assembly	BP
3	4	2.90678582092	-	3.69e-03	GO:0038110	interleukin-2-mediated signaling pathway	BP
3	4	2.90678582092	-	3.69e-03	GO:0097411	hypoxia-inducible factor-1alpha signaling pathway	BP
3	4	2.90678582092	-	3.69e-03	GO:0030578	PML body organization	BP
3	4	2.90678582092	-	3.69e-03	GO:0060665	regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling	BP
3	4	2.90678582092	-	3.69e-03	GO:1901203	positive regulation of extracellular matrix assembly	BP
3	4	2.90678582092	-	3.69e-03	GO:0014042	positive regulation of neuron maturation	BP
3	4	2.90678582092	-	3.69e-03	GO:0003186	tricuspid valve morphogenesis	BP
3	4	2.90678582092	-	3.69e-03	GO:0002328	pro-B cell differentiation	BP
3	4	2.90678582092	-	3.69e-03	GO:0038127	ERBB signaling pathway	BP
3	4	2.90678582092	-	3.69e-03	GO:0033136	serine phosphorylation of STAT3 protein	BP
3	4	2.90678582092	-	3.69e-03	GO:0007258	JUN phosphorylation	BP
3	4	2.90678582092	-	3.69e-03	GO:0051835	positive regulation of synapse structural plasticity	BP
3	4	2.90678582092	-	3.69e-03	GO:0090170	regulation of Golgi inheritance	BP
3	4	2.90678582092	-	3.69e-03	GO:1902916	positive regulation of protein polyubiquitination	BP
3	4	2.90678582092	-	3.69e-03	GO:0051048	negative regulation of secretion	BP
3	4	2.90678582092	-	3.69e-03	GO:0070294	renal sodium ion absorption	BP
3	4	2.90678582092	-	3.69e-03	GO:0046449	creatinine metabolic process	BP
3	4	2.90678582092	-	3.69e-03	GO:0035404	histone-serine phosphorylation	BP
3	4	2.90678582092	-	3.69e-03	GO:0010822	positive regulation of mitochondrion organization	BP
3	4	2.90678582092	-	3.69e-03	GO:0042490	mechanoreceptor differentiation	BP
3	4	2.90678582092	-	3.69e-03	GO:0033686	positive regulation of luteinizing hormone secretion	BP
3	4	2.90678582092	-	3.69e-03	GO:0006573	valine metabolic process	BP
3	4	2.90678582092	-	3.69e-03	GO:0038028	insulin receptor signaling pathway via phosphatidylinositol 3-kinase	BP
3	4	2.90678582092	-	3.69e-03	GO:0045619	regulation of lymphocyte differentiation	BP
3	4	2.90678582092	-	3.69e-03	GO:0032909	regulation of transforming growth factor beta2 production	BP
3	4	2.90678582092	-	9.98e-04	GO:0005176	ErbB-2 class receptor binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0048408	epidermal growth factor binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0070851	growth factor receptor binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0043121	neurotrophin binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0051425	PTB domain binding	MF
3	4	2.90678582092	-	3.69e-03	GO:0004698	calcium-dependent protein kinase C activity	MF
28	38	2.88125072882	-	1.33e-11	GO:0038128	ERBB2 signaling pathway	BP
5	7	2.83639649303	-	1.76e-04	GO:0050764	regulation of phagocytosis	BP
22	31	2.82705862845	-	1.06e-11	GO:0005158	insulin receptor binding	MF
7	10	2.80725014737	-	9.01e-06	GO:0043276	anoikis	BP
7	10	2.80725014737	-	9.01e-06	GO:0045295	gamma-catenin binding	MF
16	23	2.79826136414	-	1.15e-11	GO:0043548	phosphatidylinositol 3-kinase binding	MF
9	13	2.7913086035	-	4.81e-07	GO:2000573	positive regulation of DNA biosynthetic process	BP
9	13	2.7913086035	-	4.81e-07	GO:0001784	phosphotyrosine binding	MF
11	16	2.78125493884	-	2.62e-08	GO:0005001	transmembrane receptor protein tyrosine phosphatase activity	MF
20	30	2.73686081948	-	1.06e-11	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	BP
10	15	2.73686081948	-	1.82e-07	GO:0048011	neurotrophin TRK receptor signaling pathway	BP
6	9	2.73686081948	-	6.37e-05	GO:0051146	striated muscle cell differentiation	BP
6	9	2.73686081948	-	6.37e-05	GO:0048012	hepatocyte growth factor receptor signaling pathway	BP
4	6	2.73686081948	-	1.27e-03	GO:1900744	regulation of p38MAPK cascade	BP
4	6	2.73686081948	-	1.27e-03	GO:2000323	negative regulation of glucocorticoid receptor signaling pathway	BP
4	6	2.73686081948	-	1.27e-03	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	BP
4	6	2.73686081948	-	1.27e-03	GO:0007182	common-partner SMAD protein phosphorylation	BP
4	6	2.73686081948	-	1.27e-03	GO:0060789	hair follicle placode formation	BP
4	6	2.73686081948	-	1.27e-03	GO:0035020	regulation of Rac protein signal transduction	BP
4	6	2.73686081948	-	1.27e-03	GO:0042503	tyrosine phosphorylation of Stat3 protein	BP
2	3	2.73686081948	-	9.99e-03	GO:0001828	inner cell mass cellular morphogenesis	BP
2	3	2.73686081948	-	9.99e-03	GO:0002803	positive regulation of antibacterial peptide production	BP
2	3	2.73686081948	-	9.99e-03	GO:0010482	regulation of epidermal cell division	BP
2	3	2.73686081948	-	9.99e-03	GO:0060916	mesenchymal cell proliferation involved in lung development	BP
2	3	2.73686081948	-	9.99e-03	GO:0021847	ventricular zone neuroblast division	BP
2	3	2.73686081948	-	9.99e-03	GO:0002679	respiratory burst involved in defense response	BP
2	3	2.73686081948	-	9.99e-03	GO:0001547	antral ovarian follicle growth	BP
2	3	2.73686081948	-	9.99e-03	GO:0051668	localization within membrane	BP
2	3	2.73686081948	-	9.99e-03	GO:0060769	positive regulation of epithelial cell proliferation involved in prostate gland development	BP
2	3	2.73686081948	-	9.99e-03	GO:0023016	signal transduction by trans-phosphorylation	BP
2	3	2.73686081948	-	9.99e-03	GO:0060523	prostate epithelial cord elongation	BP
2	3	2.73686081948	-	2.80e-02	GO:0002553	histamine secretion by mast cell	BP
2	3	2.73686081948	-	2.80e-02	GO:0002513	tolerance induction to self antigen	BP
2	3	2.73686081948	-	2.80e-02	GO:0035793	positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:1904037	positive regulation of epithelial cell apoptotic process	BP
2	3	2.73686081948	-	2.80e-02	GO:0038091	positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:0071226	cellular response to molecule of fungal origin	BP
2	3	2.73686081948	-	2.80e-02	GO:0072277	metanephric glomerular capillary formation	BP
2	3	2.73686081948	-	2.80e-02	GO:1903432	regulation of TORC1 signaling	BP
2	3	2.73686081948	-	2.80e-02	GO:1905426	positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:0060453	regulation of gastric acid secretion	BP
2	3	2.73686081948	-	2.80e-02	GO:0033590	response to cobalamin	BP
2	3	2.73686081948	-	2.80e-02	GO:0030241	skeletal muscle myosin thick filament assembly	BP
2	3	2.73686081948	-	2.80e-02	GO:0070602	regulation of centromeric sister chromatid cohesion	BP
2	3	2.73686081948	-	2.80e-02	GO:0000320	re-entry into mitotic cell cycle	BP
2	3	2.73686081948	-	2.80e-02	GO:0048807	female genitalia morphogenesis	BP
2	3	2.73686081948	-	2.80e-02	GO:2000366	positive regulation of STAT protein import into nucleus	BP
2	3	2.73686081948	-	2.80e-02	GO:0010766	negative regulation of sodium ion transport	BP
2	3	2.73686081948	-	2.80e-02	GO:0097107	postsynaptic density assembly	BP
2	3	2.73686081948	-	2.80e-02	GO:0010725	regulation of primitive erythrocyte differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:0050803	regulation of synapse structure or activity	BP
2	3	2.73686081948	-	2.80e-02	GO:0050801	ion homeostasis	BP
2	3	2.73686081948	-	2.80e-02	GO:0007352	zygotic specification of dorsal/ventral axis	BP
2	3	2.73686081948	-	2.80e-02	GO:0002366	leukocyte activation involved in immune response	BP
2	3	2.73686081948	-	2.80e-02	GO:0050849	negative regulation of calcium-mediated signaling	BP
2	3	2.73686081948	-	2.80e-02	GO:0051712	positive regulation of killing of cells of other organism	BP
2	3	2.73686081948	-	2.80e-02	GO:0072300	positive regulation of metanephric glomerulus development	BP
2	3	2.73686081948	-	2.80e-02	GO:0090043	regulation of tubulin deacetylation	BP
2	3	2.73686081948	-	2.80e-02	GO:0038161	prolactin signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:0060374	mast cell differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:0051365	cellular response to potassium ion starvation	BP
2	3	2.73686081948	-	2.80e-02	GO:0042977	activation of JAK2 kinase activity	BP
2	3	2.73686081948	-	2.80e-02	GO:0090003	regulation of establishment of protein localization to plasma membrane	BP
2	3	2.73686081948	-	2.80e-02	GO:0098912	membrane depolarization during atrial cardiac muscle cell action potential	BP
2	3	2.73686081948	-	2.80e-02	GO:0060672	epithelial cell morphogenesis involved in placental branching	BP
2	3	2.73686081948	-	2.80e-02	GO:0003157	endocardium development	BP
2	3	2.73686081948	-	2.80e-02	GO:0070433	negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:0045217	cell-cell junction maintenance	BP
2	3	2.73686081948	-	2.80e-02	GO:0045218	zonula adherens maintenance	BP
2	3	2.73686081948	-	2.80e-02	GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
2	3	2.73686081948	-	2.80e-02	GO:0032613	interleukin-10 production	BP
2	3	2.73686081948	-	2.80e-02	GO:0060242	contact inhibition	BP
2	3	2.73686081948	-	2.80e-02	GO:0021747	cochlear nucleus development	BP
2	3	2.73686081948	-	2.80e-02	GO:0001922	B-1 B cell homeostasis	BP
2	3	2.73686081948	-	2.80e-02	GO:0042524	negative regulation of tyrosine phosphorylation of Stat5 protein	BP
2	3	2.73686081948	-	2.80e-02	GO:0090135	actin filament branching	BP
2	3	2.73686081948	-	2.80e-02	GO:0003190	atrioventricular valve formation	BP
2	3	2.73686081948	-	2.80e-02	GO:0000189	MAPK import into nucleus	BP
2	3	2.73686081948	-	2.80e-02	GO:0060368	regulation of Fc receptor mediated stimulatory signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:2000974	negative regulation of pro-B cell differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:0060437	lung growth	BP
2	3	2.73686081948	-	2.80e-02	GO:0003093	regulation of glomerular filtration	BP
2	3	2.73686081948	-	2.80e-02	GO:1902459	positive regulation of stem cell population maintenance	BP
2	3	2.73686081948	-	2.80e-02	GO:0033602	negative regulation of dopamine secretion	BP
2	3	2.73686081948	-	2.80e-02	GO:0050904	diapedesis	BP
2	3	2.73686081948	-	2.80e-02	GO:2000466	negative regulation of glycogen (starch) synthase activity	BP
2	3	2.73686081948	-	2.80e-02	GO:0003310	pancreatic A cell differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:0051097	negative regulation of helicase activity	BP
2	3	2.73686081948	-	2.80e-02	GO:2000058	regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
2	3	2.73686081948	-	2.80e-02	GO:1901097	negative regulation of autophagosome maturation	BP
2	3	2.73686081948	-	2.80e-02	GO:0090258	negative regulation of mitochondrial fission	BP
2	3	2.73686081948	-	2.80e-02	GO:0060399	positive regulation of growth hormone receptor signaling pathway	BP
2	3	2.73686081948	-	2.80e-02	GO:2000345	regulation of hepatocyte proliferation	BP
2	3	2.73686081948	-	2.80e-02	GO:1903527	positive regulation of membrane tubulation	BP
2	3	2.73686081948	-	2.80e-02	GO:2000111	positive regulation of macrophage apoptotic process	BP
2	3	2.73686081948	-	2.80e-02	GO:2001184	positive regulation of interleukin-12 secretion	BP
2	3	2.73686081948	-	2.80e-02	GO:2000630	positive regulation of miRNA metabolic process	BP
2	3	2.73686081948	-	2.80e-02	GO:0060480	lung goblet cell differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:0019065	receptor-mediated endocytosis of virus by host cell	BP
2	3	2.73686081948	-	2.80e-02	GO:0090272	negative regulation of fibroblast growth factor production	BP
2	3	2.73686081948	-	2.80e-02	GO:0018076	N-terminal peptidyl-lysine acetylation	BP
2	3	2.73686081948	-	2.80e-02	GO:0043009	chordate embryonic development	BP
2	3	2.73686081948	-	2.80e-02	GO:0032310	prostaglandin secretion	BP
2	3	2.73686081948	-	2.80e-02	GO:0002520	immune system development	BP
2	3	2.73686081948	-	2.80e-02	GO:2000687	negative regulation of rubidium ion transmembrane transporter activity	BP
2	3	2.73686081948	-	2.80e-02	GO:0045588	positive regulation of gamma-delta T cell differentiation	BP
2	3	2.73686081948	-	2.80e-02	GO:0002232	leukocyte chemotaxis involved in inflammatory response	BP
2	3	2.73686081948	-	2.80e-02	GO:1904640	response to methionine	BP
2	3	2.73686081948	-	2.80e-02	GO:0021769	orbitofrontal cortex development	BP
34	51	2.73686081948	-	2.21e-11	GO:0004715	non-membrane spanning protein tyrosine kinase activity	MF
8	12	2.73686081948	-	3.36e-06	GO:0000989	transcription factor activity, transcription factor binding	MF
4	6	2.73686081948	-	4.58e-04	GO:0046935	1-phosphatidylinositol-3-kinase regulator activity	MF
4	6	2.73686081948	-	1.27e-03	GO:0010997	anaphase-promoting complex binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0031752	D5 dopamine receptor binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0001156	TFIIIC-class transcription factor binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0004705	JUN kinase activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0032137	guanine/thymine mispair binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0022890	inorganic cation transmembrane transporter activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0005111	type 2 fibroblast growth factor receptor binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0055100	adiponectin binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0004911	interleukin-2 receptor activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0045159	myosin II binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0008384	IkappaB kinase activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0097472	cyclin-dependent protein kinase activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0019976	interleukin-2 binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0001030	RNA polymerase III type 1 promoter DNA binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0001031	RNA polymerase III type 2 promoter DNA binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0016314	phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0043120	tumor necrosis factor binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0043398	HLH domain binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0004924	oncostatin-M receptor activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0004699	calcium-independent protein kinase C activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0004711	ribosomal protein S6 kinase activity	MF
2	3	2.73686081948	-	2.80e-02	GO:0051022	Rho GDP-dissociation inhibitor binding	MF
2	3	2.73686081948	-	2.80e-02	GO:0031692	alpha-1B adrenergic receptor binding	MF
20	31	2.6895551047	-	5.21e-11	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	BP
9	14	2.68439339959	-	1.62e-07	GO:1901185	negative regulation of ERBB signaling pathway	BP
9	14	2.68439339959	-	1.23e-06	GO:0031996	thioesterase binding	MF
7	11	2.66974662362	-	2.26e-05	GO:0004707	MAP kinase activity	MF
7	11	2.66974662362	-	2.26e-05	GO:0070411	I-SMAD binding	MF
19	30	2.66286023804	-	1.06e-11	GO:0004714	transmembrane receptor protein tyrosine kinase activity	MF
5	8	2.64375141509	-	1.76e-04	GO:0007183	SMAD protein complex assembly	BP
5	8	2.64375141509	-	4.29e-04	GO:0070102	interleukin-6-mediated signaling pathway	BP
5	8	2.64375141509	-	4.29e-04	GO:0006975	DNA damage induced protein phosphorylation	BP
5	8	2.64375141509	-	4.29e-04	GO:2000587	negative regulation of platelet-derived growth factor receptor-beta signaling pathway	BP
34	55	2.62792644793	-	2.22e-11	GO:0007173	epidermal growth factor receptor signaling pathway	BP
8	13	2.62138360206	-	1.23e-06	GO:0046628	positive regulation of insulin receptor signaling pathway	BP
8	13	2.62138360206	-	7.97e-06	GO:0042176	regulation of protein catabolic process	BP
35	57	2.61821632298	-	5.99e-11	GO:0005070	SH3/SH2 adaptor activity	MF
14	23	2.6056162862	-	1.39e-09	GO:0071889	14-3-3 protein binding	MF
9	15	2.58485772603	-	1.23e-06	GO:0060397	JAK-STAT cascade involved in growth hormone signaling pathway	BP
9	15	2.58485772603	-	2.79e-06	GO:0046328	regulation of JNK cascade	BP
3	5	2.58485772603	-	3.69e-03	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	BP
3	5	2.58485772603	-	3.69e-03	GO:0060956	endocardial cell differentiation	BP
3	5	2.58485772603	-	3.69e-03	GO:2001028	positive regulation of endothelial cell chemotaxis	BP
3	5	2.58485772603	-	3.69e-03	GO:0060019	radial glial cell differentiation	BP
3	5	2.58485772603	-	8.55e-03	GO:0002551	mast cell chemotaxis	BP
3	5	2.58485772603	-	8.55e-03	GO:0046825	regulation of protein export from nucleus	BP
3	5	2.58485772603	-	8.55e-03	GO:0034134	toll-like receptor 2 signaling pathway	BP
3	5	2.58485772603	-	8.55e-03	GO:0050882	voluntary musculoskeletal movement	BP
3	5	2.58485772603	-	8.55e-03	GO:0010715	regulation of extracellular matrix disassembly	BP
3	5	2.58485772603	-	8.55e-03	GO:1990441	negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
3	5	2.58485772603	-	8.55e-03	GO:0046578	regulation of Ras protein signal transduction	BP
3	5	2.58485772603	-	8.55e-03	GO:1903898	negative regulation of PERK-mediated unfolded protein response	BP
3	5	2.58485772603	-	8.55e-03	GO:0048143	astrocyte activation	BP
3	5	2.58485772603	-	8.55e-03	GO:0040020	regulation of meiotic nuclear division	BP
3	5	2.58485772603	-	8.55e-03	GO:0006896	Golgi to vacuole transport	BP
3	5	2.58485772603	-	8.55e-03	GO:0016202	regulation of striated muscle tissue development	BP
3	5	2.58485772603	-	8.55e-03	GO:0055062	phosphate ion homeostasis	BP
3	5	2.58485772603	-	8.55e-03	GO:0072584	caveolin-mediated endocytosis	BP
3	5	2.58485772603	-	8.55e-03	GO:0010543	regulation of platelet activation	BP
3	5	2.58485772603	-	8.55e-03	GO:0038033	positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	BP
3	5	2.58485772603	-	8.55e-03	GO:0090330	regulation of platelet aggregation	BP
3	5	2.58485772603	-	8.55e-03	GO:0090335	regulation of brown fat cell differentiation	BP
3	5	2.58485772603	-	8.55e-03	GO:0006924	activation-induced cell death of T cells	BP
3	5	2.58485772603	-	8.55e-03	GO:0090188	negative regulation of pancreatic juice secretion	BP
3	5	2.58485772603	-	8.55e-03	GO:0051343	positive regulation of cyclic-nucleotide phosphodiesterase activity	BP
15	25	2.58485772603	-	1.15e-09	GO:0046875	ephrin receptor binding	MF
3	5	2.58485772603	-	3.69e-03	GO:0005007	fibroblast growth factor-activated receptor activity	MF
3	5	2.58485772603	-	8.55e-03	GO:0051373	FATZ binding	MF
3	5	2.58485772603	-	8.55e-03	GO:0035174	histone serine kinase activity	MF
3	5	2.58485772603	-	8.55e-03	GO:0042609	CD4 receptor binding	MF
3	5	2.58485772603	-	8.55e-03	GO:0030911	TPR domain binding	MF
3	5	2.58485772603	-	8.55e-03	GO:0030618	transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity	MF
3	5	2.58485772603	-	8.55e-03	GO:0005131	growth hormone receptor binding	MF
3	5	2.58485772603	-	8.55e-03	GO:0043426	MRF binding	MF
3	5	2.58485772603	-	8.55e-03	GO:0032407	MutSalpha complex binding	MF
3	5	2.58485772603	-	8.55e-03	GO:0035254	glutamate receptor binding	MF
53	89	2.5740103438	-	3.55e-11	GO:0007169	transmembrane receptor protein tyrosine kinase signaling pathway	BP
16	27	2.56693581804	-	1.85e-10	GO:0048008	platelet-derived growth factor receptor signaling pathway	BP
39	66	2.5628314197	-	8.54e-11	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	MF
17	29	2.55130516632	-	6.70e-11	GO:0046627	negative regulation of insulin receptor signaling pathway	BP
7	12	2.54421574154	-	4.96e-05	GO:1904668	positive regulation of ubiquitin protein ligase activity	BP
7	12	2.54421574154	-	4.96e-05	GO:0060444	branching involved in mammary gland duct morphogenesis	BP
7	12	2.54421574154	-	2.26e-05	GO:0050321	tau-protein kinase activity	MF
11	19	2.53332742539	-	3.41e-07	GO:0004709	MAP kinase kinase kinase activity	MF
8	14	2.51446839814	-	1.70e-05	GO:0048009	insulin-like growth factor receptor signaling pathway	BP
4	7	2.51446839814	-	1.27e-03	GO:0071455	cellular response to hyperoxia	BP
4	7	2.51446839814	-	1.27e-03	GO:2000650	negative regulation of sodium ion transmembrane transporter activity	BP
4	7	2.51446839814	-	1.27e-03	GO:1901017	negative regulation of potassium ion transmembrane transporter activity	BP
4	7	2.51446839814	-	1.27e-03	GO:0061298	retina vasculature development in camera-type eye	BP
4	7	2.51446839814	-	1.27e-03	GO:0060449	bud elongation involved in lung branching	BP
4	7	2.51446839814	-	1.27e-03	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	BP
4	7	2.51446839814	-	2.72e-03	GO:2000641	regulation of early endosome to late endosome transport	BP
4	7	2.51446839814	-	2.72e-03	GO:0042921	glucocorticoid receptor signaling pathway	BP
4	7	2.51446839814	-	2.72e-03	GO:0034141	positive regulation of toll-like receptor 3 signaling pathway	BP
4	7	2.51446839814	-	2.72e-03	GO:0034351	negative regulation of glial cell apoptotic process	BP
4	7	2.51446839814	-	2.72e-03	GO:2000210	positive regulation of anoikis	BP
4	7	2.51446839814	-	2.72e-03	GO:0030239	myofibril assembly	BP
4	7	2.51446839814	-	2.72e-03	GO:0044321	response to leptin	BP
4	7	2.51446839814	-	2.72e-03	GO:0031659	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
8	14	2.51446839814	-	1.70e-05	GO:0031434	mitogen-activated protein kinase kinase binding	MF
4	7	2.51446839814	-	1.27e-03	GO:0035005	1-phosphatidylinositol-4-phosphate 3-kinase activity	MF
4	7	2.51446839814	-	2.72e-03	GO:0005021	vascular endothelial growth factor-activated receptor activity	MF
9	16	2.49174832164	-	2.79e-06	GO:0031435	mitogen-activated protein kinase kinase kinase binding	MF
14	25	2.48532205248	-	1.39e-09	GO:0045840	positive regulation of mitotic nuclear division	BP
10	18	2.47382641365	-	9.76e-07	GO:0046579	positive regulation of Ras protein signal transduction	BP
5	9	2.47382641365	-	4.29e-04	GO:0010469	regulation of receptor activity	BP
5	9	2.47382641365	-	4.29e-04	GO:0032835	glomerulus development	BP
5	9	2.47382641365	-	8.86e-04	GO:0042304	regulation of fatty acid biosynthetic process	BP
5	9	2.47382641365	-	8.86e-04	GO:0036312	phosphatidylinositol 3-kinase regulatory subunit binding	MF
16	29	2.46384232507	-	1.77e-09	GO:1900740	positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	BP
11	20	2.45932684395	-	6.89e-07	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
11	20	2.45932684395	-	6.89e-07	GO:1901216	positive regulation of neuron death	BP
11	20	2.45932684395	-	1.58e-07	GO:0043539	protein serine/threonine kinase activator activity	MF
35	64	2.45110633715	-	1.93e-11	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	BP
6	11	2.44735420229	-	2.93e-04	GO:0033628	regulation of cell adhesion mediated by integrin	BP
6	11	2.44735420229	-	2.93e-04	GO:0007175	negative regulation of epidermal growth factor-activated receptor activity	BP
6	11	2.44735420229	-	1.46e-04	GO:0005068	transmembrane receptor protein tyrosine kinase adaptor activity	MF
7	13	2.42873852412	-	9.82e-05	GO:0097284	hepatocyte apoptotic process	BP
44	82	2.42370293422	-	2.72e-11	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	BP
23	43	2.41912052156	-	5.04e-11	GO:0016303	1-phosphatidylinositol-3-kinase activity	MF
8	15	2.41493272459	-	3.31e-05	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BP
8	15	2.41493272459	-	3.31e-05	GO:0031929	TOR signaling	BP
8	15	2.41493272459	-	3.31e-05	GO:0004697	protein kinase C activity	MF
9	17	2.40428548039	-	5.81e-06	GO:0043536	positive regulation of blood vessel endothelial cell migration	BP
10	19	2.39582390164	-	9.76e-07	GO:0042246	tissue regeneration	BP
10	19	2.39582390164	-	2.00e-06	GO:0043153	entrainment of circadian clock by photoperiod	BP
10	19	2.39582390164	-	3.84e-06	GO:0070064	proline-rich region binding	MF
58	111	2.38538844898	-	5.58e-11	GO:0048015	phosphatidylinositol-mediated signaling	BP
36	69	2.38322386487	-	6.13e-11	GO:0007265	Ras protein signal transduction	BP
32	63	2.3445433967	-	4.76e-11	GO:0019903	protein phosphatase binding	MF
36	71	2.34200120214	-	3.35e-11	GO:0048010	vascular endothelial growth factor receptor signaling pathway	BP
61	121	2.33369742049	-	3.79e-11	GO:0004713	protein tyrosine kinase activity	MF
13	26	2.3218233202	-	2.83e-07	GO:0045931	positive regulation of mitotic cell cycle	BP
7	14	2.3218233202	-	1.79e-04	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	BP
7	14	2.3218233202	-	1.79e-04	GO:0032516	positive regulation of phosphoprotein phosphatase activity	BP
7	14	2.3218233202	-	1.79e-04	GO:0032006	regulation of TOR signaling	BP
4	8	2.3218233202	-	4.58e-04	GO:0048512	circadian behavior	BP
6	12	2.3218233202	-	5.37e-04	GO:0007252	I-kappaB phosphorylation	BP
5	10	2.3218233202	-	8.86e-04	GO:0033673	negative regulation of kinase activity	BP
5	10	2.3218233202	-	8.86e-04	GO:0060044	negative regulation of cardiac muscle cell proliferation	BP
5	10	2.3218233202	-	8.86e-04	GO:0045792	negative regulation of cell size	BP
5	10	2.3218233202	-	1.63e-03	GO:1903827	regulation of cellular protein localization	BP
5	10	2.3218233202	-	1.63e-03	GO:0031571	mitotic G1 DNA damage checkpoint	BP
5	10	2.3218233202	-	1.63e-03	GO:0016064	immunoglobulin mediated immune response	BP
4	8	2.3218233202	-	2.72e-03	GO:0035265	organ growth	BP
4	8	2.3218233202	-	2.72e-03	GO:0045410	positive regulation of interleukin-6 biosynthetic process	BP
4	8	2.3218233202	-	2.72e-03	GO:0034393	positive regulation of smooth muscle cell apoptotic process	BP
4	8	2.3218233202	-	2.72e-03	GO:0005979	regulation of glycogen biosynthetic process	BP
4	8	2.3218233202	-	2.72e-03	GO:1901380	negative regulation of potassium ion transmembrane transport	BP
4	8	2.3218233202	-	2.72e-03	GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction	BP
4	8	2.3218233202	-	2.72e-03	GO:0035357	peroxisome proliferator activated receptor signaling pathway	BP
4	8	2.3218233202	-	2.72e-03	GO:0010954	positive regulation of protein processing	BP
3	6	2.3218233202	-	3.69e-03	GO:0009913	epidermal cell differentiation	BP
4	8	2.3218233202	-	5.01e-03	GO:0070723	response to cholesterol	BP
4	8	2.3218233202	-	5.01e-03	GO:0071550	death-inducing signaling complex assembly	BP
4	8	2.3218233202	-	5.01e-03	GO:0033598	mammary gland epithelial cell proliferation	BP
4	8	2.3218233202	-	5.01e-03	GO:0010888	negative regulation of lipid storage	BP
4	8	2.3218233202	-	5.01e-03	GO:0048762	mesenchymal cell differentiation	BP
4	8	2.3218233202	-	5.01e-03	GO:0010544	negative regulation of platelet activation	BP
4	8	2.3218233202	-	5.01e-03	GO:0043497	regulation of protein heterodimerization activity	BP
3	6	2.3218233202	-	8.55e-03	GO:0002318	myeloid progenitor cell differentiation	BP
3	6	2.3218233202	-	8.55e-03	GO:0010594	regulation of endothelial cell migration	BP
2	4	2.3218233202	-	9.99e-03	GO:0072672	neutrophil extravasation	BP
2	4	2.3218233202	-	9.99e-03	GO:0090403	oxidative stress-induced premature senescence	BP
3	6	2.3218233202	-	1.58e-02	GO:0051271	negative regulation of cellular component movement	BP
3	6	2.3218233202	-	1.58e-02	GO:0031584	activation of phospholipase D activity	BP
3	6	2.3218233202	-	1.58e-02	GO:0051101	regulation of DNA binding	BP
3	6	2.3218233202	-	1.58e-02	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	BP
3	6	2.3218233202	-	1.58e-02	GO:2000171	negative regulation of dendrite development	BP
3	6	2.3218233202	-	1.58e-02	GO:0072307	regulation of metanephric nephron tubule epithelial cell differentiation	BP
3	6	2.3218233202	-	1.58e-02	GO:0051902	negative regulation of mitochondrial depolarization	BP
3	6	2.3218233202	-	1.58e-02	GO:0032025	response to cobalt ion	BP
3	6	2.3218233202	-	1.58e-02	GO:0006101	citrate metabolic process	BP
3	6	2.3218233202	-	1.58e-02	GO:0003158	endothelium development	BP
3	6	2.3218233202	-	1.58e-02	GO:1901016	regulation of potassium ion transmembrane transporter activity	BP
3	6	2.3218233202	-	1.58e-02	GO:0046881	positive regulation of follicle-stimulating hormone secretion	BP
3	6	2.3218233202	-	1.58e-02	GO:0060762	regulation of branching involved in mammary gland duct morphogenesis	BP
3	6	2.3218233202	-	1.58e-02	GO:0051152	positive regulation of smooth muscle cell differentiation	BP
3	6	2.3218233202	-	1.58e-02	GO:0045084	positive regulation of interleukin-12 biosynthetic process	BP
3	6	2.3218233202	-	1.58e-02	GO:0097527	necroptotic signaling pathway	BP
3	6	2.3218233202	-	1.58e-02	GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	BP
2	4	2.3218233202	-	2.80e-02	GO:0045918	negative regulation of cytolysis	BP
2	4	2.3218233202	-	2.80e-02	GO:0048368	lateral mesoderm development	BP
2	4	2.3218233202	-	2.80e-02	GO:0048608	reproductive structure development	BP
2	4	2.3218233202	-	2.80e-02	GO:1902806	regulation of cell cycle G1/S phase transition	BP
2	4	2.3218233202	-	2.80e-02	GO:0003338	metanephros morphogenesis	BP
2	4	2.3218233202	-	2.80e-02	GO:0060742	epithelial cell differentiation involved in prostate gland development	BP
2	4	2.3218233202	-	2.80e-02	GO:0048808	male genitalia morphogenesis	BP
2	4	2.3218233202	-	2.80e-02	GO:0031113	regulation of microtubule polymerization	BP
2	4	2.3218233202	-	2.80e-02	GO:0070857	regulation of bile acid biosynthetic process	BP
2	4	2.3218233202	-	2.80e-02	GO:0072606	interleukin-8 secretion	BP
2	4	2.3218233202	-	2.80e-02	GO:0044331	cell-cell adhesion mediated by cadherin	BP
2	4	2.3218233202	-	2.80e-02	GO:2000048	negative regulation of cell-cell adhesion mediated by cadherin	BP
2	4	2.3218233202	-	2.80e-02	GO:1900127	positive regulation of hyaluronan biosynthetic process	BP
2	4	2.3218233202	-	2.80e-02	GO:0044245	polysaccharide digestion	BP
2	4	2.3218233202	-	2.80e-02	GO:0045759	negative regulation of action potential	BP
2	4	2.3218233202	-	2.80e-02	GO:0060043	regulation of cardiac muscle cell proliferation	BP
2	4	2.3218233202	-	2.80e-02	GO:0060571	morphogenesis of an epithelial fold	BP
2	4	2.3218233202	-	2.80e-02	GO:0002768	immune response-regulating cell surface receptor signaling pathway	BP
2	4	2.3218233202	-	2.80e-02	GO:0051055	negative regulation of lipid biosynthetic process	BP
2	4	2.3218233202	-	2.80e-02	GO:0016321	female meiosis chromosome segregation	BP
2	4	2.3218233202	-	5.23e-02	GO:0030835	negative regulation of actin filament depolymerization	BP
2	4	2.3218233202	-	5.23e-02	GO:0043201	response to leucine	BP
2	4	2.3218233202	-	5.23e-02	GO:0035799	ureter maturation	BP
2	4	2.3218233202	-	5.23e-02	GO:0035655	interleukin-18-mediated signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:0070445	regulation of oligodendrocyte progenitor proliferation	BP
2	4	2.3218233202	-	5.23e-02	GO:0051106	positive regulation of DNA ligation	BP
2	4	2.3218233202	-	5.23e-02	GO:0007091	metaphase/anaphase transition of mitotic cell cycle	BP
2	4	2.3218233202	-	5.23e-02	GO:0008356	asymmetric cell division	BP
2	4	2.3218233202	-	5.23e-02	GO:0010883	regulation of lipid storage	BP
2	4	2.3218233202	-	5.23e-02	GO:2000481	positive regulation of cAMP-dependent protein kinase activity	BP
2	4	2.3218233202	-	5.23e-02	GO:0032079	positive regulation of endodeoxyribonuclease activity	BP
2	4	2.3218233202	-	5.23e-02	GO:0097300	programmed necrotic cell death	BP
2	4	2.3218233202	-	5.23e-02	GO:0002248	connective tissue replacement involved in inflammatory response wound healing	BP
2	4	2.3218233202	-	5.23e-02	GO:0060513	prostatic bud formation	BP
2	4	2.3218233202	-	5.23e-02	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:0002326	B cell lineage commitment	BP
2	4	2.3218233202	-	5.23e-02	GO:0060336	negative regulation of interferon-gamma-mediated signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:0035089	establishment of apical/basal cell polarity	BP
2	4	2.3218233202	-	5.23e-02	GO:0050847	progesterone receptor signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:0038165	oncostatin-M-mediated signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:1903753	negative regulation of p38MAPK cascade	BP
2	4	2.3218233202	-	5.23e-02	GO:0003104	positive regulation of glomerular filtration	BP
2	4	2.3218233202	-	5.23e-02	GO:1905323	telomerase holoenzyme complex assembly	BP
2	4	2.3218233202	-	5.23e-02	GO:1903899	positive regulation of PERK-mediated unfolded protein response	BP
2	4	2.3218233202	-	5.23e-02	GO:2000491	positive regulation of hepatic stellate cell activation	BP
2	4	2.3218233202	-	5.23e-02	GO:0051450	myoblast proliferation	BP
2	4	2.3218233202	-	5.23e-02	GO:0030035	microspike assembly	BP
2	4	2.3218233202	-	5.23e-02	GO:0043570	maintenance of DNA repeat elements	BP
2	4	2.3218233202	-	5.23e-02	GO:1990182	exosomal secretion	BP
2	4	2.3218233202	-	5.23e-02	GO:0051599	response to hydrostatic pressure	BP
2	4	2.3218233202	-	5.23e-02	GO:0030950	establishment or maintenance of actin cytoskeleton polarity	BP
2	4	2.3218233202	-	5.23e-02	GO:1902108	regulation of mitochondrial membrane permeability involved in apoptotic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0048679	regulation of axon regeneration	BP
2	4	2.3218233202	-	5.23e-02	GO:0051660	establishment of centrosome localization	BP
2	4	2.3218233202	-	5.23e-02	GO:0061419	positive regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
2	4	2.3218233202	-	5.23e-02	GO:0070885	negative regulation of calcineurin-NFAT signaling cascade	BP
2	4	2.3218233202	-	5.23e-02	GO:0006344	maintenance of chromatin silencing	BP
2	4	2.3218233202	-	5.23e-02	GO:2001200	positive regulation of dendritic cell differentiation	BP
2	4	2.3218233202	-	5.23e-02	GO:0090240	positive regulation of histone H4 acetylation	BP
2	4	2.3218233202	-	5.23e-02	GO:0007260	tyrosine phosphorylation of STAT protein	BP
2	4	2.3218233202	-	5.23e-02	GO:0005981	regulation of glycogen catabolic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0006534	cysteine metabolic process	BP
2	4	2.3218233202	-	5.23e-02	GO:1990834	response to odorant	BP
2	4	2.3218233202	-	5.23e-02	GO:0002051	osteoblast fate commitment	BP
2	4	2.3218233202	-	5.23e-02	GO:0031999	negative regulation of fatty acid beta-oxidation	BP
2	4	2.3218233202	-	5.23e-02	GO:0071947	protein deubiquitination involved in ubiquitin-dependent protein catabolic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0060574	intestinal epithelial cell maturation	BP
2	4	2.3218233202	-	5.23e-02	GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation	BP
2	4	2.3218233202	-	5.23e-02	GO:0010748	negative regulation of plasma membrane long-chain fatty acid transport	BP
2	4	2.3218233202	-	5.23e-02	GO:2000110	negative regulation of macrophage apoptotic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0097167	circadian regulation of translation	BP
2	4	2.3218233202	-	5.23e-02	GO:0050798	activated T cell proliferation	BP
2	4	2.3218233202	-	5.23e-02	GO:0033133	positive regulation of glucokinase activity	BP
2	4	2.3218233202	-	5.23e-02	GO:0048549	positive regulation of pinocytosis	BP
2	4	2.3218233202	-	5.23e-02	GO:0046886	positive regulation of hormone biosynthetic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0032095	regulation of response to food	BP
2	4	2.3218233202	-	5.23e-02	GO:0034123	positive regulation of toll-like receptor signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:0002159	desmosome assembly	BP
2	4	2.3218233202	-	5.23e-02	GO:2001236	regulation of extrinsic apoptotic signaling pathway	BP
2	4	2.3218233202	-	5.23e-02	GO:0045906	negative regulation of vasoconstriction	BP
2	4	2.3218233202	-	5.23e-02	GO:0033158	regulation of protein import into nucleus, translocation	BP
2	4	2.3218233202	-	5.23e-02	GO:0021861	forebrain radial glial cell differentiation	BP
2	4	2.3218233202	-	5.23e-02	GO:1901985	positive regulation of protein acetylation	BP
2	4	2.3218233202	-	5.23e-02	GO:0030050	vesicle transport along actin filament	BP
2	4	2.3218233202	-	5.23e-02	GO:0070849	response to epidermal growth factor	BP
2	4	2.3218233202	-	5.23e-02	GO:0048633	positive regulation of skeletal muscle tissue growth	BP
2	4	2.3218233202	-	5.23e-02	GO:0045716	positive regulation of low-density lipoprotein particle receptor biosynthetic process	BP
2	4	2.3218233202	-	5.23e-02	GO:0060442	branching involved in prostate gland morphogenesis	BP
2	4	2.3218233202	-	5.23e-02	GO:0051572	negative regulation of histone H3-K4 methylation	BP
2	4	2.3218233202	-	5.23e-02	GO:0051385	response to mineralocorticoid	BP
2	4	2.3218233202	-	5.23e-02	GO:0097350	neutrophil clearance	BP
2	4	2.3218233202	-	5.23e-02	GO:0042506	tyrosine phosphorylation of Stat5 protein	BP
2	4	2.3218233202	-	5.23e-02	GO:0021955	central nervous system neuron axonogenesis	BP
2	4	2.3218233202	-	5.23e-02	GO:0060528	secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development	BP
1	2	2.3218233202	-	1.00e-01	GO:0072079	nephron tubule formation	BP
1	2	2.3218233202	-	1.00e-01	GO:0070564	positive regulation of vitamin D receptor signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:0046031	ADP metabolic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0042226	interleukin-6 biosynthetic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0002072	optic cup morphogenesis involved in camera-type eye development	BP
1	2	2.3218233202	-	1.00e-01	GO:0097553	calcium ion transmembrane import into cytosol	BP
1	2	2.3218233202	-	1.00e-01	GO:0045720	negative regulation of integrin biosynthetic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0044381	glucose import in response to insulin stimulus	BP
1	2	2.3218233202	-	1.00e-01	GO:0033594	response to hydroxyisoflavone	BP
1	2	2.3218233202	-	1.00e-01	GO:1901857	positive regulation of cellular respiration	BP
1	2	2.3218233202	-	1.00e-01	GO:0015888	thiamine transport	BP
1	2	2.3218233202	-	1.00e-01	GO:0045922	negative regulation of fatty acid metabolic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0021842	chemorepulsion involved in interneuron migration from the subpallium to the cortex	BP
1	2	2.3218233202	-	1.00e-01	GO:0070106	interleukin-27-mediated signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:0009072	aromatic amino acid family metabolic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0060460	left lung morphogenesis	BP
1	2	2.3218233202	-	1.00e-01	GO:0097035	regulation of membrane lipid distribution	BP
1	2	2.3218233202	-	1.00e-01	GO:0009103	lipopolysaccharide biosynthetic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0021831	embryonic olfactory bulb interneuron precursor migration	BP
1	2	2.3218233202	-	1.00e-01	GO:0010730	negative regulation of hydrogen peroxide biosynthetic process	BP
1	2	2.3218233202	-	1.00e-01	GO:2001204	regulation of osteoclast development	BP
1	2	2.3218233202	-	1.00e-01	GO:1903263	positive regulation of serine phosphorylation of STAT3 protein	BP
1	2	2.3218233202	-	1.00e-01	GO:0002684	positive regulation of immune system process	BP
1	2	2.3218233202	-	1.00e-01	GO:0060369	positive regulation of Fc receptor mediated stimulatory signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:0045976	negative regulation of mitotic cell cycle, embryonic	BP
1	2	2.3218233202	-	1.00e-01	GO:0021623	oculomotor nerve formation	BP
1	2	2.3218233202	-	1.00e-01	GO:1901979	regulation of inward rectifier potassium channel activity	BP
1	2	2.3218233202	-	1.00e-01	GO:0003050	regulation of systemic arterial blood pressure by atrial natriuretic peptide	BP
1	2	2.3218233202	-	1.00e-01	GO:0030222	eosinophil differentiation	BP
1	2	2.3218233202	-	1.00e-01	GO:0002228	natural killer cell mediated immunity	BP
1	2	2.3218233202	-	1.00e-01	GO:0032528	microvillus organization	BP
1	2	2.3218233202	-	1.00e-01	GO:0014835	myoblast differentiation involved in skeletal muscle regeneration	BP
1	2	2.3218233202	-	1.00e-01	GO:0072166	posterior mesonephric tubule development	BP
1	2	2.3218233202	-	1.00e-01	GO:1905408	negative regulation of creatine transmembrane transporter activity	BP
1	2	2.3218233202	-	1.00e-01	GO:0035358	regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:0021551	central nervous system morphogenesis	BP
1	2	2.3218233202	-	1.00e-01	GO:0002720	positive regulation of cytokine production involved in immune response	BP
1	2	2.3218233202	-	1.00e-01	GO:0051053	negative regulation of DNA metabolic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0034165	positive regulation of toll-like receptor 9 signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:1903053	regulation of extracellular matrix organization	BP
1	2	2.3218233202	-	1.00e-01	GO:0042595	behavioral response to starvation	BP
1	2	2.3218233202	-	1.00e-01	GO:0090276	regulation of peptide hormone secretion	BP
1	2	2.3218233202	-	1.00e-01	GO:1902613	negative regulation of anti-Mullerian hormone signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:0008207	C21-steroid hormone metabolic process	BP
1	2	2.3218233202	-	1.00e-01	GO:0002879	positive regulation of acute inflammatory response to non-antigenic stimulus	BP
1	2	2.3218233202	-	1.00e-01	GO:0090657	telomeric loop disassembly	BP
1	2	2.3218233202	-	1.00e-01	GO:1900224	positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
1	2	2.3218233202	-	1.00e-01	GO:0010623	programmed cell death involved in cell development	BP
1	2	2.3218233202	-	1.00e-01	GO:0071393	cellular response to progesterone stimulus	BP
1	2	2.3218233202	-	1.00e-01	GO:1903445	protein transport from ciliary membrane to plasma membrane	BP
1	2	2.3218233202	-	1.00e-01	GO:0035063	nuclear speck organization	BP
1	2	2.3218233202	-	1.00e-01	GO:0010455	positive regulation of cell fate commitment	BP
1	2	2.3218233202	-	1.00e-01	GO:0051386	regulation of neurotrophin TRK receptor signaling pathway	BP
1	2	2.3218233202	-	1.00e-01	GO:0097681	double-strand break repair via alternative nonhomologous end joining	BP
1	2	2.3218233202	-	1.00e-01	GO:0003241	growth involved in heart morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0031204	posttranslational protein targeting to membrane, translocation	BP
1	2	2.3218233202	-	1.90e-01	GO:1904528	positive regulation of microtubule binding	BP
1	2	2.3218233202	-	1.90e-01	GO:0032431	activation of phospholipase A2 activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0045659	negative regulation of neutrophil differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0045655	regulation of monocyte differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0071109	superior temporal gyrus development	BP
1	2	2.3218233202	-	1.90e-01	GO:0097156	fasciculation of motor neuron axon	BP
1	2	2.3218233202	-	1.90e-01	GO:1904956	regulation of midbrain dopaminergic neuron differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0002924	negative regulation of humoral immune response mediated by circulating immunoglobulin	BP
1	2	2.3218233202	-	1.90e-01	GO:1903044	protein localization to membrane raft	BP
1	2	2.3218233202	-	1.90e-01	GO:0003207	cardiac chamber formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0032675	regulation of interleukin-6 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0061325	cell proliferation involved in outflow tract morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0017055	negative regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:1990414	replication-born double-strand break repair via sister chromatid exchange	BP
1	2	2.3218233202	-	1.90e-01	GO:0002378	immunoglobulin biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0001776	leukocyte homeostasis	BP
1	2	2.3218233202	-	1.90e-01	GO:0071140	resolution of mitotic recombination intermediates	BP
1	2	2.3218233202	-	1.90e-01	GO:0046636	negative regulation of alpha-beta T cell activation	BP
1	2	2.3218233202	-	1.90e-01	GO:1904527	negative regulation of microtubule binding	BP
1	2	2.3218233202	-	1.90e-01	GO:0038111	interleukin-7-mediated signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0086053	AV node cell to bundle of His cell communication by electrical coupling	BP
1	2	2.3218233202	-	1.90e-01	GO:0090260	negative regulation of retinal ganglion cell axon guidance	BP
1	2	2.3218233202	-	1.90e-01	GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0021855	hypothalamus cell migration	BP
1	2	2.3218233202	-	1.90e-01	GO:0097252	oligodendrocyte apoptotic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0072182	regulation of nephron tubule epithelial cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:2000724	positive regulation of cardiac vascular smooth muscle cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:1900454	positive regulation of long term synaptic depression	BP
1	2	2.3218233202	-	1.90e-01	GO:1900451	positive regulation of glutamate receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0046543	development of secondary female sexual characteristics	BP
1	2	2.3218233202	-	1.90e-01	GO:0048320	axial mesoderm formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0060341	regulation of cellular localization	BP
1	2	2.3218233202	-	1.90e-01	GO:0006525	arginine metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0098905	regulation of bundle of His cell action potential	BP
1	2	2.3218233202	-	1.90e-01	GO:0016198	axon choice point recognition	BP
1	2	2.3218233202	-	1.90e-01	GO:1901205	negative regulation of adrenergic receptor signaling pathway involved in heart process	BP
1	2	2.3218233202	-	1.90e-01	GO:1901201	regulation of extracellular matrix assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0046732	active induction of host immune response by virus	BP
1	2	2.3218233202	-	1.90e-01	GO:0036269	swimming behavior	BP
1	2	2.3218233202	-	1.90e-01	GO:0042732	D-xylose metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0014916	regulation of lung blood pressure	BP
1	2	2.3218233202	-	1.90e-01	GO:0071417	cellular response to organonitrogen compound	BP
1	2	2.3218233202	-	1.90e-01	GO:0040013	negative regulation of locomotion	BP
1	2	2.3218233202	-	1.90e-01	GO:0043335	protein unfolding	BP
1	2	2.3218233202	-	1.90e-01	GO:1905664	regulation of calcium ion import across plasma membrane	BP
1	2	2.3218233202	-	1.90e-01	GO:0010611	regulation of cardiac muscle hypertrophy	BP
1	2	2.3218233202	-	1.90e-01	GO:0021681	cerebellar granular layer development	BP
1	2	2.3218233202	-	1.90e-01	GO:0060599	lateral sprouting involved in mammary gland duct morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0002032	desensitization of G-protein coupled receptor protein signaling pathway by arrestin	BP
1	2	2.3218233202	-	1.90e-01	GO:0051445	regulation of meiotic cell cycle	BP
1	2	2.3218233202	-	1.90e-01	GO:0060454	positive regulation of gastric acid secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0014040	positive regulation of Schwann cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0032071	regulation of endodeoxyribonuclease activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0019249	lactate biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0035507	regulation of myosin-light-chain-phosphatase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0061035	regulation of cartilage development	BP
1	2	2.3218233202	-	1.90e-01	GO:0061032	visceral serous pericardium development	BP
1	2	2.3218233202	-	1.90e-01	GO:0061033	secretion by lung epithelial cell involved in lung growth	BP
1	2	2.3218233202	-	1.90e-01	GO:1902532	negative regulation of intracellular signal transduction	BP
1	2	2.3218233202	-	1.90e-01	GO:0032509	endosome transport via multivesicular body sorting pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0060557	positive regulation of vitamin D biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0050922	negative regulation of chemotaxis	BP
1	2	2.3218233202	-	1.90e-01	GO:0097069	cellular response to thyroxine stimulus	BP
1	2	2.3218233202	-	1.90e-01	GO:0043331	response to dsRNA	BP
1	2	2.3218233202	-	1.90e-01	GO:1900275	negative regulation of phospholipase C activity	BP
1	2	2.3218233202	-	1.90e-01	GO:1904211	membrane protein proteolysis involved in retrograde protein transport, ER to cytosol	BP
1	2	2.3218233202	-	1.90e-01	GO:0006423	cysteinyl-tRNA aminoacylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0044236	multicellular organism metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0051563	smooth endoplasmic reticulum calcium ion homeostasis	BP
1	2	2.3218233202	-	1.90e-01	GO:0042495	detection of triacyl bacterial lipopeptide	BP
1	2	2.3218233202	-	1.90e-01	GO:1901666	positive regulation of NAD+ ADP-ribosyltransferase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:1901660	calcium ion export	BP
1	2	2.3218233202	-	1.90e-01	GO:0060748	tertiary branching involved in mammary gland duct morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0048210	Golgi vesicle fusion to target membrane	BP
1	2	2.3218233202	-	1.90e-01	GO:0097695	establishment of macromolecular complex localization to telomere	BP
1	2	2.3218233202	-	1.90e-01	GO:0097694	establishment of RNA localization to telomere	BP
1	2	2.3218233202	-	1.90e-01	GO:1902227	negative regulation of macrophage colony-stimulating factor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0055059	asymmetric neuroblast division	BP
1	2	2.3218233202	-	1.90e-01	GO:0023035	CD40 signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0035585	calcium-mediated signaling using extracellular calcium source	BP
1	2	2.3218233202	-	1.90e-01	GO:0046642	negative regulation of alpha-beta T cell proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:0002282	microglial cell activation involved in immune response	BP
1	2	2.3218233202	-	1.90e-01	GO:0002283	neutrophil activation involved in immune response	BP
1	2	2.3218233202	-	1.90e-01	GO:0070075	tear secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0071306	cellular response to vitamin E	BP
1	2	2.3218233202	-	1.90e-01	GO:0051650	establishment of vesicle localization	BP
1	2	2.3218233202	-	1.90e-01	GO:0086021	SA node cell to atrial cardiac muscle cell communication by electrical coupling	BP
1	2	2.3218233202	-	1.90e-01	GO:0006116	NADH oxidation	BP
1	2	2.3218233202	-	1.90e-01	GO:0032915	positive regulation of transforming growth factor beta2 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0032916	positive regulation of transforming growth factor beta3 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0032912	negative regulation of transforming growth factor beta2 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0035947	regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter	BP
1	2	2.3218233202	-	1.90e-01	GO:0032620	interleukin-17 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0070178	D-serine metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0031393	negative regulation of prostaglandin biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0046877	regulation of saliva secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0001912	positive regulation of leukocyte mediated cytotoxicity	BP
1	2	2.3218233202	-	1.90e-01	GO:0001914	regulation of T cell mediated cytotoxicity	BP
1	2	2.3218233202	-	1.90e-01	GO:0060139	positive regulation of apoptotic process by virus	BP
1	2	2.3218233202	-	1.90e-01	GO:1901374	acetate ester transport	BP
1	2	2.3218233202	-	1.90e-01	GO:0071174	mitotic spindle checkpoint	BP
1	2	2.3218233202	-	1.90e-01	GO:0030862	positive regulation of polarized epithelial cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0010934	macrophage cytokine production	BP
1	2	2.3218233202	-	1.90e-01	GO:0046605	regulation of centrosome cycle	BP
1	2	2.3218233202	-	1.90e-01	GO:0048069	eye pigmentation	BP
1	2	2.3218233202	-	1.90e-01	GO:0019087	transformation of host cell by virus	BP
1	2	2.3218233202	-	1.90e-01	GO:0007356	thorax and anterior abdomen determination	BP
1	2	2.3218233202	-	1.90e-01	GO:0086067	AV node cell to bundle of His cell communication	BP
1	2	2.3218233202	-	1.90e-01	GO:0014891	striated muscle atrophy	BP
1	2	2.3218233202	-	1.90e-01	GO:0001838	embryonic epithelial tube formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0071624	positive regulation of granulocyte chemotaxis	BP
1	2	2.3218233202	-	1.90e-01	GO:0046831	regulation of RNA export from nucleus	BP
1	2	2.3218233202	-	1.90e-01	GO:0046833	positive regulation of RNA export from nucleus	BP
1	2	2.3218233202	-	1.90e-01	GO:0035669	TRAM-dependent toll-like receptor 4 signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0003430	growth plate cartilage chondrocyte growth	BP
1	2	2.3218233202	-	1.90e-01	GO:0051946	regulation of glutamate uptake involved in transmission of nerve impulse	BP
1	2	2.3218233202	-	1.90e-01	GO:0003220	left ventricular cardiac muscle tissue morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0099553	trans-synaptic signaling by endocannabinoid, modulating synaptic transmission	BP
1	2	2.3218233202	-	1.90e-01	GO:0090045	positive regulation of deacetylase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:1903033	positive regulation of microtubule plus-end binding	BP
1	2	2.3218233202	-	1.90e-01	GO:0021633	optic nerve structural organization	BP
1	2	2.3218233202	-	1.90e-01	GO:0061104	adrenal chromaffin cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0044334	canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition	BP
1	2	2.3218233202	-	1.90e-01	GO:0021849	neuroblast division in subventricular zone	BP
1	2	2.3218233202	-	1.90e-01	GO:0070101	positive regulation of chemokine-mediated signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:2001045	negative regulation of integrin-mediated signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0071460	cellular response to cell-matrix adhesion	BP
1	2	2.3218233202	-	1.90e-01	GO:0044860	protein localization to plasma membrane raft	BP
1	2	2.3218233202	-	1.90e-01	GO:2000594	positive regulation of metanephric DCT cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0030997	regulation of centriole-centriole cohesion	BP
1	2	2.3218233202	-	1.90e-01	GO:0006542	glutamine biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0060443	mammary gland morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0032741	positive regulation of interleukin-18 production	BP
1	2	2.3218233202	-	1.90e-01	GO:1904049	negative regulation of spontaneous neurotransmitter secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0015847	putrescine transport	BP
1	2	2.3218233202	-	1.90e-01	GO:0002673	regulation of acute inflammatory response	BP
1	2	2.3218233202	-	1.90e-01	GO:0048145	regulation of fibroblast proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:0061709	reticulophagy	BP
1	2	2.3218233202	-	1.90e-01	GO:0060073	micturition	BP
1	2	2.3218233202	-	1.90e-01	GO:0072305	negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0036369	transcription factor catabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0003064	regulation of heart rate by hormone	BP
1	2	2.3218233202	-	1.90e-01	GO:0032707	negative regulation of interleukin-23 production	BP
1	2	2.3218233202	-	1.90e-01	GO:1905451	positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis	BP
1	2	2.3218233202	-	1.90e-01	GO:0031345	negative regulation of cell projection organization	BP
1	2	2.3218233202	-	1.90e-01	GO:0060032	notochord regression	BP
1	2	2.3218233202	-	1.90e-01	GO:1902523	positive regulation of protein K63-linked ubiquitination	BP
1	2	2.3218233202	-	1.90e-01	GO:0010643	cell communication by chemical coupling	BP
1	2	2.3218233202	-	1.90e-01	GO:0036324	vascular endothelial growth factor receptor-2 signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:2000041	negative regulation of planar cell polarity pathway involved in axis elongation	BP
1	2	2.3218233202	-	1.90e-01	GO:0032511	late endosome to vacuole transport via multivesicular body sorting pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0042109	lymphotoxin A biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0072738	cellular response to diamide	BP
1	2	2.3218233202	-	1.90e-01	GO:0021589	cerebellum structural organization	BP
1	2	2.3218233202	-	1.90e-01	GO:0045213	neurotransmitter receptor metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0033032	regulation of myeloid cell apoptotic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0002431	Fc receptor mediated stimulatory signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0061614	pri-miRNA transcription from RNA polymerase II promoter	BP
1	2	2.3218233202	-	1.90e-01	GO:0060800	regulation of cell differentiation involved in embryonic placenta development	BP
1	2	2.3218233202	-	1.90e-01	GO:0032490	detection of molecule of bacterial origin	BP
1	2	2.3218233202	-	1.90e-01	GO:1904313	response to methamphetamine hydrochloride	BP
1	2	2.3218233202	-	1.90e-01	GO:0050748	negative regulation of lipoprotein metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:2001288	positive regulation of caveolin-mediated endocytosis	BP
1	2	2.3218233202	-	1.90e-01	GO:0036496	regulation of translational initiation by eIF2 alpha dephosphorylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0045401	positive regulation of interleukin-3 biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:1904781	positive regulation of protein localization to centrosome	BP
1	2	2.3218233202	-	1.90e-01	GO:0002730	regulation of dendritic cell cytokine production	BP
1	2	2.3218233202	-	1.90e-01	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0071506	cellular response to mycophenolic acid	BP
1	2	2.3218233202	-	1.90e-01	GO:0055025	positive regulation of cardiac muscle tissue development	BP
1	2	2.3218233202	-	1.90e-01	GO:0051252	regulation of RNA metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0001927	exocyst assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0016340	calcium-dependent cell-matrix adhesion	BP
1	2	2.3218233202	-	1.90e-01	GO:0003404	optic vesicle morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0048710	regulation of astrocyte differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:2000291	regulation of myoblast proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:0070252	actin-mediated cell contraction	BP
1	2	2.3218233202	-	1.90e-01	GO:0070254	mucus secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:1900168	positive regulation of glial cell-derived neurotrophic factor secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0051873	killing by host of symbiont cells	BP
1	2	2.3218233202	-	1.90e-01	GO:1905075	positive regulation of occluding junction disassembly	BP
1	2	2.3218233202	-	1.90e-01	GO:2000620	positive regulation of histone H4-K16 acetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0071396	cellular response to lipid	BP
1	2	2.3218233202	-	1.90e-01	GO:0035441	cell migration involved in vasculogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0014728	regulation of the force of skeletal muscle contraction	BP
1	2	2.3218233202	-	1.90e-01	GO:0003193	pulmonary valve formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0060125	negative regulation of growth hormone secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0046619	optic placode formation involved in camera-type eye formation	BP
1	2	2.3218233202	-	1.90e-01	GO:2001202	negative regulation of transforming growth factor-beta secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0090071	negative regulation of ribosome biogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0072053	renal inner medulla development	BP
1	2	2.3218233202	-	1.90e-01	GO:0072054	renal outer medulla development	BP
1	2	2.3218233202	-	1.90e-01	GO:0001300	chronological cell aging	BP
1	2	2.3218233202	-	1.90e-01	GO:2000506	negative regulation of energy homeostasis	BP
1	2	2.3218233202	-	1.90e-01	GO:0061153	trachea gland development	BP
1	2	2.3218233202	-	1.90e-01	GO:1903721	positive regulation of I-kappaB phosphorylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0021873	forebrain neuroblast division	BP
1	2	2.3218233202	-	1.90e-01	GO:0061302	smooth muscle cell-matrix adhesion	BP
1	2	2.3218233202	-	1.90e-01	GO:0003156	regulation of animal organ formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0007497	posterior midgut development	BP
1	2	2.3218233202	-	1.90e-01	GO:2001076	positive regulation of metanephric ureteric bud development	BP
1	2	2.3218233202	-	1.90e-01	GO:1903923	positive regulation of protein processing in phagocytic vesicle	BP
1	2	2.3218233202	-	1.90e-01	GO:0090035	positive regulation of chaperone-mediated protein complex assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0019050	suppression by virus of host apoptotic process	BP
1	2	2.3218233202	-	1.90e-01	GO:2000098	negative regulation of smooth muscle cell-matrix adhesion	BP
1	2	2.3218233202	-	1.90e-01	GO:0032305	positive regulation of icosanoid secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0071670	smooth muscle cell chemotaxis	BP
1	2	2.3218233202	-	1.90e-01	GO:2000397	positive regulation of ubiquitin-dependent endocytosis	BP
1	2	2.3218233202	-	1.90e-01	GO:2000978	negative regulation of forebrain neuron differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0060434	bronchus morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0002643	regulation of tolerance induction	BP
1	2	2.3218233202	-	1.90e-01	GO:1902170	cellular response to reactive nitrogen species	BP
1	2	2.3218233202	-	1.90e-01	GO:0071322	cellular response to carbohydrate stimulus	BP
1	2	2.3218233202	-	1.90e-01	GO:2000707	positive regulation of dense core granule biogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0035802	adrenal cortex formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0009069	serine family amino acid metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0002866	positive regulation of acute inflammatory response to antigenic stimulus	BP
1	2	2.3218233202	-	1.90e-01	GO:0001805	positive regulation of type III hypersensitivity	BP
1	2	2.3218233202	-	1.90e-01	GO:0051124	synaptic growth at neuromuscular junction	BP
1	2	2.3218233202	-	1.90e-01	GO:0070668	positive regulation of mast cell proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:1904059	regulation of locomotor rhythm	BP
1	2	2.3218233202	-	1.90e-01	GO:1904424	regulation of GTP binding	BP
1	2	2.3218233202	-	1.90e-01	GO:1900215	negative regulation of apoptotic process involved in metanephric collecting duct development	BP
1	2	2.3218233202	-	1.90e-01	GO:1900218	negative regulation of apoptotic process involved in metanephric nephron tubule development	BP
1	2	2.3218233202	-	1.90e-01	GO:0097531	mast cell migration	BP
1	2	2.3218233202	-	1.90e-01	GO:0070427	nucleotide-binding oligomerization domain containing 1 signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0048669	collateral sprouting in absence of injury	BP
1	2	2.3218233202	-	1.90e-01	GO:0007525	somatic muscle development	BP
1	2	2.3218233202	-	1.90e-01	GO:0071900	regulation of protein serine/threonine kinase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:2000017	positive regulation of determination of dorsal identity	BP
1	2	2.3218233202	-	1.90e-01	GO:0003057	regulation of the force of heart contraction by chemical signal	BP
1	2	2.3218233202	-	1.90e-01	GO:0006808	regulation of nitrogen utilization	BP
1	2	2.3218233202	-	1.90e-01	GO:1903849	positive regulation of aorta morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0019265	glycine biosynthetic process, by transamination of glyoxylate	BP
1	2	2.3218233202	-	1.90e-01	GO:0043506	regulation of JUN kinase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0061833	protein localization to tricellular tight junction	BP
1	2	2.3218233202	-	1.90e-01	GO:2000194	regulation of female gonad development	BP
1	2	2.3218233202	-	1.90e-01	GO:2000191	regulation of fatty acid transport	BP
1	2	2.3218233202	-	1.90e-01	GO:0019100	male germ-line sex determination	BP
1	2	2.3218233202	-	1.90e-01	GO:0030221	basophil differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0050716	positive regulation of interleukin-1 secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0072709	cellular response to sorbitol	BP
1	2	2.3218233202	-	1.90e-01	GO:0060577	pulmonary vein morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0090325	regulation of locomotion involved in locomotory behavior	BP
1	2	2.3218233202	-	1.90e-01	GO:0002762	negative regulation of myeloid leukocyte differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0042496	detection of diacyl bacterial lipopeptide	BP
1	2	2.3218233202	-	1.90e-01	GO:1902722	positive regulation of prolactin secretion	BP
1	2	2.3218233202	-	1.90e-01	GO:0007070	negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle	BP
1	2	2.3218233202	-	1.90e-01	GO:0033007	negative regulation of mast cell activation involved in immune response	BP
1	2	2.3218233202	-	1.90e-01	GO:0035922	foramen ovale closure	BP
1	2	2.3218233202	-	1.90e-01	GO:0043314	negative regulation of neutrophil degranulation	BP
1	2	2.3218233202	-	1.90e-01	GO:0043313	regulation of neutrophil degranulation	BP
1	2	2.3218233202	-	1.90e-01	GO:0097324	melanocyte migration	BP
1	2	2.3218233202	-	1.90e-01	GO:0035566	regulation of metanephros size	BP
1	2	2.3218233202	-	1.90e-01	GO:0009609	response to symbiotic bacterium	BP
1	2	2.3218233202	-	1.90e-01	GO:2000156	regulation of retrograde vesicle-mediated transport, Golgi to ER	BP
1	2	2.3218233202	-	1.90e-01	GO:0021940	positive regulation of cerebellar granule cell precursor proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:0021941	negative regulation of cerebellar granule cell precursor proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:0031134	sister chromatid biorientation	BP
1	2	2.3218233202	-	1.90e-01	GO:0034243	regulation of transcription elongation from RNA polymerase II promoter	BP
1	2	2.3218233202	-	1.90e-01	GO:1902943	positive regulation of voltage-gated chloride channel activity	BP
1	2	2.3218233202	-	1.90e-01	GO:0032607	interferon-alpha production	BP
1	2	2.3218233202	-	1.90e-01	GO:0060251	regulation of glial cell proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:2000340	positive regulation of chemokine (C-X-C motif) ligand 1 production	BP
1	2	2.3218233202	-	1.90e-01	GO:2000349	negative regulation of CD40 signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0061647	histone H3-K9 modification	BP
1	2	2.3218233202	-	1.90e-01	GO:1903526	negative regulation of membrane tubulation	BP
1	2	2.3218233202	-	1.90e-01	GO:1900195	positive regulation of oocyte maturation	BP
1	2	2.3218233202	-	1.90e-01	GO:0046666	retinal cell programmed cell death	BP
1	2	2.3218233202	-	1.90e-01	GO:1905065	positive regulation of vascular smooth muscle cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0021514	ventral spinal cord interneuron differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:1904884	positive regulation of telomerase catalytic core complex assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0061402	positive regulation of transcription from RNA polymerase II promoter in response to acidic pH	BP
1	2	2.3218233202	-	1.90e-01	GO:0042412	taurine biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0021650	vestibulocochlear nerve formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0001976	neurological system process involved in regulation of systemic arterial blood pressure	BP
1	2	2.3218233202	-	1.90e-01	GO:2000309	positive regulation of tumor necrosis factor (ligand) superfamily member 11 production	BP
1	2	2.3218233202	-	1.90e-01	GO:0035606	peptidyl-cysteine S-trans-nitrosylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0014733	regulation of skeletal muscle adaptation	BP
1	2	2.3218233202	-	1.90e-01	GO:0014736	negative regulation of muscle atrophy	BP
1	2	2.3218233202	-	1.90e-01	GO:1990791	dorsal root ganglion development	BP
1	2	2.3218233202	-	1.90e-01	GO:0060152	microtubule-based peroxisome localization	BP
1	2	2.3218233202	-	1.90e-01	GO:0002302	CD8-positive, alpha-beta T cell differentiation involved in immune response	BP
1	2	2.3218233202	-	1.90e-01	GO:0034124	regulation of MyD88-dependent toll-like receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0050867	positive regulation of cell activation	BP
1	2	2.3218233202	-	1.90e-01	GO:0043970	histone H3-K9 acetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0080135	regulation of cellular response to stress	BP
1	2	2.3218233202	-	1.90e-01	GO:0086043	bundle of His cell action potential	BP
1	2	2.3218233202	-	1.90e-01	GO:2000538	positive regulation of B cell chemotaxis	BP
1	2	2.3218233202	-	1.90e-01	GO:0033484	nitric oxide homeostasis	BP
1	2	2.3218233202	-	1.90e-01	GO:0032682	negative regulation of chemokine production	BP
1	2	2.3218233202	-	1.90e-01	GO:0010512	negative regulation of phosphatidylinositol biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:1990619	histone H3-K9 deacetylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0035411	catenin import into nucleus	BP
1	2	2.3218233202	-	1.90e-01	GO:0060978	angiogenesis involved in coronary vascular morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:1901255	nucleotide-excision repair involved in interstrand cross-link repair	BP
1	2	2.3218233202	-	1.90e-01	GO:0003160	endocardium morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0003162	atrioventricular node development	BP
1	2	2.3218233202	-	1.90e-01	GO:0003169	coronary vein morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0031943	regulation of glucocorticoid metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0061762	CAMKK-AMPK signaling cascade	BP
1	2	2.3218233202	-	1.90e-01	GO:0043006	activation of phospholipase A2 activity by calcium-mediated signaling	BP
1	2	2.3218233202	-	1.90e-01	GO:0072368	regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter	BP
1	2	2.3218233202	-	1.90e-01	GO:0072369	regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter	BP
1	2	2.3218233202	-	1.90e-01	GO:0032834	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response	BP
1	2	2.3218233202	-	1.90e-01	GO:0005997	xylulose metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0098792	xenophagy	BP
1	2	2.3218233202	-	1.90e-01	GO:0002522	leukocyte migration involved in immune response	BP
1	2	2.3218233202	-	1.90e-01	GO:0018205	peptidyl-lysine modification	BP
1	2	2.3218233202	-	1.90e-01	GO:0032762	mast cell cytokine production	BP
1	2	2.3218233202	-	1.90e-01	GO:0071874	cellular response to norepinephrine stimulus	BP
1	2	2.3218233202	-	1.90e-01	GO:0071879	positive regulation of adrenergic receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:1904684	negative regulation of metalloendopeptidase activity	BP
1	2	2.3218233202	-	1.90e-01	GO:2000779	regulation of double-strand break repair	BP
1	2	2.3218233202	-	1.90e-01	GO:0061723	glycophagy	BP
1	2	2.3218233202	-	1.90e-01	GO:0039003	pronephric field specification	BP
1	2	2.3218233202	-	1.90e-01	GO:0031247	actin rod assembly	BP
1	2	2.3218233202	-	1.90e-01	GO:0097021	lymphocyte migration into lymphoid organs	BP
1	2	2.3218233202	-	1.90e-01	GO:0048638	regulation of developmental growth	BP
1	2	2.3218233202	-	1.90e-01	GO:0019516	lactate oxidation	BP
1	2	2.3218233202	-	1.90e-01	GO:0035026	leading edge cell differentiation	BP
1	2	2.3218233202	-	1.90e-01	GO:0035022	positive regulation of Rac protein signal transduction	BP
1	2	2.3218233202	-	1.90e-01	GO:0014057	positive regulation of acetylcholine secretion, neurotransmission	BP
1	2	2.3218233202	-	1.90e-01	GO:0044027	hypermethylation of CpG island	BP
1	2	2.3218233202	-	1.90e-01	GO:0035854	eosinophil fate commitment	BP
1	2	2.3218233202	-	1.90e-01	GO:0043555	regulation of translation in response to stress	BP
1	2	2.3218233202	-	1.90e-01	GO:0051531	NFAT protein import into nucleus	BP
1	2	2.3218233202	-	1.90e-01	GO:0060979	vasculogenesis involved in coronary vascular morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0030264	nuclear fragmentation involved in apoptotic nuclear change	BP
1	2	2.3218233202	-	1.90e-01	GO:0036344	platelet morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:0015942	formate metabolic process	BP
1	2	2.3218233202	-	1.90e-01	GO:2000473	positive regulation of hematopoietic stem cell migration	BP
1	2	2.3218233202	-	1.90e-01	GO:2000474	regulation of opioid receptor signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0072134	nephrogenic mesenchyme morphogenesis	BP
1	2	2.3218233202	-	1.90e-01	GO:1905386	positive regulation of protein localization to presynapse	BP
1	2	2.3218233202	-	1.90e-01	GO:1990426	mitotic recombination-dependent replication fork processing	BP
1	2	2.3218233202	-	1.90e-01	GO:0009631	cold acclimation	BP
1	2	2.3218233202	-	1.90e-01	GO:0002692	negative regulation of cellular extravasation	BP
1	2	2.3218233202	-	1.90e-01	GO:0070230	positive regulation of lymphocyte apoptotic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0003006	developmental process involved in reproduction	BP
1	2	2.3218233202	-	1.90e-01	GO:0086097	phospholipase C-activating angiotensin-activated signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0032943	mononuclear cell proliferation	BP
1	2	2.3218233202	-	1.90e-01	GO:0031328	positive regulation of cellular biosynthetic process	BP
1	2	2.3218233202	-	1.90e-01	GO:0072179	nephric duct formation	BP
1	2	2.3218233202	-	1.90e-01	GO:0097359	UDP-glucosylation	BP
1	2	2.3218233202	-	1.90e-01	GO:0021894	cerebral cortex GABAergic interneuron development	BP
1	2	2.3218233202	-	1.90e-01	GO:0021897	forebrain astrocyte development	BP
1	2	2.3218233202	-	1.90e-01	GO:0097111	endoplasmic reticulum-Golgi intermediate compartment organization	BP
1	2	2.3218233202	-	1.90e-01	GO:0060715	syncytiotrophoblast cell differentiation involved in labyrinthine layer development	BP
1	2	2.3218233202	-	1.90e-01	GO:0002717	positive regulation of natural killer cell mediated immunity	BP
1	2	2.3218233202	-	1.90e-01	GO:0038194	thyroid-stimulating hormone signaling pathway	BP
1	2	2.3218233202	-	1.90e-01	GO:0045994	positive regulation of translational initiation by iron	BP
1	2	2.3218233202	-	1.90e-01	GO:0072033	renal vesicle formation	BP
7	14	2.3218233202	-	4.96e-05	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
6	12	2.3218233202	-	5.37e-04	GO:0004861	cyclin-dependent protein serine/threonine kinase inhibitor activity	MF
4	8	2.3218233202	-	5.01e-03	GO:0004726	non-membrane spanning protein tyrosine phosphatase activity	MF
2	4	2.3218233202	-	9.99e-03	GO:0016286	small conductance calcium-activated potassium channel activity	MF
2	4	2.3218233202	-	9.99e-03	GO:0004515	nicotinate-nucleotide adenylyltransferase activity	MF
3	6	2.3218233202	-	1.58e-02	GO:0005024	transforming growth factor beta-activated receptor activity	MF
3	6	2.3218233202	-	1.58e-02	GO:0019870	potassium channel inhibitor activity	MF
3	6	2.3218233202	-	1.58e-02	GO:0072542	protein phosphatase activator activity	MF
3	6	2.3218233202	-	1.58e-02	GO:0031730	CCR5 chemokine receptor binding	MF
3	6	2.3218233202	-	1.58e-02	GO:0030346	protein phosphatase 2B binding	MF
3	6	2.3218233202	-	1.58e-02	GO:0009931	calcium-dependent protein serine/threonine kinase activity	MF
3	6	2.3218233202	-	1.58e-02	GO:0043559	insulin binding	MF
2	4	2.3218233202	-	2.80e-02	GO:0001032	RNA polymerase III type 3 promoter DNA binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0005105	type 1 fibroblast growth factor receptor binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0004740	pyruvate dehydrogenase (acetyl-transferring) kinase activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0004677	DNA-dependent protein kinase activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0030546	receptor activator activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0038085	vascular endothelial growth factor binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0019210	kinase inhibitor activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0035877	death effector domain binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0034056	estrogen response element binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0035325	Toll-like receptor binding	MF
2	4	2.3218233202	-	5.23e-02	GO:0035173	histone kinase activity	MF
2	4	2.3218233202	-	5.23e-02	GO:0033192	calmodulin-dependent protein phosphatase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0051377	mannose-ethanolamine phosphotransferase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0017098	sulfonylurea receptor binding	MF
1	2	2.3218233202	-	1.00e-01	GO:0008294	calcium- and calmodulin-responsive adenylate cyclase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0005026	transforming growth factor beta receptor activity, type II	MF
1	2	2.3218233202	-	1.00e-01	GO:0002134	UTP binding	MF
1	2	2.3218233202	-	1.00e-01	GO:0086062	voltage-gated sodium channel activity involved in Purkinje myocyte action potential	MF
1	2	2.3218233202	-	1.00e-01	GO:0003920	GMP reductase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0060072	large conductance calcium-activated potassium channel activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0016857	racemase and epimerase activity, acting on carbohydrates and derivatives	MF
1	2	2.3218233202	-	1.00e-01	GO:0090555	phosphatidylethanolamine-translocating ATPase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0016433	rRNA (adenine) methyltransferase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0004458	D-lactate dehydrogenase (cytochrome) activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0046811	histone deacetylase inhibitor activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0045509	interleukin-27 receptor activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0004510	tryptophan 5-monooxygenase activity	MF
1	2	2.3218233202	-	1.00e-01	GO:0016151	nickel cation binding	MF
1	2	2.3218233202	-	1.00e-01	GO:0042284	sphingolipid delta-4 desaturase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004996	thyroid-stimulating hormone receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004991	parathyroid hormone receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004667	prostaglandin-D synthase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0016362	activin receptor activity, type II	MF
1	2	2.3218233202	-	1.90e-01	GO:0034736	cholesterol O-acyltransferase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0031755	Edg-2 lysophosphatidic acid receptor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0004743	pyruvate kinase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0010698	acetyltransferase activator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0019912	cyclin-dependent protein kinase activating kinase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0030366	molybdopterin synthase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004917	interleukin-7 receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0001632	leukotriene B4 receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0030984	kininogen binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0015432	bile acid-exporting ATPase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0033883	pyridoxal phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0052642	lysophosphatidic acid phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0051990	(R)-2-hydroxyglutarate dehydrogenase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008781	N-acylneuraminate cytidylyltransferase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0050436	microfibril binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0052815	medium-chain acyl-CoA hydrolase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004356	glutamate-ammonia ligase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004357	glutamate-cysteine ligase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004352	glutamate dehydrogenase (NAD+) activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0071074	eukaryotic initiation factor eIF2 binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0016410	N-acyltransferase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0031802	type 5 metabotropic glutamate receptor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0086020	gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling	MF
1	2	2.3218233202	-	1.90e-01	GO:0019981	interleukin-6 binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0032422	purine-rich negative regulatory element binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0016005	phospholipase A2 activator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0051717	inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0032143	single thymine insertion binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0004906	interferon-gamma receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0048101	calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0016524	latrotoxin receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0019002	GMP binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0004053	arginase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0032181	dinucleotide repeat insertion binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0004915	interleukin-6 receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004913	interleukin-4 receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0043532	angiostatin binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0015489	putrescine transmembrane transporter activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0030109	HLA-B specific inhibitory MHC class I receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0086077	gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling	MF
1	2	2.3218233202	-	1.90e-01	GO:0061752	telomeric repeat-containing RNA binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0034988	Fc-gamma receptor I complex binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0001071	nucleic acid binding transcription factor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004723	calcium-dependent protein serine/threonine phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0097003	adipokinetic hormone receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0005006	epidermal growth factor-activated receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0035014	phosphatidylinositol 3-kinase regulator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0015085	calcium ion transmembrane transporter activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0005048	signal sequence binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0005042	netrin receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004353	glutamate dehydrogenase [NAD(P)+] activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0005174	CD40 receptor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0046969	NAD-dependent histone deacetylase activity (H3-K9 specific)	MF
1	2	2.3218233202	-	1.90e-01	GO:0004613	phosphoenolpyruvate carboxykinase (GTP) activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0005137	interleukin-5 receptor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0005163	nerve growth factor receptor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0033549	MAP kinase phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0017042	glycosylceramidase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0031729	CCR4 chemokine receptor binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0004365	glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004923	leukemia inhibitory factor receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0016780	phosphotransferase activity, for other substituted phosphate groups	MF
1	2	2.3218233202	-	1.90e-01	GO:0070080	titin Z domain binding	MF
1	2	2.3218233202	-	1.90e-01	GO:0001641	group II metabotropic glutamate receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004074	biliverdin reductase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0003980	UDP-glucose:glycoprotein glucosyltransferase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0038062	protein tyrosine kinase collagen receptor activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0005072	transforming growth factor beta receptor, cytoplasmic mediator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0008160	protein tyrosine phosphatase activator activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0051800	phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004342	glucosamine-6-phosphate deaminase activity	MF
1	2	2.3218233202	-	1.90e-01	GO:0004817	cysteine-tRNA ligase activity	MF
18	37	2.28229495601	-	4.15e-10	GO:0071902	positive regulation of protein serine/threonine kinase activity	BP
16	33	2.27742920084	-	1.17e-08	GO:0010718	positive regulation of epithelial to mesenchymal transition	BP
13	27	2.26737553618	-	1.56e-07	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	BP
13	27	2.26737553618	-	2.83e-07	GO:0035329	hippo signaling	BP
11	23	2.25769298278	-	4.17e-06	GO:0030295	protein kinase activator activity	MF
9	19	2.2438208082	-	1.13e-05	GO:0014911	positive regulation of smooth muscle cell migration	BP
9	19	2.2438208082	-	2.05e-05	GO:0046827	positive regulation of protein export from nucleus	BP
15	32	2.22871391581	-	3.37e-08	GO:0005154	epidermal growth factor receptor binding	MF
28	60	2.22228764665	-	2.12e-11	GO:0009967	positive regulation of signal transduction	BP
21	45	2.22228764665	-	3.08e-10	GO:0000186	activation of MAPKK activity	BP
7	15	2.22228764665	-	1.79e-04	GO:2000251	positive regulation of actin cytoskeleton reorganization	BP
7	15	2.22228764665	-	3.08e-04	GO:0045725	positive regulation of glycogen biosynthetic process	BP
7	15	2.22228764665	-	1.79e-04	GO:0005161	platelet-derived growth factor receptor binding	MF
19	41	2.21219882903	-	8.63e-10	GO:0045740	positive regulation of DNA replication	BP
6	13	2.20634610278	-	2.93e-04	GO:0061029	eyelid development in camera-type eye	BP
6	13	2.20634610278	-	2.93e-04	GO:0048546	digestive tract morphogenesis	BP
6	13	2.20634610278	-	9.14e-04	GO:0001678	cellular glucose homeostasis	BP
6	13	2.20634610278	-	9.14e-04	GO:0097296	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
6	13	2.20634610278	-	9.14e-04	GO:0045197	establishment or maintenance of epithelial cell apical/basal polarity	BP
6	13	2.20634610278	-	9.14e-04	GO:0045821	positive regulation of glycolytic process	BP
23	50	2.20152908648	-	2.06e-11	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	BP
11	24	2.19629243812	-	7.01e-06	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	BP
10	22	2.18431979645	-	6.99e-06	GO:0035924	cellular response to vascular endothelial growth factor stimulus	BP
5	11	2.18431979645	-	1.76e-04	GO:0031643	positive regulation of myelination	BP
5	11	2.18431979645	-	1.63e-03	GO:0051489	regulation of filopodium assembly	BP
5	11	2.18431979645	-	2.74e-03	GO:0032495	response to muramyl dipeptide	BP
5	11	2.18431979645	-	2.74e-03	GO:0042511	positive regulation of tyrosine phosphorylation of Stat1 protein	BP
5	11	2.18431979645	-	2.74e-03	GO:0045667	regulation of osteoblast differentiation	BP
10	22	2.18431979645	-	2.03e-05	GO:0035257	nuclear hormone receptor binding	MF
5	11	2.18431979645	-	2.74e-03	GO:0008093	cytoskeletal adaptor activity	MF
14	31	2.17498193187	-	9.76e-08	GO:0032007	negative regulation of TOR signaling	BP
13	29	2.16428204321	-	8.40e-07	GO:0030032	lamellipodium assembly	BP
4	9	2.15189831876	-	2.72e-03	GO:0043304	regulation of mast cell degranulation	BP
4	9	2.15189831876	-	2.72e-03	GO:0010907	positive regulation of glucose metabolic process	BP
4	9	2.15189831876	-	5.01e-03	GO:0019953	sexual reproduction	BP
4	9	2.15189831876	-	5.01e-03	GO:0030857	negative regulation of epithelial cell differentiation	BP
4	9	2.15189831876	-	5.01e-03	GO:0070886	positive regulation of calcineurin-NFAT signaling cascade	BP
4	9	2.15189831876	-	5.01e-03	GO:0061564	axon development	BP
4	9	2.15189831876	-	8.31e-03	GO:2000727	positive regulation of cardiac muscle cell differentiation	BP
4	9	2.15189831876	-	8.31e-03	GO:0008354	germ cell migration	BP
4	9	2.15189831876	-	8.31e-03	GO:0033160	positive regulation of protein import into nucleus, translocation	BP
4	9	2.15189831876	-	8.31e-03	GO:0044320	cellular response to leptin stimulus	BP
4	9	2.15189831876	-	8.31e-03	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	BP
4	9	2.15189831876	-	8.31e-03	GO:0016572	histone phosphorylation	BP
4	9	2.15189831876	-	8.31e-03	GO:0033762	response to glucagon	BP
4	9	2.15189831876	-	8.31e-03	GO:0006000	fructose metabolic process	BP
19	43	2.14348607894	-	8.63e-10	GO:0030971	receptor tyrosine kinase binding	MF
7	16	2.12917824226	-	3.08e-04	GO:2000811	negative regulation of anoikis	BP
7	16	2.12917824226	-	1.79e-04	GO:0043274	phospholipase binding	MF
7	16	2.12917824226	-	5.00e-04	GO:0050998	nitric-oxide synthase binding	MF
10	23	2.12018945903	-	1.22e-05	GO:0070372	regulation of ERK1 and ERK2 cascade	BP
51	118	2.11160561281	-	7.42e-11	GO:0005088	Ras guanyl-nucleotide exchange factor activity	MF
19	44	2.11031921501	-	6.77e-09	GO:0032147	activation of protein kinase activity	BP
66	153	2.10882959687	-	6.91e-11	GO:0018108	peptidyl-tyrosine phosphorylation	BP
12	28	2.09943089886	-	1.44e-06	GO:2000145	regulation of cell motility	BP
9	21	2.09943089886	-	3.55e-05	GO:0048870	cell motility	BP
9	21	2.09943089886	-	5.88e-05	GO:0010165	response to X-ray	BP
9	21	2.09943089886	-	5.88e-05	GO:0071901	negative regulation of protein serine/threonine kinase activity	BP
9	21	2.09943089886	-	9.39e-05	GO:0051403	stress-activated MAPK cascade	BP
6	14	2.09943089886	-	2.93e-04	GO:0022408	negative regulation of cell-cell adhesion	BP
6	14	2.09943089886	-	5.37e-04	GO:0060065	uterus development	BP
6	14	2.09943089886	-	9.14e-04	GO:0060749	mammary gland alveolus development	BP
6	14	2.09943089886	-	9.14e-04	GO:2000060	positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
6	14	2.09943089886	-	1.46e-03	GO:0031529	ruffle organization	BP
6	14	2.09943089886	-	1.46e-03	GO:0043254	regulation of protein complex assembly	BP
3	7	2.09943089886	-	8.55e-03	GO:0030432	peristalsis	BP
3	7	2.09943089886	-	8.55e-03	GO:0002281	macrophage activation involved in immune response	BP
3	7	2.09943089886	-	8.55e-03	GO:0009950	dorsal/ventral axis specification	BP
3	7	2.09943089886	-	8.55e-03	GO:0045577	regulation of B cell differentiation	BP
3	7	2.09943089886	-	8.55e-03	GO:0090336	positive regulation of brown fat cell differentiation	BP
3	7	2.09943089886	-	8.55e-03	GO:0010518	positive regulation of phospholipase activity	BP
3	7	2.09943089886	-	1.58e-02	GO:0034138	toll-like receptor 3 signaling pathway	BP
3	7	2.09943089886	-	1.58e-02	GO:0045722	positive regulation of gluconeogenesis	BP
3	7	2.09943089886	-	1.58e-02	GO:0072112	glomerular visceral epithelial cell differentiation	BP
3	7	2.09943089886	-	1.58e-02	GO:0001542	ovulation from ovarian follicle	BP
3	7	2.09943089886	-	1.58e-02	GO:0051001	negative regulation of nitric-oxide synthase activity	BP
3	7	2.09943089886	-	1.58e-02	GO:0042518	negative regulation of tyrosine phosphorylation of Stat3 protein	BP
3	7	2.09943089886	-	1.58e-02	GO:0051057	positive regulation of small GTPase mediated signal transduction	BP
3	7	2.09943089886	-	1.58e-02	GO:0008366	axon ensheathment	BP
3	7	2.09943089886	-	1.58e-02	GO:0060563	neuroepithelial cell differentiation	BP
3	7	2.09943089886	-	1.58e-02	GO:0043457	regulation of cellular respiration	BP
3	7	2.09943089886	-	2.57e-02	GO:0019896	axonal transport of mitochondrion	BP
3	7	2.09943089886	-	2.57e-02	GO:0043405	regulation of MAP kinase activity	BP
3	7	2.09943089886	-	2.57e-02	GO:0010870	positive regulation of receptor biosynthetic process	BP
3	7	2.09943089886	-	2.57e-02	GO:1903896	positive regulation of IRE1-mediated unfolded protein response	BP
3	7	2.09943089886	-	2.57e-02	GO:1901841	regulation of high voltage-gated calcium channel activity	BP
3	7	2.09943089886	-	2.57e-02	GO:0030388	fructose 1,6-bisphosphate metabolic process	BP
3	7	2.09943089886	-	2.57e-02	GO:0003183	mitral valve morphogenesis	BP
3	7	2.09943089886	-	2.57e-02	GO:0061051	positive regulation of cell growth involved in cardiac muscle cell development	BP
3	7	2.09943089886	-	2.57e-02	GO:0060687	regulation of branching involved in prostate gland morphogenesis	BP
3	7	2.09943089886	-	2.57e-02	GO:0048708	astrocyte differentiation	BP
3	7	2.09943089886	-	2.57e-02	GO:0007185	transmembrane receptor protein tyrosine phosphatase signaling pathway	BP
3	7	2.09943089886	-	2.57e-02	GO:0032872	regulation of stress-activated MAPK cascade	BP
3	7	2.09943089886	-	2.57e-02	GO:0038066	p38MAPK cascade	BP
3	7	2.09943089886	-	2.57e-02	GO:1902715	positive regulation of interferon-gamma secretion	BP
3	7	2.09943089886	-	2.57e-02	GO:2000601	positive regulation of Arp2/3 complex-mediated actin nucleation	BP
3	7	2.09943089886	-	1.58e-02	GO:0005004	GPI-linked ephrin receptor activity	MF
3	7	2.09943089886	-	2.57e-02	GO:0008432	JUN kinase binding	MF
3	7	2.09943089886	-	2.57e-02	GO:0031433	telethonin binding	MF
3	7	2.09943089886	-	2.57e-02	GO:0030306	ADP-ribosylation factor binding	MF
3	7	2.09943089886	-	2.57e-02	GO:0004691	cAMP-dependent protein kinase activity	MF
3	7	2.09943089886	-	2.57e-02	GO:0005078	MAP-kinase scaffold activity	MF
42	99	2.0847841229	-	5.05e-11	GO:0046854	phosphatidylinositol phosphorylation	BP
11	26	2.0808152207	-	4.17e-06	GO:0014065	phosphatidylinositol 3-kinase signaling	BP
13	31	2.06806672796	-	3.47e-06	GO:0031663	lipopolysaccharide-mediated signaling pathway	BP
10	24	2.05878891437	-	2.03e-05	GO:0071158	positive regulation of cell cycle arrest	BP
10	24	2.05878891437	-	3.27e-05	GO:0048041	focal adhesion assembly	BP
10	24	2.05878891437	-	5.10e-05	GO:0016239	positive regulation of macroautophagy	BP
5	12	2.05878891437	-	1.63e-03	GO:0060391	positive regulation of SMAD protein import into nucleus	BP
5	12	2.05878891437	-	1.63e-03	GO:0090399	replicative senescence	BP
5	12	2.05878891437	-	2.74e-03	GO:1900181	negative regulation of protein localization to nucleus	BP
5	12	2.05878891437	-	2.74e-03	GO:0010763	positive regulation of fibroblast migration	BP
5	12	2.05878891437	-	2.74e-03	GO:0031669	cellular response to nutrient levels	BP
5	12	2.05878891437	-	2.74e-03	GO:0030212	hyaluronan metabolic process	BP
5	12	2.05878891437	-	4.31e-03	GO:0046710	GDP metabolic process	BP
5	12	2.05878891437	-	4.31e-03	GO:0031994	insulin-like growth factor I binding	MF
5	12	2.05878891437	-	4.31e-03	GO:0043422	protein kinase B binding	MF
7	17	2.04171540101	-	3.08e-04	GO:0071375	cellular response to peptide hormone stimulus	BP
7	17	2.04171540101	-	7.77e-04	GO:0031333	negative regulation of protein complex assembly	BP
68	166	2.0342467301	-	6.20e-11	GO:0046777	protein autophosphorylation	BP
9	22	2.03231670301	-	9.39e-05	GO:0031954	positive regulation of protein autophosphorylation	BP
15	37	2.01926055018	-	4.35e-07	GO:0071364	cellular response to epidermal growth factor stimulus	BP
12	30	1.99989522531	-	3.97e-06	GO:0007259	JAK-STAT cascade	BP
12	30	1.99989522531	-	6.31e-06	GO:0046326	positive regulation of glucose import	BP
12	30	1.99989522531	-	6.31e-06	GO:0001932	regulation of protein phosphorylation	BP
6	15	1.99989522531	-	2.24e-03	GO:0010801	negative regulation of peptidyl-threonine phosphorylation	BP
6	15	1.99989522531	-	2.24e-03	GO:0060997	dendritic spine morphogenesis	BP
6	15	1.99989522531	-	2.24e-03	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	BP
6	15	1.99989522531	-	9.14e-04	GO:0017016	Ras GTPase binding	MF
6	15	1.99989522531	-	2.24e-03	GO:0005123	death receptor binding	MF
6	15	1.99989522531	-	2.24e-03	GO:0051393	alpha-actinin binding	MF
10	25	1.99989522531	-	3.27e-05	GO:0002053	positive regulation of mesenchymal cell proliferation	BP
8	20	1.99989522531	-	4.11e-04	GO:1900182	positive regulation of protein localization to nucleus	BP
8	20	1.99989522531	-	4.11e-04	GO:0042326	negative regulation of phosphorylation	BP
4	10	1.99989522531	-	5.01e-03	GO:0035414	negative regulation of catenin import into nucleus	BP
4	10	1.99989522531	-	8.31e-03	GO:0010762	regulation of fibroblast migration	BP
4	10	1.99989522531	-	8.31e-03	GO:0014894	response to denervation involved in regulation of muscle adaptation	BP
4	10	1.99989522531	-	8.31e-03	GO:0001952	regulation of cell-matrix adhesion	BP
4	10	1.99989522531	-	8.31e-03	GO:2000009	negative regulation of protein localization to cell surface	BP
4	10	1.99989522531	-	8.31e-03	GO:0003214	cardiac left ventricle morphogenesis	BP
4	10	1.99989522531	-	8.31e-03	GO:0060484	lung-associated mesenchyme development	BP
4	10	1.99989522531	-	8.31e-03	GO:0045793	positive regulation of cell size	BP
2	5	1.99989522531	-	9.99e-03	GO:0045026	plasma membrane fusion	BP
4	10	1.99989522531	-	1.28e-02	GO:0051272	positive regulation of cellular component movement	BP
4	10	1.99989522531	-	1.28e-02	GO:0071803	positive regulation of podosome assembly	BP
4	10	1.99989522531	-	1.28e-02	GO:0051918	negative regulation of fibrinolysis	BP
4	10	1.99989522531	-	1.28e-02	GO:1902237	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
4	10	1.99989522531	-	1.28e-02	GO:0090136	epithelial cell-cell adhesion	BP
4	10	1.99989522531	-	1.28e-02	GO:0050678	regulation of epithelial cell proliferation	BP
4	10	1.99989522531	-	1.28e-02	GO:0060252	positive regulation of glial cell proliferation	BP
4	10	1.99989522531	-	1.28e-02	GO:0032930	positive regulation of superoxide anion generation	BP
4	10	1.99989522531	-	1.28e-02	GO:0043114	regulation of vascular permeability	BP
4	10	1.99989522531	-	1.28e-02	GO:0031000	response to caffeine	BP
4	10	1.99989522531	-	1.28e-02	GO:2000146	negative regulation of cell motility	BP
2	5	1.99989522531	-	2.80e-02	GO:0038203	TORC2 signaling	BP
2	5	1.99989522531	-	2.80e-02	GO:0003105	negative regulation of glomerular filtration	BP
2	5	1.99989522531	-	2.80e-02	GO:0006144	purine nucleobase metabolic process	BP
2	5	1.99989522531	-	2.80e-02	GO:0021879	forebrain neuron differentiation	BP
2	5	1.99989522531	-	2.80e-02	GO:0002385	mucosal immune response	BP
2	5	1.99989522531	-	2.80e-02	GO:0007144	female meiosis I	BP
2	5	1.99989522531	-	5.23e-02	GO:1900180	regulation of protein localization to nucleus	BP
2	5	1.99989522531	-	5.23e-02	GO:0050851	antigen receptor-mediated signaling pathway	BP
2	5	1.99989522531	-	5.23e-02	GO:0003283	atrial septum development	BP
2	5	1.99989522531	-	5.23e-02	GO:0060666	dichotomous subdivision of terminal units involved in salivary gland branching	BP
2	5	1.99989522531	-	5.23e-02	GO:1900747	negative regulation of vascular endothelial growth factor signaling pathway	BP
2	5	1.99989522531	-	5.23e-02	GO:0060510	Type II pneumocyte differentiation	BP
2	5	1.99989522531	-	5.23e-02	GO:0051754	meiotic sister chromatid cohesion, centromeric	BP
2	5	1.99989522531	-	5.23e-02	GO:0019217	regulation of fatty acid metabolic process	BP
2	5	1.99989522531	-	5.23e-02	GO:0072284	metanephric S-shaped body morphogenesis	BP
2	5	1.99989522531	-	5.23e-02	GO:0035630	bone mineralization involved in bone maturation	BP
2	5	1.99989522531	-	5.23e-02	GO:0090080	positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway	BP
2	5	1.99989522531	-	5.23e-02	GO:0001302	replicative cell aging	BP
2	5	1.99989522531	-	5.23e-02	GO:0031914	negative regulation of synaptic plasticity	BP
2	5	1.99989522531	-	5.23e-02	GO:0010632	regulation of epithelial cell migration	BP
2	5	1.99989522531	-	5.23e-02	GO:0072162	metanephric mesenchymal cell differentiation	BP
2	5	1.99989522531	-	5.23e-02	GO:0007406	negative regulation of neuroblast proliferation	BP
2	5	1.99989522531	-	5.23e-02	GO:0086045	membrane depolarization during AV node cell action potential	BP
2	5	1.99989522531	-	5.23e-02	GO:0072207	metanephric epithelium development	BP
2	5	1.99989522531	-	5.23e-02	GO:0070231	T cell apoptotic process	BP
2	5	1.99989522531	-	8.14e-02	GO:0042634	regulation of hair cycle	BP
2	5	1.99989522531	-	8.14e-02	GO:0007262	STAT protein import into nucleus	BP
2	5	1.99989522531	-	8.14e-02	GO:0036016	cellular response to interleukin-3	BP
2	5	1.99989522531	-	8.14e-02	GO:0072378	blood coagulation, fibrin clot formation	BP
2	5	1.99989522531	-	8.14e-02	GO:0045953	negative regulation of natural killer cell mediated cytotoxicity	BP
2	5	1.99989522531	-	8.14e-02	GO:0002074	extraocular skeletal muscle development	BP
2	5	1.99989522531	-	8.14e-02	GO:0034349	glial cell apoptotic process	BP
2	5	1.99989522531	-	8.14e-02	GO:0065004	protein-DNA complex assembly	BP
2	5	1.99989522531	-	8.14e-02	GO:0051823	regulation of synapse structural plasticity	BP
2	5	1.99989522531	-	8.14e-02	GO:1902749	regulation of cell cycle G2/M phase transition	BP
2	5	1.99989522531	-	8.14e-02	GO:1905007	positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	BP
2	5	1.99989522531	-	8.14e-02	GO:0045063	T-helper 1 cell differentiation	BP
2	5	1.99989522531	-	8.14e-02	GO:0034392	negative regulation of smooth muscle cell apoptotic process	BP
2	5	1.99989522531	-	8.14e-02	GO:1904714	regulation of chaperone-mediated autophagy	BP
2	5	1.99989522531	-	8.14e-02	GO:0034109	homotypic cell-cell adhesion	BP
2	5	1.99989522531	-	8.14e-02	GO:0021631	optic nerve morphogenesis	BP
2	5	1.99989522531	-	8.14e-02	GO:0008063	Toll signaling pathway	BP
2	5	1.99989522531	-	8.14e-02	GO:0014031	mesenchymal cell development	BP
2	5	1.99989522531	-	8.14e-02	GO:0038084	vascular endothelial growth factor signaling pathway	BP
2	5	1.99989522531	-	8.14e-02	GO:1903912	negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation	BP
2	5	1.99989522531	-	8.14e-02	GO:0034620	cellular response to unfolded protein	BP
2	5	1.99989522531	-	8.14e-02	GO:0098914	membrane repolarization during atrial cardiac muscle cell action potential	BP
2	5	1.99989522531	-	8.14e-02	GO:0032747	positive regulation of interleukin-23 production	BP
2	5	1.99989522531	-	8.14e-02	GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
2	5	1.99989522531	-	8.14e-02	GO:0038007	netrin-activated signaling pathway	BP
2	5	1.99989522531	-	8.14e-02	GO:0048755	branching morphogenesis of a nerve	BP
2	5	1.99989522531	-	8.14e-02	GO:0045639	positive regulation of myeloid cell differentiation	BP
2	5	1.99989522531	-	8.14e-02	GO:0045637	regulation of myeloid cell differentiation	BP
2	5	1.99989522531	-	8.14e-02	GO:0042699	follicle-stimulating hormone signaling pathway	BP
2	5	1.99989522531	-	8.14e-02	GO:2001171	positive regulation of ATP biosynthetic process	BP
2	5	1.99989522531	-	8.14e-02	GO:0071332	cellular response to fructose stimulus	BP
2	5	1.99989522531	-	8.14e-02	GO:0048170	positive regulation of long-term neuronal synaptic plasticity	BP
2	5	1.99989522531	-	8.14e-02	GO:0060603	mammary gland duct morphogenesis	BP
2	5	1.99989522531	-	8.14e-02	GO:0033081	regulation of T cell differentiation in thymus	BP
2	5	1.99989522531	-	8.14e-02	GO:0002821	positive regulation of adaptive immune response	BP
2	5	1.99989522531	-	8.14e-02	GO:2000467	positive regulation of glycogen (starch) synthase activity	BP
2	5	1.99989522531	-	8.14e-02	GO:0032713	negative regulation of interleukin-4 production	BP
2	5	1.99989522531	-	8.14e-02	GO:0043353	enucleate erythrocyte differentiation	BP
2	5	1.99989522531	-	8.14e-02	GO:0036336	dendritic cell migration	BP
2	5	1.99989522531	-	8.14e-02	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	BP
2	5	1.99989522531	-	8.14e-02	GO:1904885	beta-catenin destruction complex assembly	BP
2	5	1.99989522531	-	8.14e-02	GO:0051220	cytoplasmic sequestering of protein	BP
2	5	1.99989522531	-	8.14e-02	GO:0033153	T cell receptor V(D)J recombination	BP
2	5	1.99989522531	-	8.14e-02	GO:0051534	negative regulation of NFAT protein import into nucleus	BP
2	5	1.99989522531	-	8.14e-02	GO:0045794	negative regulation of cell volume	BP
2	5	1.99989522531	-	8.14e-02	GO:0060561	apoptotic process involved in morphogenesis	BP
2	5	1.99989522531	-	8.14e-02	GO:0051023	regulation of immunoglobulin secretion	BP
4	10	1.99989522531	-	5.01e-03	GO:0004629	phospholipase C activity	MF
4	10	1.99989522531	-	8.31e-03	GO:0051428	peptide hormone receptor binding	MF
4	10	1.99989522531	-	1.28e-02	GO:0045294	alpha-catenin binding	MF
4	10	1.99989522531	-	1.28e-02	GO:0017166	vinculin binding	MF
4	10	1.99989522531	-	1.28e-02	GO:0042975	peroxisome proliferator activated receptor binding	MF
2	5	1.99989522531	-	5.23e-02	GO:0097153	cysteine-type endopeptidase activity involved in apoptotic process	MF
2	5	1.99989522531	-	5.23e-02	GO:0098821	BMP receptor activity	MF
2	5	1.99989522531	-	5.23e-02	GO:0061665	SUMO ligase activity	MF
2	5	1.99989522531	-	5.23e-02	GO:0071813	lipoprotein particle binding	MF
2	5	1.99989522531	-	5.23e-02	GO:0019871	sodium channel inhibitor activity	MF
2	5	1.99989522531	-	5.23e-02	GO:0031404	chloride ion binding	MF
2	5	1.99989522531	-	5.23e-02	GO:0070290	N-acylphosphatidylethanolamine-specific phospholipase D activity	MF
2	5	1.99989522531	-	8.14e-02	GO:1990239	steroid hormone binding	MF
2	5	1.99989522531	-	8.14e-02	GO:0070061	fructose binding	MF
2	5	1.99989522531	-	8.14e-02	GO:0038132	neuregulin binding	MF
2	5	1.99989522531	-	8.14e-02	GO:0001875	lipopolysaccharide receptor activity	MF
2	5	1.99989522531	-	8.14e-02	GO:0071253	connexin binding	MF
2	5	1.99989522531	-	8.14e-02	GO:0000988	transcription factor activity, protein binding	MF
13	33	1.97786891898	-	5.32e-06	GO:0043491	protein kinase B signaling	BP
11	28	1.97390001678	-	2.76e-05	GO:0090004	positive regulation of establishment of protein localization to plasma membrane	BP
11	28	1.97390001678	-	2.76e-05	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	BP
9	23	1.96818636559	-	2.17e-04	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	BP
9	23	1.96818636559	-	2.17e-04	GO:0051439	regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
14	36	1.95925324082	-	1.90e-06	GO:0042517	positive regulation of tyrosine phosphorylation of Stat3 protein	BP
7	18	1.95925324082	-	7.77e-04	GO:2000249	regulation of actin cytoskeleton reorganization	BP
7	18	1.95925324082	-	7.77e-04	GO:0051412	response to corticosterone	BP
19	49	1.95504098953	-	2.62e-08	GO:0042752	regulation of circadian rhythm	BP
12	31	1.95258951054	-	6.31e-06	GO:0030217	T cell differentiation	BP
17	44	1.94985454281	-	5.44e-08	GO:0030838	positive regulation of actin filament polymerization	BP
10	26	1.94331169695	-	3.27e-05	GO:0048709	oligodendrocyte differentiation	BP
10	26	1.94331169695	-	7.74e-05	GO:0050999	regulation of nitric-oxide synthase activity	BP
5	13	1.94331169695	-	8.86e-04	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	BP
5	13	1.94331169695	-	2.74e-03	GO:0031641	regulation of myelination	BP
5	13	1.94331169695	-	4.31e-03	GO:0019395	fatty acid oxidation	BP
5	13	1.94331169695	-	4.31e-03	GO:0031274	positive regulation of pseudopodium assembly	BP
5	13	1.94331169695	-	4.31e-03	GO:0071285	cellular response to lithium ion	BP
5	13	1.94331169695	-	6.43e-03	GO:0070306	lens fiber cell differentiation	BP
5	13	1.94331169695	-	6.43e-03	GO:0045579	positive regulation of B cell differentiation	BP
10	26	1.94331169695	-	1.22e-05	GO:0019838	growth factor binding	MF
5	13	1.94331169695	-	4.31e-03	GO:0030695	GTPase regulator activity	MF
5	13	1.94331169695	-	6.43e-03	GO:0004385	guanylate kinase activity	MF
29	76	1.93187680189	-	2.22e-11	GO:0008286	insulin receptor signaling pathway	BP
8	21	1.92950589742	-	4.11e-04	GO:0051000	positive regulation of nitric-oxide synthase activity	BP
8	21	1.92950589742	-	4.11e-04	GO:0035307	positive regulation of protein dephosphorylation	BP
8	21	1.92950589742	-	6.05e-04	GO:0060045	positive regulation of cardiac muscle cell proliferation	BP
8	21	1.92950589742	-	6.05e-04	GO:0030316	osteoclast differentiation	BP
8	21	1.92950589742	-	4.11e-04	GO:0070412	R-SMAD binding	MF
55	145	1.92327394371	-	1.28e-10	GO:0018105	peptidyl-serine phosphorylation	BP
11	29	1.92327394371	-	1.14e-05	GO:0045595	regulation of cell differentiation	BP
11	29	1.92327394371	-	4.13e-05	GO:0042169	SH2 domain binding	MF
14	37	1.91972487663	-	1.23e-06	GO:0051898	negative regulation of protein kinase B signaling	BP
14	37	1.91972487663	-	4.28e-06	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	BP
27	72	1.90678582092	-	6.13e-11	GO:0043410	positive regulation of MAPK cascade	BP
24	64	1.90678582092	-	5.64e-10	GO:0018107	peptidyl-threonine phosphorylation	BP
9	24	1.90678582092	-	3.16e-04	GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway	BP
6	16	1.90678582092	-	9.14e-04	GO:0048714	positive regulation of oligodendrocyte differentiation	BP
6	16	1.90678582092	-	2.24e-03	GO:0046037	GMP metabolic process	BP
6	16	1.90678582092	-	2.24e-03	GO:0035162	embryonic hemopoiesis	BP
6	16	1.90678582092	-	3.28e-03	GO:0035994	response to muscle stretch	BP
6	16	1.90678582092	-	3.28e-03	GO:0007094	mitotic spindle assembly checkpoint	BP
6	16	1.90678582092	-	3.28e-03	GO:0031396	regulation of protein ubiquitination	BP
6	16	1.90678582092	-	3.28e-03	GO:0042523	positive regulation of tyrosine phosphorylation of Stat5 protein	BP
3	8	1.90678582092	-	8.55e-03	GO:0003073	regulation of systemic arterial blood pressure	BP
3	8	1.90678582092	-	1.58e-02	GO:0051896	regulation of protein kinase B signaling	BP
3	8	1.90678582092	-	1.58e-02	GO:0042058	regulation of epidermal growth factor receptor signaling pathway	BP
3	8	1.90678582092	-	1.58e-02	GO:0046324	regulation of glucose import	BP
3	8	1.90678582092	-	1.58e-02	GO:1904948	midbrain dopaminergic neuron differentiation	BP
3	8	1.90678582092	-	1.58e-02	GO:0060259	regulation of feeding behavior	BP
3	8	1.90678582092	-	2.57e-02	GO:0072075	metanephric mesenchyme development	BP
3	8	1.90678582092	-	2.57e-02	GO:0033629	negative regulation of cell adhesion mediated by integrin	BP
3	8	1.90678582092	-	2.57e-02	GO:0007167	enzyme linked receptor protein signaling pathway	BP
3	8	1.90678582092	-	2.57e-02	GO:2000001	regulation of DNA damage checkpoint	BP
3	8	1.90678582092	-	2.57e-02	GO:0006972	hyperosmotic response	BP
3	8	1.90678582092	-	2.57e-02	GO:0016264	gap junction assembly	BP
3	8	1.90678582092	-	2.57e-02	GO:0090277	positive regulation of peptide hormone secretion	BP
3	8	1.90678582092	-	2.57e-02	GO:0060316	positive regulation of ryanodine-sensitive calcium-release channel activity	BP
3	8	1.90678582092	-	2.57e-02	GO:0071316	cellular response to nicotine	BP
3	8	1.90678582092	-	3.81e-02	GO:0070307	lens fiber cell development	BP
3	8	1.90678582092	-	3.81e-02	GO:0032731	positive regulation of interleukin-1 beta production	BP
3	8	1.90678582092	-	3.81e-02	GO:0035148	tube formation	BP
3	8	1.90678582092	-	3.81e-02	GO:0072577	endothelial cell apoptotic process	BP
3	8	1.90678582092	-	3.81e-02	GO:0006987	activation of signaling protein activity involved in unfolded protein response	BP
3	8	1.90678582092	-	3.81e-02	GO:0070262	peptidyl-serine dephosphorylation	BP
3	8	1.90678582092	-	3.81e-02	GO:0001955	blood vessel maturation	BP
3	8	1.90678582092	-	3.81e-02	GO:1902305	regulation of sodium ion transmembrane transport	BP
3	8	1.90678582092	-	3.81e-02	GO:0060670	branching involved in labyrinthine layer morphogenesis	BP
3	8	1.90678582092	-	3.81e-02	GO:0003300	cardiac muscle hypertrophy	BP
3	8	1.90678582092	-	3.81e-02	GO:1903599	positive regulation of mitophagy	BP
3	8	1.90678582092	-	3.81e-02	GO:1900119	positive regulation of execution phase of apoptosis	BP
3	8	1.90678582092	-	3.81e-02	GO:0038180	nerve growth factor signaling pathway	BP
3	8	1.90678582092	-	3.81e-02	GO:0042982	amyloid precursor protein metabolic process	BP
3	8	1.90678582092	-	3.81e-02	GO:0014732	skeletal muscle atrophy	BP
3	8	1.90678582092	-	3.81e-02	GO:0014909	smooth muscle cell migration	BP
3	8	1.90678582092	-	3.81e-02	GO:2000774	positive regulation of cellular senescence	BP
3	8	1.90678582092	-	3.81e-02	GO:0006002	fructose 6-phosphate metabolic process	BP
3	8	1.90678582092	-	8.55e-03	GO:0019213	deacetylase activity	MF
3	8	1.90678582092	-	3.81e-02	GO:0097027	ubiquitin-protein transferase activator activity	MF
3	8	1.90678582092	-	3.81e-02	GO:0008140	cAMP response element binding protein binding	MF
3	8	1.90678582092	-	3.81e-02	GO:0031995	insulin-like growth factor II binding	MF
3	8	1.90678582092	-	3.81e-02	GO:0035591	signaling adaptor activity	MF
28	75	1.90035955176	-	1.37e-10	GO:0019900	kinase binding	MF
41	110	1.89801561129	-	2.95e-11	GO:0030168	platelet activation	BP
32	86	1.8955585655	-	2.47e-11	GO:0048013	ephrin receptor signaling pathway	BP
16	43	1.8955585655	-	2.41e-07	GO:0042110	T cell activation	BP
10	27	1.88886391293	-	7.74e-05	GO:0040014	regulation of multicellular organism growth	BP
14	38	1.88125072882	-	6.25e-06	GO:0030155	regulation of cell adhesion	BP
7	19	1.88125072882	-	1.68e-03	GO:0070932	histone H3 deacetylation	BP
11	30	1.87436434323	-	8.71e-05	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	BP
16	44	1.86239170156	-	2.41e-07	GO:0023014	signal transduction by protein phosphorylation	BP
4	11	1.86239170156	-	2.72e-03	GO:0042551	neuron maturation	BP
4	11	1.86239170156	-	5.01e-03	GO:0002089	lens morphogenesis in camera-type eye	BP
4	11	1.86239170156	-	8.31e-03	GO:0070997	neuron death	BP
4	11	1.86239170156	-	8.31e-03	GO:0045745	positive regulation of G-protein coupled receptor protein signaling pathway	BP
4	11	1.86239170156	-	8.31e-03	GO:2000737	negative regulation of stem cell differentiation	BP
4	11	1.86239170156	-	1.28e-02	GO:0001944	vasculature development	BP
4	11	1.86239170156	-	1.28e-02	GO:0042770	signal transduction in response to DNA damage	BP
4	11	1.86239170156	-	1.28e-02	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	BP
4	11	1.86239170156	-	1.28e-02	GO:0050921	positive regulation of chemotaxis	BP
4	11	1.86239170156	-	1.28e-02	GO:0098911	regulation of ventricular cardiac muscle cell action potential	BP
4	11	1.86239170156	-	1.28e-02	GO:0070935	3'-UTR-mediated mRNA stabilization	BP
4	11	1.86239170156	-	1.28e-02	GO:0035413	positive regulation of catenin import into nucleus	BP
4	11	1.86239170156	-	1.28e-02	GO:0045945	positive regulation of transcription from RNA polymerase III promoter	BP
4	11	1.86239170156	-	1.85e-02	GO:0051279	regulation of release of sequestered calcium ion into cytosol	BP
4	11	1.86239170156	-	1.85e-02	GO:0050927	positive regulation of positive chemotaxis	BP
4	11	1.86239170156	-	1.85e-02	GO:0060544	regulation of necroptotic process	BP
4	11	1.86239170156	-	1.85e-02	GO:0035970	peptidyl-threonine dephosphorylation	BP
4	11	1.86239170156	-	1.85e-02	GO:0006853	carnitine shuttle	BP
28	77	1.86239170156	-	4.04e-11	GO:0016301	kinase activity	MF
8	22	1.86239170156	-	6.05e-04	GO:0004683	calmodulin-dependent protein kinase activity	MF
4	11	1.86239170156	-	1.85e-02	GO:0035259	glucocorticoid receptor binding	MF
9	25	1.84789213187	-	9.39e-05	GO:0045930	negative regulation of mitotic cell cycle	BP
10	28	1.83639649303	-	2.35e-04	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	BP
5	14	1.83639649303	-	1.63e-03	GO:0031103	axon regeneration	BP
5	14	1.83639649303	-	2.74e-03	GO:0043303	mast cell degranulation	BP
5	14	1.83639649303	-	4.31e-03	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	BP
5	14	1.83639649303	-	4.31e-03	GO:2001275	positive regulation of glucose import in response to insulin stimulus	BP
5	14	1.83639649303	-	4.31e-03	GO:0000712	resolution of meiotic recombination intermediates	BP
5	14	1.83639649303	-	6.43e-03	GO:2001241	positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
5	14	1.83639649303	-	9.20e-03	GO:0097067	cellular response to thyroid hormone stimulus	BP
5	14	1.83639649303	-	9.20e-03	GO:2000353	positive regulation of endothelial cell apoptotic process	BP
5	14	1.83639649303	-	9.20e-03	GO:0043923	positive regulation by host of viral transcription	BP
5	14	1.83639649303	-	9.20e-03	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	BP
5	14	1.83639649303	-	9.20e-03	GO:0035729	cellular response to hepatocyte growth factor stimulus	BP
5	14	1.83639649303	-	9.20e-03	GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator	BP
38	107	1.82828384724	-	1.03e-10	GO:0000187	activation of MAPK activity	BP
6	17	1.81932297967	-	9.14e-04	GO:0048514	blood vessel morphogenesis	BP
6	17	1.81932297967	-	2.24e-03	GO:0046427	positive regulation of JAK-STAT cascade	BP
6	17	1.81932297967	-	3.28e-03	GO:0030225	macrophage differentiation	BP
6	17	1.81932297967	-	4.64e-03	GO:0010039	response to iron ion	BP
49	139	1.81759209159	-	4.38e-11	GO:0007050	cell cycle arrest	BP
25	71	1.81593239047	-	3.06e-09	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP
13	37	1.81280967271	-	5.32e-06	GO:0034332	adherens junction organization	BP
13	37	1.81280967271	-	1.17e-05	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	BP
7	20	1.80725014737	-	7.77e-04	GO:0034614	cellular response to reactive oxygen species	BP
7	20	1.80725014737	-	1.16e-03	GO:0043113	receptor clustering	BP
7	20	1.80725014737	-	1.68e-03	GO:0031572	G2 DNA damage checkpoint	BP
15	43	1.80244916111	-	2.29e-06	GO:0021762	substantia nigra development	BP
8	23	1.79826136414	-	6.05e-04	GO:0034394	protein localization to cell surface	BP
8	23	1.79826136414	-	6.05e-04	GO:0070371	ERK1 and ERK2 cascade	BP
8	23	1.79826136414	-	8.69e-04	GO:0045648	positive regulation of erythrocyte differentiation	BP
9	26	1.7913086035	-	2.17e-04	GO:0030010	establishment of cell polarity	BP
9	26	1.7913086035	-	3.16e-04	GO:0032148	activation of protein kinase B activity	BP
9	26	1.7913086035	-	6.29e-04	GO:0051721	protein phosphatase 2A binding	MF
66	191	1.78878861152	-	4.68e-11	GO:0004672	protein kinase activity	MF
19	55	1.78839112012	-	2.68e-07	GO:0070373	negative regulation of ERK1 and ERK2 cascade	BP
10	29	1.78577041996	-	3.27e-04	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
10	29	1.78577041996	-	2.35e-04	GO:0004712	protein serine/threonine/tyrosine kinase activity	MF
11	32	1.78125493884	-	8.71e-05	GO:0010507	negative regulation of autophagy	BP
17	50	1.76542997168	-	6.56e-07	GO:0048146	positive regulation of fibroblast proliferation	BP
20	59	1.76110836573	-	2.81e-07	GO:0031398	positive regulation of protein ubiquitination	BP
26	77	1.75547649765	-	7.34e-11	GO:0031295	T cell costimulation	BP
56	166	1.75413881091	-	6.06e-11	GO:0016477	cell migration	BP
89	266	1.74227431567	-	1.73e-10	GO:0000165	MAPK cascade	BP
126	377	1.74068253043	-	1.07e-10	GO:0019901	protein kinase binding	MF
20	60	1.73686081948	-	2.81e-07	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	BP
10	30	1.73686081948	-	2.35e-04	GO:0042177	negative regulation of protein catabolic process	BP
5	15	1.73686081948	-	9.20e-03	GO:0030502	negative regulation of bone mineralization	BP
5	15	1.73686081948	-	9.20e-03	GO:0030330	DNA damage response, signal transduction by p53 class mediator	BP
5	15	1.73686081948	-	9.20e-03	GO:0010608	posttranscriptional regulation of gene expression	BP
5	15	1.73686081948	-	9.20e-03	GO:0010633	negative regulation of epithelial cell migration	BP
5	15	1.73686081948	-	9.20e-03	GO:0000729	DNA double-strand break processing	BP
5	15	1.73686081948	-	1.27e-02	GO:0030889	negative regulation of B cell proliferation	BP
5	15	1.73686081948	-	6.43e-03	GO:0019789	SUMO transferase activity	MF
5	15	1.73686081948	-	9.20e-03	GO:0000987	core promoter proximal region sequence-specific DNA binding	MF
8	24	1.73686081948	-	8.69e-04	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	BP
8	24	1.73686081948	-	1.67e-03	GO:0043388	positive regulation of DNA binding	BP
6	18	1.73686081948	-	3.28e-03	GO:0036120	cellular response to platelet-derived growth factor stimulus	BP
6	18	1.73686081948	-	6.38e-03	GO:0031668	cellular response to extracellular stimulus	BP
4	12	1.73686081948	-	1.28e-02	GO:0001779	natural killer cell differentiation	BP
4	12	1.73686081948	-	1.28e-02	GO:0097028	dendritic cell differentiation	BP
4	12	1.73686081948	-	1.28e-02	GO:0030278	regulation of ossification	BP
4	12	1.73686081948	-	1.28e-02	GO:0050868	negative regulation of T cell activation	BP
4	12	1.73686081948	-	1.28e-02	GO:0071391	cellular response to estrogen stimulus	BP
4	12	1.73686081948	-	1.28e-02	GO:0007600	sensory perception	BP
3	9	1.73686081948	-	1.58e-02	GO:0048617	embryonic foregut morphogenesis	BP
3	9	1.73686081948	-	1.58e-02	GO:0022010	central nervous system myelination	BP
4	12	1.73686081948	-	1.85e-02	GO:0008340	determination of adult lifespan	BP
4	12	1.73686081948	-	1.85e-02	GO:0006107	oxaloacetate metabolic process	BP
4	12	1.73686081948	-	1.85e-02	GO:2000505	regulation of energy homeostasis	BP
4	12	1.73686081948	-	1.85e-02	GO:0045744	negative regulation of G-protein coupled receptor protein signaling pathway	BP
4	12	1.73686081948	-	2.56e-02	GO:0016242	negative regulation of macroautophagy	BP
4	12	1.73686081948	-	2.56e-02	GO:0046902	regulation of mitochondrial membrane permeability	BP
4	12	1.73686081948	-	2.56e-02	GO:0033630	positive regulation of cell adhesion mediated by integrin	BP
4	12	1.73686081948	-	2.56e-02	GO:0032801	receptor catabolic process	BP
4	12	1.73686081948	-	2.56e-02	GO:0040007	growth	BP
4	12	1.73686081948	-	2.56e-02	GO:2000273	positive regulation of receptor activity	BP
4	12	1.73686081948	-	2.56e-02	GO:0045820	negative regulation of glycolytic process	BP
3	9	1.73686081948	-	2.57e-02	GO:0086014	atrial cardiac muscle cell action potential	BP
3	9	1.73686081948	-	2.57e-02	GO:2001223	negative regulation of neuron migration	BP
3	9	1.73686081948	-	2.57e-02	GO:0010838	positive regulation of keratinocyte proliferation	BP
3	9	1.73686081948	-	2.57e-02	GO:0045741	positive regulation of epidermal growth factor-activated receptor activity	BP
3	9	1.73686081948	-	2.57e-02	GO:0097120	receptor localization to synapse	BP
3	9	1.73686081948	-	2.57e-02	GO:0061314	Notch signaling involved in heart development	BP
2	6	1.73686081948	-	2.80e-02	GO:0048856	anatomical structure development	BP
3	9	1.73686081948	-	3.81e-02	GO:2000810	regulation of bicellular tight junction assembly	BP
3	9	1.73686081948	-	3.81e-02	GO:0042473	outer ear morphogenesis	BP
3	9	1.73686081948	-	3.81e-02	GO:0006105	succinate metabolic process	BP
3	9	1.73686081948	-	3.81e-02	GO:0003197	endocardial cushion development	BP
3	9	1.73686081948	-	3.81e-02	GO:0032886	regulation of microtubule-based process	BP
3	9	1.73686081948	-	3.81e-02	GO:1901223	negative regulation of NIK/NF-kappaB signaling	BP
3	9	1.73686081948	-	3.81e-02	GO:0048660	regulation of smooth muscle cell proliferation	BP
3	9	1.73686081948	-	3.81e-02	GO:0042754	negative regulation of circadian rhythm	BP
3	9	1.73686081948	-	3.81e-02	GO:0002726	positive regulation of T cell cytokine production	BP
2	6	1.73686081948	-	5.23e-02	GO:0060267	positive regulation of respiratory burst	BP
2	6	1.73686081948	-	5.23e-02	GO:0086015	SA node cell action potential	BP
2	6	1.73686081948	-	5.23e-02	GO:0021853	cerebral cortex GABAergic interneuron migration	BP
2	6	1.73686081948	-	5.23e-02	GO:0051127	positive regulation of actin nucleation	BP
2	6	1.73686081948	-	5.23e-02	GO:0055123	digestive system development	BP
2	6	1.73686081948	-	5.23e-02	GO:0061000	negative regulation of dendritic spine development	BP
3	9	1.73686081948	-	5.29e-02	GO:0001771	immunological synapse formation	BP
3	9	1.73686081948	-	5.29e-02	GO:0034405	response to fluid shear stress	BP
3	9	1.73686081948	-	5.29e-02	GO:0031053	primary miRNA processing	BP
3	9	1.73686081948	-	5.29e-02	GO:0010224	response to UV-B	BP
3	9	1.73686081948	-	5.29e-02	GO:0035372	protein localization to microtubule	BP
3	9	1.73686081948	-	5.29e-02	GO:0046641	positive regulation of alpha-beta T cell proliferation	BP
3	9	1.73686081948	-	5.29e-02	GO:1904706	negative regulation of vascular smooth muscle cell proliferation	BP
3	9	1.73686081948	-	5.29e-02	GO:0034145	positive regulation of toll-like receptor 4 signaling pathway	BP
3	9	1.73686081948	-	5.29e-02	GO:0071340	skeletal muscle acetylcholine-gated channel clustering	BP
3	9	1.73686081948	-	5.29e-02	GO:0043068	positive regulation of programmed cell death	BP
3	9	1.73686081948	-	5.29e-02	GO:0002675	positive regulation of acute inflammatory response	BP
3	9	1.73686081948	-	5.29e-02	GO:0043534	blood vessel endothelial cell migration	BP
3	9	1.73686081948	-	5.29e-02	GO:0000075	cell cycle checkpoint	BP
3	9	1.73686081948	-	5.29e-02	GO:0043589	skin morphogenesis	BP
3	9	1.73686081948	-	5.29e-02	GO:0007184	SMAD protein import into nucleus	BP
3	9	1.73686081948	-	5.29e-02	GO:0046621	negative regulation of organ growth	BP
3	9	1.73686081948	-	5.29e-02	GO:0034333	adherens junction assembly	BP
3	9	1.73686081948	-	5.29e-02	GO:0022407	regulation of cell-cell adhesion	BP
3	9	1.73686081948	-	5.29e-02	GO:0010666	positive regulation of cardiac muscle cell apoptotic process	BP
3	9	1.73686081948	-	5.29e-02	GO:0060711	labyrinthine layer development	BP
3	9	1.73686081948	-	5.29e-02	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
2	6	1.73686081948	-	8.14e-02	GO:0090344	negative regulation of cell aging	BP
2	6	1.73686081948	-	8.14e-02	GO:0030579	ubiquitin-dependent SMAD protein catabolic process	BP
2	6	1.73686081948	-	8.14e-02	GO:0003179	heart valve morphogenesis	BP
2	6	1.73686081948	-	8.14e-02	GO:0038092	nodal signaling pathway	BP
2	6	1.73686081948	-	8.14e-02	GO:0060664	epithelial cell proliferation involved in salivary gland morphogenesis	BP
2	6	1.73686081948	-	8.14e-02	GO:0007098	centrosome cycle	BP
2	6	1.73686081948	-	8.14e-02	GO:0002320	lymphoid progenitor cell differentiation	BP
2	6	1.73686081948	-	8.14e-02	GO:0061469	regulation of type B pancreatic cell proliferation	BP
2	6	1.73686081948	-	8.14e-02	GO:0060372	regulation of atrial cardiac muscle cell membrane repolarization	BP
2	6	1.73686081948	-	8.14e-02	GO:0060373	regulation of ventricular cardiac muscle cell membrane depolarization	BP
2	6	1.73686081948	-	8.14e-02	GO:0060428	lung epithelium development	BP
2	6	1.73686081948	-	8.14e-02	GO:0032808	lacrimal gland development	BP
2	6	1.73686081948	-	8.14e-02	GO:0021984	adenohypophysis development	BP
2	6	1.73686081948	-	8.14e-02	GO:0032717	negative regulation of interleukin-8 production	BP
2	6	1.73686081948	-	8.14e-02	GO:0035315	hair cell differentiation	BP
2	6	1.73686081948	-	8.14e-02	GO:0033211	adiponectin-activated signaling pathway	BP
2	6	1.73686081948	-	8.14e-02	GO:0046850	regulation of bone remodeling	BP
2	6	1.73686081948	-	8.14e-02	GO:0045719	negative regulation of glycogen biosynthetic process	BP
2	6	1.73686081948	-	8.14e-02	GO:0060056	mammary gland involution	BP
1	3	1.73686081948	-	1.00e-01	GO:0070172	positive regulation of tooth mineralization	BP
1	3	1.73686081948	-	1.00e-01	GO:0042269	regulation of natural killer cell mediated cytotoxicity	BP
1	3	1.73686081948	-	1.00e-01	GO:0038093	Fc receptor signaling pathway	BP
1	3	1.73686081948	-	1.00e-01	GO:0060914	heart formation	BP
1	3	1.73686081948	-	1.00e-01	GO:0034628	'de novo' NAD biosynthetic process from aspartate	BP
1	3	1.73686081948	-	1.00e-01	GO:0044240	multicellular organismal lipid catabolic process	BP
1	3	1.73686081948	-	1.00e-01	GO:0038171	cannabinoid signaling pathway	BP
1	3	1.73686081948	-	1.00e-01	GO:0042369	vitamin D catabolic process	BP
1	3	1.73686081948	-	1.00e-01	GO:0002093	auditory receptor cell morphogenesis	BP
1	3	1.73686081948	-	1.00e-01	GO:0086047	membrane depolarization during Purkinje myocyte cell action potential	BP
1	3	1.73686081948	-	1.00e-01	GO:0060447	bud outgrowth involved in lung branching	BP
2	6	1.73686081948	-	1.14e-01	GO:0046632	alpha-beta T cell differentiation	BP
2	6	1.73686081948	-	1.14e-01	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
2	6	1.73686081948	-	1.14e-01	GO:0014910	regulation of smooth muscle cell migration	BP
2	6	1.73686081948	-	1.14e-01	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	BP
2	6	1.73686081948	-	1.14e-01	GO:0046321	positive regulation of fatty acid oxidation	BP
2	6	1.73686081948	-	1.14e-01	GO:0090166	Golgi disassembly	BP
2	6	1.73686081948	-	1.14e-01	GO:0035900	response to isolation stress	BP
2	6	1.73686081948	-	1.14e-01	GO:0055013	cardiac muscle cell development	BP
2	6	1.73686081948	-	1.14e-01	GO:1903715	regulation of aerobic respiration	BP
2	6	1.73686081948	-	1.14e-01	GO:0003223	ventricular compact myocardium morphogenesis	BP
2	6	1.73686081948	-	1.14e-01	GO:0036006	cellular response to macrophage colony-stimulating factor stimulus	BP
2	6	1.73686081948	-	1.14e-01	GO:0097755	positive regulation of blood vessel diameter	BP
2	6	1.73686081948	-	1.14e-01	GO:0003309	type B pancreatic cell differentiation	BP
2	6	1.73686081948	-	1.14e-01	GO:1904354	negative regulation of telomere capping	BP
2	6	1.73686081948	-	1.14e-01	GO:0060770	negative regulation of epithelial cell proliferation involved in prostate gland development	BP
2	6	1.73686081948	-	1.14e-01	GO:0060501	positive regulation of epithelial cell proliferation involved in lung morphogenesis	BP
2	6	1.73686081948	-	1.14e-01	GO:1903140	regulation of establishment of endothelial barrier	BP
2	6	1.73686081948	-	1.14e-01	GO:0061154	endothelial tube morphogenesis	BP
2	6	1.73686081948	-	1.14e-01	GO:0051353	positive regulation of oxidoreductase activity	BP
2	6	1.73686081948	-	1.14e-01	GO:0071476	cellular hypotonic response	BP
2	6	1.73686081948	-	1.14e-01	GO:0071474	cellular hyperosmotic response	BP
2	6	1.73686081948	-	1.14e-01	GO:0033601	positive regulation of mammary gland epithelial cell proliferation	BP
2	6	1.73686081948	-	1.14e-01	GO:0035520	monoubiquitinated protein deubiquitination	BP
2	6	1.73686081948	-	1.14e-01	GO:0048668	collateral sprouting	BP
2	6	1.73686081948	-	1.14e-01	GO:0001553	luteinization	BP
2	6	1.73686081948	-	1.14e-01	GO:2000052	positive regulation of non-canonical Wnt signaling pathway	BP
2	6	1.73686081948	-	1.14e-01	GO:0001765	membrane raft assembly	BP
2	6	1.73686081948	-	1.14e-01	GO:0032873	negative regulation of stress-activated MAPK cascade	BP
2	6	1.73686081948	-	1.14e-01	GO:0090279	regulation of calcium ion import	BP
2	6	1.73686081948	-	1.14e-01	GO:0032680	regulation of tumor necrosis factor production	BP
2	6	1.73686081948	-	1.14e-01	GO:1990000	amyloid fibril formation	BP
2	6	1.73686081948	-	1.14e-01	GO:0051346	negative regulation of hydrolase activity	BP
2	6	1.73686081948	-	1.14e-01	GO:0033194	response to hydroperoxide	BP
2	6	1.73686081948	-	1.14e-01	GO:0010035	response to inorganic substance	BP
2	6	1.73686081948	-	1.14e-01	GO:0007044	cell-substrate junction assembly	BP
2	6	1.73686081948	-	1.14e-01	GO:0035897	proteolysis in other organism	BP
2	6	1.73686081948	-	1.14e-01	GO:0051573	negative regulation of histone H3-K9 methylation	BP
2	6	1.73686081948	-	1.14e-01	GO:0007435	salivary gland morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0010751	negative regulation of nitric oxide mediated signal transduction	BP
1	3	1.73686081948	-	1.90e-01	GO:0048732	gland development	BP
1	3	1.73686081948	-	1.90e-01	GO:0002554	serotonin secretion by platelet	BP
1	3	1.73686081948	-	1.90e-01	GO:1990418	response to insulin-like growth factor stimulus	BP
1	3	1.73686081948	-	1.90e-01	GO:0002374	cytokine secretion involved in immune response	BP
1	3	1.73686081948	-	1.90e-01	GO:0034136	negative regulation of toll-like receptor 2 signaling pathway	BP
1	3	1.73686081948	-	1.90e-01	GO:0061368	behavioral response to formalin induced pain	BP
1	3	1.73686081948	-	1.90e-01	GO:0045950	negative regulation of mitotic recombination	BP
1	3	1.73686081948	-	1.90e-01	GO:1904693	midbrain morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:1904694	negative regulation of vascular smooth muscle contraction	BP
1	3	1.73686081948	-	1.90e-01	GO:0002667	regulation of T cell anergy	BP
1	3	1.73686081948	-	1.90e-01	GO:0060066	oviduct development	BP
1	3	1.73686081948	-	1.90e-01	GO:0032289	central nervous system myelin formation	BP
1	3	1.73686081948	-	1.90e-01	GO:2000035	regulation of stem cell division	BP
1	3	1.73686081948	-	1.90e-01	GO:0045726	positive regulation of integrin biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0072278	metanephric comma-shaped body morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0032732	positive regulation of interleukin-1 production	BP
1	3	1.73686081948	-	1.90e-01	GO:0001781	neutrophil apoptotic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0001787	natural killer cell proliferation	BP
1	3	1.73686081948	-	1.90e-01	GO:0061031	endodermal digestive tract morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:2000078	positive regulation of type B pancreatic cell development	BP
1	3	1.73686081948	-	1.90e-01	GO:0009436	glyoxylate catabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0051797	regulation of hair follicle development	BP
1	3	1.73686081948	-	1.90e-01	GO:0055014	atrial cardiac muscle cell development	BP
1	3	1.73686081948	-	1.90e-01	GO:0061146	Peyer's patch morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0002369	T cell cytokine production	BP
1	3	1.73686081948	-	1.90e-01	GO:0072600	establishment of protein localization to Golgi	BP
1	3	1.73686081948	-	1.90e-01	GO:0031223	auditory behavior	BP
1	3	1.73686081948	-	1.90e-01	GO:0044336	canonical Wnt signaling pathway involved in negative regulation of apoptotic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0034625	fatty acid elongation, monounsaturated fatty acid	BP
1	3	1.73686081948	-	1.90e-01	GO:0010573	vascular endothelial growth factor production	BP
1	3	1.73686081948	-	1.90e-01	GO:0032596	protein transport into membrane raft	BP
1	3	1.73686081948	-	1.90e-01	GO:0051490	negative regulation of filopodium assembly	BP
1	3	1.73686081948	-	1.90e-01	GO:0030718	germ-line stem cell population maintenance	BP
1	3	1.73686081948	-	1.90e-01	GO:0035701	hematopoietic stem cell migration	BP
1	3	1.73686081948	-	1.90e-01	GO:0070634	transepithelial ammonium transport	BP
1	3	1.73686081948	-	1.90e-01	GO:0002774	Fc receptor mediated inhibitory signaling pathway	BP
1	3	1.73686081948	-	1.90e-01	GO:0071543	diphosphoinositol polyphosphate metabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0042997	negative regulation of Golgi to plasma membrane protein transport	BP
1	3	1.73686081948	-	1.90e-01	GO:1904667	negative regulation of ubiquitin protein ligase activity	BP
1	3	1.73686081948	-	1.90e-01	GO:0007418	ventral midline development	BP
1	3	1.73686081948	-	1.90e-01	GO:0010909	positive regulation of heparan sulfate proteoglycan biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0048382	mesendoderm development	BP
1	3	1.73686081948	-	1.90e-01	GO:0021502	neural fold elevation formation	BP
1	3	1.73686081948	-	1.90e-01	GO:0003192	mitral valve formation	BP
1	3	1.73686081948	-	1.90e-01	GO:0030104	water homeostasis	BP
1	3	1.73686081948	-	1.90e-01	GO:0072050	S-shaped body morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0032696	negative regulation of interleukin-13 production	BP
1	3	1.73686081948	-	1.90e-01	GO:0010866	regulation of triglyceride biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0033326	cerebrospinal fluid secretion	BP
1	3	1.73686081948	-	1.90e-01	GO:0010980	positive regulation of vitamin D 24-hydroxylase activity	BP
1	3	1.73686081948	-	1.90e-01	GO:0048302	regulation of isotype switching to IgG isotypes	BP
1	3	1.73686081948	-	1.90e-01	GO:1900042	positive regulation of interleukin-2 secretion	BP
1	3	1.73686081948	-	1.90e-01	GO:0043585	nose morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0072350	tricarboxylic acid metabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0002820	negative regulation of adaptive immune response	BP
1	3	1.73686081948	-	1.90e-01	GO:0070970	interleukin-2 secretion	BP
1	3	1.73686081948	-	1.90e-01	GO:0016476	regulation of embryonic cell shape	BP
1	3	1.73686081948	-	1.90e-01	GO:0003358	noradrenergic neuron development	BP
1	3	1.73686081948	-	1.90e-01	GO:0003350	pulmonary myocardium development	BP
1	3	1.73686081948	-	1.90e-01	GO:0032485	regulation of Ral protein signal transduction	BP
1	3	1.73686081948	-	1.90e-01	GO:2001140	positive regulation of phospholipid transport	BP
1	3	1.73686081948	-	1.90e-01	GO:0034766	negative regulation of ion transmembrane transport	BP
1	3	1.73686081948	-	1.90e-01	GO:0009396	folic acid-containing compound biosynthetic process	BP
1	3	1.73686081948	-	1.90e-01	GO:1904383	response to sodium phosphate	BP
1	3	1.73686081948	-	1.90e-01	GO:0019062	virion attachment to host cell	BP
1	3	1.73686081948	-	1.90e-01	GO:0086048	membrane depolarization during bundle of His cell action potential	BP
1	3	1.73686081948	-	1.90e-01	GO:0072049	comma-shaped body morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0015742	alpha-ketoglutarate transport	BP
1	3	1.73686081948	-	1.90e-01	GO:0036023	embryonic skeletal limb joint morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:1902617	response to fluoride	BP
1	3	1.73686081948	-	1.90e-01	GO:0042668	auditory receptor cell fate determination	BP
1	3	1.73686081948	-	1.90e-01	GO:0072044	collecting duct development	BP
1	3	1.73686081948	-	1.90e-01	GO:2000381	negative regulation of mesoderm development	BP
1	3	1.73686081948	-	1.90e-01	GO:1903215	negative regulation of protein targeting to mitochondrion	BP
1	3	1.73686081948	-	1.90e-01	GO:0071930	negative regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
1	3	1.73686081948	-	1.90e-01	GO:0043369	CD4-positive or CD8-positive, alpha-beta T cell lineage commitment	BP
1	3	1.73686081948	-	1.90e-01	GO:0006007	glucose catabolic process	BP
1	3	1.73686081948	-	1.90e-01	GO:0035720	intraciliary anterograde transport	BP
1	3	1.73686081948	-	1.90e-01	GO:2000479	regulation of cAMP-dependent protein kinase activity	BP
1	3	1.73686081948	-	1.90e-01	GO:0072133	metanephric mesenchyme morphogenesis	BP
1	3	1.73686081948	-	1.90e-01	GO:0072136	metanephric mesenchymal cell proliferation involved in metanephros development	BP
1	3	1.73686081948	-	1.90e-01	GO:0010454	negative regulation of cell fate commitment	BP
1	3	1.73686081948	-	1.90e-01	GO:1904339	negative regulation of dopaminergic neuron differentiation	BP
1	3	1.73686081948	-	1.90e-01	GO:0050954	sensory perception of mechanical stimulus	BP
1	3	1.73686081948	-	1.90e-01	GO:0007060	male meiosis chromosome segregation	BP
1	3	1.73686081948	-	1.90e-01	GO:0042508	tyrosine phosphorylation of Stat1 protein	BP
1	3	1.73686081948	-	1.90e-01	GO:1902093	positive regulation of flagellated sperm motility	BP
1	3	1.73686081948	-	1.90e-01	GO:0048017	inositol lipid-mediated signaling	BP
1	3	1.73686081948	-	1.90e-01	GO:0042427	serotonin biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0034776	response to histamine	BP
1	3	1.73686081948	-	2.71e-01	GO:0060266	negative regulation of respiratory burst involved in inflammatory response	BP
1	3	1.73686081948	-	2.71e-01	GO:0002457	T cell antigen processing and presentation	BP
1	3	1.73686081948	-	2.71e-01	GO:0002331	pre-B cell allelic exclusion	BP
1	3	1.73686081948	-	2.71e-01	GO:0033387	putrescine biosynthetic process from ornithine	BP
1	3	1.73686081948	-	2.71e-01	GO:0097155	fasciculation of sensory neuron axon	BP
1	3	1.73686081948	-	2.71e-01	GO:1903984	positive regulation of TRAIL-activated apoptotic signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0035993	deltoid tuberosity development	BP
1	3	1.73686081948	-	2.71e-01	GO:0043415	positive regulation of skeletal muscle tissue regeneration	BP
1	3	1.73686081948	-	2.71e-01	GO:0070562	regulation of vitamin D receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0072125	negative regulation of glomerular mesangial cell proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0044346	fibroblast apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0060923	cardiac muscle cell fate commitment	BP
1	3	1.73686081948	-	2.71e-01	GO:0060350	endochondral bone morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0006499	N-terminal protein myristoylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0035617	stress granule disassembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0060492	lung induction	BP
1	3	1.73686081948	-	2.71e-01	GO:0060491	regulation of cell projection assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	BP
1	3	1.73686081948	-	2.71e-01	GO:2001016	positive regulation of skeletal muscle cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0001773	myeloid dendritic cell activation	BP
1	3	1.73686081948	-	2.71e-01	GO:0071494	cellular response to UV-C	BP
1	3	1.73686081948	-	2.71e-01	GO:0034137	positive regulation of toll-like receptor 2 signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0000054	ribosomal subunit export from nucleus	BP
1	3	1.73686081948	-	2.71e-01	GO:0008218	bioluminescence	BP
1	3	1.73686081948	-	2.71e-01	GO:1903748	negative regulation of establishment of protein localization to mitochondrion	BP
1	3	1.73686081948	-	2.71e-01	GO:0016052	carbohydrate catabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:1904031	positive regulation of cyclin-dependent protein kinase activity	BP
1	3	1.73686081948	-	2.71e-01	GO:0031937	positive regulation of chromatin silencing	BP
1	3	1.73686081948	-	2.71e-01	GO:1900452	regulation of long term synaptic depression	BP
1	3	1.73686081948	-	2.71e-01	GO:1900024	regulation of substrate adhesion-dependent cell spreading	BP
1	3	1.73686081948	-	2.71e-01	GO:0046209	nitric oxide metabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0030538	embryonic genitalia morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0098904	regulation of AV node cell action potential	BP
1	3	1.73686081948	-	2.71e-01	GO:0098903	regulation of membrane repolarization during action potential	BP
1	3	1.73686081948	-	2.71e-01	GO:0098908	regulation of neuronal action potential	BP
1	3	1.73686081948	-	2.71e-01	GO:0010560	positive regulation of glycoprotein biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0031587	positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	BP
1	3	1.73686081948	-	2.71e-01	GO:0015874	norepinephrine transport	BP
1	3	1.73686081948	-	2.71e-01	GO:0002669	positive regulation of T cell anergy	BP
1	3	1.73686081948	-	2.71e-01	GO:0030043	actin filament fragmentation	BP
1	3	1.73686081948	-	2.71e-01	GO:1904996	positive regulation of leukocyte adhesion to vascular endothelial cell	BP
1	3	1.73686081948	-	2.71e-01	GO:0008298	intracellular mRNA localization	BP
1	3	1.73686081948	-	2.71e-01	GO:0030001	metal ion transport	BP
1	3	1.73686081948	-	2.71e-01	GO:0014043	negative regulation of neuron maturation	BP
1	3	1.73686081948	-	2.71e-01	GO:0014041	regulation of neuron maturation	BP
1	3	1.73686081948	-	2.71e-01	GO:0003331	positive regulation of extracellular matrix constituent secretion	BP
1	3	1.73686081948	-	2.71e-01	GO:0060024	rhythmic synaptic transmission	BP
1	3	1.73686081948	-	2.71e-01	GO:1903660	negative regulation of complement-dependent cytotoxicity	BP
1	3	1.73686081948	-	2.71e-01	GO:2000074	regulation of type B pancreatic cell development	BP
1	3	1.73686081948	-	2.71e-01	GO:0071389	cellular response to mineralocorticoid stimulus	BP
1	3	1.73686081948	-	2.71e-01	GO:0071386	cellular response to corticosterone stimulus	BP
1	3	1.73686081948	-	2.71e-01	GO:0060559	positive regulation of calcidiol 1-monooxygenase activity	BP
1	3	1.73686081948	-	2.71e-01	GO:0048871	multicellular organismal homeostasis	BP
1	3	1.73686081948	-	2.71e-01	GO:0055098	response to low-density lipoprotein particle	BP
1	3	1.73686081948	-	2.71e-01	GO:0055096	low-density lipoprotein particle mediated signaling	BP
1	3	1.73686081948	-	2.71e-01	GO:1901896	positive regulation of calcium-transporting ATPase activity	BP
1	3	1.73686081948	-	2.71e-01	GO:1901897	regulation of relaxation of cardiac muscle	BP
1	3	1.73686081948	-	2.71e-01	GO:0034435	cholesterol esterification	BP
1	3	1.73686081948	-	2.71e-01	GO:0046320	regulation of fatty acid oxidation	BP
1	3	1.73686081948	-	2.71e-01	GO:0089700	protein kinase D signaling	BP
1	3	1.73686081948	-	2.71e-01	GO:0060743	epithelial cell maturation involved in prostate gland development	BP
1	3	1.73686081948	-	2.71e-01	GO:0060745	mammary gland branching involved in pregnancy	BP
1	3	1.73686081948	-	2.71e-01	GO:0048936	peripheral nervous system neuron axonogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:1904798	positive regulation of core promoter binding	BP
1	3	1.73686081948	-	2.71e-01	GO:0051612	negative regulation of serotonin uptake	BP
1	3	1.73686081948	-	2.71e-01	GO:1990928	response to amino acid starvation	BP
1	3	1.73686081948	-	2.71e-01	GO:0090312	positive regulation of protein deacetylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0021885	forebrain cell migration	BP
1	3	1.73686081948	-	2.71e-01	GO:0021773	striatal medium spiny neuron differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0071899	negative regulation of estrogen receptor binding	BP
1	3	1.73686081948	-	2.71e-01	GO:0071895	odontoblast differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0003413	chondrocyte differentiation involved in endochondral bone morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0048769	sarcomerogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:2000286	receptor internalization involved in canonical Wnt signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0021965	spinal cord ventral commissure morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0045608	negative regulation of auditory receptor cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0072537	fibroblast activation	BP
1	3	1.73686081948	-	2.71e-01	GO:0035583	sequestering of TGFbeta in extracellular matrix	BP
1	3	1.73686081948	-	2.71e-01	GO:0036462	TRAIL-activated apoptotic signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:2000619	negative regulation of histone H4-K16 acetylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0060215	primitive hemopoiesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0006114	glycerol biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0014854	response to inactivity	BP
1	3	1.73686081948	-	2.71e-01	GO:0015722	canalicular bile acid transport	BP
1	3	1.73686081948	-	2.71e-01	GO:1902263	apoptotic process involved in embryonic digit morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:1902268	negative regulation of polyamine transmembrane transport	BP
1	3	1.73686081948	-	2.71e-01	GO:0045061	thymic T cell selection	BP
1	3	1.73686081948	-	2.71e-01	GO:0045069	regulation of viral genome replication	BP
1	3	1.73686081948	-	2.71e-01	GO:0034140	negative regulation of toll-like receptor 3 signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:2001212	regulation of vasculogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0038123	toll-like receptor TLR1:TLR2 signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0048294	negative regulation of isotype switching to IgE isotypes	BP
1	3	1.73686081948	-	2.71e-01	GO:0048298	positive regulation of isotype switching to IgA isotypes	BP
1	3	1.73686081948	-	2.71e-01	GO:0035986	senescence-associated heterochromatin focus assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0010871	negative regulation of receptor biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0045351	type I interferon biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0060379	cardiac muscle cell myoblast differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0051280	negative regulation of release of sequestered calcium ion into cytosol	BP
1	3	1.73686081948	-	2.71e-01	GO:0033688	regulation of osteoblast proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:1903238	positive regulation of leukocyte tethering or rolling	BP
1	3	1.73686081948	-	2.71e-01	GO:1902186	regulation of viral release from host cell	BP
1	3	1.73686081948	-	2.71e-01	GO:1902306	negative regulation of sodium ion transmembrane transport	BP
1	3	1.73686081948	-	2.71e-01	GO:1902309	negative regulation of peptidyl-serine dephosphorylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0098910	regulation of atrial cardiac muscle cell action potential	BP
1	3	1.73686081948	-	2.71e-01	GO:0001812	positive regulation of type I hypersensitivity	BP
1	3	1.73686081948	-	2.71e-01	GO:0031063	regulation of histone deacetylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0070672	response to interleukin-15	BP
1	3	1.73686081948	-	2.71e-01	GO:0070671	response to interleukin-12	BP
1	3	1.73686081948	-	2.71e-01	GO:1901491	negative regulation of lymphangiogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:1902856	negative regulation of non-motile cilium assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0019218	regulation of steroid metabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0000350	generation of catalytic spliceosome for second transesterification step	BP
1	3	1.73686081948	-	2.71e-01	GO:0039530	MDA-5 signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0070358	actin polymerization-dependent cell motility	BP
1	3	1.73686081948	-	2.71e-01	GO:1900738	positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:1903421	regulation of synaptic vesicle recycling	BP
1	3	1.73686081948	-	2.71e-01	GO:0009912	auditory receptor cell fate commitment	BP
1	3	1.73686081948	-	2.71e-01	GO:0099590	neurotransmitter receptor internalization	BP
1	3	1.73686081948	-	2.71e-01	GO:0018394	peptidyl-lysine acetylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0010644	cell communication by electrical coupling	BP
1	3	1.73686081948	-	2.71e-01	GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0021587	cerebellum morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:1902731	negative regulation of chondrocyte proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0016447	somatic recombination of immunoglobulin gene segments	BP
1	3	1.73686081948	-	2.71e-01	GO:0090324	negative regulation of oxidative phosphorylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0006438	valyl-tRNA aminoacylation	BP
1	3	1.73686081948	-	2.71e-01	GO:0021545	cranial nerve development	BP
1	3	1.73686081948	-	2.71e-01	GO:1902951	negative regulation of dendritic spine maintenance	BP
1	3	1.73686081948	-	2.71e-01	GO:0071500	cellular response to nitrosative stress	BP
1	3	1.73686081948	-	2.71e-01	GO:0035973	aggrephagy	BP
1	3	1.73686081948	-	2.71e-01	GO:1902897	regulation of postsynaptic density protein 95 clustering	BP
1	3	1.73686081948	-	2.71e-01	GO:0023021	termination of signal transduction	BP
1	3	1.73686081948	-	2.71e-01	GO:0051250	negative regulation of lymphocyte activation	BP
1	3	1.73686081948	-	2.71e-01	GO:0090204	protein localization to nuclear pore	BP
1	3	1.73686081948	-	2.71e-01	GO:1903551	regulation of extracellular exosome assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0030859	polarized epithelial cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:2001170	negative regulation of ATP biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0048388	endosomal lumen acidification	BP
1	3	1.73686081948	-	2.71e-01	GO:0048385	regulation of retinoic acid receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0002904	positive regulation of B cell apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:1901797	negative regulation of signal transduction by p53 class mediator	BP
1	3	1.73686081948	-	2.71e-01	GO:0033861	negative regulation of NAD(P)H oxidase activity	BP
1	3	1.73686081948	-	2.71e-01	GO:0072017	distal tubule development	BP
1	3	1.73686081948	-	2.71e-01	GO:0072011	glomerular endothelium development	BP
1	3	1.73686081948	-	2.71e-01	GO:0060126	somatotropin secreting cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0001754	eye photoreceptor cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0044752	response to human chorionic gonadotropin	BP
1	3	1.73686081948	-	2.71e-01	GO:2000669	negative regulation of dendritic cell apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0003274	endocardial cushion fusion	BP
1	3	1.73686081948	-	2.71e-01	GO:0046058	cAMP metabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0060948	cardiac vascular smooth muscle cell development	BP
1	3	1.73686081948	-	2.71e-01	GO:0060160	negative regulation of dopamine receptor signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0019448	L-cysteine catabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0034112	positive regulation of homotypic cell-cell adhesion	BP
1	3	1.73686081948	-	2.71e-01	GO:0051707	response to other organism	BP
1	3	1.73686081948	-	2.71e-01	GO:0019932	second-messenger-mediated signaling	BP
1	3	1.73686081948	-	2.71e-01	GO:0034465	response to carbon monoxide	BP
1	3	1.73686081948	-	2.71e-01	GO:0090435	protein localization to nuclear envelope	BP
1	3	1.73686081948	-	2.71e-01	GO:0010829	negative regulation of glucose transport	BP
1	3	1.73686081948	-	2.71e-01	GO:1903598	positive regulation of gap junction assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0000819	sister chromatid segregation	BP
1	3	1.73686081948	-	2.71e-01	GO:0048625	myoblast fate commitment	BP
1	3	1.73686081948	-	2.71e-01	GO:0070093	negative regulation of glucagon secretion	BP
1	3	1.73686081948	-	2.71e-01	GO:0003095	pressure natriuresis	BP
1	3	1.73686081948	-	2.71e-01	GO:0070669	response to interleukin-2	BP
1	3	1.73686081948	-	2.71e-01	GO:1900212	negative regulation of mesenchymal cell apoptotic process involved in metanephros development	BP
1	3	1.73686081948	-	2.71e-01	GO:0045123	cellular extravasation	BP
1	3	1.73686081948	-	2.71e-01	GO:0071173	spindle assembly checkpoint	BP
1	3	1.73686081948	-	2.71e-01	GO:0060083	smooth muscle contraction involved in micturition	BP
1	3	1.73686081948	-	2.71e-01	GO:0097049	motor neuron apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0031998	regulation of fatty acid beta-oxidation	BP
1	3	1.73686081948	-	2.71e-01	GO:0032053	ciliary basal body organization	BP
1	3	1.73686081948	-	2.71e-01	GO:0035886	vascular smooth muscle cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0045163	clustering of voltage-gated potassium channels	BP
1	3	1.73686081948	-	2.71e-01	GO:2000195	negative regulation of female gonad development	BP
1	3	1.73686081948	-	2.71e-01	GO:0071733	transcriptional activation by promoter-enhancer looping	BP
1	3	1.73686081948	-	2.71e-01	GO:0030223	neutrophil differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0060763	mammary duct terminal end bud growth	BP
1	3	1.73686081948	-	2.71e-01	GO:0001555	oocyte growth	BP
1	3	1.73686081948	-	2.71e-01	GO:0034201	response to oleic acid	BP
1	3	1.73686081948	-	2.71e-01	GO:0060688	regulation of morphogenesis of a branching structure	BP
1	3	1.73686081948	-	2.71e-01	GO:0045200	establishment of neuroblast polarity	BP
1	3	1.73686081948	-	2.71e-01	GO:0022007	convergent extension involved in neural plate elongation	BP
1	3	1.73686081948	-	2.71e-01	GO:0002408	myeloid dendritic cell chemotaxis	BP
1	3	1.73686081948	-	2.71e-01	GO:0051586	positive regulation of dopamine uptake involved in synaptic transmission	BP
1	3	1.73686081948	-	2.71e-01	GO:0032488	Cdc42 protein signal transduction	BP
1	3	1.73686081948	-	2.71e-01	GO:0030888	regulation of B cell proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0033687	osteoblast proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0021553	olfactory nerve development	BP
1	3	1.73686081948	-	2.71e-01	GO:0003256	regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0032608	interferon-beta production	BP
1	3	1.73686081948	-	2.71e-01	GO:0000720	pyrimidine dimer repair by nucleotide-excision repair	BP
1	3	1.73686081948	-	2.71e-01	GO:0001936	regulation of endothelial cell proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:1901315	negative regulation of histone H2A K63-linked ubiquitination	BP
1	3	1.73686081948	-	2.71e-01	GO:1902593	single-organism nuclear import	BP
1	3	1.73686081948	-	2.71e-01	GO:0045007	depurination	BP
1	3	1.73686081948	-	2.71e-01	GO:0070168	negative regulation of biomineral tissue development	BP
1	3	1.73686081948	-	2.71e-01	GO:0061684	chaperone-mediated autophagy	BP
1	3	1.73686081948	-	2.71e-01	GO:0097286	iron ion import	BP
1	3	1.73686081948	-	2.71e-01	GO:0060154	cellular process regulating host cell cycle in response to virus	BP
1	3	1.73686081948	-	2.71e-01	GO:2001027	negative regulation of endothelial cell chemotaxis	BP
1	3	1.73686081948	-	2.71e-01	GO:0002158	osteoclast proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0051882	mitochondrial depolarization	BP
1	3	1.73686081948	-	2.71e-01	GO:1900126	negative regulation of hyaluronan biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:2000670	positive regulation of dendritic cell apoptotic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0060313	negative regulation of blood vessel remodeling	BP
1	3	1.73686081948	-	2.71e-01	GO:0033152	immunoglobulin V(D)J recombination	BP
1	3	1.73686081948	-	2.71e-01	GO:0044313	protein K6-linked deubiquitination	BP
1	3	1.73686081948	-	2.71e-01	GO:0018242	protein O-linked glycosylation via serine	BP
1	3	1.73686081948	-	2.71e-01	GO:0060197	cloacal septation	BP
1	3	1.73686081948	-	2.71e-01	GO:1903378	positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:2001274	negative regulation of glucose import in response to insulin stimulus	BP
1	3	1.73686081948	-	2.71e-01	GO:0060312	regulation of blood vessel remodeling	BP
1	3	1.73686081948	-	2.71e-01	GO:0090230	regulation of centromere complex assembly	BP
1	3	1.73686081948	-	2.71e-01	GO:1903774	positive regulation of viral budding via host ESCRT complex	BP
1	3	1.73686081948	-	2.71e-01	GO:1903772	regulation of viral budding via host ESCRT complex	BP
1	3	1.73686081948	-	2.71e-01	GO:0032765	positive regulation of mast cell cytokine production	BP
1	3	1.73686081948	-	2.71e-01	GO:0071871	response to epinephrine	BP
1	3	1.73686081948	-	2.71e-01	GO:0045715	negative regulation of low-density lipoprotein particle receptor biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0035494	SNARE complex disassembly	BP
1	3	1.73686081948	-	2.71e-01	GO:0046890	regulation of lipid biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0032252	secretory granule localization	BP
1	3	1.73686081948	-	2.71e-01	GO:1903679	positive regulation of cap-independent translational initiation	BP
1	3	1.73686081948	-	2.71e-01	GO:0001560	regulation of cell growth by extracellular stimulus	BP
1	3	1.73686081948	-	2.71e-01	GO:0072282	metanephric nephron tubule morphogenesis	BP
1	3	1.73686081948	-	2.71e-01	GO:0035722	interleukin-12-mediated signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0019858	cytosine metabolic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0071727	cellular response to triacyl bacterial lipopeptide	BP
1	3	1.73686081948	-	2.71e-01	GO:1990167	protein K27-linked deubiquitination	BP
1	3	1.73686081948	-	2.71e-01	GO:1990168	protein K33-linked deubiquitination	BP
1	3	1.73686081948	-	2.71e-01	GO:0032946	positive regulation of mononuclear cell proliferation	BP
1	3	1.73686081948	-	2.71e-01	GO:0061577	calcium ion transmembrane transport via high voltage-gated calcium channel	BP
1	3	1.73686081948	-	2.71e-01	GO:1904646	cellular response to beta-amyloid	BP
1	3	1.73686081948	-	2.71e-01	GO:1904645	response to beta-amyloid	BP
1	3	1.73686081948	-	2.71e-01	GO:2000370	positive regulation of clathrin-dependent endocytosis	BP
1	3	1.73686081948	-	2.71e-01	GO:0033563	dorsal/ventral axon guidance	BP
1	3	1.73686081948	-	2.71e-01	GO:0002277	myeloid dendritic cell activation involved in immune response	BP
1	3	1.73686081948	-	2.71e-01	GO:0048014	Tie signaling pathway	BP
1	3	1.73686081948	-	2.71e-01	GO:0045425	positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process	BP
1	3	1.73686081948	-	2.71e-01	GO:0010992	ubiquitin homeostasis	BP
8	24	1.73686081948	-	1.67e-03	GO:0043425	bHLH transcription factor binding	MF
6	18	1.73686081948	-	4.64e-03	GO:0008157	protein phosphatase 1 binding	MF
6	18	1.73686081948	-	6.38e-03	GO:0051019	mitogen-activated protein kinase binding	MF
2	6	1.73686081948	-	9.99e-03	GO:0003828	alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity	MF
2	6	1.73686081948	-	2.80e-02	GO:0045545	syndecan binding	MF
3	9	1.73686081948	-	3.81e-02	GO:0030291	protein serine/threonine kinase inhibitor activity	MF
3	9	1.73686081948	-	3.81e-02	GO:0045236	CXCR chemokine receptor binding	MF
2	6	1.73686081948	-	5.23e-02	GO:0004630	phospholipase D activity	MF
2	6	1.73686081948	-	5.23e-02	GO:0070097	delta-catenin binding	MF
3	9	1.73686081948	-	5.29e-02	GO:0034713	type I transforming growth factor beta receptor binding	MF
3	9	1.73686081948	-	5.29e-02	GO:0019887	protein kinase regulator activity	MF
3	9	1.73686081948	-	5.29e-02	GO:0019855	calcium channel inhibitor activity	MF
2	6	1.73686081948	-	8.14e-02	GO:0004430	1-phosphatidylinositol 4-kinase activity	MF
1	3	1.73686081948	-	1.00e-01	GO:0004949	cannabinoid receptor activity	MF
1	3	1.73686081948	-	1.00e-01	GO:0000309	nicotinamide-nucleotide adenylyltransferase activity	MF
1	3	1.73686081948	-	1.00e-01	GO:0030298	receptor signaling protein tyrosine kinase activator activity	MF
2	6	1.73686081948	-	1.14e-01	GO:1990782	protein tyrosine kinase binding	MF
2	6	1.73686081948	-	1.14e-01	GO:0048406	nerve growth factor binding	MF
2	6	1.73686081948	-	1.14e-01	GO:0016004	phospholipase activator activity	MF
2	6	1.73686081948	-	1.14e-01	GO:0030275	LRR domain binding	MF
2	6	1.73686081948	-	1.14e-01	GO:0019237	centromeric DNA binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0030369	ICAM-3 receptor activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0019958	C-X-C chemokine binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0019862	IgA binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0048403	brain-derived neurotrophic factor binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0052812	phosphatidylinositol-3,4-bisphosphate 5-kinase activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0070573	metallodipeptidase activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0035276	ethanol binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0015403	thiamine uptake transmembrane transporter activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0015234	thiamine transmembrane transporter activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0004117	calmodulin-dependent cyclic-nucleotide phosphodiesterase activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0023024	MHC class I protein complex binding	MF
1	3	1.73686081948	-	1.90e-01	GO:1990050	phosphatidic acid transporter activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0060002	plus-end directed microfilament motor activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0003941	L-serine ammonia-lyase activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0046625	sphingolipid binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0097677	STAT family protein binding	MF
1	3	1.73686081948	-	1.90e-01	GO:0015299	solute:proton antiporter activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0005277	acetylcholine transmembrane transporter activity	MF
1	3	1.73686081948	-	1.90e-01	GO:0008321	Ral guanyl-nucleotide exchange factor activity	MF
1	3	1.73686081948	-	1.90e-01	GO:1902936	phosphatidylinositol bisphosphate binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0035614	snRNA stem-loop binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0086056	voltage-gated calcium channel activity involved in AV node cell action potential	MF
1	3	1.73686081948	-	2.71e-01	GO:0061676	importin-alpha family protein binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0001159	core promoter proximal region DNA binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0032139	dinucleotide insertion or deletion binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0001012	RNA polymerase II regulatory region DNA binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0070644	vitamin D response element binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0004332	fructose-bisphosphate aldolase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0005157	macrophage colony-stimulating factor receptor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0034979	NAD-dependent protein deacetylase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0044729	hemi-methylated DNA-binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0035662	Toll-like receptor 4 binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0035663	Toll-like receptor 2 binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0030172	troponin C binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0032142	single guanine insertion binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0016278	lysine N-methyltransferase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0005010	insulin-like growth factor-activated receptor activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0019211	phosphatase activator activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0015616	DNA translocase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0005166	neurotrophin p75 receptor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0004832	valine-tRNA ligase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0034714	type III transforming growth factor beta receptor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0005333	norepinephrine transmembrane transporter activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0047045	testosterone 17-beta-dehydrogenase (NADP+) activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0017136	NAD-dependent histone deacetylase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0004396	hexokinase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0004563	beta-N-acetylhexosaminidase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0008073	ornithine decarboxylase inhibitor activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0070095	fructose-6-phosphate binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0003872	6-phosphofructokinase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0004882	androgen receptor activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0004886	9-cis retinoic acid receptor activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0032564	dATP binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0008513	secondary active organic cation transmembrane transporter activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0031826	type 2A serotonin receptor binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0004060	arylamine N-acetyltransferase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0034648	histone demethylase activity (H3-dimethyl-K4 specific)	MF
1	3	1.73686081948	-	2.71e-01	GO:0005220	inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0097016	L27 domain binding	MF
1	3	1.73686081948	-	2.71e-01	GO:0004517	nitric-oxide synthase activity	MF
1	3	1.73686081948	-	2.71e-01	GO:0016429	tRNA (adenine-N1-)-methyltransferase activity	MF
9	27	1.73686081948	-	9.39e-05	GO:0031069	hair follicle morphogenesis	BP
7	21	1.73686081948	-	7.77e-04	GO:0071157	negative regulation of cell cycle arrest	BP
7	21	1.73686081948	-	1.68e-03	GO:0042730	fibrinolysis	BP
7	21	1.73686081948	-	1.68e-03	GO:0060999	positive regulation of dendritic spine development	BP
42	127	1.72545605621	-	6.72e-11	GO:0001934	positive regulation of protein phosphorylation	BP
22	67	1.71516574838	-	1.09e-07	GO:0002039	p53 binding	MF
18	55	1.71038860812	-	2.42e-07	GO:0001570	vasculogenesis	BP
29	89	1.70407088436	-	6.89e-10	GO:0007179	transforming growth factor beta receptor signaling pathway	BP
14	43	1.70291348756	-	8.99e-06	GO:0048538	thymus development	BP
13	40	1.70033494345	-	3.38e-05	GO:0097191	extrinsic apoptotic signaling pathway	BP
13	40	1.70033494345	-	6.37e-05	GO:0045429	positive regulation of nitric oxide biosynthetic process	BP
48	148	1.69733245529	-	4.70e-11	GO:0050852	T cell receptor signaling pathway	BP
24	74	1.69733245529	-	5.73e-09	GO:0042060	wound healing	BP
11	34	1.69379209759	-	2.33e-04	GO:0010634	positive regulation of epithelial cell migration	BP
11	34	1.69379209759	-	3.13e-04	GO:1990090	cellular response to nerve growth factor stimulus	BP
19	59	1.68710778428	-	7.34e-07	GO:0001933	negative regulation of protein phosphorylation	BP
54	168	1.68439339959	-	1.06e-10	GO:0030335	positive regulation of cell migration	BP
18	56	1.68439339959	-	7.13e-07	GO:0006950	response to stress	BP
9	28	1.68439339959	-	1.16e-03	GO:0010332	response to gamma radiation	BP
18	56	1.68439339959	-	7.13e-07	GO:0004722	protein serine/threonine phosphatase activity	MF
9	28	1.68439339959	-	1.16e-03	GO:0051059	NF-kappaB binding	MF
17	53	1.68136570689	-	3.60e-06	GO:0004702	signal transducer, downstream of receptor, with serine/threonine kinase activity	MF
8	25	1.67796713043	-	8.69e-04	GO:0046580	negative regulation of Ras protein signal transduction	BP
8	25	1.67796713043	-	1.22e-03	GO:0043542	endothelial cell migration	BP
8	25	1.67796713043	-	2.24e-03	GO:0051149	positive regulation of muscle cell differentiation	BP
14	44	1.66974662362	-	6.25e-06	GO:0030178	negative regulation of Wnt signaling pathway	BP
14	44	1.66974662362	-	6.01e-05	GO:0043525	positive regulation of neuron apoptotic process	BP
7	22	1.66974662362	-	2.37e-03	GO:0046329	negative regulation of JNK cascade	BP
7	22	1.66974662362	-	2.37e-03	GO:1904886	beta-catenin destruction complex disassembly	BP
7	22	1.66974662362	-	3.25e-03	GO:0005978	glycogen biosynthetic process	BP
7	22	1.66974662362	-	3.25e-03	GO:0002092	positive regulation of receptor internalization	BP
7	22	1.66974662362	-	3.25e-03	GO:0071480	cellular response to gamma radiation	BP
7	22	1.66974662362	-	4.36e-03	GO:0001954	positive regulation of cell-matrix adhesion	BP
7	22	1.66974662362	-	4.36e-03	GO:0032465	regulation of cytokinesis	BP
7	22	1.66974662362	-	3.25e-03	GO:0035255	ionotropic glutamate receptor binding	MF
13	41	1.66471103372	-	1.14e-04	GO:0050681	androgen receptor binding	MF
25	79	1.6618987618	-	2.24e-08	GO:0008013	beta-catenin binding	MF
18	57	1.65885830748	-	2.59e-06	GO:0048661	positive regulation of smooth muscle cell proliferation	BP
12	38	1.65885830748	-	3.20e-05	GO:0045597	positive regulation of cell differentiation	BP
6	19	1.65885830748	-	2.24e-03	GO:0002028	regulation of sodium ion transport	BP
6	19	1.65885830748	-	3.28e-03	GO:0030220	platelet formation	BP
6	19	1.65885830748	-	6.38e-03	GO:0045453	bone resorption	BP
6	19	1.65885830748	-	8.55e-03	GO:0043393	regulation of protein binding	BP
12	38	1.65885830748	-	8.91e-05	GO:0004721	phosphoprotein phosphatase activity	MF
12	38	1.65885830748	-	1.22e-04	GO:0001102	RNA polymerase II activating transcription factor binding	MF
17	54	1.65439865929	-	8.84e-06	GO:0045732	positive regulation of protein catabolic process	BP
11	35	1.65197192189	-	2.33e-04	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
15	48	1.64375141509	-	4.19e-05	GO:0007254	JNK cascade	BP
10	32	1.64375141509	-	7.74e-05	GO:0007498	mesoderm development	BP
10	32	1.64375141509	-	6.01e-04	GO:0046677	response to antibiotic	BP
10	32	1.64375141509	-	7.96e-04	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	BP
10	32	1.64375141509	-	7.96e-04	GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway	BP
5	16	1.64375141509	-	6.43e-03	GO:0032012	regulation of ARF protein signal transduction	BP
5	16	1.64375141509	-	6.43e-03	GO:0050767	regulation of neurogenesis	BP
5	16	1.64375141509	-	9.20e-03	GO:0031293	membrane protein intracellular domain proteolysis	BP
5	16	1.64375141509	-	1.27e-02	GO:0006349	regulation of gene expression by genetic imprinting	BP
5	16	1.64375141509	-	1.27e-02	GO:0071732	cellular response to nitric oxide	BP
5	16	1.64375141509	-	1.69e-02	GO:0034142	toll-like receptor 4 signaling pathway	BP
5	16	1.64375141509	-	1.69e-02	GO:0032270	positive regulation of cellular protein metabolic process	BP
5	16	1.64375141509	-	1.69e-02	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	BP
5	16	1.64375141509	-	1.69e-02	GO:0050860	negative regulation of T cell receptor signaling pathway	BP
10	32	1.64375141509	-	7.96e-04	GO:0070491	repressing transcription factor binding	MF
39	125	1.6414412544	-	1.26e-10	GO:0006470	protein dephosphorylation	BP
28	90	1.63732514593	-	9.29e-10	GO:0010976	positive regulation of neuron projection development	BP
12	39	1.62138360206	-	1.64e-04	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	BP
8	26	1.62138360206	-	2.24e-03	GO:0000732	strand displacement	BP
4	13	1.62138360206	-	8.31e-03	GO:0010001	glial cell differentiation	BP
4	13	1.62138360206	-	1.85e-02	GO:0050872	white fat cell differentiation	BP
4	13	1.62138360206	-	1.85e-02	GO:0007171	activation of transmembrane receptor protein tyrosine kinase activity	BP
4	13	1.62138360206	-	1.85e-02	GO:0032228	regulation of synaptic transmission, GABAergic	BP
4	13	1.62138360206	-	1.85e-02	GO:0055089	fatty acid homeostasis	BP
4	13	1.62138360206	-	2.56e-02	GO:0045651	positive regulation of macrophage differentiation	BP
4	13	1.62138360206	-	2.56e-02	GO:0007096	regulation of exit from mitosis	BP
4	13	1.62138360206	-	2.56e-02	GO:0010745	negative regulation of macrophage derived foam cell differentiation	BP
4	13	1.62138360206	-	2.56e-02	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
4	13	1.62138360206	-	2.56e-02	GO:0035810	positive regulation of urine volume	BP
4	13	1.62138360206	-	3.41e-02	GO:0060134	prepulse inhibition	BP
4	13	1.62138360206	-	3.41e-02	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	BP
4	13	1.62138360206	-	3.41e-02	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
4	13	1.62138360206	-	3.41e-02	GO:0002756	MyD88-independent toll-like receptor signaling pathway	BP
4	13	1.62138360206	-	8.31e-03	GO:0070403	NAD+ binding	MF
15	49	1.61400407169	-	9.39e-06	GO:0097110	scaffold protein binding	MF
26	85	1.6128721022	-	5.19e-08	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	BP
7	23	1.6056162862	-	4.36e-03	GO:0090398	cellular senescence	BP
38	125	1.60396654898	-	1.08e-10	GO:1901796	regulation of signal transduction by p53 class mediator	BP
17	56	1.60193123939	-	1.17e-05	GO:0032091	negative regulation of protein binding	BP
13	43	1.59599828364	-	1.96e-04	GO:0034644	cellular response to UV	BP
9	30	1.58485772603	-	6.29e-04	GO:2000379	positive regulation of reactive oxygen species metabolic process	BP
6	20	1.58485772603	-	6.38e-03	GO:0097150	neuronal stem cell population maintenance	BP
6	20	1.58485772603	-	6.38e-03	GO:0051493	regulation of cytoskeleton organization	BP
6	20	1.58485772603	-	6.38e-03	GO:0045862	positive regulation of proteolysis	BP
6	20	1.58485772603	-	6.38e-03	GO:0071310	cellular response to organic substance	BP
6	20	1.58485772603	-	1.12e-02	GO:0008361	regulation of cell size	BP
3	10	1.58485772603	-	1.58e-02	GO:0001775	cell activation	BP
3	10	1.58485772603	-	1.58e-02	GO:0060174	limb bud formation	BP
3	10	1.58485772603	-	2.57e-02	GO:0060306	regulation of membrane repolarization	BP
3	10	1.58485772603	-	2.57e-02	GO:0009100	glycoprotein metabolic process	BP
3	10	1.58485772603	-	3.81e-02	GO:0046325	negative regulation of glucose import	BP
3	10	1.58485772603	-	5.29e-02	GO:0003334	keratinocyte development	BP
3	10	1.58485772603	-	5.29e-02	GO:0003181	atrioventricular valve morphogenesis	BP
3	10	1.58485772603	-	5.29e-02	GO:0051901	positive regulation of mitochondrial depolarization	BP
3	10	1.58485772603	-	5.29e-02	GO:0071236	cellular response to antibiotic	BP
3	10	1.58485772603	-	5.29e-02	GO:0043268	positive regulation of potassium ion transport	BP
3	10	1.58485772603	-	5.29e-02	GO:0003014	renal system process	BP
3	10	1.58485772603	-	5.29e-02	GO:0046626	regulation of insulin receptor signaling pathway	BP
3	10	1.58485772603	-	7.01e-02	GO:0071383	cellular response to steroid hormone stimulus	BP
3	10	1.58485772603	-	7.01e-02	GO:0006983	ER overload response	BP
3	10	1.58485772603	-	7.01e-02	GO:0030071	regulation of mitotic metaphase/anaphase transition	BP
3	10	1.58485772603	-	7.01e-02	GO:0043306	positive regulation of mast cell degranulation	BP
3	10	1.58485772603	-	7.01e-02	GO:0090129	positive regulation of synapse maturation	BP
3	10	1.58485772603	-	7.01e-02	GO:0001759	organ induction	BP
3	10	1.58485772603	-	7.01e-02	GO:0071372	cellular response to follicle-stimulating hormone stimulus	BP
3	10	1.58485772603	-	7.01e-02	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	BP
3	10	1.58485772603	-	7.01e-02	GO:2000772	regulation of cellular senescence	BP
3	10	1.58485772603	-	7.01e-02	GO:2000773	negative regulation of cellular senescence	BP
3	10	1.58485772603	-	7.01e-02	GO:0050765	negative regulation of phagocytosis	BP
6	20	1.58485772603	-	4.64e-03	GO:0005086	ARF guanyl-nucleotide exchange factor activity	MF
6	20	1.58485772603	-	8.55e-03	GO:0033613	activating transcription factor binding	MF
3	10	1.58485772603	-	3.81e-02	GO:0019911	structural constituent of myelin sheath	MF
3	10	1.58485772603	-	5.29e-02	GO:0008440	inositol-1,4,5-trisphosphate 3-kinase activity	MF
3	10	1.58485772603	-	5.29e-02	GO:0016504	peptidase activator activity	MF
3	10	1.58485772603	-	7.01e-02	GO:0016208	AMP binding	MF
3	10	1.58485772603	-	7.01e-02	GO:0033558	protein deacetylase activity	MF
3	10	1.58485772603	-	7.01e-02	GO:0031702	type 1 angiotensin receptor binding	MF
54	181	1.57686493528	-	7.50e-11	GO:0038095	Fc-epsilon receptor signaling pathway	BP
51	171	1.57639614729	-	6.06e-11	GO:0042127	regulation of cell proliferation	BP
11	37	1.57180157321	-	2.33e-04	GO:0007611	learning or memory	BP
11	37	1.57180157321	-	4.16e-04	GO:0048469	cell maturation	BP
19	64	1.56975083364	-	5.66e-06	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
129	435	1.56817898489	-	2.02e-10	GO:0006468	protein phosphorylation	BP
102	344	1.56798390747	-	2.04e-10	GO:0004674	protein serine/threonine kinase activity	MF
16	54	1.56693581804	-	9.29e-06	GO:0043406	positive regulation of MAP kinase activity	BP
8	27	1.56693581804	-	2.24e-03	GO:0006611	protein export from nucleus	BP
8	27	1.56693581804	-	2.95e-03	GO:0043392	negative regulation of DNA binding	BP
8	27	1.56693581804	-	3.83e-03	GO:0043278	response to morphine	BP
8	27	1.56693581804	-	3.83e-03	GO:0050690	regulation of defense response to virus by virus	BP
15	51	1.55628857384	-	1.76e-05	GO:0045860	positive regulation of protein kinase activity	BP
10	34	1.55628857384	-	7.96e-04	GO:0001837	epithelial to mesenchymal transition	BP
5	17	1.55628857384	-	1.27e-02	GO:0071380	cellular response to prostaglandin E stimulus	BP
5	17	1.55628857384	-	1.27e-02	GO:0001702	gastrulation with mouth forming second	BP
5	17	1.55628857384	-	1.27e-02	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	BP
5	17	1.55628857384	-	1.69e-02	GO:0048854	brain morphogenesis	BP
5	17	1.55628857384	-	1.69e-02	GO:1904707	positive regulation of vascular smooth muscle cell proliferation	BP
5	17	1.55628857384	-	1.69e-02	GO:0090201	negative regulation of release of cytochrome c from mitochondria	BP
5	17	1.55628857384	-	1.69e-02	GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	BP
29	99	1.55044769525	-	4.41e-09	GO:0035335	peptidyl-tyrosine dephosphorylation	BP
26	89	1.54652960738	-	2.93e-08	GO:0004725	protein tyrosine phosphatase activity	MF
28	96	1.54421574154	-	4.57e-09	GO:0042593	glucose homeostasis	BP
7	24	1.54421574154	-	1.16e-03	GO:0030878	thyroid gland development	BP
7	24	1.54421574154	-	4.36e-03	GO:0042327	positive regulation of phosphorylation	BP
9	31	1.53755201126	-	3.16e-04	GO:0048701	embryonic cranial skeleton morphogenesis	BP
9	31	1.53755201126	-	1.16e-03	GO:0043200	response to amino acid	BP
11	38	1.53332742539	-	7.07e-04	GO:0097194	execution phase of apoptosis	BP
23	80	1.52345718137	-	1.46e-07	GO:0007229	integrin-mediated signaling pathway	BP
22	77	1.51446839814	-	8.52e-07	GO:0032869	cellular response to insulin stimulus	BP
16	56	1.51446839814	-	6.24e-05	GO:0032922	circadian regulation of gene expression	BP
10	35	1.51446839814	-	1.04e-03	GO:0050918	positive chemotaxis	BP
4	14	1.51446839814	-	2.56e-02	GO:0045721	negative regulation of gluconeogenesis	BP
4	14	1.51446839814	-	2.56e-02	GO:0043409	negative regulation of MAPK cascade	BP
4	14	1.51446839814	-	2.56e-02	GO:0043537	negative regulation of blood vessel endothelial cell migration	BP
4	14	1.51446839814	-	2.56e-02	GO:2000310	regulation of NMDA receptor activity	BP
4	14	1.51446839814	-	3.41e-02	GO:0006940	regulation of smooth muscle contraction	BP
4	14	1.51446839814	-	3.41e-02	GO:0014912	negative regulation of smooth muscle cell migration	BP
4	14	1.51446839814	-	4.41e-02	GO:0043069	negative regulation of programmed cell death	BP
4	14	1.51446839814	-	4.41e-02	GO:0042953	lipoprotein transport	BP
4	14	1.51446839814	-	4.41e-02	GO:0042993	positive regulation of transcription factor import into nucleus	BP
4	14	1.51446839814	-	4.41e-02	GO:0010243	response to organonitrogen compound	BP
4	14	1.51446839814	-	4.41e-02	GO:0043508	negative regulation of JUN kinase activity	BP
4	14	1.51446839814	-	4.41e-02	GO:0051770	positive regulation of nitric-oxide synthase biosynthetic process	BP
4	14	1.51446839814	-	4.41e-02	GO:0045948	positive regulation of translational initiation	BP
2	7	1.51446839814	-	5.23e-02	GO:0045606	positive regulation of epidermal cell differentiation	BP
2	7	1.51446839814	-	5.23e-02	GO:0060371	regulation of atrial cardiac muscle cell membrane depolarization	BP
2	7	1.51446839814	-	5.23e-02	GO:0051782	negative regulation of cell division	BP
2	7	1.51446839814	-	5.23e-02	GO:0085029	extracellular matrix assembly	BP
2	7	1.51446839814	-	8.14e-02	GO:0003209	cardiac atrium morphogenesis	BP
2	7	1.51446839814	-	8.14e-02	GO:0060740	prostate gland epithelium morphogenesis	BP
2	7	1.51446839814	-	8.14e-02	GO:0034144	negative regulation of toll-like receptor 4 signaling pathway	BP
2	7	1.51446839814	-	8.14e-02	GO:0033135	regulation of peptidyl-serine phosphorylation	BP
2	7	1.51446839814	-	8.14e-02	GO:0060463	lung lobe morphogenesis	BP
2	7	1.51446839814	-	8.14e-02	GO:0003344	pericardium morphogenesis	BP
2	7	1.51446839814	-	8.14e-02	GO:0032927	positive regulation of activin receptor signaling pathway	BP
2	7	1.51446839814	-	8.14e-02	GO:0003360	brainstem development	BP
2	7	1.51446839814	-	8.14e-02	GO:2000427	positive regulation of apoptotic cell clearance	BP
2	7	1.51446839814	-	8.14e-02	GO:0060736	prostate gland growth	BP
2	7	1.51446839814	-	8.14e-02	GO:0051151	negative regulation of smooth muscle cell differentiation	BP
2	7	1.51446839814	-	8.14e-02	GO:0097011	cellular response to granulocyte macrophage colony-stimulating factor stimulus	BP
2	7	1.51446839814	-	8.14e-02	GO:0036302	atrioventricular canal development	BP
2	7	1.51446839814	-	1.14e-01	GO:0045656	negative regulation of monocyte differentiation	BP
2	7	1.51446839814	-	1.14e-01	GO:0014009	glial cell proliferation	BP
2	7	1.51446839814	-	1.14e-01	GO:2000617	positive regulation of histone H3-K9 acetylation	BP
2	7	1.51446839814	-	1.14e-01	GO:1903077	negative regulation of protein localization to plasma membrane	BP
2	7	1.51446839814	-	1.14e-01	GO:0019048	modulation by virus of host morphology or physiology	BP
2	7	1.51446839814	-	1.14e-01	GO:0010837	regulation of keratinocyte proliferation	BP
2	7	1.51446839814	-	1.14e-01	GO:0022612	gland morphogenesis	BP
2	7	1.51446839814	-	1.14e-01	GO:0006475	internal protein amino acid acetylation	BP
2	7	1.51446839814	-	1.14e-01	GO:0061384	heart trabecula morphogenesis	BP
2	7	1.51446839814	-	1.14e-01	GO:0032691	negative regulation of interleukin-1 beta production	BP
2	7	1.51446839814	-	1.14e-01	GO:0090140	regulation of mitochondrial fission	BP
2	7	1.51446839814	-	1.14e-01	GO:0007617	mating behavior	BP
2	7	1.51446839814	-	1.14e-01	GO:0009649	entrainment of circadian clock	BP
2	7	1.51446839814	-	1.14e-01	GO:0050869	negative regulation of B cell activation	BP
2	7	1.51446839814	-	1.14e-01	GO:0050861	positive regulation of B cell receptor signaling pathway	BP
2	7	1.51446839814	-	1.14e-01	GO:1902004	positive regulation of beta-amyloid formation	BP
2	7	1.51446839814	-	1.14e-01	GO:0016255	attachment of GPI anchor to protein	BP
2	7	1.51446839814	-	1.14e-01	GO:0014902	myotube differentiation	BP
2	7	1.51446839814	-	1.14e-01	GO:0048671	negative regulation of collateral sprouting	BP
2	7	1.51446839814	-	1.14e-01	GO:0042297	vocal learning	BP
2	7	1.51446839814	-	1.14e-01	GO:0035726	common myeloid progenitor cell proliferation	BP
2	7	1.51446839814	-	1.14e-01	GO:0060017	parathyroid gland development	BP
2	7	1.51446839814	-	1.14e-01	GO:0051574	positive regulation of histone H3-K9 methylation	BP
2	7	1.51446839814	-	1.14e-01	GO:0042129	regulation of T cell proliferation	BP
2	7	1.51446839814	-	1.50e-01	GO:0006595	polyamine metabolic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0045650	negative regulation of macrophage differentiation	BP
2	7	1.51446839814	-	1.50e-01	GO:0045657	positive regulation of monocyte differentiation	BP
2	7	1.51446839814	-	1.50e-01	GO:0050810	regulation of steroid biosynthetic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0046826	negative regulation of protein export from nucleus	BP
2	7	1.51446839814	-	1.50e-01	GO:0090050	positive regulation of cell migration involved in sprouting angiogenesis	BP
2	7	1.51446839814	-	1.50e-01	GO:0032825	positive regulation of natural killer cell differentiation	BP
2	7	1.51446839814	-	1.50e-01	GO:1990314	cellular response to insulin-like growth factor stimulus	BP
2	7	1.51446839814	-	1.50e-01	GO:0061626	pharyngeal arch artery morphogenesis	BP
2	7	1.51446839814	-	1.50e-01	GO:2000177	regulation of neural precursor cell proliferation	BP
2	7	1.51446839814	-	1.50e-01	GO:0006110	regulation of glycolytic process	BP
2	7	1.51446839814	-	1.50e-01	GO:1903071	positive regulation of ER-associated ubiquitin-dependent protein catabolic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0051683	establishment of Golgi localization	BP
2	7	1.51446839814	-	1.50e-01	GO:0048102	autophagic cell death	BP
2	7	1.51446839814	-	1.50e-01	GO:0090267	positive regulation of mitotic cell cycle spindle assembly checkpoint	BP
2	7	1.51446839814	-	1.50e-01	GO:0042148	strand invasion	BP
2	7	1.51446839814	-	1.50e-01	GO:0048261	negative regulation of receptor-mediated endocytosis	BP
2	7	1.51446839814	-	1.50e-01	GO:0051988	regulation of attachment of spindle microtubules to kinetochore	BP
2	7	1.51446839814	-	1.50e-01	GO:0030916	otic vesicle formation	BP
2	7	1.51446839814	-	1.50e-01	GO:0060732	positive regulation of inositol phosphate biosynthetic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0032966	negative regulation of collagen biosynthetic process	BP
2	7	1.51446839814	-	1.50e-01	GO:2000394	positive regulation of lamellipodium morphogenesis	BP
2	7	1.51446839814	-	1.50e-01	GO:0034616	response to laminar fluid shear stress	BP
2	7	1.51446839814	-	1.50e-01	GO:0060290	transdifferentiation	BP
2	7	1.51446839814	-	1.50e-01	GO:0031642	negative regulation of myelination	BP
2	7	1.51446839814	-	1.50e-01	GO:0044351	macropinocytosis	BP
2	7	1.51446839814	-	1.50e-01	GO:0021795	cerebral cortex cell migration	BP
2	7	1.51446839814	-	1.50e-01	GO:0071447	cellular response to hydroperoxide	BP
2	7	1.51446839814	-	1.50e-01	GO:0070417	cellular response to cold	BP
2	7	1.51446839814	-	1.50e-01	GO:2000270	negative regulation of fibroblast apoptotic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0007270	neuron-neuron synaptic transmission	BP
2	7	1.51446839814	-	1.50e-01	GO:0061049	cell growth involved in cardiac muscle cell development	BP
2	7	1.51446839814	-	1.50e-01	GO:0042167	heme catabolic process	BP
2	7	1.51446839814	-	1.50e-01	GO:0014049	positive regulation of glutamate secretion	BP
2	7	1.51446839814	-	1.50e-01	GO:0043496	regulation of protein homodimerization activity	BP
2	7	1.51446839814	-	1.50e-01	GO:2000144	positive regulation of DNA-templated transcription, initiation	BP
4	14	1.51446839814	-	4.41e-02	GO:0031432	titin binding	MF
4	14	1.51446839814	-	4.41e-02	GO:0070182	DNA polymerase binding	MF
4	14	1.51446839814	-	4.41e-02	GO:0034236	protein kinase A catalytic subunit binding	MF
2	7	1.51446839814	-	8.14e-02	GO:0030297	transmembrane receptor protein tyrosine kinase activator activity	MF
2	7	1.51446839814	-	1.14e-01	GO:0001848	complement binding	MF
2	7	1.51446839814	-	1.50e-01	GO:0019209	kinase activator activity	MF
2	7	1.51446839814	-	1.50e-01	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	MF
2	7	1.51446839814	-	1.50e-01	GO:0005114	type II transforming growth factor beta receptor binding	MF
2	7	1.51446839814	-	1.50e-01	GO:0004972	NMDA glutamate receptor activity	MF
2	7	1.51446839814	-	1.50e-01	GO:0008603	cAMP-dependent protein kinase regulator activity	MF
2	7	1.51446839814	-	1.50e-01	GO:0005049	nuclear export signal receptor activity	MF
2	7	1.51446839814	-	1.50e-01	GO:0008329	signaling pattern recognition receptor activity	MF
31	109	1.50783530581	-	2.22e-09	GO:0044325	ion channel binding	MF
9	32	1.49174832164	-	2.57e-03	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	BP
9	32	1.49174832164	-	2.57e-03	GO:0002755	MyD88-dependent toll-like receptor signaling pathway	BP
9	32	1.49174832164	-	1.53e-03	GO:0016791	phosphatase activity	MF
23	82	1.48783327164	-	3.45e-07	GO:0051897	positive regulation of protein kinase B signaling	BP
7	25	1.48532205248	-	3.08e-04	GO:0009880	embryonic pattern specification	BP
7	25	1.48532205248	-	9.41e-03	GO:0071353	cellular response to interleukin-4	BP
15	54	1.47382641365	-	7.11e-05	GO:0051592	response to calcium ion	BP
10	36	1.47382641365	-	1.34e-03	GO:0051402	neuron apoptotic process	BP
5	18	1.47382641365	-	1.27e-02	GO:0060324	face development	BP
5	18	1.47382641365	-	1.27e-02	GO:0006970	response to osmotic stress	BP
5	18	1.47382641365	-	1.69e-02	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	BP
5	18	1.47382641365	-	1.69e-02	GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	BP
5	18	1.47382641365	-	2.21e-02	GO:1990138	neuron projection extension	BP
5	18	1.47382641365	-	2.21e-02	GO:0007250	activation of NF-kappaB-inducing kinase activity	BP
5	18	1.47382641365	-	2.21e-02	GO:0050870	positive regulation of T cell activation	BP
5	18	1.47382641365	-	2.21e-02	GO:0035066	positive regulation of histone acetylation	BP
21	76	1.46621322954	-	9.05e-06	GO:1900034	regulation of cellular response to heat	BP
48	174	1.46384232507	-	6.06e-11	GO:0007411	axon guidance	BP
16	58	1.46384232507	-	1.25e-05	GO:0043087	regulation of GTPase activity	BP
8	29	1.46384232507	-	1.67e-03	GO:0001569	branching involved in blood vessel morphogenesis	BP
8	29	1.46384232507	-	3.83e-03	GO:0060412	ventricular septum morphogenesis	BP
8	29	1.46384232507	-	3.83e-03	GO:0045765	regulation of angiogenesis	BP
8	29	1.46384232507	-	4.91e-03	GO:0007093	mitotic cell cycle checkpoint	BP
33	120	1.45932684395	-	8.78e-09	GO:0017124	SH3 domain binding	MF
11	40	1.45932684395	-	7.07e-04	GO:0032024	positive regulation of insulin secretion	BP
11	40	1.45932684395	-	1.44e-03	GO:0010508	positive regulation of autophagy	BP
105	382	1.45864000983	-	1.57e-10	GO:0035556	intracellular signal transduction	BP
14	51	1.45675290029	-	7.93e-05	GO:0060326	cell chemotaxis	BP
12	44	1.44735420229	-	4.79e-04	GO:0006094	gluconeogenesis	BP
6	22	1.44735420229	-	1.81e-02	GO:0051894	positive regulation of focal adhesion assembly	BP
3	11	1.44735420229	-	2.57e-02	GO:0002064	epithelial cell development	BP
3	11	1.44735420229	-	3.81e-02	GO:0033690	positive regulation of osteoblast proliferation	BP
3	11	1.44735420229	-	5.29e-02	GO:0001893	maternal placenta development	BP
3	11	1.44735420229	-	5.29e-02	GO:0046488	phosphatidylinositol metabolic process	BP
3	11	1.44735420229	-	5.29e-02	GO:0042445	hormone metabolic process	BP
3	11	1.44735420229	-	7.01e-02	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
3	11	1.44735420229	-	7.01e-02	GO:0030833	regulation of actin filament polymerization	BP
3	11	1.44735420229	-	7.01e-02	GO:0055015	ventricular cardiac muscle cell development	BP
3	11	1.44735420229	-	7.01e-02	GO:0006473	protein acetylation	BP
3	11	1.44735420229	-	7.01e-02	GO:0050707	regulation of cytokine secretion	BP
3	11	1.44735420229	-	7.01e-02	GO:0006937	regulation of muscle contraction	BP
3	11	1.44735420229	-	7.01e-02	GO:0060315	negative regulation of ryanodine-sensitive calcium-release channel activity	BP
3	11	1.44735420229	-	7.01e-02	GO:0060445	branching involved in salivary gland morphogenesis	BP
3	11	1.44735420229	-	7.01e-02	GO:0061045	negative regulation of wound healing	BP
3	11	1.44735420229	-	7.01e-02	GO:0048715	negative regulation of oligodendrocyte differentiation	BP
3	11	1.44735420229	-	8.95e-02	GO:0002031	G-protein coupled receptor internalization	BP
3	11	1.44735420229	-	8.95e-02	GO:1900273	positive regulation of long-term synaptic potentiation	BP
3	11	1.44735420229	-	8.95e-02	GO:0006312	mitotic recombination	BP
3	11	1.44735420229	-	8.95e-02	GO:1904754	positive regulation of vascular associated smooth muscle cell migration	BP
3	11	1.44735420229	-	8.95e-02	GO:0006600	creatine metabolic process	BP
3	11	1.44735420229	-	8.95e-02	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	BP
3	11	1.44735420229	-	8.95e-02	GO:0061001	regulation of dendritic spine morphogenesis	BP
6	22	1.44735420229	-	6.38e-03	GO:0005104	fibroblast growth factor receptor binding	MF
3	11	1.44735420229	-	7.01e-02	GO:0048407	platelet-derived growth factor binding	MF
3	11	1.44735420229	-	7.01e-02	GO:0016407	acetyltransferase activity	MF
3	11	1.44735420229	-	8.95e-02	GO:0070410	co-SMAD binding	MF
3	11	1.44735420229	-	8.95e-02	GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	MF
9	33	1.44735420229	-	1.53e-03	GO:0002931	response to ischemia	BP
9	33	1.44735420229	-	3.26e-03	GO:0043507	positive regulation of JUN kinase activity	BP
9	33	1.44735420229	-	1.99e-03	GO:0051219	phosphoprotein binding	MF
16	59	1.43918027084	-	1.25e-05	GO:0050679	positive regulation of epithelial cell proliferation	BP
13	48	1.43730053762	-	5.17e-04	GO:0042542	response to hydrogen peroxide	BP
10	37	1.43429804946	-	2.71e-03	GO:0007257	activation of JUN kinase activity	BP
35	130	1.42873852412	-	1.09e-10	GO:0038096	Fc-gamma receptor signaling pathway involved in phagocytosis	BP
7	26	1.42873852412	-	1.68e-03	GO:0060338	regulation of type I interferon-mediated signaling pathway	BP
7	26	1.42873852412	-	5.73e-03	GO:0021983	pituitary gland development	BP
7	26	1.42873852412	-	7.40e-03	GO:2000352	negative regulation of endothelial cell apoptotic process	BP
7	26	1.42873852412	-	1.18e-02	GO:0061621	canonical glycolysis	BP
8	30	1.41493272459	-	1.67e-03	GO:0048873	homeostasis of number of cells within a tissue	BP
8	30	1.41493272459	-	3.83e-03	GO:0007616	long-term memory	BP
4	15	1.41493272459	-	1.85e-02	GO:0006112	energy reserve metabolic process	BP
4	15	1.41493272459	-	2.56e-02	GO:0030279	negative regulation of ossification	BP
4	15	1.41493272459	-	2.56e-02	GO:0086005	ventricular cardiac muscle cell action potential	BP
4	15	1.41493272459	-	2.56e-02	GO:0006691	leukotriene metabolic process	BP
4	15	1.41493272459	-	4.41e-02	GO:0071850	mitotic cell cycle arrest	BP
4	15	1.41493272459	-	4.41e-02	GO:0070848	response to growth factor	BP
4	15	1.41493272459	-	4.41e-02	GO:0034162	toll-like receptor 9 signaling pathway	BP
4	15	1.41493272459	-	4.41e-02	GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
4	15	1.41493272459	-	4.41e-02	GO:0070498	interleukin-1-mediated signaling pathway	BP
4	15	1.41493272459	-	5.55e-02	GO:0051895	negative regulation of focal adhesion assembly	BP
4	15	1.41493272459	-	5.55e-02	GO:0036503	ERAD pathway	BP
4	15	1.41493272459	-	5.55e-02	GO:1903543	positive regulation of exosomal secretion	BP
4	15	1.41493272459	-	5.55e-02	GO:0001935	endothelial cell proliferation	BP
4	15	1.41493272459	-	5.55e-02	GO:2000679	positive regulation of transcription regulatory region DNA binding	BP
4	15	1.41493272459	-	5.55e-02	GO:0048168	regulation of neuronal synaptic plasticity	BP
4	15	1.41493272459	-	5.55e-02	GO:0051571	positive regulation of histone H3-K4 methylation	BP
4	15	1.41493272459	-	4.41e-02	GO:0001076	transcription factor activity, RNA polymerase II transcription factor binding	MF
4	15	1.41493272459	-	5.55e-02	GO:0070742	C2H2 zinc finger domain binding	MF
12	45	1.41493272459	-	7.70e-04	GO:0031100	animal organ regeneration	BP
12	45	1.41493272459	-	4.79e-04	GO:0005080	protein kinase C binding	MF
33	124	1.41202112917	-	4.15e-09	GO:0002223	stimulatory C-type lectin receptor signaling pathway	BP
9	34	1.40428548039	-	5.08e-03	GO:0000731	DNA synthesis involved in DNA repair	BP
14	53	1.4012577877	-	1.72e-04	GO:0048511	rhythmic process	BP
5	19	1.39582390164	-	2.21e-02	GO:0055117	regulation of cardiac muscle contraction	BP
5	19	1.39582390164	-	2.21e-02	GO:0051968	positive regulation of synaptic transmission, glutamatergic	BP
5	19	1.39582390164	-	2.81e-02	GO:0010906	regulation of glucose metabolic process	BP
5	19	1.39582390164	-	3.51e-02	GO:0043011	myeloid dendritic cell differentiation	BP
5	19	1.39582390164	-	2.21e-02	GO:0030506	ankyrin binding	MF
46	175	1.39417416443	-	6.06e-11	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP
11	42	1.38893751606	-	2.76e-05	GO:0046426	negative regulation of JAK-STAT cascade	BP
11	42	1.38893751606	-	1.80e-03	GO:0031397	negative regulation of protein ubiquitination	BP
18	69	1.38322386487	-	2.27e-05	GO:0001938	positive regulation of endothelial cell proliferation	BP
12	46	1.38322386487	-	3.72e-04	GO:0051591	response to cAMP	BP
12	46	1.38322386487	-	4.79e-04	GO:0032956	regulation of actin cytoskeleton organization	BP
6	23	1.38322386487	-	1.44e-02	GO:0048754	branching morphogenesis of an epithelial tube	BP
6	23	1.38322386487	-	1.81e-02	GO:2000378	negative regulation of reactive oxygen species metabolic process	BP
6	23	1.38322386487	-	2.25e-02	GO:0030866	cortical actin cytoskeleton organization	BP
6	23	1.38322386487	-	1.81e-02	GO:0030332	cyclin binding	MF
7	27	1.3742907401	-	1.68e-03	GO:0007131	reciprocal meiotic recombination	BP
7	27	1.3742907401	-	1.46e-02	GO:0009314	response to radiation	BP
7	27	1.3742907401	-	3.25e-03	GO:0004435	phosphatidylinositol phospholipase C activity	MF
30	116	1.37073292068	-	1.13e-07	GO:0030308	negative regulation of cell growth	BP
15	58	1.37073292068	-	1.48e-04	GO:0031490	chromatin DNA binding	MF
16	62	1.36762700981	-	1.25e-05	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	BP
8	31	1.36762700981	-	4.91e-03	GO:0042220	response to cocaine	BP
9	35	1.3624653047	-	5.08e-03	GO:0031648	protein destabilization	BP
9	35	1.3624653047	-	6.24e-03	GO:0043407	negative regulation of MAP kinase activity	BP
9	35	1.3624653047	-	5.08e-03	GO:0005057	signal transducer activity, downstream of receptor	MF
10	39	1.35834919623	-	1.72e-03	GO:0009968	negative regulation of signal transduction	BP
11	43	1.35499018414	-	2.22e-03	GO:0051496	positive regulation of stress fiber assembly	BP
34	133	1.35400372595	-	1.60e-07	GO:0051092	positive regulation of NF-kappaB transcription factor activity	BP
15	59	1.34607086645	-	3.57e-04	GO:0007249	I-kappaB kinase/NF-kappaB signaling	BP
15	60	1.3218233202	-	9.16e-05	GO:0051291	protein heterooligomerization	BP
15	60	1.3218233202	-	3.57e-04	GO:0030334	regulation of cell migration	BP
11	44	1.3218233202	-	4.16e-04	GO:0032870	cellular response to hormone stimulus	BP
12	48	1.3218233202	-	7.70e-04	GO:0034097	response to cytokine	BP
11	44	1.3218233202	-	2.22e-03	GO:0002224	toll-like receptor signaling pathway	BP
6	24	1.3218233202	-	1.81e-02	GO:0042113	B cell activation	BP
6	24	1.3218233202	-	1.81e-02	GO:0033137	negative regulation of peptidyl-serine phosphorylation	BP
6	24	1.3218233202	-	1.81e-02	GO:0002040	sprouting angiogenesis	BP
6	24	1.3218233202	-	1.81e-02	GO:0007569	cell aging	BP
6	24	1.3218233202	-	2.75e-02	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	BP
3	12	1.3218233202	-	3.81e-02	GO:0032026	response to magnesium ion	BP
3	12	1.3218233202	-	3.81e-02	GO:0046889	positive regulation of lipid biosynthetic process	BP
3	12	1.3218233202	-	5.29e-02	GO:0010759	positive regulation of macrophage chemotaxis	BP
3	12	1.3218233202	-	5.29e-02	GO:0050777	negative regulation of immune response	BP
3	12	1.3218233202	-	5.29e-02	GO:0034122	negative regulation of toll-like receptor signaling pathway	BP
3	12	1.3218233202	-	5.29e-02	GO:0007041	lysosomal transport	BP
3	12	1.3218233202	-	7.01e-02	GO:0045078	positive regulation of interferon-gamma biosynthetic process	BP
3	12	1.3218233202	-	7.01e-02	GO:0010717	regulation of epithelial to mesenchymal transition	BP
3	12	1.3218233202	-	7.01e-02	GO:0043616	keratinocyte proliferation	BP
3	12	1.3218233202	-	7.01e-02	GO:0045995	regulation of embryonic development	BP
3	12	1.3218233202	-	8.95e-02	GO:0043922	negative regulation by host of viral transcription	BP
3	12	1.3218233202	-	8.95e-02	GO:0008154	actin polymerization or depolymerization	BP
3	12	1.3218233202	-	8.95e-02	GO:0090162	establishment of epithelial cell polarity	BP
3	12	1.3218233202	-	8.95e-02	GO:0060707	trophoblast giant cell differentiation	BP
3	12	1.3218233202	-	8.95e-02	GO:0045060	negative thymic T cell selection	BP
3	12	1.3218233202	-	8.95e-02	GO:2000010	positive regulation of protein localization to cell surface	BP
3	12	1.3218233202	-	1.11e-01	GO:0055003	cardiac myofibril assembly	BP
3	12	1.3218233202	-	1.11e-01	GO:0021819	layer formation in cerebral cortex	BP
3	12	1.3218233202	-	1.11e-01	GO:0055093	response to hyperoxia	BP
3	12	1.3218233202	-	1.11e-01	GO:0048024	regulation of mRNA splicing, via spliceosome	BP
3	12	1.3218233202	-	1.11e-01	GO:0043149	stress fiber assembly	BP
3	12	1.3218233202	-	1.11e-01	GO:0042994	cytoplasmic sequestering of transcription factor	BP
3	12	1.3218233202	-	1.11e-01	GO:0048712	negative regulation of astrocyte differentiation	BP
3	12	1.3218233202	-	1.11e-01	GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation	BP
3	12	1.3218233202	-	1.11e-01	GO:0061099	negative regulation of protein tyrosine kinase activity	BP
3	12	1.3218233202	-	1.11e-01	GO:0060644	mammary gland epithelial cell differentiation	BP
3	12	1.3218233202	-	1.11e-01	GO:0045086	positive regulation of interleukin-2 biosynthetic process	BP
3	12	1.3218233202	-	1.11e-01	GO:0021954	central nervous system neuron development	BP
3	12	1.3218233202	-	3.81e-02	GO:0015078	hydrogen ion transmembrane transporter activity	MF
3	12	1.3218233202	-	1.11e-01	GO:0004708	MAP kinase kinase activity	MF
3	12	1.3218233202	-	1.11e-01	GO:0008179	adenylate cyclase binding	MF
3	12	1.3218233202	-	1.11e-01	GO:0097200	cysteine-type endopeptidase activity involved in execution phase of apoptosis	MF
3	12	1.3218233202	-	1.11e-01	GO:0000983	transcription factor activity, RNA polymerase II core promoter sequence-specific	MF
19	76	1.3218233202	-	7.35e-06	GO:0007623	circadian rhythm	BP
9	36	1.3218233202	-	1.16e-03	GO:0045859	regulation of protein kinase activity	BP
9	36	1.3218233202	-	1.99e-03	GO:0015758	glucose transport	BP
9	36	1.3218233202	-	3.26e-03	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	BP
8	32	1.3218233202	-	4.91e-03	GO:0002027	regulation of heart rate	BP
9	36	1.3218233202	-	5.08e-03	GO:0006605	protein targeting	BP
7	28	1.3218233202	-	5.73e-03	GO:0003281	ventricular septum development	BP
8	32	1.3218233202	-	6.19e-03	GO:0071479	cellular response to ionizing radiation	BP
7	28	1.3218233202	-	7.40e-03	GO:0048863	stem cell differentiation	BP
8	32	1.3218233202	-	7.72e-03	GO:0070555	response to interleukin-1	BP
7	28	1.3218233202	-	9.41e-03	GO:0005977	glycogen metabolic process	BP
8	32	1.3218233202	-	9.51e-03	GO:0042594	response to starvation	BP
8	32	1.3218233202	-	1.16e-02	GO:0097421	liver regeneration	BP
5	20	1.3218233202	-	1.69e-02	GO:0031334	positive regulation of protein complex assembly	BP
7	28	1.3218233202	-	1.78e-02	GO:0032008	positive regulation of TOR signaling	BP
4	16	1.3218233202	-	2.56e-02	GO:0032924	activin receptor signaling pathway	BP
4	16	1.3218233202	-	3.41e-02	GO:0010975	regulation of neuron projection development	BP
4	16	1.3218233202	-	3.41e-02	GO:0014850	response to muscle activity	BP
5	20	1.3218233202	-	3.51e-02	GO:0045861	negative regulation of proteolysis	BP
5	20	1.3218233202	-	4.31e-02	GO:0001836	release of cytochrome c from mitochondria	BP
4	16	1.3218233202	-	4.41e-02	GO:0006103	2-oxoglutarate metabolic process	BP
4	16	1.3218233202	-	4.41e-02	GO:1900745	positive regulation of p38MAPK cascade	BP
4	16	1.3218233202	-	4.41e-02	GO:0042307	positive regulation of protein import into nucleus	BP
4	16	1.3218233202	-	4.41e-02	GO:0050770	regulation of axonogenesis	BP
4	16	1.3218233202	-	4.41e-02	GO:0003222	ventricular trabecula myocardium morphogenesis	BP
4	16	1.3218233202	-	4.41e-02	GO:0048384	retinoic acid receptor signaling pathway	BP
4	16	1.3218233202	-	4.41e-02	GO:0090026	positive regulation of monocyte chemotaxis	BP
4	16	1.3218233202	-	4.41e-02	GO:0035855	megakaryocyte development	BP
2	8	1.3218233202	-	5.23e-02	GO:0050863	regulation of T cell activation	BP
2	8	1.3218233202	-	8.14e-02	GO:0031666	positive regulation of lipopolysaccharide-mediated signaling pathway	BP
1	4	1.3218233202	-	1.00e-01	GO:0048859	formation of anatomical boundary	BP
2	8	1.3218233202	-	1.14e-01	GO:0035137	hindlimb morphogenesis	BP
2	8	1.3218233202	-	1.14e-01	GO:2000369	regulation of clathrin-dependent endocytosis	BP
2	8	1.3218233202	-	1.14e-01	GO:0032963	collagen metabolic process	BP
2	8	1.3218233202	-	1.14e-01	GO:0045056	transcytosis	BP
2	8	1.3218233202	-	1.14e-01	GO:0071374	cellular response to parathyroid hormone stimulus	BP
2	8	1.3218233202	-	1.14e-01	GO:0040036	regulation of fibroblast growth factor receptor signaling pathway	BP
2	8	1.3218233202	-	1.14e-01	GO:0032099	negative regulation of appetite	BP
2	8	1.3218233202	-	1.14e-01	GO:0048339	paraxial mesoderm development	BP
2	8	1.3218233202	-	1.50e-01	GO:0055001	muscle cell development	BP
2	8	1.3218233202	-	1.50e-01	GO:0030836	positive regulation of actin filament depolymerization	BP
2	8	1.3218233202	-	1.50e-01	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	BP
2	8	1.3218233202	-	1.50e-01	GO:0042119	neutrophil activation	BP
2	8	1.3218233202	-	1.50e-01	GO:0060993	kidney morphogenesis	BP
2	8	1.3218233202	-	1.50e-01	GO:0071168	protein localization to chromatin	BP
2	8	1.3218233202	-	1.50e-01	GO:0048103	somatic stem cell division	BP
2	8	1.3218233202	-	1.50e-01	GO:0090005	negative regulation of establishment of protein localization to plasma membrane	BP
2	8	1.3218233202	-	1.50e-01	GO:0001818	negative regulation of cytokine production	BP
2	8	1.3218233202	-	1.50e-01	GO:0060982	coronary artery morphogenesis	BP
2	8	1.3218233202	-	1.50e-01	GO:0045059	positive thymic T cell selection	BP
2	8	1.3218233202	-	1.50e-01	GO:0050663	cytokine secretion	BP
2	8	1.3218233202	-	1.50e-01	GO:0060124	positive regulation of growth hormone secretion	BP
2	8	1.3218233202	-	1.50e-01	GO:0001841	neural tube formation	BP
2	8	1.3218233202	-	1.50e-01	GO:1903351	cellular response to dopamine	BP
2	8	1.3218233202	-	1.50e-01	GO:0010591	regulation of lamellipodium assembly	BP
2	8	1.3218233202	-	1.87e-01	GO:0048739	cardiac muscle fiber development	BP
2	8	1.3218233202	-	1.87e-01	GO:0045348	positive regulation of MHC class II biosynthetic process	BP
2	8	1.3218233202	-	1.87e-01	GO:0071493	cellular response to UV-B	BP
2	8	1.3218233202	-	1.87e-01	GO:0007097	nuclear migration	BP
2	8	1.3218233202	-	1.87e-01	GO:0071711	basement membrane organization	BP
2	8	1.3218233202	-	1.87e-01	GO:2000510	positive regulation of dendritic cell chemotaxis	BP
2	8	1.3218233202	-	1.87e-01	GO:0072383	plus-end-directed vesicle transport along microtubule	BP
2	8	1.3218233202	-	1.87e-01	GO:0035234	ectopic germ cell programmed cell death	BP
2	8	1.3218233202	-	1.87e-01	GO:0002674	negative regulation of acute inflammatory response	BP
2	8	1.3218233202	-	1.87e-01	GO:0071548	response to dexamethasone	BP
2	8	1.3218233202	-	1.87e-01	GO:0010941	regulation of cell death	BP
2	8	1.3218233202	-	1.87e-01	GO:0002903	negative regulation of B cell apoptotic process	BP
2	8	1.3218233202	-	1.87e-01	GO:0001960	negative regulation of cytokine-mediated signaling pathway	BP
2	8	1.3218233202	-	1.87e-01	GO:0090073	positive regulation of protein homodimerization activity	BP
2	8	1.3218233202	-	1.87e-01	GO:0033129	positive regulation of histone phosphorylation	BP
2	8	1.3218233202	-	1.87e-01	GO:0048304	positive regulation of isotype switching to IgG isotypes	BP
2	8	1.3218233202	-	1.87e-01	GO:0042753	positive regulation of circadian rhythm	BP
2	8	1.3218233202	-	1.87e-01	GO:0033151	V(D)J recombination	BP
1	4	1.3218233202	-	1.90e-01	GO:1904954	canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	BP
1	4	1.3218233202	-	1.90e-01	GO:0051919	positive regulation of fibrinolysis	BP
1	4	1.3218233202	-	1.90e-01	GO:0048609	multicellular organismal reproductive process	BP
1	4	1.3218233202	-	1.90e-01	GO:0031119	tRNA pseudouridine synthesis	BP
1	4	1.3218233202	-	1.90e-01	GO:0021575	hindbrain morphogenesis	BP
1	4	1.3218233202	-	1.90e-01	GO:0034626	fatty acid elongation, polyunsaturated fatty acid	BP
1	4	1.3218233202	-	1.90e-01	GO:0006772	thiamine metabolic process	BP
1	4	1.3218233202	-	1.90e-01	GO:1901657	glycosyl compound metabolic process	BP
1	4	1.3218233202	-	1.90e-01	GO:0035092	sperm chromatin condensation	BP
1	4	1.3218233202	-	1.90e-01	GO:1901991	negative regulation of mitotic cell cycle phase transition	BP
1	4	1.3218233202	-	1.90e-01	GO:0072126	positive regulation of glomerular mesangial cell proliferation	BP
1	4	1.3218233202	-	1.90e-01	GO:0072086	specification of loop of Henle identity	BP
1	4	1.3218233202	-	1.90e-01	GO:0006651	diacylglycerol biosynthetic process	BP
1	4	1.3218233202	-	1.90e-01	GO:0042662	negative regulation of mesodermal cell fate specification	BP
1	4	1.3218233202	-	1.90e-01	GO:0019556	histidine catabolic process to glutamate and formamide	BP
1	4	1.3218233202	-	1.90e-01	GO:0019557	histidine catabolic process to glutamate and formate	BP
1	4	1.3218233202	-	1.90e-01	GO:0071934	thiamine transmembrane transport	BP
1	4	1.3218233202	-	1.90e-01	GO:0007386	compartment pattern specification	BP
1	4	1.3218233202	-	2.71e-01	GO:0050819	negative regulation of coagulation	BP
1	4	1.3218233202	-	2.71e-01	GO:0036438	maintenance of lens transparency	BP
1	4	1.3218233202	-	2.71e-01	GO:0086016	AV node cell action potential	BP
1	4	1.3218233202	-	2.71e-01	GO:0035616	histone H2B conserved C-terminal lysine deubiquitination	BP
1	4	1.3218233202	-	2.71e-01	GO:0031098	stress-activated protein kinase signaling cascade	BP
1	4	1.3218233202	-	2.71e-01	GO:0031547	brain-derived neurotrophic factor receptor signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:0060965	negative regulation of gene silencing by miRNA	BP
1	4	1.3218233202	-	2.71e-01	GO:0009987	cellular process	BP
1	4	1.3218233202	-	2.71e-01	GO:0072189	ureter development	BP
1	4	1.3218233202	-	2.71e-01	GO:1990035	calcium ion import into cell	BP
1	4	1.3218233202	-	2.71e-01	GO:0002666	positive regulation of T cell tolerance induction	BP
1	4	1.3218233202	-	2.71e-01	GO:0032286	central nervous system myelin maintenance	BP
1	4	1.3218233202	-	2.71e-01	GO:0022414	reproductive process	BP
1	4	1.3218233202	-	2.71e-01	GO:1901911	adenosine 5'-(hexahydrogen pentaphosphate) catabolic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0061030	epithelial cell differentiation involved in mammary gland alveolus development	BP
1	4	1.3218233202	-	2.71e-01	GO:0070384	Harderian gland development	BP
1	4	1.3218233202	-	2.71e-01	GO:1904179	positive regulation of adipose tissue development	BP
1	4	1.3218233202	-	2.71e-01	GO:0006054	N-acetylneuraminate metabolic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0072144	glomerular mesangial cell development	BP
1	4	1.3218233202	-	2.71e-01	GO:0070858	negative regulation of bile acid biosynthetic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0045607	regulation of auditory receptor cell differentiation	BP
1	4	1.3218233202	-	2.71e-01	GO:0003272	endocardial cushion formation	BP
1	4	1.3218233202	-	2.71e-01	GO:0003273	cell migration involved in endocardial cushion formation	BP
1	4	1.3218233202	-	2.71e-01	GO:0051208	sequestering of calcium ion	BP
1	4	1.3218233202	-	2.71e-01	GO:0050672	negative regulation of lymphocyte proliferation	BP
1	4	1.3218233202	-	2.71e-01	GO:2000653	regulation of genetic imprinting	BP
1	4	1.3218233202	-	2.71e-01	GO:0060335	positive regulation of interferon-gamma-mediated signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:0003231	cardiac ventricle development	BP
1	4	1.3218233202	-	2.71e-01	GO:0035088	establishment or maintenance of apical/basal cell polarity	BP
1	4	1.3218233202	-	2.71e-01	GO:0002360	T cell lineage commitment	BP
1	4	1.3218233202	-	2.71e-01	GO:0034103	regulation of tissue remodeling	BP
1	4	1.3218233202	-	2.71e-01	GO:0071466	cellular response to xenobiotic stimulus	BP
1	4	1.3218233202	-	2.71e-01	GO:0097756	negative regulation of blood vessel diameter	BP
1	4	1.3218233202	-	2.71e-01	GO:0006779	porphyrin-containing compound biosynthetic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0072221	metanephric distal convoluted tubule development	BP
1	4	1.3218233202	-	2.71e-01	GO:0031064	negative regulation of histone deacetylation	BP
1	4	1.3218233202	-	2.71e-01	GO:1900245	positive regulation of MDA-5 signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:1904358	positive regulation of telomere maintenance via telomere lengthening	BP
1	4	1.3218233202	-	2.71e-01	GO:0021938	smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation	BP
1	4	1.3218233202	-	2.71e-01	GO:1903142	positive regulation of establishment of endothelial barrier	BP
1	4	1.3218233202	-	2.71e-01	GO:0000730	DNA recombinase assembly	BP
1	4	1.3218233202	-	2.71e-01	GO:0048550	negative regulation of pinocytosis	BP
1	4	1.3218233202	-	2.71e-01	GO:0021782	glial cell development	BP
1	4	1.3218233202	-	2.71e-01	GO:0032414	positive regulation of ion transmembrane transporter activity	BP
1	4	1.3218233202	-	2.71e-01	GO:0070741	response to interleukin-6	BP
1	4	1.3218233202	-	2.71e-01	GO:0034154	toll-like receptor 7 signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:0048070	regulation of developmental pigmentation	BP
1	4	1.3218233202	-	2.71e-01	GO:0048133	male germ-line stem cell asymmetric division	BP
1	4	1.3218233202	-	2.71e-01	GO:2000546	positive regulation of endothelial cell chemotaxis to fibroblast growth factor	BP
1	4	1.3218233202	-	2.71e-01	GO:1902175	regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:0014028	notochord formation	BP
1	4	1.3218233202	-	2.71e-01	GO:1901525	negative regulation of macromitophagy	BP
1	4	1.3218233202	-	2.71e-01	GO:0006760	folic acid-containing compound metabolic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0032348	negative regulation of aldosterone biosynthetic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0033088	negative regulation of immature T cell proliferation in thymus	BP
1	4	1.3218233202	-	2.71e-01	GO:0014061	regulation of norepinephrine secretion	BP
1	4	1.3218233202	-	2.71e-01	GO:0043549	regulation of kinase activity	BP
1	4	1.3218233202	-	2.71e-01	GO:0042759	long-chain fatty acid biosynthetic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0001880	Mullerian duct regression	BP
1	4	1.3218233202	-	2.71e-01	GO:0060684	epithelial-mesenchymal cell signaling	BP
1	4	1.3218233202	-	2.71e-01	GO:0042491	auditory receptor cell differentiation	BP
1	4	1.3218233202	-	2.71e-01	GO:0036101	leukotriene B4 catabolic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0021559	trigeminal nerve development	BP
1	4	1.3218233202	-	2.71e-01	GO:0060393	regulation of pathway-restricted SMAD protein phosphorylation	BP
1	4	1.3218233202	-	2.71e-01	GO:0090370	negative regulation of cholesterol efflux	BP
1	4	1.3218233202	-	2.71e-01	GO:1904888	cranial skeletal system development	BP
1	4	1.3218233202	-	2.71e-01	GO:0032392	DNA geometric change	BP
1	4	1.3218233202	-	2.71e-01	GO:0006659	phosphatidylserine biosynthetic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0030644	cellular chloride ion homeostasis	BP
1	4	1.3218233202	-	2.71e-01	GO:0046596	regulation of viral entry into host cell	BP
1	4	1.3218233202	-	2.71e-01	GO:2000672	negative regulation of motor neuron apoptotic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0071603	endothelial cell-cell adhesion	BP
1	4	1.3218233202	-	2.71e-01	GO:0018243	protein O-linked glycosylation via threonine	BP
1	4	1.3218233202	-	2.71e-01	GO:0071442	positive regulation of histone H3-K14 acetylation	BP
1	4	1.3218233202	-	2.71e-01	GO:0060841	venous blood vessel development	BP
1	4	1.3218233202	-	2.71e-01	GO:2000021	regulation of ion homeostasis	BP
1	4	1.3218233202	-	2.71e-01	GO:0060050	positive regulation of protein glycosylation	BP
1	4	1.3218233202	-	2.71e-01	GO:1901909	diadenosine hexaphosphate catabolic process	BP
1	4	1.3218233202	-	2.71e-01	GO:1901907	diadenosine pentaphosphate catabolic process	BP
1	4	1.3218233202	-	2.71e-01	GO:2000065	negative regulation of cortisol biosynthetic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0007023	post-chaperonin tubulin folding pathway	BP
1	4	1.3218233202	-	2.71e-01	GO:0010897	negative regulation of triglyceride catabolic process	BP
1	4	1.3218233202	-	2.71e-01	GO:0010453	regulation of cell fate commitment	BP
1	4	1.3218233202	-	2.71e-01	GO:0070236	negative regulation of activation-induced cell death of T cells	BP
1	4	1.3218233202	-	2.71e-01	GO:0070901	mitochondrial tRNA methylation	BP
1	4	1.3218233202	-	2.71e-01	GO:0072757	cellular response to camptothecin	BP
1	4	1.3218233202	-	3.44e-01	GO:0060263	regulation of respiratory burst	BP
1	4	1.3218233202	-	3.44e-01	GO:0061470	T follicular helper cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0035995	detection of muscle stretch	BP
1	4	1.3218233202	-	3.44e-01	GO:0010716	negative regulation of extracellular matrix disassembly	BP
1	4	1.3218233202	-	3.44e-01	GO:0050859	negative regulation of B cell receptor signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0010523	negative regulation of calcium ion transport into cytosol	BP
1	4	1.3218233202	-	3.44e-01	GO:0035426	extracellular matrix-cell signaling	BP
1	4	1.3218233202	-	3.44e-01	GO:0051147	regulation of muscle cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0055118	negative regulation of cardiac muscle contraction	BP
1	4	1.3218233202	-	3.44e-01	GO:0008588	release of cytoplasmic sequestered NF-kappaB	BP
1	4	1.3218233202	-	3.44e-01	GO:0071459	protein localization to chromosome, centromeric region	BP
1	4	1.3218233202	-	3.44e-01	GO:1901509	regulation of endothelial tube morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:2001269	positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0009048	dosage compensation by inactivation of X chromosome	BP
1	4	1.3218233202	-	3.44e-01	GO:0032925	regulation of activin receptor signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:1900020	positive regulation of protein kinase C activity	BP
1	4	1.3218233202	-	3.44e-01	GO:0032369	negative regulation of lipid transport	BP
1	4	1.3218233202	-	3.44e-01	GO:0016240	autophagosome docking	BP
1	4	1.3218233202	-	3.44e-01	GO:0060669	embryonic placenta morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0071922	regulation of cohesin loading	BP
1	4	1.3218233202	-	3.44e-01	GO:0042159	lipoprotein catabolic process	BP
1	4	1.3218233202	-	3.44e-01	GO:2000483	negative regulation of interleukin-8 secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0014044	Schwann cell development	BP
1	4	1.3218233202	-	3.44e-01	GO:0042775	mitochondrial ATP synthesis coupled electron transport	BP
1	4	1.3218233202	-	3.44e-01	GO:0072108	positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0030242	pexophagy	BP
1	4	1.3218233202	-	3.44e-01	GO:0033625	positive regulation of integrin activation	BP
1	4	1.3218233202	-	3.44e-01	GO:0042345	regulation of NF-kappaB import into nucleus	BP
1	4	1.3218233202	-	3.44e-01	GO:0032507	maintenance of protein location in cell	BP
1	4	1.3218233202	-	3.44e-01	GO:0065002	intracellular protein transmembrane transport	BP
1	4	1.3218233202	-	3.44e-01	GO:0051409	response to nitrosative stress	BP
1	4	1.3218233202	-	3.44e-01	GO:1990966	ATP generation from poly-ADP-D-ribose	BP
1	4	1.3218233202	-	3.44e-01	GO:1900272	negative regulation of long-term synaptic potentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0090168	Golgi reassembly	BP
1	4	1.3218233202	-	3.44e-01	GO:0071514	genetic imprinting	BP
1	4	1.3218233202	-	3.44e-01	GO:0016080	synaptic vesicle targeting	BP
1	4	1.3218233202	-	3.44e-01	GO:0071896	protein localization to adherens junction	BP
1	4	1.3218233202	-	3.44e-01	GO:0060708	spongiotrophoblast differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0048023	positive regulation of melanin biosynthetic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0061428	negative regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
1	4	1.3218233202	-	3.44e-01	GO:0018119	peptidyl-cysteine S-nitrosylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0010724	regulation of definitive erythrocyte differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0006907	pinocytosis	BP
1	4	1.3218233202	-	3.44e-01	GO:0038124	toll-like receptor TLR6:TLR2 signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0045356	positive regulation of interferon-alpha biosynthetic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0030174	regulation of DNA-dependent DNA replication initiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0007296	vitellogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0060421	positive regulation of heart growth	BP
1	4	1.3218233202	-	3.44e-01	GO:0051900	regulation of mitochondrial depolarization	BP
1	4	1.3218233202	-	3.44e-01	GO:2001044	regulation of integrin-mediated signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0051138	positive regulation of NK T cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0070670	response to interleukin-4	BP
1	4	1.3218233202	-	3.44e-01	GO:0007089	traversing start control point of mitotic cell cycle	BP
1	4	1.3218233202	-	3.44e-01	GO:0007161	calcium-independent cell-matrix adhesion	BP
1	4	1.3218233202	-	3.44e-01	GO:0040023	establishment of nucleus localization	BP
1	4	1.3218233202	-	3.44e-01	GO:2000002	negative regulation of DNA damage checkpoint	BP
1	4	1.3218233202	-	3.44e-01	GO:0017145	stem cell division	BP
1	4	1.3218233202	-	3.44e-01	GO:0038001	paracrine signaling	BP
1	4	1.3218233202	-	3.44e-01	GO:0060033	anatomical structure regression	BP
1	4	1.3218233202	-	3.44e-01	GO:0018393	internal peptidyl-lysine acetylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0033634	positive regulation of cell-cell adhesion mediated by integrin	BP
1	4	1.3218233202	-	3.44e-01	GO:0042482	positive regulation of odontogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0051414	response to cortisol	BP
1	4	1.3218233202	-	3.44e-01	GO:1901888	regulation of cell junction assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:1900825	regulation of membrane depolarization during cardiac muscle cell action potential	BP
1	4	1.3218233202	-	3.44e-01	GO:1903347	negative regulation of bicellular tight junction assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:2001137	positive regulation of endocytic recycling	BP
1	4	1.3218233202	-	3.44e-01	GO:0001505	regulation of neurotransmitter levels	BP
1	4	1.3218233202	-	3.44e-01	GO:0008105	asymmetric protein localization	BP
1	4	1.3218233202	-	3.44e-01	GO:1903553	positive regulation of extracellular exosome assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:1901300	positive regulation of hydrogen peroxide-mediated programmed cell death	BP
1	4	1.3218233202	-	3.44e-01	GO:0002906	negative regulation of mature B cell apoptotic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0043152	induction of bacterial agglutination	BP
1	4	1.3218233202	-	3.44e-01	GO:0003266	regulation of secondary heart field cardioblast proliferation	BP
1	4	1.3218233202	-	3.44e-01	GO:0097623	potassium ion export across plasma membrane	BP
1	4	1.3218233202	-	3.44e-01	GO:0006642	triglyceride mobilization	BP
1	4	1.3218233202	-	3.44e-01	GO:0032417	positive regulation of sodium:proton antiporter activity	BP
1	4	1.3218233202	-	3.44e-01	GO:0070293	renal absorption	BP
1	4	1.3218233202	-	3.44e-01	GO:0006933	negative regulation of cell adhesion involved in substrate-bound cell migration	BP
1	4	1.3218233202	-	3.44e-01	GO:2000664	positive regulation of interleukin-5 secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0090244	Wnt signaling pathway involved in somitogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0031952	regulation of protein autophosphorylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0032455	nerve growth factor processing	BP
1	4	1.3218233202	-	3.44e-01	GO:0010988	regulation of low-density lipoprotein particle clearance	BP
1	4	1.3218233202	-	3.44e-01	GO:0010989	negative regulation of low-density lipoprotein particle clearance	BP
1	4	1.3218233202	-	3.44e-01	GO:1900041	negative regulation of interleukin-2 secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0060364	frontal suture morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0071677	positive regulation of mononuclear cell migration	BP
1	4	1.3218233202	-	3.44e-01	GO:0006538	glutamate catabolic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0071866	negative regulation of apoptotic process in bone marrow	BP
1	4	1.3218233202	-	3.44e-01	GO:0016071	mRNA metabolic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0035771	interleukin-4-mediated signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:1901222	regulation of NIK/NF-kappaB signaling	BP
1	4	1.3218233202	-	3.44e-01	GO:0071205	protein localization to juxtaparanode region of axon	BP
1	4	1.3218233202	-	3.44e-01	GO:0008038	neuron recognition	BP
1	4	1.3218233202	-	3.44e-01	GO:0035523	protein K29-linked deubiquitination	BP
1	4	1.3218233202	-	3.44e-01	GO:0035522	monoubiquitinated histone H2A deubiquitination	BP
1	4	1.3218233202	-	3.44e-01	GO:0061056	sclerotome development	BP
1	4	1.3218233202	-	3.44e-01	GO:0070192	chromosome organization involved in meiotic cell cycle	BP
1	4	1.3218233202	-	3.44e-01	GO:0034698	response to gonadotropin	BP
1	4	1.3218233202	-	3.44e-01	GO:2000051	negative regulation of non-canonical Wnt signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0034205	beta-amyloid formation	BP
1	4	1.3218233202	-	3.44e-01	GO:0070836	caveola assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:0022009	central nervous system vasculogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:1904637	cellular response to ionomycin	BP
1	4	1.3218233202	-	3.44e-01	GO:0034088	maintenance of mitotic sister chromatid cohesion	BP
1	4	1.3218233202	-	3.44e-01	GO:0032226	positive regulation of synaptic transmission, dopaminergic	BP
1	4	1.3218233202	-	3.44e-01	GO:0090559	regulation of membrane permeability	BP
1	4	1.3218233202	-	3.44e-01	GO:0021943	formation of radial glial scaffolds	BP
1	4	1.3218233202	-	3.44e-01	GO:0031860	telomeric 3' overhang formation	BP
1	4	1.3218233202	-	3.44e-01	GO:0010957	negative regulation of vitamin D biosynthetic process	BP
1	4	1.3218233202	-	3.44e-01	GO:1902083	negative regulation of peptidyl-cysteine S-nitrosylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0002725	negative regulation of T cell cytokine production	BP
1	4	1.3218233202	-	3.44e-01	GO:0003253	cardiac neural crest cell migration involved in outflow tract morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:2000343	positive regulation of chemokine (C-X-C motif) ligand 2 production	BP
1	4	1.3218233202	-	3.44e-01	GO:2000346	negative regulation of hepatocyte proliferation	BP
1	4	1.3218233202	-	3.44e-01	GO:0042089	cytokine biosynthetic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0010918	positive regulation of mitochondrial membrane potential	BP
1	4	1.3218233202	-	3.44e-01	GO:2001181	positive regulation of interleukin-10 secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0043932	ossification involved in bone remodeling	BP
1	4	1.3218233202	-	3.44e-01	GO:0045472	response to ether	BP
1	4	1.3218233202	-	3.44e-01	GO:0048541	Peyer's patch development	BP
1	4	1.3218233202	-	3.44e-01	GO:0003219	cardiac right ventricle formation	BP
1	4	1.3218233202	-	3.44e-01	GO:0032648	regulation of interferon-beta production	BP
1	4	1.3218233202	-	3.44e-01	GO:0070164	negative regulation of adiponectin secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:2000301	negative regulation of synaptic vesicle exocytosis	BP
1	4	1.3218233202	-	3.44e-01	GO:0006482	protein demethylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0060159	regulation of dopamine receptor signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0008088	axo-dendritic transport	BP
1	4	1.3218233202	-	3.44e-01	GO:0034121	regulation of toll-like receptor signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0038108	negative regulation of appetite by leptin-mediated signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0048505	regulation of timing of cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0007100	mitotic centrosome separation	BP
1	4	1.3218233202	-	3.44e-01	GO:1903936	cellular response to sodium arsenite	BP
1	4	1.3218233202	-	3.44e-01	GO:1901984	negative regulation of protein acetylation	BP
1	4	1.3218233202	-	3.44e-01	GO:0060355	positive regulation of cell adhesion molecule production	BP
1	4	1.3218233202	-	3.44e-01	GO:2000969	positive regulation of AMPA receptor activity	BP
1	4	1.3218233202	-	3.44e-01	GO:0014904	myotube cell development	BP
1	4	1.3218233202	-	3.44e-01	GO:0060842	arterial endothelial cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0022405	hair cycle process	BP
1	4	1.3218233202	-	3.44e-01	GO:0043622	cortical microtubule organization	BP
1	4	1.3218233202	-	3.44e-01	GO:0071218	cellular response to misfolded protein	BP
1	4	1.3218233202	-	3.44e-01	GO:0035021	negative regulation of Rac protein signal transduction	BP
1	4	1.3218233202	-	3.44e-01	GO:0090650	cellular response to oxygen-glucose deprivation	BP
1	4	1.3218233202	-	3.44e-01	GO:0043553	negative regulation of phosphatidylinositol 3-kinase activity	BP
1	4	1.3218233202	-	3.44e-01	GO:0061041	regulation of wound healing	BP
1	4	1.3218233202	-	3.44e-01	GO:1990086	lens fiber cell apoptotic process	BP
1	4	1.3218233202	-	3.44e-01	GO:0010626	negative regulation of Schwann cell proliferation	BP
1	4	1.3218233202	-	3.44e-01	GO:0072289	metanephric nephron tubule formation	BP
1	4	1.3218233202	-	3.44e-01	GO:0048861	leukemia inhibitory factor signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:1902714	negative regulation of interferon-gamma secretion	BP
1	4	1.3218233202	-	3.44e-01	GO:0045589	regulation of regulatory T cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0038026	reelin-mediated signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0071726	cellular response to diacyl bacterial lipopeptide	BP
1	4	1.3218233202	-	3.44e-01	GO:0060750	epithelial cell proliferation involved in mammary gland duct elongation	BP
1	4	1.3218233202	-	3.44e-01	GO:0051387	negative regulation of neurotrophin TRK receptor signaling pathway	BP
1	4	1.3218233202	-	3.44e-01	GO:0010668	ectodermal cell differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:0006990	positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response	BP
1	4	1.3218233202	-	3.44e-01	GO:1904504	positive regulation of lipophagy	BP
1	4	1.3218233202	-	3.44e-01	GO:0014829	vascular smooth muscle contraction	BP
1	4	1.3218233202	-	3.44e-01	GO:0035910	ascending aorta morphogenesis	BP
1	4	1.3218233202	-	3.44e-01	GO:0090306	spindle assembly involved in meiosis	BP
1	4	1.3218233202	-	3.44e-01	GO:0000904	cell morphogenesis involved in differentiation	BP
1	4	1.3218233202	-	3.44e-01	GO:2000373	positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity	BP
1	4	1.3218233202	-	3.44e-01	GO:0007431	salivary gland development	BP
1	4	1.3218233202	-	3.44e-01	GO:0097114	NMDA glutamate receptor clustering	BP
1	4	1.3218233202	-	3.44e-01	GO:0097113	AMPA glutamate receptor clustering	BP
1	4	1.3218233202	-	3.44e-01	GO:0097118	neuroligin clustering involved in postsynaptic membrane assembly	BP
1	4	1.3218233202	-	3.44e-01	GO:0071315	cellular response to morphine	BP
1	4	1.3218233202	-	3.44e-01	GO:0046425	regulation of JAK-STAT cascade	BP
1	4	1.3218233202	-	3.44e-01	GO:0051645	Golgi localization	BP
9	36	1.3218233202	-	3.26e-03	GO:0005547	phosphatidylinositol-3,4,5-trisphosphate binding	MF
4	16	1.3218233202	-	5.55e-02	GO:0050431	transforming growth factor beta binding	MF
4	16	1.3218233202	-	5.55e-02	GO:0023026	MHC class II protein complex binding	MF
4	16	1.3218233202	-	6.83e-02	GO:0000400	four-way junction DNA binding	MF
2	8	1.3218233202	-	1.50e-01	GO:0042379	chemokine receptor binding	MF
2	8	1.3218233202	-	1.50e-01	GO:0005005	transmembrane-ephrin receptor activity	MF
2	8	1.3218233202	-	1.50e-01	GO:0102991	myristoyl-CoA hydrolase activity	MF
2	8	1.3218233202	-	1.87e-01	GO:0030983	mismatched DNA binding	MF
2	8	1.3218233202	-	1.87e-01	GO:0000150	recombinase activity	MF
2	8	1.3218233202	-	1.87e-01	GO:0031748	D1 dopamine receptor binding	MF
2	8	1.3218233202	-	1.87e-01	GO:0050700	CARD domain binding	MF
2	8	1.3218233202	-	1.87e-01	GO:0031386	protein tag	MF
2	8	1.3218233202	-	1.87e-01	GO:0002162	dystroglycan binding	MF
2	8	1.3218233202	-	1.87e-01	GO:0001849	complement component C1q binding	MF
1	4	1.3218233202	-	1.90e-01	GO:0031628	opioid receptor binding	MF
1	4	1.3218233202	-	1.90e-01	GO:0005332	gamma-aminobutyric acid:sodium symporter activity	MF
1	4	1.3218233202	-	1.90e-01	GO:1990430	extracellular matrix protein binding	MF
1	4	1.3218233202	-	1.90e-01	GO:0055077	gap junction hemi-channel activity	MF
1	4	1.3218233202	-	1.90e-01	GO:0022841	potassium ion leak channel activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0090722	receptor-receptor interaction	MF
1	4	1.3218233202	-	2.71e-01	GO:0004634	phosphopyruvate hydratase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0000298	endopolyphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0050051	leukotriene-B4 20-monooxygenase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0001042	RNA polymerase I core binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0034431	bis(5'-adenosyl)-hexaphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0034432	bis(5'-adenosyl)-pentaphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0018685	alkane 1-monooxygenase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0008486	diphosphoinositol-polyphosphate diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0052848	inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0052845	inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0052844	inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0052847	inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0052846	inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0052841	inositol bisdiphosphate tetrakisphosphate diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0052840	inositol diphosphate tetrakisphosphate diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0052843	inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0052842	inositol diphosphate pentakisphosphate diphosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0004647	phosphoserine phosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0042030	ATPase inhibitor activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0044323	retinoic acid-responsive element binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0008453	alanine-glyoxylate transaminase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0090554	phosphatidylcholine-translocating ATPase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0001515	opioid peptide activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0016807	cysteine-type carboxypeptidase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:1990405	protein antigen binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0004035	alkaline phosphatase activity	MF
1	4	1.3218233202	-	2.71e-01	GO:0036094	small molecule binding	MF
1	4	1.3218233202	-	2.71e-01	GO:0035727	lysophosphatidic acid binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0034485	phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0030160	GKAP/Homer scaffold activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0043208	glycosphingolipid binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0031014	troponin T binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0005025	transforming growth factor beta receptor activity, type I	MF
1	4	1.3218233202	-	3.44e-01	GO:0004082	bisphosphoglycerate mutase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0097100	supercoiled DNA binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0005329	dopamine transmembrane transporter activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0003960	NADPH:quinone reductase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0030375	thyroid hormone receptor coactivator activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0046538	2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0008349	MAP kinase kinase kinase kinase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0003696	satellite DNA binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0004090	carbonyl reductase (NADPH) activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0019158	mannokinase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0034191	apolipoprotein A-I receptor binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0008569	ATP-dependent microtubule motor activity, minus-end-directed	MF
1	4	1.3218233202	-	3.44e-01	GO:0004974	leukotriene receptor activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0032795	heterotrimeric G-protein binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0034617	tetrahydrobiopterin binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0005497	androgen binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0003873	6-phosphofructo-2-kinase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0008607	phosphorylase kinase regulator activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0001882	nucleoside binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0086089	voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization	MF
1	4	1.3218233202	-	3.44e-01	GO:0008865	fructokinase activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0071535	RING-like zinc finger domain binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0070053	thrombospondin receptor activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0086007	voltage-gated calcium channel activity involved in cardiac muscle cell action potential	MF
1	4	1.3218233202	-	3.44e-01	GO:0017162	aryl hydrocarbon receptor binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0004897	ciliary neurotrophic factor receptor activity	MF
1	4	1.3218233202	-	3.44e-01	GO:0051434	BH3 domain binding	MF
1	4	1.3218233202	-	3.44e-01	GO:0031698	beta-2 adrenergic receptor binding	MF
62	249	1.31601769852	-	1.13e-10	GO:0010628	positive regulation of gene expression	BP
17	69	1.30076170467	-	1.17e-05	GO:0071300	cellular response to retinoic acid	BP
39	159	1.29434258378	-	5.39e-09	GO:0090090	negative regulation of canonical Wnt signaling pathway	BP
68	278	1.29034508873	-	6.84e-11	GO:0008134	transcription factor binding	MF
11	45	1.28940184251	-	1.80e-03	GO:0019902	phosphatase binding	MF
20	82	1.28619941047	-	4.85e-05	GO:0008543	fibroblast growth factor receptor signaling pathway	BP
10	41	1.28619941047	-	3.35e-03	GO:0014823	response to activity	BP
10	41	1.28619941047	-	5.00e-03	GO:0030521	androgen receptor signaling pathway	BP
18	74	1.28229495601	-	1.60e-04	GO:0071260	cellular response to mechanical stimulus	BP
9	37	1.28229495601	-	7.60e-03	GO:0030890	positive regulation of B cell proliferation	BP
17	70	1.28000314451	-	2.59e-05	GO:0001558	regulation of cell growth	BP
24	99	1.27742920084	-	6.86e-07	GO:0006469	negative regulation of protein kinase activity	BP
24	99	1.27742920084	-	2.14e-05	GO:0016236	macroautophagy	BP
8	33	1.27742920084	-	1.16e-02	GO:0051973	positive regulation of telomerase activity	BP
15	62	1.27451760542	-	3.57e-04	GO:0035690	cellular response to drug	BP
14	58	1.27119724713	-	2.77e-04	GO:0042102	positive regulation of T cell proliferation	BP
14	58	1.27119724713	-	3.47e-04	GO:0016525	negative regulation of angiogenesis	BP
7	29	1.27119724713	-	7.40e-03	GO:0048167	regulation of synaptic plasticity	BP
7	29	1.27119724713	-	9.41e-03	GO:0007205	protein kinase C-activating G-protein coupled receptor signaling pathway	BP
7	29	1.27119724713	-	1.18e-02	GO:0007281	germ cell development	BP
20	83	1.26871198374	-	7.20e-05	GO:0006928	movement of cell or subcellular component	BP
91	379	1.26356392223	-	1.27e-10	GO:0008285	negative regulation of cell proliferation	BP
6	25	1.26292963115	-	8.55e-03	GO:0060349	bone morphogenesis	BP
6	25	1.26292963115	-	1.12e-02	GO:0050715	positive regulation of cytokine secretion	BP
6	25	1.26292963115	-	1.81e-02	GO:0050772	positive regulation of axonogenesis	BP
6	25	1.26292963115	-	3.33e-02	GO:0032735	positive regulation of interleukin-12 production	BP
12	50	1.26292963115	-	1.47e-03	GO:0001085	RNA polymerase II transcription factor binding	MF
11	46	1.25769298278	-	1.44e-03	GO:0010506	regulation of autophagy	BP
11	46	1.25769298278	-	2.22e-03	GO:0008542	visual learning	BP
15	63	1.25143399231	-	2.33e-04	GO:0009611	response to wounding	BP
10	42	1.25143399231	-	4.11e-03	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
10	42	1.25143399231	-	5.00e-03	GO:1901215	negative regulation of neuron death	BP
5	21	1.25143399231	-	2.21e-02	GO:0045671	negative regulation of osteoclast differentiation	BP
5	21	1.25143399231	-	2.81e-02	GO:0035902	response to immobilization stress	BP
5	21	1.25143399231	-	2.81e-02	GO:0046697	decidualization	BP
5	21	1.25143399231	-	3.51e-02	GO:0001782	B cell homeostasis	BP
5	21	1.25143399231	-	4.31e-02	GO:0030879	mammary gland development	BP
14	59	1.2465351929	-	7.98e-04	GO:0001948	glycoprotein binding	MF
9	38	1.2438208082	-	2.57e-03	GO:0001657	ureteric bud development	BP
9	38	1.2438208082	-	9.17e-03	GO:0007346	regulation of mitotic cell cycle	BP
17	72	1.23936116001	-	1.23e-08	GO:0050853	B cell receptor signaling pathway	BP
32	136	1.23436047895	-	6.28e-07	GO:0008360	regulation of cell shape	BP
4	17	1.23436047895	-	3.41e-02	GO:0009948	anterior/posterior axis specification	BP
4	17	1.23436047895	-	3.41e-02	GO:0048663	neuron fate commitment	BP
4	17	1.23436047895	-	3.41e-02	GO:0001556	oocyte maturation	BP
4	17	1.23436047895	-	4.41e-02	GO:0007043	cell-cell junction assembly	BP
4	17	1.23436047895	-	5.55e-02	GO:0048488	synaptic vesicle endocytosis	BP
4	17	1.23436047895	-	5.55e-02	GO:0032722	positive regulation of chemokine production	BP
4	17	1.23436047895	-	6.83e-02	GO:0030325	adrenal gland development	BP
4	17	1.23436047895	-	6.83e-02	GO:0007026	negative regulation of microtubule depolymerization	BP
4	17	1.23436047895	-	6.83e-02	GO:2000114	regulation of establishment of cell polarity	BP
4	17	1.23436047895	-	5.55e-02	GO:0001190	transcriptional activator activity, RNA polymerase II transcription factor binding	MF
15	64	1.22871391581	-	4.37e-04	GO:0035019	somatic stem cell population maintenance	BP
14	60	1.22228764665	-	1.17e-03	GO:0070301	cellular response to hydrogen peroxide	BP
7	30	1.22228764665	-	9.41e-03	GO:0071773	cellular response to BMP stimulus	BP
7	30	1.22228764665	-	2.15e-02	GO:0051879	Hsp90 protein binding	MF
30	129	1.21748666039	-	1.14e-06	GO:0043524	negative regulation of neuron apoptotic process	BP
10	43	1.21748666039	-	6.03e-03	GO:0001046	core promoter sequence-specific DNA binding	MF
66	284	1.21647032005	-	1.80e-10	GO:0031625	ubiquitin protein ligase binding	MF
24	104	1.20634610278	-	1.42e-06	GO:0010468	regulation of gene expression	BP
21	91	1.20634610278	-	7.18e-06	GO:0009636	response to toxic substance	BP
9	39	1.20634610278	-	9.17e-03	GO:0007223	Wnt signaling pathway, calcium modulating pathway	BP
6	26	1.20634610278	-	1.44e-02	GO:0042104	positive regulation of activated T cell proliferation	BP
6	26	1.20634610278	-	2.25e-02	GO:0032715	negative regulation of interleukin-6 production	BP
6	26	1.20634610278	-	2.75e-02	GO:0006754	ATP biosynthetic process	BP
3	13	1.20634610278	-	3.81e-02	GO:0048599	oocyte development	BP
6	26	1.20634610278	-	3.97e-02	GO:0007017	microtubule-based process	BP
3	13	1.20634610278	-	5.29e-02	GO:0005513	detection of calcium ion	BP
3	13	1.20634610278	-	7.01e-02	GO:0007398	ectoderm development	BP
3	13	1.20634610278	-	7.01e-02	GO:0060389	pathway-restricted SMAD protein phosphorylation	BP
3	13	1.20634610278	-	8.95e-02	GO:0060996	dendritic spine development	BP
3	13	1.20634610278	-	1.11e-01	GO:0006622	protein targeting to lysosome	BP
3	13	1.20634610278	-	1.11e-01	GO:0060413	atrial septum morphogenesis	BP
3	13	1.20634610278	-	1.11e-01	GO:0032740	positive regulation of interleukin-17 production	BP
3	13	1.20634610278	-	1.11e-01	GO:0051974	negative regulation of telomerase activity	BP
3	13	1.20634610278	-	1.11e-01	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP
3	13	1.20634610278	-	1.11e-01	GO:0010952	positive regulation of peptidase activity	BP
3	13	1.20634610278	-	1.11e-01	GO:0060317	cardiac epithelial to mesenchymal transition	BP
3	13	1.20634610278	-	1.11e-01	GO:0071872	cellular response to epinephrine stimulus	BP
3	13	1.20634610278	-	1.34e-01	GO:0045088	regulation of innate immune response	BP
3	13	1.20634610278	-	1.34e-01	GO:0006809	nitric oxide biosynthetic process	BP
6	26	1.20634610278	-	3.33e-02	GO:0042056	chemoattractant activity	MF
6	26	1.20634610278	-	3.97e-02	GO:0035035	histone acetyltransferase binding	MF
3	13	1.20634610278	-	1.11e-01	GO:0035326	enhancer binding	MF
3	13	1.20634610278	-	1.34e-01	GO:1904264	ubiquitin protein ligase activity involved in ERAD pathway	MF
14	61	1.1984409047	-	9.68e-04	GO:0006006	glucose metabolic process	BP
11	48	1.19629243812	-	1.80e-03	GO:0043647	inositol phosphate metabolic process	BP
8	35	1.19254030326	-	4.91e-03	GO:0001890	placenta development	BP
39	171	1.18937302418	-	4.13e-07	GO:0008022	protein C-terminus binding	MF
10	44	1.18431979645	-	3.35e-03	GO:0003151	outflow tract morphogenesis	BP
5	22	1.18431979645	-	3.51e-02	GO:0001816	cytokine production	BP
5	22	1.18431979645	-	5.20e-02	GO:0003148	outflow tract septum morphogenesis	BP
5	22	1.18431979645	-	6.20e-02	GO:0016050	vesicle organization	BP
5	22	1.18431979645	-	6.20e-02	GO:0048568	embryonic organ development	BP
5	22	1.18431979645	-	6.20e-02	GO:2001235	positive regulation of apoptotic signaling pathway	BP
14	62	1.17498193187	-	1.40e-03	GO:0046330	positive regulation of JNK cascade	BP
7	31	1.17498193187	-	7.40e-03	GO:0048565	digestive tract development	BP
7	31	1.17498193187	-	7.40e-03	GO:0045907	positive regulation of vasoconstriction	BP
7	31	1.17498193187	-	3.04e-02	GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	BP
23	102	1.17295993429	-	3.18e-05	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	BP
102	453	1.17088142213	-	2.23e-10	GO:0008284	positive regulation of cell proliferation	BP
46	206	1.15888474907	-	7.08e-08	GO:0019904	protein domain specific binding	MF
71	319	1.15415782594	-	1.93e-10	GO:0019899	enzyme binding	MF
14	63	1.15189831876	-	6.54e-04	GO:0032868	response to insulin	BP
10	45	1.15189831876	-	4.11e-03	GO:0030900	forebrain development	BP
10	45	1.15189831876	-	5.00e-03	GO:0071363	cellular response to growth factor stimulus	BP
8	36	1.15189831876	-	6.19e-03	GO:0002062	chondrocyte differentiation	BP
8	36	1.15189831876	-	7.72e-03	GO:0001568	blood vessel development	BP
10	45	1.15189831876	-	8.59e-03	GO:0010595	positive regulation of endothelial cell migration	BP
8	36	1.15189831876	-	9.51e-03	GO:0032720	negative regulation of tumor necrosis factor production	BP
6	27	1.15189831876	-	1.12e-02	GO:0001755	neural crest cell migration	BP
8	36	1.15189831876	-	1.40e-02	GO:0030177	positive regulation of Wnt signaling pathway	BP
8	36	1.15189831876	-	1.67e-02	GO:0048536	spleen development	BP
8	36	1.15189831876	-	1.67e-02	GO:0050714	positive regulation of protein secretion	BP
8	36	1.15189831876	-	1.99e-02	GO:0006953	acute-phase response	BP
4	18	1.15189831876	-	2.56e-02	GO:0036342	post-anal tail morphogenesis	BP
6	27	1.15189831876	-	2.75e-02	GO:0061098	positive regulation of protein tyrosine kinase activity	BP
6	27	1.15189831876	-	3.33e-02	GO:0001975	response to amphetamine	BP
4	18	1.15189831876	-	4.41e-02	GO:0045216	cell-cell junction organization	BP
4	18	1.15189831876	-	4.41e-02	GO:0048557	embryonic digestive tract morphogenesis	BP
2	9	1.15189831876	-	5.23e-02	GO:0045141	meiotic telomere clustering	BP
4	18	1.15189831876	-	5.55e-02	GO:0042267	natural killer cell mediated cytotoxicity	BP
4	18	1.15189831876	-	5.55e-02	GO:0002076	osteoblast development	BP
4	18	1.15189831876	-	5.55e-02	GO:1903506	regulation of nucleic acid-templated transcription	BP
4	18	1.15189831876	-	6.83e-02	GO:0045954	positive regulation of natural killer cell mediated cytotoxicity	BP
2	9	1.15189831876	-	8.14e-02	GO:0097186	amelogenesis	BP
2	9	1.15189831876	-	8.14e-02	GO:1904262	negative regulation of TORC1 signaling	BP
2	9	1.15189831876	-	8.14e-02	GO:0043583	ear development	BP
2	9	1.15189831876	-	8.14e-02	GO:0045580	regulation of T cell differentiation	BP
4	18	1.15189831876	-	8.25e-02	GO:0098609	cell-cell adhesion	BP
4	18	1.15189831876	-	8.25e-02	GO:0001892	embryonic placenta development	BP
4	18	1.15189831876	-	8.25e-02	GO:0045664	regulation of neuron differentiation	BP
4	18	1.15189831876	-	8.25e-02	GO:0008045	motor neuron axon guidance	BP
4	18	1.15189831876	-	8.25e-02	GO:0048169	regulation of long-term neuronal synaptic plasticity	BP
4	18	1.15189831876	-	9.81e-02	GO:0043523	regulation of neuron apoptotic process	BP
4	18	1.15189831876	-	9.81e-02	GO:0035904	aorta development	BP
2	9	1.15189831876	-	1.14e-01	GO:0031639	plasminogen activation	BP
2	9	1.15189831876	-	1.14e-01	GO:0042448	progesterone metabolic process	BP
2	9	1.15189831876	-	1.14e-01	GO:0002315	marginal zone B cell differentiation	BP
2	9	1.15189831876	-	1.14e-01	GO:2000304	positive regulation of ceramide biosynthetic process	BP
2	9	1.15189831876	-	1.50e-01	GO:0044342	type B pancreatic cell proliferation	BP
2	9	1.15189831876	-	1.50e-01	GO:0006518	peptide metabolic process	BP
2	9	1.15189831876	-	1.50e-01	GO:0061072	iris morphogenesis	BP
2	9	1.15189831876	-	1.50e-01	GO:0048643	positive regulation of skeletal muscle tissue development	BP
2	9	1.15189831876	-	1.50e-01	GO:0042118	endothelial cell activation	BP
2	9	1.15189831876	-	1.50e-01	GO:0061549	sympathetic ganglion development	BP
2	9	1.15189831876	-	1.50e-01	GO:0050966	detection of mechanical stimulus involved in sensory perception of pain	BP
2	9	1.15189831876	-	1.50e-01	GO:0010579	positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway	BP
2	9	1.15189831876	-	1.50e-01	GO:0060039	pericardium development	BP
2	9	1.15189831876	-	1.50e-01	GO:0042698	ovulation cycle	BP
2	9	1.15189831876	-	1.50e-01	GO:0097178	ruffle assembly	BP
2	9	1.15189831876	-	1.50e-01	GO:0072358	cardiovascular system development	BP
2	9	1.15189831876	-	1.50e-01	GO:0045124	regulation of bone resorption	BP
2	9	1.15189831876	-	1.50e-01	GO:0046620	regulation of organ growth	BP
2	9	1.15189831876	-	1.50e-01	GO:0002237	response to molecule of bacterial origin	BP
2	9	1.15189831876	-	1.87e-01	GO:0003208	cardiac ventricle morphogenesis	BP
2	9	1.15189831876	-	1.87e-01	GO:0046638	positive regulation of alpha-beta T cell differentiation	BP
2	9	1.15189831876	-	1.87e-01	GO:0071223	cellular response to lipoteichoic acid	BP
2	9	1.15189831876	-	1.87e-01	GO:0060068	vagina development	BP
2	9	1.15189831876	-	1.87e-01	GO:0036500	ATF6-mediated unfolded protein response	BP
2	9	1.15189831876	-	1.87e-01	GO:0035999	tetrahydrofolate interconversion	BP
2	9	1.15189831876	-	1.87e-01	GO:0060231	mesenchymal to epithelial transition	BP
2	9	1.15189831876	-	1.87e-01	GO:0006111	regulation of gluconeogenesis	BP
2	9	1.15189831876	-	1.87e-01	GO:0060674	placenta blood vessel development	BP
2	9	1.15189831876	-	1.87e-01	GO:0006930	substrate-dependent cell migration, cell extension	BP
2	9	1.15189831876	-	1.87e-01	GO:0042088	T-helper 1 type immune response	BP
2	9	1.15189831876	-	1.87e-01	GO:0050862	positive regulation of T cell receptor signaling pathway	BP
2	9	1.15189831876	-	1.87e-01	GO:0030299	intestinal cholesterol absorption	BP
2	9	1.15189831876	-	2.25e-01	GO:0007196	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway	BP
2	9	1.15189831876	-	2.25e-01	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	BP
2	9	1.15189831876	-	2.25e-01	GO:1901030	positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	BP
2	9	1.15189831876	-	2.25e-01	GO:0010614	negative regulation of cardiac muscle hypertrophy	BP
2	9	1.15189831876	-	2.25e-01	GO:0060627	regulation of vesicle-mediated transport	BP
2	9	1.15189831876	-	2.25e-01	GO:0098779	positive regulation of macromitophagy in response to mitochondrial depolarization	BP
2	9	1.15189831876	-	2.25e-01	GO:0010761	fibroblast migration	BP
2	9	1.15189831876	-	2.25e-01	GO:2000178	negative regulation of neural precursor cell proliferation	BP
2	9	1.15189831876	-	2.25e-01	GO:0050807	regulation of synapse organization	BP
2	9	1.15189831876	-	2.25e-01	GO:0010831	positive regulation of myotube differentiation	BP
2	9	1.15189831876	-	2.25e-01	GO:0034629	cellular protein complex localization	BP
2	9	1.15189831876	-	2.25e-01	GO:2000008	regulation of protein localization to cell surface	BP
2	9	1.15189831876	-	2.25e-01	GO:0010944	negative regulation of transcription by competitive promoter binding	BP
2	9	1.15189831876	-	2.25e-01	GO:0034501	protein localization to kinetochore	BP
2	9	1.15189831876	-	2.25e-01	GO:0030851	granulocyte differentiation	BP
2	9	1.15189831876	-	2.25e-01	GO:0035563	positive regulation of chromatin binding	BP
2	9	1.15189831876	-	2.25e-01	GO:0070933	histone H4 deacetylation	BP
2	9	1.15189831876	-	2.25e-01	GO:0033689	negative regulation of osteoblast proliferation	BP
2	9	1.15189831876	-	2.25e-01	GO:0035456	response to interferon-beta	BP
2	9	1.15189831876	-	2.25e-01	GO:0045080	positive regulation of chemokine biosynthetic process	BP
2	9	1.15189831876	-	2.25e-01	GO:0010818	T cell chemotaxis	BP
2	9	1.15189831876	-	2.25e-01	GO:0032000	positive regulation of fatty acid beta-oxidation	BP
4	18	1.15189831876	-	1.28e-02	GO:0005520	insulin-like growth factor binding	MF
4	18	1.15189831876	-	2.56e-02	GO:0016746	transferase activity, transferring acyl groups	MF
4	18	1.15189831876	-	6.83e-02	GO:0098641	cadherin binding involved in cell-cell adhesion	MF
4	18	1.15189831876	-	8.25e-02	GO:0070530	K63-linked polyubiquitin binding	MF
2	9	1.15189831876	-	1.87e-01	GO:0030296	protein tyrosine kinase activator activity	MF
2	9	1.15189831876	-	1.87e-01	GO:0001191	transcriptional repressor activity, RNA polymerase II transcription factor binding	MF
2	9	1.15189831876	-	2.25e-01	GO:0019869	chloride channel inhibitor activity	MF
2	9	1.15189831876	-	2.25e-01	GO:0005522	profilin binding	MF
2	9	1.15189831876	-	2.25e-01	GO:0008821	crossover junction endodeoxyribonuclease activity	MF
2	9	1.15189831876	-	2.25e-01	GO:0045505	dynein intermediate chain binding	MF
65	294	1.14451878839	-	1.15e-10	GO:0043065	positive regulation of apoptotic process	BP
13	59	1.13961998898	-	6.30e-03	GO:0001047	core promoter binding	MF
11	50	1.13739874906	-	4.77e-03	GO:0071407	cellular response to organic cyclic compound	BP
20	91	1.13595677489	-	1.26e-04	GO:0032355	response to estradiol	BP
9	41	1.13419631703	-	1.30e-02	GO:0034613	cellular protein localization	BP
7	32	1.12917824226	-	1.78e-02	GO:0006298	mismatch repair	BP
7	32	1.12917824226	-	3.04e-02	GO:0071549	cellular response to dexamethasone stimulus	BP
7	32	1.12917824226	-	3.04e-02	GO:0019888	protein phosphatase regulator activity	MF
40	183	1.1280515768	-	2.23e-08	GO:0042981	regulation of apoptotic process	BP
36	165	1.1254261074	-	1.57e-07	GO:0007507	heart development	BP
12	55	1.1254261074	-	1.47e-03	GO:0042475	odontogenesis of dentin-containing tooth	BP
12	55	1.1254261074	-	2.19e-03	GO:0050680	negative regulation of epithelial cell proliferation	BP
17	78	1.12388394259	-	1.33e-03	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	BP
39	179	1.1234097618	-	1.51e-08	GO:0016055	Wnt signaling pathway	BP
20	92	1.12018945903	-	5.92e-05	GO:0016337	single organismal cell-cell adhesion	BP
5	23	1.12018945903	-	2.81e-02	GO:0032967	positive regulation of collagen biosynthetic process	BP
5	23	1.12018945903	-	3.51e-02	GO:0009954	proximal/distal pattern formation	BP
5	23	1.12018945903	-	4.31e-02	GO:0031018	endocrine pancreas development	BP
5	23	1.12018945903	-	5.20e-02	GO:2000463	positive regulation of excitatory postsynaptic potential	BP
5	23	1.12018945903	-	6.20e-02	GO:0007422	peripheral nervous system development	BP
5	23	1.12018945903	-	6.20e-02	GO:0003009	skeletal muscle contraction	BP
25	115	1.12018945903	-	1.73e-05	GO:0005085	guanyl-nucleotide exchange factor activity	MF
5	23	1.12018945903	-	4.31e-02	GO:0017134	fibroblast growth factor binding	MF
21	97	1.11422790079	-	2.25e-04	GO:0071456	cellular response to hypoxia	BP
8	37	1.11236995457	-	1.99e-02	GO:0034446	substrate adhesion-dependent cell spreading	BP
16	74	1.11236995457	-	1.00e-04	GO:0005089	Rho guanyl-nucleotide exchange factor activity	MF
63	292	1.10927868482	-	1.19e-09	GO:0016032	viral process	BP
11	51	1.10882959687	-	5.68e-03	GO:0040008	regulation of growth	BP
22	102	1.10882959687	-	3.21e-04	GO:0042826	histone deacetylase binding	MF
14	65	1.10681042923	-	1.67e-03	GO:0050790	regulation of catalytic activity	BP
12	56	1.09943089886	-	1.47e-03	GO:0009612	response to mechanical stimulus	BP
9	42	1.09943089886	-	1.80e-02	GO:0045785	positive regulation of cell adhesion	BP
6	28	1.09943089886	-	2.25e-02	GO:0097193	intrinsic apoptotic signaling pathway	BP
3	14	1.09943089886	-	2.57e-02	GO:0048149	behavioral response to ethanol	BP
6	28	1.09943089886	-	3.33e-02	GO:0001937	negative regulation of endothelial cell proliferation	BP
6	28	1.09943089886	-	3.97e-02	GO:0051491	positive regulation of filopodium assembly	BP
6	28	1.09943089886	-	4.69e-02	GO:0019058	viral life cycle	BP
6	28	1.09943089886	-	5.48e-02	GO:0045739	positive regulation of DNA repair	BP
3	14	1.09943089886	-	7.01e-02	GO:0010839	negative regulation of keratinocyte proliferation	BP
3	14	1.09943089886	-	7.01e-02	GO:0003382	epithelial cell morphogenesis	BP
3	14	1.09943089886	-	7.01e-02	GO:0002063	chondrocyte development	BP
3	14	1.09943089886	-	8.95e-02	GO:0010812	negative regulation of cell-substrate adhesion	BP
3	14	1.09943089886	-	1.11e-01	GO:0001708	cell fate specification	BP
3	14	1.09943089886	-	1.11e-01	GO:0050965	detection of temperature stimulus involved in sensory perception of pain	BP
3	14	1.09943089886	-	1.11e-01	GO:0060038	cardiac muscle cell proliferation	BP
3	14	1.09943089886	-	1.11e-01	GO:0006309	apoptotic DNA fragmentation	BP
3	14	1.09943089886	-	1.11e-01	GO:0042325	regulation of phosphorylation	BP
3	14	1.09943089886	-	1.11e-01	GO:0022011	myelination in peripheral nervous system	BP
3	14	1.09943089886	-	1.34e-01	GO:0007095	mitotic G2 DNA damage checkpoint	BP
3	14	1.09943089886	-	1.34e-01	GO:0044130	negative regulation of growth of symbiont in host	BP
3	14	1.09943089886	-	1.34e-01	GO:0032743	positive regulation of interleukin-2 production	BP
3	14	1.09943089886	-	1.34e-01	GO:0001921	positive regulation of receptor recycling	BP
3	14	1.09943089886	-	1.34e-01	GO:0060441	epithelial tube branching involved in lung morphogenesis	BP
3	14	1.09943089886	-	1.58e-01	GO:0001774	microglial cell activation	BP
3	14	1.09943089886	-	1.58e-01	GO:0031116	positive regulation of microtubule polymerization	BP
3	14	1.09943089886	-	1.58e-01	GO:0007212	dopamine receptor signaling pathway	BP
15	70	1.09943089886	-	1.32e-03	GO:0003690	double-stranded DNA binding	MF
6	28	1.09943089886	-	3.33e-02	GO:0001103	RNA polymerase II repressing transcription factor binding	MF
3	14	1.09943089886	-	1.58e-01	GO:0032794	GTPase activating protein binding	MF
28	131	1.09575524072	-	2.67e-05	GO:0010629	negative regulation of gene expression	BP
10	47	1.08916256341	-	7.22e-03	GO:0051781	positive regulation of cell division	BP
10	47	1.08916256341	-	1.01e-02	GO:0031532	actin cytoskeleton reorganization	BP
10	47	1.08916256341	-	7.22e-03	GO:0000976	transcription regulatory region sequence-specific DNA binding	MF
17	80	1.08735806656	-	1.23e-03	GO:0030307	positive regulation of cell growth	BP
14	66	1.0847841229	-	1.40e-03	GO:0009749	response to glucose	BP
7	33	1.0847841229	-	3.04e-02	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
7	33	1.0847841229	-	3.04e-02	GO:0045787	positive regulation of cell cycle	BP
7	33	1.0847841229	-	1.18e-02	GO:0004866	endopeptidase inhibitor activity	MF
94	444	1.08199630553	-	1.17e-10	GO:0043066	negative regulation of apoptotic process	BP
33	156	1.0808152207	-	5.01e-06	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	BP
44	208	1.0808152207	-	3.68e-08	GO:0004871	signal transducer activity	MF
23	109	1.07720095148	-	2.47e-04	GO:0000082	G1/S transition of mitotic cell cycle	BP
24	114	1.07389580676	-	1.46e-04	GO:0006461	protein complex assembly	BP
12	57	1.07389580676	-	2.19e-03	GO:0045669	positive regulation of osteoblast differentiation	BP
12	57	1.07389580676	-	4.46e-03	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	MF
4	19	1.07389580676	-	8.25e-02	GO:0008589	regulation of smoothened signaling pathway	BP
4	19	1.07389580676	-	8.25e-02	GO:0050771	negative regulation of axonogenesis	BP
4	19	1.07389580676	-	9.81e-02	GO:0042776	mitochondrial ATP synthesis coupled proton transport	BP
4	19	1.07389580676	-	9.81e-02	GO:0030099	myeloid cell differentiation	BP
21	100	1.07028455321	-	3.26e-05	GO:0005178	integrin binding	MF
45	215	1.06548356694	-	1.63e-08	GO:0001525	angiogenesis	BP
9	43	1.06548356694	-	3.26e-03	GO:0045165	cell fate commitment	BP
9	43	1.06548356694	-	9.17e-03	GO:0032880	regulation of protein localization	BP
9	43	1.06548356694	-	9.17e-03	GO:0034605	cellular response to heat	BP
9	43	1.06548356694	-	1.30e-02	GO:0046332	SMAD binding	MF
119	571	1.05929414815	-	1.78e-10	GO:0043547	positive regulation of GTPase activity	BP
5	24	1.05878891437	-	4.31e-02	GO:0014003	oligodendrocyte development	BP
5	24	1.05878891437	-	6.20e-02	GO:0030041	actin filament polymerization	BP
5	24	1.05878891437	-	6.20e-02	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	BP
5	24	1.05878891437	-	7.30e-02	GO:0007088	regulation of mitotic nuclear division	BP
16	77	1.05503677951	-	6.24e-04	GO:0060070	canonical Wnt signaling pathway	BP
6	29	1.04880482579	-	2.25e-02	GO:0045776	negative regulation of blood pressure	BP
6	29	1.04880482579	-	2.25e-02	GO:0051017	actin filament bundle assembly	BP
6	29	1.04880482579	-	3.97e-02	GO:0021915	neural tube development	BP
6	29	1.04880482579	-	4.69e-02	GO:0000060	protein import into nucleus, translocation	BP
6	29	1.04880482579	-	4.69e-02	GO:0042149	cellular response to glucose starvation	BP
6	29	1.04880482579	-	4.69e-02	GO:0048705	skeletal system morphogenesis	BP
6	29	1.04880482579	-	5.48e-02	GO:0048147	negative regulation of fibroblast proliferation	BP
26	126	1.04498311484	-	4.52e-05	GO:0002576	platelet degranulation	BP
13	63	1.04498311484	-	1.75e-03	GO:0043627	response to estrogen	BP
20	97	1.0438385729	-	4.39e-04	GO:0051726	regulation of cell cycle	BP
27	131	1.04328782083	-	1.95e-04	GO:0000086	G2/M transition of mitotic cell cycle	BP
14	68	1.04171540101	-	5.96e-03	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
7	34	1.04171540101	-	2.15e-02	GO:0048813	dendrite morphogenesis	BP
7	34	1.04171540101	-	7.40e-03	GO:0017080	sodium channel regulator activity	MF
15	73	1.03888935693	-	3.61e-03	GO:0001843	neural tube closure	BP
8	39	1.03642110134	-	1.99e-02	GO:0043434	response to peptide hormone	BP
8	39	1.03642110134	-	2.73e-02	GO:0070527	platelet aggregation	BP
8	39	1.03642110134	-	2.73e-02	GO:0030331	estrogen receptor binding	MF
17	83	1.0342467301	-	1.30e-04	GO:0007409	axonogenesis	BP
9	44	1.03231670301	-	1.54e-02	GO:0007519	skeletal muscle tissue development	BP
9	44	1.03231670301	-	3.28e-02	GO:0032760	positive regulation of tumor necrosis factor production	BP
11	54	1.02636743667	-	1.66e-02	GO:0016049	cell growth	BP
12	59	1.02414277156	-	3.77e-03	GO:0050727	regulation of inflammatory response	BP
13	64	1.02226303834	-	8.87e-03	GO:0000226	microtubule cytoskeleton organization	BP
19	94	1.01516198197	-	7.29e-04	GO:0008584	male gonad development	BP
21	104	1.01370102484	-	4.74e-04	GO:0045471	response to ethanol	BP
3	15	0.999895225314	-	1.58e-02	GO:0018298	protein-chromophore linkage	BP
6	30	0.999895225314	-	3.33e-02	GO:0001707	mesoderm formation	BP
6	30	0.999895225314	-	3.33e-02	GO:0031667	response to nutrient levels	BP
3	15	0.999895225314	-	5.29e-02	GO:0001963	synaptic transmission, dopaminergic	BP
6	30	0.999895225314	-	6.35e-02	GO:0051297	centrosome organization	BP
3	15	0.999895225314	-	8.95e-02	GO:0016446	somatic hypermutation of immunoglobulin genes	BP
3	15	0.999895225314	-	1.11e-01	GO:0048485	sympathetic nervous system development	BP
3	15	0.999895225314	-	1.34e-01	GO:0048738	cardiac muscle tissue development	BP
3	15	0.999895225314	-	1.34e-01	GO:0001953	negative regulation of cell-matrix adhesion	BP
3	15	0.999895225314	-	1.34e-01	GO:0048593	camera-type eye morphogenesis	BP
3	15	0.999895225314	-	1.58e-01	GO:0045104	intermediate filament cytoskeleton organization	BP
3	15	0.999895225314	-	1.58e-01	GO:0048872	homeostasis of number of cells	BP
3	15	0.999895225314	-	1.58e-01	GO:0031573	intra-S DNA damage checkpoint	BP
3	15	0.999895225314	-	1.58e-01	GO:0032469	endoplasmic reticulum calcium ion homeostasis	BP
3	15	0.999895225314	-	1.58e-01	GO:0043277	apoptotic cell clearance	BP
3	15	0.999895225314	-	1.58e-01	GO:0035024	negative regulation of Rho protein signal transduction	BP
3	15	0.999895225314	-	1.58e-01	GO:0045445	myoblast differentiation	BP
3	15	0.999895225314	-	1.58e-01	GO:0050768	negative regulation of neurogenesis	BP
3	15	0.999895225314	-	1.84e-01	GO:1902187	negative regulation of viral release from host cell	BP
3	15	0.999895225314	-	1.84e-01	GO:0045190	isotype switching	BP
6	30	0.999895225314	-	6.35e-02	GO:0005164	tumor necrosis factor receptor binding	MF
3	15	0.999895225314	-	1.34e-01	GO:0030676	Rac guanyl-nucleotide exchange factor activity	MF
3	15	0.999895225314	-	1.58e-01	GO:0048037	cofactor binding	MF
9	45	0.999895225314	-	4.09e-03	GO:0006633	fatty acid biosynthetic process	BP
11	55	0.999895225314	-	1.43e-02	GO:0008104	protein localization	BP
7	35	0.999895225314	-	1.46e-02	GO:0035094	response to nicotine	BP
7	35	0.999895225314	-	1.46e-02	GO:0086091	regulation of heart rate by cardiac conduction	BP
10	50	0.999895225314	-	2.49e-02	GO:0071560	cellular response to transforming growth factor beta stimulus	BP
10	50	0.999895225314	-	2.70e-02	GO:0032481	positive regulation of type I interferon production	BP
5	25	0.999895225314	-	4.31e-02	GO:0051899	membrane depolarization	BP
5	25	0.999895225314	-	4.31e-02	GO:0007202	activation of phospholipase C activity	BP
7	35	0.999895225314	-	7.99e-02	GO:0070534	protein K63-linked ubiquitination	BP
5	25	0.999895225314	-	8.49e-02	GO:0006096	glycolytic process	BP
5	25	0.999895225314	-	8.49e-02	GO:0032757	positive regulation of interleukin-8 production	BP
5	25	0.999895225314	-	8.49e-02	GO:0048678	response to axon injury	BP
5	25	0.999895225314	-	9.78e-02	GO:0000188	inactivation of MAPK activity	BP
7	35	0.999895225314	-	7.99e-02	GO:0070888	E-box binding	MF
4	20	0.999895225314	-	4.41e-02	GO:0001659	temperature homeostasis	BP
4	20	0.999895225314	-	5.55e-02	GO:0002052	positive regulation of neuroblast proliferation	BP
4	20	0.999895225314	-	6.83e-02	GO:0030101	natural killer cell activation	BP
4	20	0.999895225314	-	6.83e-02	GO:0007520	myoblast fusion	BP
4	20	0.999895225314	-	9.81e-02	GO:0071276	cellular response to cadmium ion	BP
4	20	0.999895225314	-	9.81e-02	GO:0043623	cellular protein complex assembly	BP
2	10	0.999895225314	-	1.14e-01	GO:0002021	response to dietary excess	BP
4	20	0.999895225314	-	1.15e-01	GO:0005980	glycogen catabolic process	BP
4	20	0.999895225314	-	1.33e-01	GO:0016601	Rac protein signal transduction	BP
4	20	0.999895225314	-	1.33e-01	GO:0071526	semaphorin-plexin signaling pathway	BP
2	10	0.999895225314	-	1.50e-01	GO:0048935	peripheral nervous system neuron development	BP
2	10	0.999895225314	-	1.50e-01	GO:0043586	tongue development	BP
2	10	0.999895225314	-	1.87e-01	GO:2000648	positive regulation of stem cell proliferation	BP
2	10	0.999895225314	-	1.87e-01	GO:0060411	cardiac septum morphogenesis	BP
2	10	0.999895225314	-	1.87e-01	GO:0021680	cerebellar Purkinje cell layer development	BP
2	10	0.999895225314	-	1.87e-01	GO:0048681	negative regulation of axon regeneration	BP
2	10	0.999895225314	-	1.87e-01	GO:0033674	positive regulation of kinase activity	BP
2	10	0.999895225314	-	1.87e-01	GO:0021702	cerebellar Purkinje cell differentiation	BP
2	10	0.999895225314	-	1.87e-01	GO:0031953	negative regulation of protein autophosphorylation	BP
2	10	0.999895225314	-	1.87e-01	GO:0043267	negative regulation of potassium ion transport	BP
2	10	0.999895225314	-	1.87e-01	GO:0048745	smooth muscle tissue development	BP
2	10	0.999895225314	-	1.87e-01	GO:0097202	activation of cysteine-type endopeptidase activity	BP
2	10	0.999895225314	-	1.87e-01	GO:0060055	angiogenesis involved in wound healing	BP
2	10	0.999895225314	-	1.87e-01	GO:0016322	neuron remodeling	BP
1	5	0.999895225314	-	1.90e-01	GO:0070309	lens fiber cell morphogenesis	BP
1	5	0.999895225314	-	1.90e-01	GO:0043270	positive regulation of ion transport	BP
1	5	0.999895225314	-	1.90e-01	GO:0006873	cellular ion homeostasis	BP
1	5	0.999895225314	-	1.90e-01	GO:0098703	calcium ion import across plasma membrane	BP
1	5	0.999895225314	-	1.90e-01	GO:0015812	gamma-aminobutyric acid transport	BP
1	5	0.999895225314	-	1.90e-01	GO:0003357	noradrenergic neuron differentiation	BP
1	5	0.999895225314	-	1.90e-01	GO:0042743	hydrogen peroxide metabolic process	BP
1	5	0.999895225314	-	1.90e-01	GO:1903169	regulation of calcium ion transmembrane transport	BP
1	5	0.999895225314	-	1.90e-01	GO:0033227	dsRNA transport	BP
2	10	0.999895225314	-	2.25e-01	GO:0086013	membrane repolarization during cardiac muscle cell action potential	BP
2	10	0.999895225314	-	2.25e-01	GO:0003184	pulmonary valve morphogenesis	BP
2	10	0.999895225314	-	2.25e-01	GO:1903078	positive regulation of protein localization to plasma membrane	BP
2	10	0.999895225314	-	2.25e-01	GO:0050848	regulation of calcium-mediated signaling	BP
2	10	0.999895225314	-	2.25e-01	GO:0014075	response to amine	BP
2	10	0.999895225314	-	2.25e-01	GO:1902894	negative regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
2	10	0.999895225314	-	2.25e-01	GO:0040037	negative regulation of fibroblast growth factor receptor signaling pathway	BP
2	10	0.999895225314	-	2.25e-01	GO:0045475	locomotor rhythm	BP
2	10	0.999895225314	-	2.25e-01	GO:2001022	positive regulation of response to DNA damage stimulus	BP
2	10	0.999895225314	-	2.64e-01	GO:0033148	positive regulation of intracellular estrogen receptor signaling pathway	BP
2	10	0.999895225314	-	2.64e-01	GO:0007016	cytoskeletal anchoring at plasma membrane	BP
2	10	0.999895225314	-	2.64e-01	GO:0051247	positive regulation of protein metabolic process	BP
2	10	0.999895225314	-	2.64e-01	GO:0033235	positive regulation of protein sumoylation	BP
2	10	0.999895225314	-	2.64e-01	GO:0003149	membranous septum morphogenesis	BP
2	10	0.999895225314	-	2.64e-01	GO:0031065	positive regulation of histone deacetylation	BP
2	10	0.999895225314	-	2.64e-01	GO:0035871	protein K11-linked deubiquitination	BP
2	10	0.999895225314	-	2.64e-01	GO:0043116	negative regulation of vascular permeability	BP
2	10	0.999895225314	-	2.64e-01	GO:0033327	Leydig cell differentiation	BP
2	10	0.999895225314	-	2.64e-01	GO:0006884	cell volume homeostasis	BP
2	10	0.999895225314	-	2.64e-01	GO:2000637	positive regulation of gene silencing by miRNA	BP
2	10	0.999895225314	-	2.64e-01	GO:2001020	regulation of response to DNA damage stimulus	BP
2	10	0.999895225314	-	2.64e-01	GO:0033197	response to vitamin E	BP
2	10	0.999895225314	-	2.64e-01	GO:0046785	microtubule polymerization	BP
1	5	0.999895225314	-	2.71e-01	GO:0048645	animal organ formation	BP
1	5	0.999895225314	-	2.71e-01	GO:0021889	olfactory bulb interneuron differentiation	BP
1	5	0.999895225314	-	2.71e-01	GO:0061370	testosterone biosynthetic process	BP
1	5	0.999895225314	-	2.71e-01	GO:0046219	indolalkylamine biosynthetic process	BP
1	5	0.999895225314	-	2.71e-01	GO:0042723	thiamine-containing compound metabolic process	BP
1	5	0.999895225314	-	2.71e-01	GO:1990845	adaptive thermogenesis	BP
1	5	0.999895225314	-	2.71e-01	GO:0030856	regulation of epithelial cell differentiation	BP
1	5	0.999895225314	-	2.71e-01	GO:0002682	regulation of immune system process	BP
1	5	0.999895225314	-	2.71e-01	GO:0042866	pyruvate biosynthetic process	BP
1	5	0.999895225314	-	2.71e-01	GO:0002322	B cell proliferation involved in immune response	BP
1	5	0.999895225314	-	2.71e-01	GO:0002829	negative regulation of type 2 immune response	BP
1	5	0.999895225314	-	2.71e-01	GO:0032714	negative regulation of interleukin-5 production	BP
1	5	0.999895225314	-	2.71e-01	GO:0033004	negative regulation of mast cell activation	BP
1	5	0.999895225314	-	2.71e-01	GO:0060117	auditory receptor cell development	BP
1	5	0.999895225314	-	2.71e-01	GO:0003211	cardiac ventricle formation	BP
1	5	0.999895225314	-	3.44e-01	GO:0023041	neuronal signal transduction	BP
1	5	0.999895225314	-	3.44e-01	GO:0048730	epidermis morphogenesis	BP
1	5	0.999895225314	-	3.44e-01	GO:0086011	membrane repolarization during action potential	BP
1	5	0.999895225314	-	3.44e-01	GO:0045347	negative regulation of MHC class II biosynthetic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0050856	regulation of T cell receptor signaling pathway	BP
1	5	0.999895225314	-	3.44e-01	GO:0043652	engulfment of apoptotic cell	BP
1	5	0.999895225314	-	3.44e-01	GO:0048733	sebaceous gland development	BP
1	5	0.999895225314	-	3.44e-01	GO:0000467	exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)	BP
1	5	0.999895225314	-	3.44e-01	GO:0046541	saliva secretion	BP
1	5	0.999895225314	-	3.44e-01	GO:0045591	positive regulation of regulatory T cell differentiation	BP
1	5	0.999895225314	-	3.44e-01	GO:0048680	positive regulation of axon regeneration	BP
1	5	0.999895225314	-	3.44e-01	GO:0048562	embryonic organ morphogenesis	BP
1	5	0.999895225314	-	3.44e-01	GO:0060136	embryonic process involved in female pregnancy	BP
1	5	0.999895225314	-	3.44e-01	GO:0046600	negative regulation of centriole replication	BP
1	5	0.999895225314	-	3.44e-01	GO:0060339	negative regulation of type I interferon-mediated signaling pathway	BP
1	5	0.999895225314	-	3.44e-01	GO:0072602	interleukin-4 secretion	BP
1	5	0.999895225314	-	3.44e-01	GO:0032460	negative regulation of protein oligomerization	BP
1	5	0.999895225314	-	3.44e-01	GO:0070100	negative regulation of chemokine-mediated signaling pathway	BP
1	5	0.999895225314	-	3.44e-01	GO:0097500	receptor localization to non-motile cilium	BP
1	5	0.999895225314	-	3.44e-01	GO:2000987	positive regulation of behavioral fear response	BP
1	5	0.999895225314	-	3.44e-01	GO:0033033	negative regulation of myeloid cell apoptotic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0032237	activation of store-operated calcium channel activity	BP
1	5	0.999895225314	-	3.44e-01	GO:0045636	positive regulation of melanocyte differentiation	BP
1	5	0.999895225314	-	3.44e-01	GO:0045409	negative regulation of interleukin-6 biosynthetic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0032962	positive regulation of inositol trisphosphate biosynthetic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0015696	ammonium transport	BP
1	5	0.999895225314	-	3.44e-01	GO:0003406	retinal pigment epithelium development	BP
1	5	0.999895225314	-	3.44e-01	GO:0051005	negative regulation of lipoprotein lipase activity	BP
1	5	0.999895225314	-	3.44e-01	GO:0030300	regulation of intestinal cholesterol absorption	BP
1	5	0.999895225314	-	3.44e-01	GO:0048515	spermatid differentiation	BP
1	5	0.999895225314	-	3.44e-01	GO:0090036	regulation of protein kinase C signaling	BP
1	5	0.999895225314	-	3.44e-01	GO:0009597	detection of virus	BP
1	5	0.999895225314	-	3.44e-01	GO:0016101	diterpenoid metabolic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0009414	response to water deprivation	BP
1	5	0.999895225314	-	3.44e-01	GO:1901098	positive regulation of autophagosome maturation	BP
1	5	0.999895225314	-	3.44e-01	GO:0014834	skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration	BP
1	5	0.999895225314	-	3.44e-01	GO:0032224	positive regulation of synaptic transmission, cholinergic	BP
1	5	0.999895225314	-	3.44e-01	GO:1901727	positive regulation of histone deacetylase activity	BP
1	5	0.999895225314	-	3.44e-01	GO:0086046	membrane depolarization during SA node cell action potential	BP
1	5	0.999895225314	-	3.44e-01	GO:0033157	regulation of intracellular protein transport	BP
1	5	0.999895225314	-	3.44e-01	GO:0045542	positive regulation of cholesterol biosynthetic process	BP
1	5	0.999895225314	-	3.44e-01	GO:2000738	positive regulation of stem cell differentiation	BP
1	5	0.999895225314	-	3.44e-01	GO:0050996	positive regulation of lipid catabolic process	BP
1	5	0.999895225314	-	3.44e-01	GO:0001832	blastocyst growth	BP
1	5	0.999895225314	-	3.44e-01	GO:0021696	cerebellar cortex morphogenesis	BP
1	5	0.999895225314	-	3.44e-01	GO:0043367	CD4-positive, alpha-beta T cell differentiation	BP
1	5	0.999895225314	-	3.44e-01	GO:0071394	cellular response to testosterone stimulus	BP
1	5	0.999895225314	-	3.44e-01	GO:0048864	stem cell development	BP
1	5	0.999895225314	-	3.44e-01	GO:0038027	apolipoprotein A-I-mediated signaling pathway	BP
1	5	0.999895225314	-	3.44e-01	GO:0045823	positive regulation of heart contraction	BP
1	5	0.999895225314	-	3.44e-01	GO:0031427	response to methotrexate	BP
1	5	0.999895225314	-	3.44e-01	GO:0060718	chorionic trophoblast cell differentiation	BP
1	5	0.999895225314	-	4.10e-01	GO:0006623	protein targeting to vacuole	BP
1	5	0.999895225314	-	4.10e-01	GO:0010757	negative regulation of plasminogen activation	BP
1	5	0.999895225314	-	4.10e-01	GO:0010756	positive regulation of plasminogen activation	BP
1	5	0.999895225314	-	4.10e-01	GO:0042541	hemoglobin biosynthetic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0072656	maintenance of protein location in mitochondrion	BP
1	5	0.999895225314	-	4.10e-01	GO:0072655	establishment of protein localization to mitochondrion	BP
1	5	0.999895225314	-	4.10e-01	GO:0099054	presynapse assembly	BP
1	5	0.999895225314	-	4.10e-01	GO:0044770	cell cycle phase transition	BP
1	5	0.999895225314	-	4.10e-01	GO:0044772	mitotic cell cycle phase transition	BP
1	5	0.999895225314	-	4.10e-01	GO:0000056	ribosomal small subunit export from nucleus	BP
1	5	0.999895225314	-	4.10e-01	GO:2000726	negative regulation of cardiac muscle cell differentiation	BP
1	5	0.999895225314	-	4.10e-01	GO:2001268	negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0003289	atrial septum primum morphogenesis	BP
1	5	0.999895225314	-	4.10e-01	GO:0016199	axon midline choice point recognition	BP
1	5	0.999895225314	-	4.10e-01	GO:0071225	cellular response to muramyl dipeptide	BP
1	5	0.999895225314	-	4.10e-01	GO:0061734	parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization	BP
1	5	0.999895225314	-	4.10e-01	GO:0061737	leukotriene signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0060850	regulation of transcription involved in cell fate commitment	BP
1	5	0.999895225314	-	4.10e-01	GO:0031622	positive regulation of fever generation	BP
1	5	0.999895225314	-	4.10e-01	GO:0007501	mesodermal cell fate specification	BP
1	5	0.999895225314	-	4.10e-01	GO:0070345	negative regulation of fat cell proliferation	BP
1	5	0.999895225314	-	4.10e-01	GO:1902474	positive regulation of protein localization to synapse	BP
1	5	0.999895225314	-	4.10e-01	GO:0048194	Golgi vesicle budding	BP
1	5	0.999895225314	-	4.10e-01	GO:0060028	convergent extension involved in axis elongation	BP
1	5	0.999895225314	-	4.10e-01	GO:0033599	regulation of mammary gland epithelial cell proliferation	BP
1	5	0.999895225314	-	4.10e-01	GO:0030240	skeletal muscle thin filament assembly	BP
1	5	0.999895225314	-	4.10e-01	GO:0035509	negative regulation of myosin-light-chain-phosphatase activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0050920	regulation of chemotaxis	BP
1	5	0.999895225314	-	4.10e-01	GO:1900271	regulation of long-term synaptic potentiation	BP
1	5	0.999895225314	-	4.10e-01	GO:0042306	regulation of protein import into nucleus	BP
1	5	0.999895225314	-	4.10e-01	GO:0050881	musculoskeletal movement	BP
1	5	0.999895225314	-	4.10e-01	GO:0060744	mammary gland branching involved in thelarche	BP
1	5	0.999895225314	-	4.10e-01	GO:0000707	meiotic DNA recombinase assembly	BP
1	5	0.999895225314	-	4.10e-01	GO:0061624	fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate	BP
1	5	0.999895225314	-	4.10e-01	GO:0051653	spindle localization	BP
1	5	0.999895225314	-	4.10e-01	GO:0046085	adenosine metabolic process	BP
1	5	0.999895225314	-	4.10e-01	GO:1902262	apoptotic process involved in blood vessel morphogenesis	BP
1	5	0.999895225314	-	4.10e-01	GO:0055012	ventricular cardiac muscle cell differentiation	BP
1	5	0.999895225314	-	4.10e-01	GO:0031536	positive regulation of exit from mitosis	BP
1	5	0.999895225314	-	4.10e-01	GO:0019640	glucuronate catabolic process to xylulose 5-phosphate	BP
1	5	0.999895225314	-	4.10e-01	GO:0001915	negative regulation of T cell mediated cytotoxicity	BP
1	5	0.999895225314	-	4.10e-01	GO:0045646	regulation of erythrocyte differentiation	BP
1	5	0.999895225314	-	4.10e-01	GO:0010936	negative regulation of macrophage cytokine production	BP
1	5	0.999895225314	-	4.10e-01	GO:0045927	positive regulation of growth	BP
1	5	0.999895225314	-	4.10e-01	GO:0031579	membrane raft organization	BP
1	5	0.999895225314	-	4.10e-01	GO:0060179	male mating behavior	BP
1	5	0.999895225314	-	4.10e-01	GO:0044332	Wnt signaling pathway involved in dorsal/ventral axis specification	BP
1	5	0.999895225314	-	4.10e-01	GO:0010830	regulation of myotube differentiation	BP
1	5	0.999895225314	-	4.10e-01	GO:0010310	regulation of hydrogen peroxide metabolic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0045843	negative regulation of striated muscle tissue development	BP
1	5	0.999895225314	-	4.10e-01	GO:0045842	positive regulation of mitotic metaphase/anaphase transition	BP
1	5	0.999895225314	-	4.10e-01	GO:0048841	regulation of axon extension involved in axon guidance	BP
1	5	0.999895225314	-	4.10e-01	GO:0051081	nuclear envelope disassembly	BP
1	5	0.999895225314	-	4.10e-01	GO:0032232	negative regulation of actin filament bundle assembly	BP
1	5	0.999895225314	-	4.10e-01	GO:0007598	blood coagulation, extrinsic pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0002082	regulation of oxidative phosphorylation	BP
1	5	0.999895225314	-	4.10e-01	GO:0048598	embryonic morphogenesis	BP
1	5	0.999895225314	-	4.10e-01	GO:0015697	quaternary ammonium group transport	BP
1	5	0.999895225314	-	4.10e-01	GO:0001714	endodermal cell fate specification	BP
1	5	0.999895225314	-	4.10e-01	GO:0030854	positive regulation of granulocyte differentiation	BP
1	5	0.999895225314	-	4.10e-01	GO:0046651	lymphocyte proliferation	BP
1	5	0.999895225314	-	4.10e-01	GO:0001757	somite specification	BP
1	5	0.999895225314	-	4.10e-01	GO:0032410	negative regulation of transporter activity	BP
1	5	0.999895225314	-	4.10e-01	GO:2000780	negative regulation of double-strand break repair	BP
1	5	0.999895225314	-	4.10e-01	GO:0090074	negative regulation of protein homodimerization activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0071376	cellular response to corticotropin-releasing hormone stimulus	BP
1	5	0.999895225314	-	4.10e-01	GO:0036035	osteoclast development	BP
1	5	0.999895225314	-	4.10e-01	GO:0010656	negative regulation of muscle cell apoptotic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0038170	somatostatin signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:1904261	positive regulation of basement membrane assembly involved in embryonic body morphogenesis	BP
1	5	0.999895225314	-	4.10e-01	GO:0071864	positive regulation of cell proliferation in bone marrow	BP
1	5	0.999895225314	-	4.10e-01	GO:0060430	lung saccule development	BP
1	5	0.999895225314	-	4.10e-01	GO:0046755	viral budding	BP
1	5	0.999895225314	-	4.10e-01	GO:0048341	paraxial mesoderm formation	BP
1	5	0.999895225314	-	4.10e-01	GO:1903416	response to glycoside	BP
1	5	0.999895225314	-	4.10e-01	GO:0046883	regulation of hormone secretion	BP
1	5	0.999895225314	-	4.10e-01	GO:0033600	negative regulation of mammary gland epithelial cell proliferation	BP
1	5	0.999895225314	-	4.10e-01	GO:0030263	apoptotic chromosome condensation	BP
1	5	0.999895225314	-	4.10e-01	GO:0061052	negative regulation of cell growth involved in cardiac muscle cell development	BP
1	5	0.999895225314	-	4.10e-01	GO:0051546	keratinocyte migration	BP
1	5	0.999895225314	-	4.10e-01	GO:0060761	negative regulation of response to cytokine stimulus	BP
1	5	0.999895225314	-	4.10e-01	GO:0050713	negative regulation of interleukin-1 beta secretion	BP
1	5	0.999895225314	-	4.10e-01	GO:0002192	IRES-dependent translational initiation	BP
1	5	0.999895225314	-	4.10e-01	GO:0001887	selenium compound metabolic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0051584	regulation of dopamine uptake involved in synaptic transmission	BP
1	5	0.999895225314	-	4.10e-01	GO:0031133	regulation of axon diameter	BP
1	5	0.999895225314	-	4.10e-01	GO:0002260	lymphocyte homeostasis	BP
1	5	0.999895225314	-	4.10e-01	GO:0045040	protein import into mitochondrial outer membrane	BP
1	5	0.999895225314	-	4.10e-01	GO:0070245	positive regulation of thymocyte apoptotic process	BP
1	5	0.999895225314	-	4.10e-01	GO:2000809	positive regulation of synaptic vesicle clustering	BP
1	5	0.999895225314	-	4.10e-01	GO:0080009	mRNA methylation	BP
1	5	0.999895225314	-	4.10e-01	GO:0051224	negative regulation of protein transport	BP
1	5	0.999895225314	-	4.10e-01	GO:0098887	neurotransmitter receptor transport, endosome to postsynaptic membrane	BP
1	5	0.999895225314	-	4.10e-01	GO:0060157	urinary bladder development	BP
1	5	0.999895225314	-	4.10e-01	GO:1904385	cellular response to angiotensin	BP
1	5	0.999895225314	-	4.10e-01	GO:2000535	regulation of entry of bacterium into host cell	BP
1	5	0.999895225314	-	4.10e-01	GO:0032876	negative regulation of DNA endoreduplication	BP
1	5	0.999895225314	-	4.10e-01	GO:0070120	ciliary neurotrophic factor-mediated signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0045541	negative regulation of cholesterol biosynthetic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0051964	negative regulation of synapse assembly	BP
1	5	0.999895225314	-	4.10e-01	GO:0010991	negative regulation of SMAD protein complex assembly	BP
1	5	0.999895225314	-	4.10e-01	GO:0006563	L-serine metabolic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0006003	fructose 2,6-bisphosphate metabolic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0043550	regulation of lipid kinase activity	BP
1	5	0.999895225314	-	4.10e-01	GO:0035519	protein K29-linked ubiquitination	BP
1	5	0.999895225314	-	4.10e-01	GO:1903672	positive regulation of sprouting angiogenesis	BP
1	5	0.999895225314	-	4.10e-01	GO:0010891	negative regulation of sequestering of triglyceride	BP
1	5	0.999895225314	-	4.10e-01	GO:1900103	positive regulation of endoplasmic reticulum unfolded protein response	BP
1	5	0.999895225314	-	4.10e-01	GO:0051388	positive regulation of neurotrophin TRK receptor signaling pathway	BP
1	5	0.999895225314	-	4.10e-01	GO:0006995	cellular response to nitrogen starvation	BP
1	5	0.999895225314	-	4.10e-01	GO:0006089	lactate metabolic process	BP
1	5	0.999895225314	-	4.10e-01	GO:0033564	anterior/posterior axon guidance	BP
1	5	0.999895225314	-	4.10e-01	GO:1903361	protein localization to basolateral plasma membrane	BP
1	5	0.999895225314	-	4.10e-01	GO:0060385	axonogenesis involved in innervation	BP
1	5	0.999895225314	-	4.10e-01	GO:0043456	regulation of pentose-phosphate shunt	BP
1	5	0.999895225314	-	1.00e-01	GO:0086006	voltage-gated sodium channel activity involved in cardiac muscle cell action potential	MF
4	20	0.999895225314	-	1.33e-01	GO:0016922	ligand-dependent nuclear receptor binding	MF
4	20	0.999895225314	-	1.33e-01	GO:0004896	cytokine receptor activity	MF
2	10	0.999895225314	-	2.64e-01	GO:0042805	actinin binding	MF
2	10	0.999895225314	-	2.64e-01	GO:0034452	dynactin binding	MF
1	5	0.999895225314	-	2.71e-01	GO:0042392	sphingosine-1-phosphate phosphatase activity	MF
1	5	0.999895225314	-	2.71e-01	GO:0005280	hydrogen:amino acid symporter activity	MF
1	5	0.999895225314	-	2.71e-01	GO:0017176	phosphatidylinositol N-acetylglucosaminyltransferase activity	MF
1	5	0.999895225314	-	2.71e-01	GO:0001609	G-protein coupled adenosine receptor activity	MF
1	5	0.999895225314	-	2.71e-01	GO:0008422	beta-glucosidase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0047184	1-acylglycerophosphocholine O-acyltransferase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0052811	1-phosphatidylinositol-3-phosphate 4-kinase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0042608	T cell receptor binding	MF
1	5	0.999895225314	-	3.44e-01	GO:0005127	ciliary neurotrophic factor receptor binding	MF
1	5	0.999895225314	-	3.44e-01	GO:0004445	inositol-polyphosphate 5-phosphatase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0098519	nucleotide phosphatase activity, acting on free nucleotides	MF
1	5	0.999895225314	-	3.44e-01	GO:0015562	efflux transmembrane transporter activity	MF
1	5	0.999895225314	-	3.44e-01	GO:0032451	demethylase activity	MF
1	5	0.999895225314	-	3.44e-01	GO:1990254	keratin filament binding	MF
1	5	0.999895225314	-	3.44e-01	GO:0031726	CCR1 chemokine receptor binding	MF
1	5	0.999895225314	-	3.44e-01	GO:0004556	alpha-amylase activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0004994	somatostatin receptor activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0003708	retinoic acid receptor activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0010385	double-stranded methylated DNA binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0051525	NFAT protein binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0004331	fructose-2,6-bisphosphate 2-phosphatase activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0050544	arachidonic acid binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0003923	GPI-anchor transamidase activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0048495	Roundabout binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0019212	phosphatase inhibitor activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0015651	quaternary ammonium group transmembrane transporter activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0005134	interleukin-2 receptor binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0017034	Rap guanyl-nucleotide exchange factor activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0034046	poly(G) binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0071532	ankyrin repeat binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0070878	primary miRNA binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0032405	MutLalpha complex binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0019960	C-X3-C chemokine binding	MF
1	5	0.999895225314	-	4.10e-01	GO:0004340	glucokinase activity	MF
1	5	0.999895225314	-	4.10e-01	GO:0005143	interleukin-12 receptor binding	MF
19	96	0.984788332924	-	2.95e-03	GO:0047485	protein N-terminus binding	MF
32	162	0.981973317317	-	7.40e-06	GO:0032496	response to lipopolysaccharide	BP
15	76	0.980786402366	-	1.32e-03	GO:0060021	palate development	BP
149	756	0.978749416442	-	3.36e-10	GO:0042802	identical protein binding	MF
26	132	0.977868918984	-	2.06e-04	GO:0050821	protein stabilization	BP
9	46	0.968186365586	-	4.39e-02	GO:0016241	regulation of macroautophagy	BP
8	41	0.964271315583	-	1.16e-02	GO:0048839	inner ear development	BP
8	41	0.964271315583	-	1.99e-02	GO:0043010	camera-type eye development	BP
8	41	0.964271315583	-	4.98e-02	GO:0007595	lactation	BP
8	41	0.964271315583	-	5.64e-02	GO:0030218	erythrocyte differentiation	BP
31	159	0.963136675304	-	8.76e-05	GO:0001666	response to hypoxia	BP
15	77	0.961927375115	-	1.06e-02	GO:0051437	positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition	BP
14	72	0.959253240816	-	4.18e-03	GO:0006661	phosphatidylinositol biosynthetic process	BP
14	72	0.959253240816	-	1.47e-02	GO:0051436	negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle	BP
13	67	0.956173847884	-	8.05e-03	GO:0032088	negative regulation of NF-kappaB transcription factor activity	BP
12	62	0.952589510535	-	5.25e-03	GO:0030593	neutrophil chemotaxis	BP
6	31	0.952589510535	-	2.75e-02	GO:0035115	embryonic forelimb morphogenesis	BP
6	31	0.952589510535	-	6.35e-02	GO:0030544	Hsp70 protein binding	MF
11	57	0.948364924674	-	1.97e-02	GO:0003684	damaged DNA binding	MF
15	78	0.943311696947	-	5.33e-04	GO:0035023	regulation of Rho protein signal transduction	BP
5	26	0.943311696947	-	7.30e-02	GO:0031297	replication fork processing	BP
5	26	0.943311696947	-	7.30e-02	GO:0033077	T cell differentiation in thymus	BP
5	26	0.943311696947	-	9.78e-02	GO:0051281	positive regulation of release of sequestered calcium ion into cytosol	BP
5	26	0.943311696947	-	1.76e-01	GO:0045070	positive regulation of viral genome replication	BP
19	99	0.940394213565	-	7.29e-04	GO:0001764	neuron migration	BP
14	73	0.939353683379	-	7.93e-05	GO:0030216	keratinocyte differentiation	BP
23	120	0.93849468065	-	4.43e-04	GO:0030036	actin cytoskeleton organization	BP
31	162	0.936169627703	-	7.58e-05	GO:0007568	aging	BP
8	42	0.929505897422	-	1.67e-02	GO:0045599	negative regulation of fat cell differentiation	BP
4	21	0.929505897422	-	9.81e-02	GO:0045672	positive regulation of osteoclast differentiation	BP
4	21	0.929505897422	-	1.33e-01	GO:0051443	positive regulation of ubiquitin-protein transferase activity	BP
4	21	0.929505897422	-	1.52e-01	GO:0060828	regulation of canonical Wnt signaling pathway	BP
67	354	0.920306960576	-	9.94e-09	GO:0008283	cell proliferation	BP
7	37	0.91972487663	-	9.10e-02	GO:0031623	receptor internalization	BP
7	37	0.91972487663	-	9.10e-02	GO:0004407	histone deacetylase activity	MF
10	53	0.915830960525	-	2.49e-02	GO:0071333	cellular response to glucose stimulus	BP
10	53	0.915830960525	-	3.22e-02	GO:0050729	positive regulation of inflammatory response	BP
9	48	0.906785820922	-	1.54e-02	GO:0071320	cellular response to cAMP	BP
6	32	0.906785820922	-	3.97e-02	GO:0030513	positive regulation of BMP signaling pathway	BP
6	32	0.906785820922	-	6.35e-02	GO:0070830	bicellular tight junction assembly	BP
3	16	0.906785820922	-	8.95e-02	GO:0097009	energy homeostasis	BP
3	16	0.906785820922	-	1.11e-01	GO:0060307	regulation of ventricular cardiac muscle cell membrane repolarization	BP
6	32	0.906785820922	-	1.28e-01	GO:0032212	positive regulation of telomere maintenance via telomerase	BP
3	16	0.906785820922	-	1.34e-01	GO:0030111	regulation of Wnt signaling pathway	BP
3	16	0.906785820922	-	1.84e-01	GO:0032479	regulation of type I interferon production	BP
3	16	0.906785820922	-	1.84e-01	GO:0051893	regulation of focal adhesion assembly	BP
3	16	0.906785820922	-	1.84e-01	GO:0048260	positive regulation of receptor-mediated endocytosis	BP
3	16	0.906785820922	-	1.84e-01	GO:2000785	regulation of autophagosome assembly	BP
3	16	0.906785820922	-	1.84e-01	GO:0009416	response to light stimulus	BP
3	16	0.906785820922	-	2.11e-01	GO:0003203	endocardial cushion morphogenesis	BP
3	16	0.906785820922	-	2.11e-01	GO:0010613	positive regulation of cardiac muscle hypertrophy	BP
3	16	0.906785820922	-	2.11e-01	GO:0000132	establishment of mitotic spindle orientation	BP
3	16	0.906785820922	-	2.11e-01	GO:0030224	monocyte differentiation	BP
3	16	0.906785820922	-	1.84e-01	GO:0070300	phosphatidic acid binding	MF
3	16	0.906785820922	-	2.11e-01	GO:0008353	RNA polymerase II carboxy-terminal domain kinase activity	MF
11	59	0.898611889477	-	4.34e-02	GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	BP
24	129	0.895558565499	-	1.09e-03	GO:0042787	protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
8	43	0.895558565499	-	1.40e-02	GO:0001756	somitogenesis	BP
8	43	0.895558565499	-	6.06e-02	GO:0034260	negative regulation of GTPase activity	BP
8	43	0.895558565499	-	7.11e-02	GO:1904837	beta-catenin-TCF complex assembly	BP
35	189	0.888863912925	-	2.13e-05	GO:0005516	calmodulin binding	MF
10	54	0.888863912925	-	1.19e-02	GO:0000902	cell morphogenesis	BP
15	81	0.888863912925	-	1.31e-02	GO:0031145	anaphase-promoting complex-dependent catabolic process	BP
5	27	0.888863912925	-	2.81e-02	GO:0042755	eating behavior	BP
5	27	0.888863912925	-	3.51e-02	GO:0009755	hormone-mediated signaling pathway	BP
5	27	0.888863912925	-	5.20e-02	GO:0043029	T cell homeostasis	BP
5	27	0.888863912925	-	9.78e-02	GO:0001662	behavioral fear response	BP
5	27	0.888863912925	-	5.20e-02	GO:0005496	steroid binding	MF
37	200	0.887420496055	-	7.26e-05	GO:0032403	protein complex binding	MF
12	65	0.884418007894	-	1.46e-02	GO:0007015	actin filament organization	BP
47	255	0.88205873502	-	9.58e-07	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
7	38	0.881250728815	-	9.78e-02	GO:0030049	muscle filament sliding	BP
9	49	0.877038477528	-	4.39e-02	GO:0043621	protein self-association	MF
13	71	0.872515918838	-	1.09e-02	GO:0060333	interferon-gamma-mediated signaling pathway	BP
17	93	0.870127350343	-	4.99e-03	GO:0030336	negative regulation of cell migration	BP
6	33	0.862391701564	-	5.48e-02	GO:0050808	synapse organization	BP
6	33	0.862391701564	-	5.48e-02	GO:0042130	negative regulation of T cell proliferation	BP
6	33	0.862391701564	-	1.28e-01	GO:0030100	regulation of endocytosis	BP
6	33	0.862391701564	-	1.21e-01	GO:0043531	ADP binding	MF
10	55	0.862391701564	-	3.22e-02	GO:0045727	positive regulation of translation	BP
4	22	0.862391701564	-	6.83e-02	GO:0019915	lipid storage	BP
2	11	0.862391701564	-	1.14e-01	GO:0030166	proteoglycan biosynthetic process	BP
4	22	0.862391701564	-	1.15e-01	GO:0010719	negative regulation of epithelial to mesenchymal transition	BP
4	22	0.862391701564	-	1.15e-01	GO:0007492	endoderm development	BP
4	22	0.862391701564	-	1.15e-01	GO:0051924	regulation of calcium ion transport	BP
4	22	0.862391701564	-	1.15e-01	GO:0071398	cellular response to fatty acid	BP
4	22	0.862391701564	-	1.33e-01	GO:0060173	limb development	BP
2	11	0.862391701564	-	1.50e-01	GO:0006702	androgen biosynthetic process	BP
2	11	0.862391701564	-	1.50e-01	GO:0015867	ATP transport	BP
2	11	0.862391701564	-	1.50e-01	GO:0006636	unsaturated fatty acid biosynthetic process	BP
2	11	0.862391701564	-	1.87e-01	GO:0010524	positive regulation of calcium ion transport into cytosol	BP
2	11	0.862391701564	-	1.87e-01	GO:0046849	bone remodeling	BP
2	11	0.862391701564	-	1.87e-01	GO:0045603	positive regulation of endothelial cell differentiation	BP
2	11	0.862391701564	-	1.87e-01	GO:0006346	methylation-dependent chromatin silencing	BP
2	11	0.862391701564	-	1.87e-01	GO:0003323	type B pancreatic cell development	BP
2	11	0.862391701564	-	1.87e-01	GO:0048016	inositol phosphate-mediated signaling	BP
2	11	0.862391701564	-	2.25e-01	GO:0043666	regulation of phosphoprotein phosphatase activity	BP
2	11	0.862391701564	-	2.25e-01	GO:0050673	epithelial cell proliferation	BP
2	11	0.862391701564	-	2.25e-01	GO:0032703	negative regulation of interleukin-2 production	BP
2	11	0.862391701564	-	2.25e-01	GO:0017187	peptidyl-glutamic acid carboxylation	BP
2	11	0.862391701564	-	2.25e-01	GO:0032695	negative regulation of interleukin-12 production	BP
2	11	0.862391701564	-	2.25e-01	GO:0055078	sodium ion homeostasis	BP
2	11	0.862391701564	-	2.25e-01	GO:0022409	positive regulation of cell-cell adhesion	BP
2	11	0.862391701564	-	2.25e-01	GO:2000279	negative regulation of DNA biosynthetic process	BP
2	11	0.862391701564	-	2.25e-01	GO:0072520	seminiferous tubule development	BP
2	11	0.862391701564	-	2.64e-01	GO:0071498	cellular response to fluid shear stress	BP
2	11	0.862391701564	-	2.64e-01	GO:0090051	negative regulation of cell migration involved in sprouting angiogenesis	BP
2	11	0.862391701564	-	2.64e-01	GO:0051764	actin crosslink formation	BP
2	11	0.862391701564	-	2.64e-01	GO:0001823	mesonephros development	BP
2	11	0.862391701564	-	2.64e-01	GO:0032206	positive regulation of telomere maintenance	BP
2	11	0.862391701564	-	2.64e-01	GO:1990440	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
2	11	0.862391701564	-	2.64e-01	GO:0006476	protein deacetylation	BP
2	11	0.862391701564	-	2.64e-01	GO:0048711	positive regulation of astrocyte differentiation	BP
2	11	0.862391701564	-	2.64e-01	GO:0060081	membrane hyperpolarization	BP
2	11	0.862391701564	-	2.64e-01	GO:0019068	virion assembly	BP
2	11	0.862391701564	-	2.64e-01	GO:0008610	lipid biosynthetic process	BP
2	11	0.862391701564	-	3.03e-01	GO:0090161	Golgi ribbon formation	BP
2	11	0.862391701564	-	3.03e-01	GO:0042535	positive regulation of tumor necrosis factor biosynthetic process	BP
2	11	0.862391701564	-	3.03e-01	GO:0070914	UV-damage excision repair	BP
2	11	0.862391701564	-	3.03e-01	GO:0003279	cardiac septum development	BP
2	11	0.862391701564	-	3.03e-01	GO:0032700	negative regulation of interleukin-17 production	BP
2	11	0.862391701564	-	3.03e-01	GO:0045806	negative regulation of endocytosis	BP
2	11	0.862391701564	-	3.03e-01	GO:0030238	male sex determination	BP
2	11	0.862391701564	-	3.03e-01	GO:0000185	activation of MAPKKK activity	BP
2	11	0.862391701564	-	3.03e-01	GO:1904357	negative regulation of telomere maintenance via telomere lengthening	BP
2	11	0.862391701564	-	3.03e-01	GO:0060765	regulation of androgen receptor signaling pathway	BP
2	11	0.862391701564	-	3.03e-01	GO:0060487	lung epithelial cell differentiation	BP
2	11	0.862391701564	-	3.03e-01	GO:0071481	cellular response to X-ray	BP
2	11	0.862391701564	-	3.03e-01	GO:0071404	cellular response to low-density lipoprotein particle stimulus	BP
2	11	0.862391701564	-	3.03e-01	GO:0051382	kinetochore assembly	BP
4	22	0.862391701564	-	1.33e-01	GO:0050699	WW domain binding	MF
4	22	0.862391701564	-	1.52e-01	GO:0043325	phosphatidylinositol-3,4-bisphosphate binding	MF
2	11	0.862391701564	-	2.64e-01	GO:0016290	palmitoyl-CoA hydrolase activity	MF
2	11	0.862391701564	-	3.03e-01	GO:0035615	clathrin adaptor activity	MF
2	11	0.862391701564	-	3.03e-01	GO:0008066	glutamate receptor activity	MF
2	11	0.862391701564	-	3.03e-01	GO:0051010	microtubule plus-end binding	MF
2	11	0.862391701564	-	3.03e-01	GO:0017154	semaphorin receptor activity	MF
34	187	0.862391701564	-	3.40e-05	GO:0000287	magnesium ion binding	MF
33	182	0.858422799361	-	5.46e-05	GO:0007596	blood coagulation	BP
23	127	0.856700589486	-	9.86e-06	GO:0019221	cytokine-mediated signaling pathway	BP
36	199	0.8551237011	-	8.79e-05	GO:0007049	cell cycle	BP
9	50	0.847892131869	-	3.28e-02	GO:0071277	cellular response to calcium ion	BP
7	39	0.843776023397	-	3.04e-02	GO:0030326	embryonic limb morphogenesis	BP
7	39	0.843776023397	-	3.57e-02	GO:0007190	activation of adenylate cyclase activity	BP
7	39	0.843776023397	-	1.78e-02	GO:0015459	potassium channel regulator activity	MF
5	28	0.836396493031	-	7.30e-02	GO:0007163	establishment or maintenance of cell polarity	BP
48	270	0.829970223871	-	3.28e-06	GO:0016579	protein deubiquitination	BP
8	45	0.829970223871	-	6.06e-02	GO:0006909	phagocytosis	BP
25	141	0.826128157577	-	3.02e-04	GO:0051056	regulation of small GTPase mediated signal transduction	BP
6	34	0.819322979672	-	1.81e-02	GO:0045747	positive regulation of Notch signaling pathway	BP
6	34	0.819322979672	-	5.48e-02	GO:0030501	positive regulation of bone mineralization	BP
3	17	0.819322979672	-	1.11e-01	GO:0046847	filopodium assembly	BP
3	17	0.819322979672	-	1.11e-01	GO:0006796	phosphate-containing compound metabolic process	BP
3	17	0.819322979672	-	1.58e-01	GO:0021537	telencephalon development	BP
3	17	0.819322979672	-	1.58e-01	GO:0032331	negative regulation of chondrocyte differentiation	BP
3	17	0.819322979672	-	1.58e-01	GO:1901214	regulation of neuron death	BP
3	17	0.819322979672	-	1.58e-01	GO:0030193	regulation of blood coagulation	BP
3	17	0.819322979672	-	1.84e-01	GO:0071354	cellular response to interleukin-6	BP
3	17	0.819322979672	-	1.84e-01	GO:0010804	negative regulation of tumor necrosis factor-mediated signaling pathway	BP
3	17	0.819322979672	-	1.84e-01	GO:0010880	regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	BP
3	17	0.819322979672	-	1.84e-01	GO:0045926	negative regulation of growth	BP
3	17	0.819322979672	-	1.84e-01	GO:0021542	dentate gyrus development	BP
3	17	0.819322979672	-	1.84e-01	GO:0002407	dendritic cell chemotaxis	BP
3	17	0.819322979672	-	2.11e-01	GO:1904355	positive regulation of telomere capping	BP
3	17	0.819322979672	-	2.11e-01	GO:0042789	mRNA transcription from RNA polymerase II promoter	BP
3	17	0.819322979672	-	2.38e-01	GO:0014002	astrocyte development	BP
6	34	0.819322979672	-	3.33e-02	GO:0015276	ligand-gated ion channel activity	MF
3	17	0.819322979672	-	3.81e-02	GO:0015269	calcium-activated potassium channel activity	MF
3	17	0.819322979672	-	1.34e-01	GO:0008301	DNA binding, bending	MF
3	17	0.819322979672	-	1.34e-01	GO:0048018	receptor agonist activity	MF
6	34	0.819322979672	-	1.37e-01	GO:0001540	beta-amyloid binding	MF
3	17	0.819322979672	-	2.11e-01	GO:0030234	enzyme regulator activity	MF
3	17	0.819322979672	-	2.38e-01	GO:0008656	cysteine-type endopeptidase activator activity involved in apoptotic process	MF
9	51	0.819322979672	-	5.72e-02	GO:0075733	intracellular transport of virus	BP
53	301	0.816124098005	-	1.58e-06	GO:0042493	response to drug	BP
7	40	0.807250147371	-	4.15e-02	GO:0032570	response to progesterone	BP
11	63	0.803975015339	-	1.97e-02	GO:0031647	regulation of protein stability	BP
12	69	0.798261364144	-	3.70e-02	GO:0097190	apoptotic signaling pathway	BP
12	69	0.798261364144	-	4.24e-02	GO:0043130	ubiquitin binding	MF
4	23	0.798261364144	-	8.25e-02	GO:0009617	response to bacterium	BP
4	23	0.798261364144	-	1.33e-01	GO:0032733	positive regulation of interleukin-10 production	BP
4	23	0.798261364144	-	2.81e-01	GO:0043044	ATP-dependent chromatin remodeling	BP
4	23	0.798261364144	-	2.81e-01	GO:0000715	nucleotide-excision repair, DNA damage recognition	BP
4	23	0.798261364144	-	2.81e-01	GO:0031593	polyubiquitin binding	MF
5	29	0.785770419961	-	1.84e-01	GO:0034198	cellular response to amino acid starvation	BP
5	29	0.785770419961	-	2.05e-01	GO:0006513	protein monoubiquitination	BP
5	29	0.785770419961	-	2.05e-01	GO:0000278	mitotic cell cycle	BP
35	204	0.778680995175	-	2.96e-04	GO:0006974	cellular response to DNA damage stimulus	BP
6	35	0.777502803977	-	1.56e-01	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	MF
7	41	0.771626237641	-	8.50e-02	GO:0007566	embryo implantation	BP
7	41	0.771626237641	-	1.05e-01	GO:0032947	protein complex scaffold	MF
74	434	0.769725453386	-	2.51e-10	GO:0045087	innate immune response	BP
8	47	0.767234468524	-	1.67e-02	GO:0010862	positive regulation of pathway-restricted SMAD protein phosphorylation	BP
8	47	0.767234468524	-	1.31e-01	GO:0036297	interstrand cross-link repair	BP
39	230	0.761735488119	-	2.00e-04	GO:0061024	membrane organization	BP
11	65	0.75888712581	-	2.39e-02	GO:0050796	regulation of insulin secretion	BP
89	529	0.750432839054	-	2.83e-09	GO:0006915	apoptotic process	BP
186	1106	0.749846461074	-	2.29e-10	GO:0007165	signal transduction	BP
20	119	0.748933651781	-	1.71e-03	GO:0006935	chemotaxis	BP
20	120	0.73686081948	-	1.08e-02	GO:0090263	positive regulation of canonical Wnt signaling pathway	BP
10	60	0.73686081948	-	2.49e-02	GO:0006968	cellular defense response	BP
5	30	0.73686081948	-	2.05e-01	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	BP
5	30	0.73686081948	-	2.18e-01	GO:0036258	multivesicular body assembly	BP
10	60	0.73686081948	-	2.70e-02	GO:0005518	collagen binding	MF
5	30	0.73686081948	-	7.30e-02	GO:0017147	Wnt-protein binding	MF
6	36	0.73686081948	-	4.69e-02	GO:0032467	positive regulation of cytokinesis	BP
8	48	0.73686081948	-	7.73e-02	GO:0009267	cellular response to starvation	BP
4	24	0.73686081948	-	8.25e-02	GO:0002376	immune system process	BP
2	12	0.73686081948	-	1.14e-01	GO:0036066	protein O-linked fucosylation	BP
4	24	0.73686081948	-	1.15e-01	GO:0048589	developmental growth	BP
6	36	0.73686081948	-	1.21e-01	GO:0051209	release of sequestered calcium ion into cytosol	BP
6	36	0.73686081948	-	1.37e-01	GO:0071392	cellular response to estradiol stimulus	BP
2	12	0.73686081948	-	1.50e-01	GO:0086012	membrane depolarization during cardiac muscle cell action potential	BP
2	12	0.73686081948	-	1.50e-01	GO:0046323	glucose import	BP
3	18	0.73686081948	-	1.58e-01	GO:0035249	synaptic transmission, glutamatergic	BP
3	18	0.73686081948	-	1.58e-01	GO:0010596	negative regulation of endothelial cell migration	BP
3	18	0.73686081948	-	1.84e-01	GO:0035584	calcium-mediated signaling using intracellular calcium source	BP
3	18	0.73686081948	-	1.84e-01	GO:0007597	blood coagulation, intrinsic pathway	BP
3	18	0.73686081948	-	1.84e-01	GO:0045089	positive regulation of innate immune response	BP
3	18	0.73686081948	-	1.84e-01	GO:0061436	establishment of skin barrier	BP
1	6	0.73686081948	-	1.90e-01	GO:0097211	cellular response to gonadotropin-releasing hormone	BP
1	6	0.73686081948	-	1.90e-01	GO:2000272	negative regulation of receptor activity	BP
3	18	0.73686081948	-	2.11e-01	GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	BP
2	12	0.73686081948	-	2.25e-01	GO:0050709	negative regulation of protein secretion	BP
3	18	0.73686081948	-	2.38e-01	GO:0001894	tissue homeostasis	BP
2	12	0.73686081948	-	2.64e-01	GO:0016540	protein autoprocessing	BP
2	12	0.73686081948	-	2.64e-01	GO:0002437	inflammatory response to antigenic stimulus	BP
2	12	0.73686081948	-	2.64e-01	GO:0045670	regulation of osteoclast differentiation	BP
2	12	0.73686081948	-	2.64e-01	GO:0010510	regulation of acetyl-CoA biosynthetic process from pyruvate	BP
2	12	0.73686081948	-	2.64e-01	GO:0009888	tissue development	BP
2	12	0.73686081948	-	2.64e-01	GO:0030516	regulation of axon extension	BP
2	12	0.73686081948	-	2.64e-01	GO:0042592	homeostatic process	BP
2	12	0.73686081948	-	2.64e-01	GO:0046622	positive regulation of organ growth	BP
2	12	0.73686081948	-	2.64e-01	GO:0008206	bile acid metabolic process	BP
2	12	0.73686081948	-	2.64e-01	GO:0030195	negative regulation of blood coagulation	BP
4	24	0.73686081948	-	2.70e-01	GO:0071345	cellular response to cytokine stimulus	BP
1	6	0.73686081948	-	2.71e-01	GO:0060022	hard palate development	BP
1	6	0.73686081948	-	2.71e-01	GO:0045143	homologous chromosome segregation	BP
1	6	0.73686081948	-	2.71e-01	GO:0007635	chemosensory behavior	BP
1	6	0.73686081948	-	2.71e-01	GO:0051552	flavone metabolic process	BP
1	6	0.73686081948	-	2.71e-01	GO:0001696	gastric acid secretion	BP
1	6	0.73686081948	-	2.71e-01	GO:0071286	cellular response to magnesium ion	BP
1	6	0.73686081948	-	2.71e-01	GO:0051155	positive regulation of striated muscle cell differentiation	BP
4	24	0.73686081948	-	2.81e-01	GO:0051966	regulation of synaptic transmission, glutamatergic	BP
2	12	0.73686081948	-	3.03e-01	GO:0001736	establishment of planar polarity	BP
2	12	0.73686081948	-	3.03e-01	GO:0001946	lymphangiogenesis	BP
2	12	0.73686081948	-	3.03e-01	GO:0006119	oxidative phosphorylation	BP
2	12	0.73686081948	-	3.03e-01	GO:0060425	lung morphogenesis	BP
2	12	0.73686081948	-	3.03e-01	GO:0051131	chaperone-mediated protein complex assembly	BP
2	12	0.73686081948	-	3.03e-01	GO:0045779	negative regulation of bone resorption	BP
2	12	0.73686081948	-	3.03e-01	GO:0060766	negative regulation of androgen receptor signaling pathway	BP
2	12	0.73686081948	-	3.03e-01	GO:0086004	regulation of cardiac muscle cell contraction	BP
2	12	0.73686081948	-	3.03e-01	GO:0003215	cardiac right ventricle morphogenesis	BP
2	12	0.73686081948	-	3.03e-01	GO:0071361	cellular response to ethanol	BP
2	12	0.73686081948	-	3.03e-01	GO:0071360	cellular response to exogenous dsRNA	BP
2	12	0.73686081948	-	3.41e-01	GO:0055008	cardiac muscle tissue morphogenesis	BP
2	12	0.73686081948	-	3.41e-01	GO:0047496	vesicle transport along microtubule	BP
2	12	0.73686081948	-	3.41e-01	GO:2000484	positive regulation of interleukin-8 secretion	BP
2	12	0.73686081948	-	3.41e-01	GO:0046688	response to copper ion	BP
2	12	0.73686081948	-	3.41e-01	GO:0090179	planar cell polarity pathway involved in neural tube closure	BP
2	12	0.73686081948	-	3.41e-01	GO:0045019	negative regulation of nitric oxide biosynthetic process	BP
2	12	0.73686081948	-	3.41e-01	GO:0006301	postreplication repair	BP
2	12	0.73686081948	-	3.41e-01	GO:0036499	PERK-mediated unfolded protein response	BP
2	12	0.73686081948	-	3.41e-01	GO:0090656	t-circle formation	BP
2	12	0.73686081948	-	3.41e-01	GO:0010458	exit from mitosis	BP
1	6	0.73686081948	-	3.44e-01	GO:0045345	positive regulation of MHC class I biosynthetic process	BP
1	6	0.73686081948	-	3.44e-01	GO:0045910	negative regulation of DNA recombination	BP
1	6	0.73686081948	-	3.44e-01	GO:0010694	positive regulation of alkaline phosphatase activity	BP
1	6	0.73686081948	-	3.44e-01	GO:2001054	negative regulation of mesenchymal cell apoptotic process	BP
1	6	0.73686081948	-	3.44e-01	GO:0045187	regulation of circadian sleep/wake cycle, sleep	BP
1	6	0.73686081948	-	3.44e-01	GO:0006739	NADP metabolic process	BP
1	6	0.73686081948	-	3.44e-01	GO:0060426	lung vasculature development	BP
1	6	0.73686081948	-	3.44e-01	GO:2000252	negative regulation of feeding behavior	BP
1	6	0.73686081948	-	3.44e-01	GO:0046486	glycerolipid metabolic process	BP
1	6	0.73686081948	-	3.44e-01	GO:0060323	head morphogenesis	BP
1	6	0.73686081948	-	3.44e-01	GO:2000507	positive regulation of energy homeostasis	BP
1	6	0.73686081948	-	3.44e-01	GO:0048793	pronephros development	BP
1	6	0.73686081948	-	3.44e-01	GO:0035754	B cell chemotaxis	BP
1	6	0.73686081948	-	3.44e-01	GO:0071774	response to fibroblast growth factor	BP
1	6	0.73686081948	-	3.44e-01	GO:0048664	neuron fate determination	BP
1	6	0.73686081948	-	3.44e-01	GO:0045743	positive regulation of fibroblast growth factor receptor signaling pathway	BP
1	6	0.73686081948	-	3.44e-01	GO:1900116	extracellular negative regulation of signal transduction	BP
1	6	0.73686081948	-	3.44e-01	GO:0019800	peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	BP
1	6	0.73686081948	-	3.44e-01	GO:0042989	sequestering of actin monomers	BP
1	6	0.73686081948	-	3.44e-01	GO:0007530	sex determination	BP
1	6	0.73686081948	-	3.44e-01	GO:0090527	actin filament reorganization	BP
1	6	0.73686081948	-	3.44e-01	GO:0051026	chiasma assembly	BP
1	6	0.73686081948	-	3.44e-01	GO:0060710	chorio-allantoic fusion	BP
1	6	0.73686081948	-	4.10e-01	GO:0006596	polyamine biosynthetic process	BP
1	6	0.73686081948	-	4.10e-01	GO:0032364	oxygen homeostasis	BP
1	6	0.73686081948	-	4.10e-01	GO:1990668	vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane	BP
1	6	0.73686081948	-	4.10e-01	GO:0031017	exocrine pancreas development	BP
1	6	0.73686081948	-	4.10e-01	GO:0035864	response to potassium ion	BP
1	6	0.73686081948	-	4.10e-01	GO:1901621	negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	BP
1	6	0.73686081948	-	4.10e-01	GO:0045760	positive regulation of action potential	BP
1	6	0.73686081948	-	4.10e-01	GO:0010887	negative regulation of cholesterol storage	BP
1	6	0.73686081948	-	4.10e-01	GO:0060992	response to fungicide	BP
1	6	0.73686081948	-	4.10e-01	GO:0032204	regulation of telomere maintenance	BP
1	6	0.73686081948	-	4.10e-01	GO:0042536	negative regulation of tumor necrosis factor biosynthetic process	BP
1	6	0.73686081948	-	4.10e-01	GO:0001913	T cell mediated cytotoxicity	BP
1	6	0.73686081948	-	4.10e-01	GO:0048524	positive regulation of viral process	BP
1	6	0.73686081948	-	4.10e-01	GO:0001957	intramembranous ossification	BP
1	6	0.73686081948	-	4.10e-01	GO:0031960	response to corticosteroid	BP
1	6	0.73686081948	-	4.10e-01	GO:0072384	organelle transport along microtubule	BP
1	6	0.73686081948	-	4.10e-01	GO:0060074	synapse maturation	BP
1	6	0.73686081948	-	4.10e-01	GO:2000553	positive regulation of T-helper 2 cell cytokine production	BP
1	6	0.73686081948	-	4.10e-01	GO:0043620	regulation of DNA-templated transcription in response to stress	BP
1	6	0.73686081948	-	4.10e-01	GO:0048806	genitalia development	BP
1	6	0.73686081948	-	4.10e-01	GO:0046533	negative regulation of photoreceptor cell differentiation	BP
1	6	0.73686081948	-	4.10e-01	GO:0060075	regulation of resting membrane potential	BP
1	6	0.73686081948	-	4.10e-01	GO:0002091	negative regulation of receptor internalization	BP
1	6	0.73686081948	-	4.10e-01	GO:0061180	mammary gland epithelium development	BP
1	6	0.73686081948	-	4.10e-01	GO:0072540	T-helper 17 cell lineage commitment	BP
1	6	0.73686081948	-	4.10e-01	GO:0042693	muscle cell fate commitment	BP
1	6	0.73686081948	-	4.10e-01	GO:0070257	positive regulation of mucus secretion	BP
1	6	0.73686081948	-	4.10e-01	GO:0050667	homocysteine metabolic process	BP
1	6	0.73686081948	-	4.10e-01	GO:0032792	negative regulation of CREB transcription factor activity	BP
1	6	0.73686081948	-	4.10e-01	GO:0060836	lymphatic endothelial cell differentiation	BP
1	6	0.73686081948	-	4.10e-01	GO:0010631	epithelial cell migration	BP
1	6	0.73686081948	-	4.10e-01	GO:0021902	commitment of neuronal cell to specific neuron type in forebrain	BP
1	6	0.73686081948	-	4.10e-01	GO:0071287	cellular response to manganese ion	BP
1	6	0.73686081948	-	4.10e-01	GO:0042415	norepinephrine metabolic process	BP
1	6	0.73686081948	-	4.10e-01	GO:0006929	substrate-dependent cell migration	BP
1	6	0.73686081948	-	4.10e-01	GO:0051150	regulation of smooth muscle cell differentiation	BP
1	6	0.73686081948	-	4.10e-01	GO:0042048	olfactory behavior	BP
1	6	0.73686081948	-	4.10e-01	GO:0051438	regulation of ubiquitin-protein transferase activity	BP
1	6	0.73686081948	-	4.10e-01	GO:0072719	cellular response to cisplatin	BP
1	6	0.73686081948	-	4.10e-01	GO:0061635	regulation of protein complex stability	BP
1	6	0.73686081948	-	4.10e-01	GO:1903363	negative regulation of cellular protein catabolic process	BP
1	6	0.73686081948	-	4.10e-01	GO:0010960	magnesium ion homeostasis	BP
1	6	0.73686081948	-	4.10e-01	GO:0042421	norepinephrine biosynthetic process	BP
3	18	0.73686081948	-	4.16e-01	GO:0030705	cytoskeleton-dependent intracellular transport	BP
3	18	0.73686081948	-	4.16e-01	GO:0008637	apoptotic mitochondrial changes	BP
3	18	0.73686081948	-	4.16e-01	GO:1904380	endoplasmic reticulum mannose trimming	BP
1	6	0.73686081948	-	4.69e-01	GO:2001014	regulation of skeletal muscle cell differentiation	BP
1	6	0.73686081948	-	4.69e-01	GO:0000018	regulation of DNA recombination	BP
1	6	0.73686081948	-	4.69e-01	GO:0010792	DNA double-strand break processing involved in repair via single-strand annealing	BP
1	6	0.73686081948	-	4.69e-01	GO:0012501	programmed cell death	BP
1	6	0.73686081948	-	4.69e-01	GO:0051444	negative regulation of ubiquitin-protein transferase activity	BP
1	6	0.73686081948	-	4.69e-01	GO:0061037	negative regulation of cartilage development	BP
1	6	0.73686081948	-	4.69e-01	GO:0048642	negative regulation of skeletal muscle tissue development	BP
1	6	0.73686081948	-	4.69e-01	GO:1902533	positive regulation of intracellular signal transduction	BP
1	6	0.73686081948	-	4.69e-01	GO:0071559	response to transforming growth factor beta	BP
1	6	0.73686081948	-	4.69e-01	GO:0035331	negative regulation of hippo signaling	BP
1	6	0.73686081948	-	4.69e-01	GO:0043486	histone exchange	BP
1	6	0.73686081948	-	4.69e-01	GO:2000288	positive regulation of myoblast proliferation	BP
1	6	0.73686081948	-	4.69e-01	GO:0036465	synaptic vesicle recycling	BP
1	6	0.73686081948	-	4.69e-01	GO:0003180	aortic valve morphogenesis	BP
1	6	0.73686081948	-	4.69e-01	GO:0050671	positive regulation of lymphocyte proliferation	BP
1	6	0.73686081948	-	4.69e-01	GO:0007253	cytoplasmic sequestering of NF-kappaB	BP
1	6	0.73686081948	-	4.69e-01	GO:0001956	positive regulation of neurotransmitter secretion	BP
1	6	0.73686081948	-	4.69e-01	GO:0034105	positive regulation of tissue remodeling	BP
1	6	0.73686081948	-	4.69e-01	GO:0010535	positive regulation of activation of JAK2 kinase activity	BP
1	6	0.73686081948	-	4.69e-01	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	6	0.73686081948	-	4.69e-01	GO:0034315	regulation of Arp2/3 complex-mediated actin nucleation	BP
1	6	0.73686081948	-	4.69e-01	GO:2001046	positive regulation of integrin-mediated signaling pathway	BP
1	6	0.73686081948	-	4.69e-01	GO:0014033	neural crest cell differentiation	BP
1	6	0.73686081948	-	4.69e-01	GO:0006777	Mo-molybdopterin cofactor biosynthetic process	BP
1	6	0.73686081948	-	4.69e-01	GO:0001661	conditioned taste aversion	BP
1	6	0.73686081948	-	4.69e-01	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	BP
1	6	0.73686081948	-	4.69e-01	GO:1904417	positive regulation of xenophagy	BP
1	6	0.73686081948	-	4.69e-01	GO:0002819	regulation of adaptive immune response	BP
1	6	0.73686081948	-	4.69e-01	GO:0042487	regulation of odontogenesis of dentin-containing tooth	BP
1	6	0.73686081948	-	4.69e-01	GO:0010216	maintenance of DNA methylation	BP
1	6	0.73686081948	-	4.69e-01	GO:0043535	regulation of blood vessel endothelial cell migration	BP
1	6	0.73686081948	-	4.69e-01	GO:0030953	astral microtubule organization	BP
1	6	0.73686081948	-	4.69e-01	GO:0046931	pore complex assembly	BP
1	6	0.73686081948	-	4.69e-01	GO:0036289	peptidyl-serine autophosphorylation	BP
1	6	0.73686081948	-	4.69e-01	GO:0001711	endodermal cell fate commitment	BP
1	6	0.73686081948	-	4.69e-01	GO:0030853	negative regulation of granulocyte differentiation	BP
1	6	0.73686081948	-	4.69e-01	GO:0071371	cellular response to gonadotropin stimulus	BP
1	6	0.73686081948	-	4.69e-01	GO:2000667	positive regulation of interleukin-13 secretion	BP
1	6	0.73686081948	-	4.69e-01	GO:0086073	bundle of His cell-Purkinje myocyte adhesion involved in cell communication	BP
1	6	0.73686081948	-	4.69e-01	GO:2000503	positive regulation of natural killer cell chemotaxis	BP
1	6	0.73686081948	-	4.69e-01	GO:0071638	negative regulation of monocyte chemotactic protein-1 production	BP
1	6	0.73686081948	-	4.69e-01	GO:1903265	positive regulation of tumor necrosis factor-mediated signaling pathway	BP
1	6	0.73686081948	-	4.69e-01	GO:0010324	membrane invagination	BP
1	6	0.73686081948	-	4.69e-01	GO:0001844	protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	BP
1	6	0.73686081948	-	4.69e-01	GO:0006537	glutamate biosynthetic process	BP
1	6	0.73686081948	-	4.69e-01	GO:0010042	response to manganese ion	BP
1	6	0.73686081948	-	4.69e-01	GO:0071470	cellular response to osmotic stress	BP
1	6	0.73686081948	-	4.69e-01	GO:0030510	regulation of BMP signaling pathway	BP
1	6	0.73686081948	-	4.69e-01	GO:1901018	positive regulation of potassium ion transmembrane transporter activity	BP
1	6	0.73686081948	-	4.69e-01	GO:0035773	insulin secretion involved in cellular response to glucose stimulus	BP
1	6	0.73686081948	-	4.69e-01	GO:0016576	histone dephosphorylation	BP
1	6	0.73686081948	-	4.69e-01	GO:0048667	cell morphogenesis involved in neuron differentiation	BP
1	6	0.73686081948	-	4.69e-01	GO:0043615	astrocyte cell migration	BP
1	6	0.73686081948	-	4.69e-01	GO:0051096	positive regulation of helicase activity	BP
1	6	0.73686081948	-	4.69e-01	GO:1900113	negative regulation of histone H3-K9 trimethylation	BP
1	6	0.73686081948	-	4.69e-01	GO:0048743	positive regulation of skeletal muscle fiber development	BP
1	6	0.73686081948	-	4.69e-01	GO:0060536	cartilage morphogenesis	BP
1	6	0.73686081948	-	4.69e-01	GO:0035965	cardiolipin acyl-chain remodeling	BP
1	6	0.73686081948	-	4.69e-01	GO:0006616	SRP-dependent cotranslational protein targeting to membrane, translocation	BP
1	6	0.73686081948	-	4.69e-01	GO:0045661	regulation of myoblast differentiation	BP
1	6	0.73686081948	-	4.69e-01	GO:0070244	negative regulation of thymocyte apoptotic process	BP
1	6	0.73686081948	-	4.69e-01	GO:0032933	SREBP signaling pathway	BP
1	6	0.73686081948	-	4.69e-01	GO:0006333	chromatin assembly or disassembly	BP
1	6	0.73686081948	-	4.69e-01	GO:0071156	regulation of cell cycle arrest	BP
1	6	0.73686081948	-	4.69e-01	GO:0031087	deadenylation-independent decapping of nuclear-transcribed mRNA	BP
1	6	0.73686081948	-	4.69e-01	GO:0061312	BMP signaling pathway involved in heart development	BP
1	6	0.73686081948	-	4.69e-01	GO:0052548	regulation of endopeptidase activity	BP
1	6	0.73686081948	-	4.69e-01	GO:0042045	epithelial fluid transport	BP
1	6	0.73686081948	-	4.69e-01	GO:0060052	neurofilament cytoskeleton organization	BP
1	6	0.73686081948	-	4.69e-01	GO:0035065	regulation of histone acetylation	BP
1	6	0.73686081948	-	4.69e-01	GO:0045822	negative regulation of heart contraction	BP
1	6	0.73686081948	-	4.69e-01	GO:0061002	negative regulation of dendritic spine morphogenesis	BP
1	6	0.73686081948	-	4.69e-01	GO:0006207	'de novo' pyrimidine nucleobase biosynthetic process	BP
15	90	0.73686081948	-	2.61e-02	GO:0002020	protease binding	MF
3	18	0.73686081948	-	1.11e-01	GO:0005539	glycosaminoglycan binding	MF
2	12	0.73686081948	-	1.14e-01	GO:0008373	sialyltransferase activity	MF
3	18	0.73686081948	-	1.34e-01	GO:0031267	small GTPase binding	MF
2	12	0.73686081948	-	1.87e-01	GO:0005542	folic acid binding	MF
1	6	0.73686081948	-	1.90e-01	GO:0000155	phosphorelay sensor kinase activity	MF
1	6	0.73686081948	-	1.90e-01	GO:0015193	L-proline transmembrane transporter activity	MF
4	24	0.73686081948	-	2.70e-01	GO:0030742	GTP-dependent protein binding	MF
1	6	0.73686081948	-	2.71e-01	GO:0015187	glycine transmembrane transporter activity	MF
1	6	0.73686081948	-	2.71e-01	GO:0008374	O-acyltransferase activity	MF
1	6	0.73686081948	-	2.71e-01	GO:0005347	ATP transmembrane transporter activity	MF
1	6	0.73686081948	-	2.71e-01	GO:0047035	testosterone dehydrogenase (NAD+) activity	MF
1	6	0.73686081948	-	2.71e-01	GO:0015217	ADP transmembrane transporter activity	MF
4	24	0.73686081948	-	2.94e-01	GO:0051020	GTPase binding	MF
2	12	0.73686081948	-	3.03e-01	GO:0051959	dynein light intermediate chain binding	MF
2	12	0.73686081948	-	3.41e-01	GO:0008143	poly(A) binding	MF
2	12	0.73686081948	-	3.41e-01	GO:0042623	ATPase activity, coupled	MF
2	12	0.73686081948	-	3.41e-01	GO:0042974	retinoic acid receptor binding	MF
1	6	0.73686081948	-	3.44e-01	GO:0004024	alcohol dehydrogenase activity, zinc-dependent	MF
1	6	0.73686081948	-	3.44e-01	GO:0003836	beta-galactoside (CMP) alpha-2,3-sialyltransferase activity	MF
1	6	0.73686081948	-	3.44e-01	GO:0008517	folic acid transporter activity	MF
1	6	0.73686081948	-	3.44e-01	GO:0048019	receptor antagonist activity	MF
1	6	0.73686081948	-	4.10e-01	GO:0004468	lysine N-acetyltransferase activity, acting on acetyl phosphate as donor	MF
1	6	0.73686081948	-	4.10e-01	GO:0070728	leucine binding	MF
1	6	0.73686081948	-	4.10e-01	GO:0048029	monosaccharide binding	MF
1	6	0.73686081948	-	4.10e-01	GO:1990226	histone methyltransferase binding	MF
1	6	0.73686081948	-	4.10e-01	GO:0043237	laminin-1 binding	MF
1	6	0.73686081948	-	4.10e-01	GO:0072341	modified amino acid binding	MF
1	6	0.73686081948	-	4.10e-01	GO:0030619	U1 snRNA binding	MF
1	6	0.73686081948	-	4.10e-01	GO:0030020	extracellular matrix structural constituent conferring tensile strength	MF
1	6	0.73686081948	-	4.69e-01	GO:0003958	NADPH-hemoprotein reductase activity	MF
1	6	0.73686081948	-	4.69e-01	GO:0004704	NF-kappaB-inducing kinase activity	MF
1	6	0.73686081948	-	4.69e-01	GO:0061133	endopeptidase activator activity	MF
1	6	0.73686081948	-	4.69e-01	GO:0032453	histone demethylase activity (H3-K4 specific)	MF
1	6	0.73686081948	-	4.69e-01	GO:0034618	arginine binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0001221	transcription cofactor binding	MF
1	6	0.73686081948	-	4.69e-01	GO:0086083	cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication	MF
1	6	0.73686081948	-	4.69e-01	GO:0019784	NEDD8-specific protease activity	MF
7	42	0.73686081948	-	4.15e-02	GO:0001658	branching involved in ureteric bud morphogenesis	BP
9	54	0.73686081948	-	5.72e-02	GO:0030097	hemopoiesis	BP
7	42	0.73686081948	-	1.14e-01	GO:0006986	response to unfolded protein	BP
9	54	0.73686081948	-	1.30e-02	GO:0004860	protein kinase inhibitor activity	MF
9	54	0.73686081948	-	9.47e-02	GO:0004197	cysteine-type endopeptidase activity	MF
82	496	0.725179014432	-	1.96e-07	GO:0045893	positive regulation of transcription, DNA-templated	BP
14	85	0.719787306121	-	8.24e-03	GO:0009887	animal organ morphogenesis	BP
14	85	0.719787306121	-	3.88e-02	GO:0030165	PDZ domain binding	MF
12	73	0.716961262042	-	2.98e-02	GO:0050728	negative regulation of inflammatory response	BP
9	55	0.710388608119	-	4.79e-02	GO:0045665	negative regulation of neuron differentiation	BP
8	49	0.707113476086	-	1.42e-01	GO:0007266	Rho protein signal transduction	BP
8	49	0.707113476086	-	1.31e-01	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	MF
116	711	0.706098565709	-	2.44e-10	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	BP
13	80	0.700334943455	-	2.40e-02	GO:0035264	multicellular organism growth	BP
18	111	0.697332455293	-	8.27e-03	GO:0007219	Notch signaling pathway	BP
18	111	0.697332455293	-	8.63e-03	GO:0045766	positive regulation of angiogenesis	BP
6	37	0.697332455293	-	3.97e-02	GO:0005267	potassium channel activity	MF
6	37	0.697332455293	-	1.68e-01	GO:0019894	kinesin binding	MF
10	62	0.689555104702	-	6.56e-02	GO:0051289	protein homotetramerization	BP
10	62	0.689555104702	-	7.23e-02	GO:0051384	response to glucocorticoid	BP
5	31	0.689555104702	-	9.78e-02	GO:0048286	lung alveolus development	BP
9	56	0.684393399586	-	3.74e-02	GO:0042277	peptide binding	MF
25	156	0.680277291114	-	3.77e-03	GO:0007010	cytoskeleton organization	BP
4	25	0.677967130426	-	2.70e-01	GO:0034612	response to tumor necrosis factor	BP
4	25	0.677967130426	-	2.81e-01	GO:0022604	regulation of cell morphogenesis	BP
4	25	0.677967130426	-	2.81e-01	GO:0060612	adipose tissue development	BP
4	25	0.677967130426	-	2.94e-01	GO:0055010	ventricular cardiac muscle tissue morphogenesis	BP
4	25	0.677967130426	-	2.94e-01	GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity	BP
4	25	0.677967130426	-	2.94e-01	GO:0060976	coronary vasculature development	BP
4	25	0.677967130426	-	3.08e-01	GO:0043027	cysteine-type endopeptidase inhibitor activity involved in apoptotic process	MF
235	1469	0.67772158621	-	2.74e-10	GO:0005524	ATP binding	MF
18	113	0.671569359228	-	2.34e-02	GO:0071222	cellular response to lipopolysaccharide	BP
75	471	0.671058761084	-	8.57e-07	GO:0045892	negative regulation of transcription, DNA-templated	BP
7	44	0.669746623621	-	7.56e-02	GO:0006631	fatty acid metabolic process	BP
7	44	0.669746623621	-	1.89e-01	GO:0016575	histone deacetylation	BP
10	63	0.666471491589	-	1.28e-01	GO:0016197	endosomal transport	BP
155	981	0.659838399256	-	2.39e-10	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	BP
12	76	0.658858307479	-	3.12e-02	GO:0043085	positive regulation of catalytic activity	BP
3	19	0.658858307479	-	8.95e-02	GO:0030539	male genitalia development	BP
6	38	0.658858307479	-	1.46e-01	GO:0009790	embryo development	BP
3	19	0.658858307479	-	1.84e-01	GO:0050850	positive regulation of calcium-mediated signaling	BP
3	19	0.658858307479	-	2.11e-01	GO:0032332	positive regulation of chondrocyte differentiation	BP
3	19	0.658858307479	-	2.11e-01	GO:0045879	negative regulation of smoothened signaling pathway	BP
3	19	0.658858307479	-	4.16e-01	GO:0046716	muscle cell cellular homeostasis	BP
3	19	0.658858307479	-	4.16e-01	GO:0046597	negative regulation of viral entry into host cell	BP
3	19	0.658858307479	-	4.29e-01	GO:0070987	error-free translesion synthesis	BP
3	19	0.658858307479	-	1.84e-01	GO:0001158	enhancer sequence-specific DNA binding	MF
3	19	0.658858307479	-	4.16e-01	GO:0019955	cytokine binding	MF
3	19	0.658858307479	-	4.29e-01	GO:0017022	myosin binding	MF
32	203	0.656487403016	-	1.10e-06	GO:0050900	leukocyte migration	BP
55	349	0.656099807516	-	5.16e-06	GO:0005102	receptor binding	MF
11	70	0.651971921894	-	4.34e-02	GO:0009791	post-embryonic development	BP
11	70	0.651971921894	-	6.06e-02	GO:0001889	liver development	BP
5	32	0.643751415089	-	6.20e-02	GO:0042100	B cell proliferation	BP
5	32	0.643751415089	-	1.94e-01	GO:0040018	positive regulation of multicellular organism growth	BP
5	32	0.643751415089	-	2.46e-01	GO:0070911	global genome nucleotide-excision repair	BP
17	109	0.641101836675	-	2.49e-02	GO:0071356	cellular response to tumor necrosis factor	BP
7	45	0.637325145929	-	7.56e-02	GO:0019722	calcium-mediated signaling	BP
7	45	0.637325145929	-	1.05e-01	GO:0060048	cardiac muscle contraction	BP
9	58	0.633767326516	-	5.23e-02	GO:0005546	phosphatidylinositol-4,5-bisphosphate binding	MF
12	78	0.62138360206	-	1.46e-02	GO:0008544	epidermis development	BP
10	65	0.62138360206	-	3.89e-02	GO:0030183	B cell differentiation	BP
6	39	0.62138360206	-	1.37e-01	GO:0090002	establishment of protein localization to plasma membrane	BP
6	39	0.62138360206	-	2.77e-01	GO:0030522	intracellular receptor signaling pathway	BP
2	13	0.62138360206	-	1.50e-01	GO:1901386	negative regulation of voltage-gated calcium channel activity	BP
4	26	0.62138360206	-	1.52e-01	GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus	BP
2	13	0.62138360206	-	1.87e-01	GO:0001964	startle response	BP
2	13	0.62138360206	-	2.25e-01	GO:0072488	ammonium transmembrane transport	BP
2	13	0.62138360206	-	2.25e-01	GO:0009395	phospholipid catabolic process	BP
2	13	0.62138360206	-	2.64e-01	GO:0014032	neural crest cell development	BP
2	13	0.62138360206	-	2.64e-01	GO:0032230	positive regulation of synaptic transmission, GABAergic	BP
2	13	0.62138360206	-	2.64e-01	GO:0042073	intraciliary transport	BP
2	13	0.62138360206	-	2.64e-01	GO:0031076	embryonic camera-type eye development	BP
4	26	0.62138360206	-	2.70e-01	GO:0019216	regulation of lipid metabolic process	BP
2	13	0.62138360206	-	3.03e-01	GO:0051145	smooth muscle cell differentiation	BP
2	13	0.62138360206	-	3.03e-01	GO:0006536	glutamate metabolic process	BP
2	13	0.62138360206	-	3.03e-01	GO:0099133	ATP hydrolysis coupled anion transmembrane transport	BP
4	26	0.62138360206	-	3.08e-01	GO:0071108	protein K48-linked deubiquitination	BP
2	13	0.62138360206	-	3.41e-01	GO:0044030	regulation of DNA methylation	BP
2	13	0.62138360206	-	3.41e-01	GO:0035909	aorta morphogenesis	BP
2	13	0.62138360206	-	3.41e-01	GO:0046685	response to arsenic-containing substance	BP
2	13	0.62138360206	-	3.41e-01	GO:0019725	cellular homeostasis	BP
2	13	0.62138360206	-	3.41e-01	GO:0010821	regulation of mitochondrion organization	BP
2	13	0.62138360206	-	3.41e-01	GO:0060047	heart contraction	BP
2	13	0.62138360206	-	3.41e-01	GO:0045780	positive regulation of bone resorption	BP
2	13	0.62138360206	-	3.79e-01	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	BP
2	13	0.62138360206	-	3.79e-01	GO:2001234	negative regulation of apoptotic signaling pathway	BP
2	13	0.62138360206	-	3.79e-01	GO:0035815	positive regulation of renal sodium excretion	BP
2	13	0.62138360206	-	3.79e-01	GO:0070986	left/right axis specification	BP
44	286	0.62138360206	-	2.55e-03	GO:0045296	cadherin binding	MF
32	208	0.62138360206	-	5.41e-03	GO:0044212	transcription regulatory region DNA binding	MF
4	26	0.62138360206	-	1.52e-01	GO:0003785	actin monomer binding	MF
2	13	0.62138360206	-	2.64e-01	GO:0008253	5'-nucleotidase activity	MF
2	13	0.62138360206	-	3.79e-01	GO:0051787	misfolded protein binding	MF
2	13	0.62138360206	-	3.79e-01	GO:0034450	ubiquitin-ubiquitin ligase activity	MF
2	13	0.62138360206	-	3.79e-01	GO:0035497	cAMP response element binding	MF
33	215	0.61802458997	-	1.14e-03	GO:0007264	small GTPase mediated signal transduction	BP
13	85	0.612872102205	-	2.56e-02	GO:0007565	female pregnancy	BP
9	59	0.609105272282	-	1.04e-01	GO:0032092	positive regulation of protein binding	BP
7	46	0.605616286202	-	1.83e-01	GO:0071230	cellular response to amino acid stimulus	BP
7	46	0.605616286202	-	2.02e-01	GO:0008307	structural constituent of muscle	MF
5	33	0.59935729573	-	1.94e-01	GO:0051262	protein tetramerization	BP
5	33	0.59935729573	-	2.31e-01	GO:0032480	negative regulation of type I interferon production	BP
5	33	0.59935729573	-	2.31e-01	GO:0001974	blood vessel remodeling	BP
5	33	0.59935729573	-	9.78e-02	GO:0016874	ligase activity	MF
10	66	0.59935729573	-	1.36e-01	GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	MF
15	99	0.59935729573	-	4.94e-02	GO:0031175	neuron projection development	BP
30	199	0.592089295266	-	9.65e-03	GO:0003714	transcription corepressor activity	MF
55	366	0.587483195442	-	4.82e-06	GO:0006954	inflammatory response	BP
9	60	0.584857726035	-	1.09e-01	GO:0034599	cellular response to oxidative stress	BP
3	20	0.584857726035	-	8.95e-02	GO:0097503	sialylation	BP
3	20	0.584857726035	-	1.11e-01	GO:0055074	calcium ion homeostasis	BP
6	40	0.584857726035	-	1.56e-01	GO:0060291	long-term synaptic potentiation	BP
3	20	0.584857726035	-	1.84e-01	GO:0031016	pancreas development	BP
3	20	0.584857726035	-	2.11e-01	GO:0060716	labyrinthine layer blood vessel development	BP
6	40	0.584857726035	-	2.63e-01	GO:0045668	negative regulation of osteoblast differentiation	BP
3	20	0.584857726035	-	4.16e-01	GO:0030520	intracellular estrogen receptor signaling pathway	BP
3	20	0.584857726035	-	4.29e-01	GO:0007051	spindle organization	BP
3	20	0.584857726035	-	4.44e-01	GO:0039702	viral budding via host ESCRT complex	BP
3	20	0.584857726035	-	4.44e-01	GO:0045663	positive regulation of myoblast differentiation	BP
3	20	0.584857726035	-	1.84e-01	GO:0005112	Notch binding	MF
3	20	0.584857726035	-	4.16e-01	GO:0031683	G-protein beta/gamma-subunit complex binding	MF
3	20	0.584857726035	-	4.29e-01	GO:0030159	receptor signaling complex scaffold activity	MF
7	47	0.574589390581	-	1.83e-01	GO:0048812	neuron projection morphogenesis	BP
12	81	0.566935818038	-	1.79e-02	GO:0030509	BMP signaling pathway	BP
24	162	0.566935818038	-	1.37e-03	GO:0008083	growth factor activity	MF
4	27	0.566935818038	-	2.70e-01	GO:0010575	positive regulation of vascular endothelial growth factor production	BP
4	27	0.566935818038	-	2.81e-01	GO:0016358	dendrite development	BP
4	27	0.566935818038	-	2.94e-01	GO:0035987	endodermal cell differentiation	BP
4	27	0.566935818038	-	2.94e-01	GO:0090023	positive regulation of neutrophil chemotaxis	BP
4	27	0.566935818038	-	2.94e-01	GO:0050766	positive regulation of phagocytosis	BP
4	27	0.566935818038	-	3.23e-01	GO:0051603	proteolysis involved in cellular protein catabolic process	BP
4	27	0.566935818038	-	2.81e-01	GO:0004857	enzyme inhibitor activity	MF
4	27	0.566935818038	-	2.81e-01	GO:0004693	cyclin-dependent protein serine/threonine kinase activity	MF
30	203	0.563377998625	-	1.53e-02	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	BP
13	88	0.562831419705	-	2.26e-02	GO:0016311	dephosphorylation	BP
15	102	0.556288573838	-	4.94e-02	GO:0001649	osteoblast differentiation	BP
5	34	0.556288573838	-	6.20e-02	GO:0043330	response to exogenous dsRNA	BP
5	34	0.556288573838	-	2.18e-01	GO:0033574	response to testosterone	BP
54	368	0.553148866308	-	4.61e-04	GO:0003682	chromatin binding	MF
11	75	0.552436248343	-	1.67e-01	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
6	41	0.549233816304	-	1.46e-01	GO:0009725	response to hormone	BP
7	48	0.544215741538	-	2.02e-01	GO:0060548	negative regulation of cell death	BP
7	48	0.544215741538	-	2.10e-01	GO:0010977	negative regulation of neuron projection development	BP
7	48	0.544215741538	-	1.05e-01	GO:0030145	manganese ion binding	MF
8	55	0.540463606677	-	1.36e-01	GO:0042733	embryonic digit morphogenesis	BP
8	55	0.540463606677	-	1.63e-01	GO:0003712	transcription cofactor activity	MF
9	62	0.537552011257	-	1.74e-01	GO:0006302	double-strand break repair	BP
10	69	0.53522695831	-	1.28e-01	GO:0045444	fat cell differentiation	BP
11	76	0.533327425395	-	1.60e-01	GO:0007030	Golgi organization	BP
25	174	0.522736014127	-	4.44e-05	GO:0002250	adaptive immune response	BP
15	105	0.514468398144	-	4.67e-02	GO:0006914	autophagy	BP
6	42	0.514468398144	-	1.46e-01	GO:0001541	ovarian follicle development	BP
6	42	0.514468398144	-	1.46e-01	GO:0032526	response to retinoic acid	BP
5	35	0.514468398144	-	3.74e-01	GO:0045786	negative regulation of cell cycle	BP
3	21	0.514468398144	-	4.44e-01	GO:0045921	positive regulation of exocytosis	BP
3	21	0.514468398144	-	4.44e-01	GO:0090103	cochlea morphogenesis	BP
3	21	0.514468398144	-	4.44e-01	GO:0050769	positive regulation of neurogenesis	BP
3	21	0.514468398144	-	4.61e-01	GO:0090316	positive regulation of intracellular protein transport	BP
3	21	0.514468398144	-	4.61e-01	GO:0007004	telomere maintenance via telomerase	BP
3	21	0.514468398144	-	2.11e-01	GO:0001530	lipopolysaccharide binding	MF
6	42	0.514468398144	-	2.69e-01	GO:0048365	Rac GTPase binding	MF
5	35	0.514468398144	-	3.74e-01	GO:0001105	RNA polymerase II transcription coactivator activity	MF
11	77	0.514468398144	-	5.02e-02	GO:0030324	lung development	BP
1	7	0.514468398144	-	1.00e-01	GO:0006766	vitamin metabolic process	BP
4	28	0.514468398144	-	1.33e-01	GO:0007194	negative regulation of adenylate cyclase activity	BP
2	14	0.514468398144	-	1.50e-01	GO:0051481	negative regulation of cytosolic calcium ion concentration	BP
4	28	0.514468398144	-	1.52e-01	GO:0022400	regulation of rhodopsin mediated signaling pathway	BP
1	7	0.514468398144	-	1.90e-01	GO:0001574	ganglioside biosynthetic process	BP
2	14	0.514468398144	-	2.25e-01	GO:0021854	hypothalamus development	BP
8	56	0.514468398144	-	2.45e-01	GO:0051259	protein oligomerization	BP
4	28	0.514468398144	-	2.70e-01	GO:0007628	adult walking behavior	BP
1	7	0.514468398144	-	2.71e-01	GO:0019367	fatty acid elongation, saturated fatty acid	BP
1	7	0.514468398144	-	2.71e-01	GO:0015816	glycine transport	BP
1	7	0.514468398144	-	2.71e-01	GO:0035524	proline transmembrane transport	BP
1	7	0.514468398144	-	2.71e-01	GO:0000160	phosphorelay signal transduction system	BP
2	14	0.514468398144	-	3.03e-01	GO:0010875	positive regulation of cholesterol efflux	BP
2	14	0.514468398144	-	3.03e-01	GO:0032461	positive regulation of protein oligomerization	BP
2	14	0.514468398144	-	3.03e-01	GO:0003407	neural retina development	BP
4	28	0.514468398144	-	3.08e-01	GO:0000422	mitophagy	BP
4	28	0.514468398144	-	3.23e-01	GO:0007528	neuromuscular junction development	BP
2	14	0.514468398144	-	3.41e-01	GO:0071625	vocalization behavior	BP
2	14	0.514468398144	-	3.41e-01	GO:0051016	barbed-end actin filament capping	BP
2	14	0.514468398144	-	3.41e-01	GO:2000678	negative regulation of transcription regulatory region DNA binding	BP
2	14	0.514468398144	-	3.41e-01	GO:0090303	positive regulation of wound healing	BP
1	7	0.514468398144	-	3.44e-01	GO:0001945	lymph vessel development	BP
1	7	0.514468398144	-	3.44e-01	GO:0051694	pointed-end actin filament capping	BP
1	7	0.514468398144	-	3.44e-01	GO:0015808	L-alanine transport	BP
1	7	0.514468398144	-	3.44e-01	GO:0002043	blood vessel endothelial cell proliferation involved in sprouting angiogenesis	BP
1	7	0.514468398144	-	3.44e-01	GO:0014807	regulation of somitogenesis	BP
1	7	0.514468398144	-	3.44e-01	GO:0071679	commissural neuron axon guidance	BP
1	7	0.514468398144	-	3.44e-01	GO:0035356	cellular triglyceride homeostasis	BP
1	7	0.514468398144	-	3.44e-01	GO:0032049	cardiolipin biosynthetic process	BP
1	7	0.514468398144	-	3.44e-01	GO:0048771	tissue remodeling	BP
2	14	0.514468398144	-	3.79e-01	GO:0072657	protein localization to membrane	BP
2	14	0.514468398144	-	3.79e-01	GO:0014898	cardiac muscle hypertrophy in response to stress	BP
2	14	0.514468398144	-	3.79e-01	GO:0001817	regulation of cytokine production	BP
2	14	0.514468398144	-	3.79e-01	GO:0030194	positive regulation of blood coagulation	BP
2	14	0.514468398144	-	3.79e-01	GO:0050892	intestinal absorption	BP
2	14	0.514468398144	-	3.79e-01	GO:0070528	protein kinase C signaling	BP
1	7	0.514468398144	-	4.10e-01	GO:0043654	recognition of apoptotic cell	BP
1	7	0.514468398144	-	4.10e-01	GO:0009620	response to fungus	BP
1	7	0.514468398144	-	4.10e-01	GO:1903546	protein localization to photoreceptor outer segment	BP
1	7	0.514468398144	-	4.10e-01	GO:0015884	folic acid transport	BP
1	7	0.514468398144	-	4.10e-01	GO:0072643	interferon-gamma secretion	BP
1	7	0.514468398144	-	4.10e-01	GO:2001259	positive regulation of cation channel activity	BP
1	7	0.514468398144	-	4.10e-01	GO:0048842	positive regulation of axon extension involved in axon guidance	BP
1	7	0.514468398144	-	4.10e-01	GO:0035878	nail development	BP
1	7	0.514468398144	-	4.10e-01	GO:0051045	negative regulation of membrane protein ectodomain proteolysis	BP
1	7	0.514468398144	-	4.10e-01	GO:0045576	mast cell activation	BP
1	7	0.514468398144	-	4.10e-01	GO:0008593	regulation of Notch signaling pathway	BP
1	7	0.514468398144	-	4.10e-01	GO:0003085	negative regulation of systemic arterial blood pressure	BP
1	7	0.514468398144	-	4.10e-01	GO:0070613	regulation of protein processing	BP
1	7	0.514468398144	-	4.10e-01	GO:0070233	negative regulation of T cell apoptotic process	BP
1	7	0.514468398144	-	4.10e-01	GO:0070234	positive regulation of T cell apoptotic process	BP
1	7	0.514468398144	-	4.69e-01	GO:0048539	bone marrow development	BP
1	7	0.514468398144	-	4.69e-01	GO:0048251	elastic fiber assembly	BP
1	7	0.514468398144	-	4.69e-01	GO:0072205	metanephric collecting duct development	BP
1	7	0.514468398144	-	4.69e-01	GO:0015872	dopamine transport	BP
1	7	0.514468398144	-	4.69e-01	GO:0032287	peripheral nervous system myelin maintenance	BP
1	7	0.514468398144	-	4.69e-01	GO:0043569	negative regulation of insulin-like growth factor receptor signaling pathway	BP
1	7	0.514468398144	-	4.69e-01	GO:0060998	regulation of dendritic spine development	BP
1	7	0.514468398144	-	4.69e-01	GO:0009629	response to gravity	BP
1	7	0.514468398144	-	4.69e-01	GO:1902260	negative regulation of delayed rectifier potassium channel activity	BP
1	7	0.514468398144	-	4.69e-01	GO:0014037	Schwann cell differentiation	BP
1	7	0.514468398144	-	4.69e-01	GO:0070474	positive regulation of uterine smooth muscle contraction	BP
1	7	0.514468398144	-	4.69e-01	GO:0000578	embryonic axis specification	BP
1	7	0.514468398144	-	4.69e-01	GO:0043305	negative regulation of mast cell degranulation	BP
1	7	0.514468398144	-	4.69e-01	GO:0031102	neuron projection regeneration	BP
1	7	0.514468398144	-	4.69e-01	GO:0090281	negative regulation of calcium ion import	BP
1	7	0.514468398144	-	4.69e-01	GO:0032926	negative regulation of activin receptor signaling pathway	BP
1	7	0.514468398144	-	4.69e-01	GO:1900246	positive regulation of RIG-I signaling pathway	BP
1	7	0.514468398144	-	4.69e-01	GO:0032411	positive regulation of transporter activity	BP
1	7	0.514468398144	-	4.69e-01	GO:0072678	T cell migration	BP
1	7	0.514468398144	-	4.69e-01	GO:0030814	regulation of cAMP metabolic process	BP
1	7	0.514468398144	-	4.69e-01	GO:0019054	modulation by virus of host process	BP
1	7	0.514468398144	-	4.69e-01	GO:0097237	cellular response to toxic substance	BP
1	7	0.514468398144	-	4.69e-01	GO:0060080	inhibitory postsynaptic potential	BP
1	7	0.514468398144	-	4.69e-01	GO:0034983	peptidyl-lysine deacetylation	BP
1	7	0.514468398144	-	4.69e-01	GO:0045835	negative regulation of meiotic nuclear division	BP
1	7	0.514468398144	-	4.69e-01	GO:0051549	positive regulation of keratinocyte migration	BP
1	7	0.514468398144	-	4.69e-01	GO:0060576	intestinal epithelial cell development	BP
1	7	0.514468398144	-	4.69e-01	GO:0071281	cellular response to iron ion	BP
1	7	0.514468398144	-	4.69e-01	GO:0021554	optic nerve development	BP
1	7	0.514468398144	-	4.69e-01	GO:0051014	actin filament severing	BP
1	7	0.514468398144	-	4.69e-01	GO:0034497	protein localization to pre-autophagosomal structure	BP
1	7	0.514468398144	-	4.69e-01	GO:0046069	cGMP catabolic process	BP
1	7	0.514468398144	-	4.69e-01	GO:0060972	left/right pattern formation	BP
1	7	0.514468398144	-	4.69e-01	GO:0021860	pyramidal neuron development	BP
1	7	0.514468398144	-	4.69e-01	GO:0008595	anterior/posterior axis specification, embryo	BP
1	7	0.514468398144	-	4.69e-01	GO:0001878	response to yeast	BP
1	7	0.514468398144	-	4.69e-01	GO:0017121	phospholipid scrambling	BP
1	7	0.514468398144	-	4.69e-01	GO:0006527	arginine catabolic process	BP
1	7	0.514468398144	-	4.69e-01	GO:0060840	artery development	BP
1	7	0.514468398144	-	4.69e-01	GO:0003084	positive regulation of systemic arterial blood pressure	BP
1	7	0.514468398144	-	4.69e-01	GO:2000271	positive regulation of fibroblast apoptotic process	BP
1	7	0.514468398144	-	4.69e-01	GO:0072711	cellular response to hydroxyurea	BP
1	7	0.514468398144	-	4.69e-01	GO:0045617	negative regulation of keratinocyte differentiation	BP
4	28	0.514468398144	-	5.20e-01	GO:0000077	DNA damage checkpoint	BP
1	7	0.514468398144	-	5.22e-01	GO:0006625	protein targeting to peroxisome	BP
1	7	0.514468398144	-	5.22e-01	GO:0055009	atrial cardiac muscle tissue morphogenesis	BP
1	7	0.514468398144	-	5.22e-01	GO:0035385	Roundabout signaling pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0007221	positive regulation of transcription of Notch receptor target	BP
1	7	0.514468398144	-	5.22e-01	GO:1990416	cellular response to brain-derived neurotrophic factor stimulus	BP
1	7	0.514468398144	-	5.22e-01	GO:1901799	negative regulation of proteasomal protein catabolic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0032471	negative regulation of endoplasmic reticulum calcium ion concentration	BP
1	7	0.514468398144	-	5.22e-01	GO:0000055	ribosomal large subunit export from nucleus	BP
1	7	0.514468398144	-	5.22e-01	GO:0032324	molybdopterin cofactor biosynthetic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0036010	protein localization to endosome	BP
1	7	0.514468398144	-	5.22e-01	GO:0045955	negative regulation of calcium ion-dependent exocytosis	BP
1	7	0.514468398144	-	5.22e-01	GO:0001961	positive regulation of cytokine-mediated signaling pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0003337	mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	7	0.514468398144	-	5.22e-01	GO:0090091	positive regulation of extracellular matrix disassembly	BP
1	7	0.514468398144	-	5.22e-01	GO:0001783	B cell apoptotic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0033622	integrin activation	BP
1	7	0.514468398144	-	5.22e-01	GO:0046903	secretion	BP
1	7	0.514468398144	-	5.22e-01	GO:0016458	gene silencing	BP
1	7	0.514468398144	-	5.22e-01	GO:0050773	regulation of dendrite development	BP
1	7	0.514468398144	-	5.22e-01	GO:0060706	cell differentiation involved in embryonic placenta development	BP
1	7	0.514468398144	-	5.22e-01	GO:0006900	membrane budding	BP
1	7	0.514468398144	-	5.22e-01	GO:0045359	positive regulation of interferon-beta biosynthetic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0032819	positive regulation of natural killer cell proliferation	BP
1	7	0.514468398144	-	5.22e-01	GO:0031023	microtubule organizing center organization	BP
1	7	0.514468398144	-	5.22e-01	GO:0010642	negative regulation of platelet-derived growth factor receptor signaling pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0048699	generation of neurons	BP
1	7	0.514468398144	-	5.22e-01	GO:1902231	positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
1	7	0.514468398144	-	5.22e-01	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0021785	branchiomotor neuron axon guidance	BP
1	7	0.514468398144	-	5.22e-01	GO:0014883	transition between fast and slow fiber	BP
1	7	0.514468398144	-	5.22e-01	GO:0071639	positive regulation of monocyte chemotactic protein-1 production	BP
1	7	0.514468398144	-	5.22e-01	GO:2000096	positive regulation of Wnt signaling pathway, planar cell polarity pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0051932	synaptic transmission, GABAergic	BP
1	7	0.514468398144	-	5.22e-01	GO:1903608	protein localization to cytoplasmic stress granule	BP
1	7	0.514468398144	-	5.22e-01	GO:0042178	xenobiotic catabolic process	BP
1	7	0.514468398144	-	5.22e-01	GO:0060008	Sertoli cell differentiation	BP
1	7	0.514468398144	-	5.22e-01	GO:0060575	intestinal epithelial cell differentiation	BP
1	7	0.514468398144	-	5.22e-01	GO:0030042	actin filament depolymerization	BP
1	7	0.514468398144	-	5.22e-01	GO:1903358	regulation of Golgi organization	BP
1	7	0.514468398144	-	5.22e-01	GO:0032609	interferon-gamma production	BP
1	7	0.514468398144	-	5.22e-01	GO:0023052	signaling	BP
1	7	0.514468398144	-	5.22e-01	GO:1901838	positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	BP
1	7	0.514468398144	-	5.22e-01	GO:0031497	chromatin assembly	BP
1	7	0.514468398144	-	5.22e-01	GO:0034128	negative regulation of MyD88-independent toll-like receptor signaling pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0038063	collagen-activated tyrosine kinase receptor signaling pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0038166	angiotensin-activated signaling pathway	BP
1	7	0.514468398144	-	5.22e-01	GO:0035308	negative regulation of protein dephosphorylation	BP
1	7	0.514468398144	-	5.22e-01	GO:0030219	megakaryocyte differentiation	BP
1	7	0.514468398144	-	5.22e-01	GO:0050891	multicellular organismal water homeostasis	BP
1	7	0.514468398144	-	5.22e-01	GO:0021952	central nervous system projection neuron axonogenesis	BP
2	14	0.514468398144	-	6.44e-01	GO:0034975	protein folding in endoplasmic reticulum	BP
2	14	0.514468398144	-	6.44e-01	GO:0042026	protein refolding	BP
2	14	0.514468398144	-	6.44e-01	GO:0098586	cellular response to virus	BP
2	14	0.514468398144	-	6.44e-01	GO:0048268	clathrin coat assembly	BP
2	14	0.514468398144	-	6.44e-01	GO:0050930	induction of positive chemotaxis	BP
2	14	0.514468398144	-	6.44e-01	GO:0022904	respiratory electron transport chain	BP
2	14	0.514468398144	-	6.44e-01	GO:0030970	retrograde protein transport, ER to cytosol	BP
47	329	0.514468398144	-	6.87e-04	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	MF
1	7	0.514468398144	-	1.90e-01	GO:0050291	sphingosine N-acyltransferase activity	MF
1	7	0.514468398144	-	2.71e-01	GO:0102337	3-oxo-cerotoyl-CoA synthase activity	MF
1	7	0.514468398144	-	2.71e-01	GO:0102336	3-oxo-arachidoyl-CoA synthase activity	MF
1	7	0.514468398144	-	2.71e-01	GO:0102338	3-oxo-lignoceronyl-CoA synthase activity	MF
1	7	0.514468398144	-	2.71e-01	GO:0015108	chloride transmembrane transporter activity	MF
1	7	0.514468398144	-	2.71e-01	GO:0015101	organic cation transmembrane transporter activity	MF
1	7	0.514468398144	-	2.71e-01	GO:0009922	fatty acid elongase activity	MF
2	14	0.514468398144	-	3.41e-01	GO:0008528	G-protein coupled peptide receptor activity	MF
1	7	0.514468398144	-	3.44e-01	GO:0015180	L-alanine transmembrane transporter activity	MF
1	7	0.514468398144	-	3.44e-01	GO:0008519	ammonium transmembrane transporter activity	MF
2	14	0.514468398144	-	3.79e-01	GO:0030169	low-density lipoprotein particle binding	MF
2	14	0.514468398144	-	3.79e-01	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	MF
1	7	0.514468398144	-	4.10e-01	GO:0005501	retinoid binding	MF
1	7	0.514468398144	-	4.10e-01	GO:0015271	outward rectifier potassium channel activity	MF
1	7	0.514468398144	-	4.10e-01	GO:0016308	1-phosphatidylinositol-4-phosphate 5-kinase activity	MF
1	7	0.514468398144	-	4.10e-01	GO:0050072	m7G(5')pppN diphosphatase activity	MF
1	7	0.514468398144	-	4.10e-01	GO:0005003	ephrin receptor activity	MF
1	7	0.514468398144	-	4.69e-01	GO:0035612	AP-2 adaptor complex binding	MF
1	7	0.514468398144	-	4.69e-01	GO:0000405	bubble DNA binding	MF
1	7	0.514468398144	-	4.69e-01	GO:0015280	ligand-gated sodium channel activity	MF
1	7	0.514468398144	-	4.69e-01	GO:0086008	voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization	MF
1	7	0.514468398144	-	4.69e-01	GO:0008559	xenobiotic-transporting ATPase activity	MF
1	7	0.514468398144	-	5.22e-01	GO:0097157	pre-mRNA intronic binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0000014	single-stranded DNA endodeoxyribonuclease activity	MF
1	7	0.514468398144	-	5.22e-01	GO:0032036	myosin heavy chain binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0043184	vascular endothelial growth factor receptor 2 binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0030274	LIM domain binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0031406	carboxylic acid binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0005138	interleukin-6 receptor binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0003720	telomerase activity	MF
1	7	0.514468398144	-	5.22e-01	GO:0008046	axon guidance receptor activity	MF
1	7	0.514468398144	-	5.22e-01	GO:0034235	GPI anchor binding	MF
1	7	0.514468398144	-	5.22e-01	GO:0043495	protein anchor	MF
1	7	0.514468398144	-	5.22e-01	GO:0019787	ubiquitin-like protein transferase activity	MF
2	14	0.514468398144	-	6.44e-01	GO:0034185	apolipoprotein binding	MF
2	14	0.514468398144	-	6.44e-01	GO:0070063	RNA polymerase binding	MF
18	127	0.503063634871	-	9.58e-03	GO:0007204	positive regulation of cytosolic calcium ion concentration	BP
17	120	0.502395565843	-	5.27e-02	GO:0044267	cellular protein metabolic process	BP
10	71	0.494004295584	-	1.46e-01	GO:0071347	cellular response to interleukin-1	BP
10	71	0.494004295584	-	2.15e-01	GO:0007584	response to nutrient	BP
8	57	0.488933306036	-	6.55e-02	GO:0060395	SMAD protein signal transduction	BP
6	43	0.48052106622	-	5.48e-02	GO:0030514	negative regulation of BMP signaling pathway	BP
11	79	0.477474190661	-	2.39e-02	GO:0006813	potassium ion transport	BP
5	36	0.473826413646	-	8.49e-02	GO:0010811	positive regulation of cell-substrate adhesion	BP
10	72	0.473826413646	-	1.28e-01	GO:0006816	calcium ion transport	BP
39	281	0.472799218842	-	7.30e-04	GO:0005096	GTPase activator activity	MF
24	173	0.472157593286	-	3.19e-02	GO:0001701	in utero embryonic development	BP
46	333	0.466006909187	-	9.91e-03	GO:0051301	cell division	BP
12	87	0.463842325074	-	3.95e-02	GO:0090630	activation of GTPase activity	BP
8	58	0.463842325074	-	1.48e-01	GO:0021766	hippocampus development	BP
4	29	0.463842325074	-	1.52e-01	GO:0030163	protein catabolic process	BP
4	29	0.463842325074	-	2.70e-01	GO:0002088	lens development in camera-type eye	BP
4	29	0.463842325074	-	2.94e-01	GO:0060325	face morphogenesis	BP
4	29	0.463842325074	-	3.08e-01	GO:0090200	positive regulation of release of cytochrome c from mitochondria	BP
4	29	0.463842325074	-	3.23e-01	GO:0010033	response to organic substance	BP
4	29	0.463842325074	-	3.40e-01	GO:0034504	protein localization to nucleus	BP
4	29	0.463842325074	-	5.20e-01	GO:0048662	negative regulation of smooth muscle cell proliferation	BP
4	29	0.463842325074	-	3.23e-01	GO:0008234	cysteine-type peptidase activity	MF
13	95	0.452407430011	-	1.03e-01	GO:0016192	vesicle-mediated transport	BP
6	44	0.447354202285	-	1.56e-01	GO:0042552	myelination	BP
3	22	0.447354202285	-	2.38e-01	GO:0002227	innate immune response in mucosa	BP
3	22	0.447354202285	-	4.16e-01	GO:0017157	regulation of exocytosis	BP
3	22	0.447354202285	-	4.29e-01	GO:0032435	negative regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
3	22	0.447354202285	-	4.29e-01	GO:0006941	striated muscle contraction	BP
6	44	0.447354202285	-	4.44e-01	GO:0007077	mitotic nuclear envelope disassembly	BP
3	22	0.447354202285	-	4.61e-01	GO:0046835	carbohydrate phosphorylation	BP
3	22	0.447354202285	-	4.61e-01	GO:0006607	NLS-bearing protein import into nucleus	BP
3	22	0.447354202285	-	4.78e-01	GO:0000717	nucleotide-excision repair, DNA duplex unwinding	BP
5	37	0.43429804946	-	2.46e-01	GO:0045184	establishment of protein localization	BP
5	37	0.43429804946	-	2.18e-01	GO:0001786	phosphatidylserine binding	MF
64	476	0.427005556893	-	1.16e-06	GO:0030154	cell differentiation	BP
13	97	0.422350196155	-	2.37e-01	GO:0097711	ciliary basal body docking	BP
2	15	0.414932724593	-	1.50e-01	GO:0015695	organic cation transport	BP
4	30	0.414932724593	-	1.52e-01	GO:0046676	negative regulation of insulin secretion	BP
2	15	0.414932724593	-	1.87e-01	GO:0016254	preassembly of GPI anchor in ER membrane	BP
2	15	0.414932724593	-	2.25e-01	GO:2000311	regulation of AMPA receptor activity	BP
2	15	0.414932724593	-	2.64e-01	GO:0010569	regulation of double-strand break repair via homologous recombination	BP
8	60	0.414932724593	-	2.73e-01	GO:0021987	cerebral cortex development	BP
4	30	0.414932724593	-	2.94e-01	GO:0099132	ATP hydrolysis coupled cation transmembrane transport	BP
2	15	0.414932724593	-	3.41e-01	GO:0090280	positive regulation of calcium ion import	BP
2	15	0.414932724593	-	3.41e-01	GO:0008585	female gonad development	BP
2	15	0.414932724593	-	3.41e-01	GO:0010765	positive regulation of sodium ion transport	BP
2	15	0.414932724593	-	3.41e-01	GO:1901379	regulation of potassium ion transmembrane transport	BP
2	15	0.414932724593	-	3.41e-01	GO:0050708	regulation of protein secretion	BP
2	15	0.414932724593	-	3.41e-01	GO:0035050	embryonic heart tube development	BP
2	15	0.414932724593	-	3.79e-01	GO:0060347	heart trabecula formation	BP
2	15	0.414932724593	-	3.79e-01	GO:0007548	sex differentiation	BP
2	15	0.414932724593	-	3.79e-01	GO:0001824	blastocyst development	BP
2	15	0.414932724593	-	3.79e-01	GO:0002042	cell migration involved in sprouting angiogenesis	BP
2	15	0.414932724593	-	3.79e-01	GO:0032793	positive regulation of CREB transcription factor activity	BP
2	15	0.414932724593	-	3.79e-01	GO:0044849	estrous cycle	BP
2	15	0.414932724593	-	3.79e-01	GO:0050995	negative regulation of lipid catabolic process	BP
2	15	0.414932724593	-	3.79e-01	GO:0015671	oxygen transport	BP
2	15	0.414932724593	-	6.44e-01	GO:0030048	actin filament-based movement	BP
2	15	0.414932724593	-	6.44e-01	GO:0051044	positive regulation of membrane protein ectodomain proteolysis	BP
2	15	0.414932724593	-	6.44e-01	GO:0090141	positive regulation of mitochondrial fission	BP
2	15	0.414932724593	-	6.44e-01	GO:0035458	cellular response to interferon-beta	BP
2	15	0.414932724593	-	6.44e-01	GO:0032874	positive regulation of stress-activated MAPK cascade	BP
2	15	0.414932724593	-	6.44e-01	GO:0006414	translational elongation	BP
2	15	0.414932724593	-	6.57e-01	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
2	15	0.414932724593	-	6.57e-01	GO:0030214	hyaluronan catabolic process	BP
2	15	0.414932724593	-	3.41e-01	GO:0008191	metalloendopeptidase inhibitor activity	MF
2	15	0.414932724593	-	3.41e-01	GO:0016594	glycine binding	MF
4	30	0.414932724593	-	5.27e-01	GO:0031492	nucleosomal DNA binding	MF
2	15	0.414932724593	-	6.57e-01	GO:0042809	vitamin D receptor binding	MF
2	15	0.414932724593	-	6.57e-01	GO:0046965	retinoid X receptor binding	MF
6	45	0.414932724593	-	1.68e-01	GO:0008047	enzyme activator activity	MF
15	113	0.408534953395	-	4.67e-02	GO:0007417	central nervous system development	BP
31	234	0.405654911005	-	5.45e-02	GO:0007067	mitotic nuclear division	BP
9	68	0.404285480393	-	2.83e-01	GO:0034976	response to endoplasmic reticulum stress	BP
7	53	0.401257787696	-	7.56e-02	GO:0042472	inner ear morphogenesis	BP
5	38	0.395823901645	-	8.49e-02	GO:0009409	response to cold	BP
5	38	0.395823901645	-	3.91e-01	GO:0021549	cerebellum development	BP
3	23	0.383223864865	-	4.16e-01	GO:0001819	positive regulation of cytokine production	BP
3	23	0.383223864865	-	4.29e-01	GO:0055088	lipid homeostasis	BP
3	23	0.383223864865	-	4.61e-01	GO:0032456	endocytic recycling	BP
3	23	0.383223864865	-	4.61e-01	GO:0048675	axon extension	BP
3	23	0.383223864865	-	4.78e-01	GO:0000083	regulation of transcription involved in G1/S transition of mitotic cell cycle	BP
18	138	0.383223864865	-	9.31e-02	GO:0051015	actin filament binding	MF
3	23	0.383223864865	-	2.11e-01	GO:0050840	extracellular matrix binding	MF
92	706	0.381860902987	-	5.58e-05	GO:0042803	protein homodimerization activity	MF
10	77	0.376964874394	-	1.41e-01	GO:0005543	phospholipid binding	MF
10	77	0.376964874394	-	3.24e-01	GO:0004843	thiol-dependent ubiquitin-specific protease activity	MF
14	108	0.374290740095	-	1.73e-01	GO:0009615	response to virus	BP
7	54	0.374290740095	-	4.87e-01	GO:0019003	GDP binding	MF
12	93	0.367627009814	-	1.27e-01	GO:0006464	cellular protein modification process	BP
8	62	0.367627009814	-	5.64e-02	GO:0007416	synapse assembly	BP
4	31	0.367627009814	-	3.40e-01	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	BP
5	39	0.358349196226	-	7.30e-02	GO:0007631	feeding behavior	BP
5	39	0.358349196226	-	3.82e-01	GO:0007162	negative regulation of cell adhesion	BP
6	47	0.352196969245	-	4.66e-01	GO:0070936	protein K48-linked ubiquitination	BP
13	102	0.349837696371	-	3.14e-01	GO:0043488	regulation of mRNA stability	BP
13	102	0.349837696371	-	1.47e-01	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
7	55	0.347818528734	-	3.28e-01	GO:0071346	cellular response to interferon-gamma	BP
8	63	0.344543396701	-	2.45e-01	GO:0008203	cholesterol metabolic process	BP
8	63	0.344543396701	-	3.98e-01	GO:0006303	double-strand break repair via nonhomologous end joining	BP
52	410	0.342782938837	-	7.28e-03	GO:0016567	protein ubiquitination	BP
19	150	0.340932143149	-	2.68e-01	GO:0006367	transcription initiation from RNA polymerase II promoter	BP
58	460	0.334314264384	-	3.81e-03	GO:0046982	protein heterodimerization activity	MF
6	48	0.321823320201	-	2.63e-01	GO:0045600	positive regulation of fat cell differentiation	BP
15	120	0.321823320201	-	2.73e-01	GO:0033209	tumor necrosis factor-mediated signaling pathway	BP
6	48	0.321823320201	-	4.39e-01	GO:0009408	response to heat	BP
3	24	0.321823320201	-	4.44e-01	GO:0007159	leukocyte cell-cell adhesion	BP
3	24	0.321823320201	-	4.61e-01	GO:0008306	associative learning	BP
3	24	0.321823320201	-	4.61e-01	GO:0051928	positive regulation of calcium ion transport	BP
3	24	0.321823320201	-	4.78e-01	GO:0055007	cardiac muscle cell differentiation	BP
3	24	0.321823320201	-	4.78e-01	GO:0001578	microtubule bundle formation	BP
3	24	0.321823320201	-	4.78e-01	GO:0051602	response to electrical stimulus	BP
3	24	0.321823320201	-	4.97e-01	GO:0097352	autophagosome maturation	BP
3	24	0.321823320201	-	7.28e-01	GO:0035235	ionotropic glutamate receptor signaling pathway	BP
3	24	0.321823320201	-	7.28e-01	GO:0046686	response to cadmium ion	BP
3	24	0.321823320201	-	4.61e-01	GO:0005246	calcium channel regulator activity	MF
5	40	0.321823320201	-	1.84e-01	GO:0001895	retina homeostasis	BP
1	8	0.321823320201	-	1.90e-01	GO:0016051	carbohydrate biosynthetic process	BP
7	56	0.321823320201	-	2.02e-01	GO:0016485	protein processing	BP
2	16	0.321823320201	-	2.64e-01	GO:0008209	androgen metabolic process	BP
2	16	0.321823320201	-	2.64e-01	GO:0048240	sperm capacitation	BP
4	32	0.321823320201	-	2.81e-01	GO:0051480	regulation of cytosolic calcium ion concentration	BP
2	16	0.321823320201	-	3.03e-01	GO:0086002	cardiac muscle cell action potential involved in contraction	BP
2	16	0.321823320201	-	3.41e-01	GO:0006171	cAMP biosynthetic process	BP
1	8	0.321823320201	-	3.44e-01	GO:0042074	cell migration involved in gastrulation	BP
1	8	0.321823320201	-	3.44e-01	GO:0030210	heparin biosynthetic process	BP
1	8	0.321823320201	-	3.44e-01	GO:0051601	exocyst localization	BP
5	40	0.321823320201	-	3.74e-01	GO:0048704	embryonic skeletal system morphogenesis	BP
2	16	0.321823320201	-	3.79e-01	GO:0021522	spinal cord motor neuron differentiation	BP
5	40	0.321823320201	-	4.01e-01	GO:0002548	monocyte chemotaxis	BP
1	8	0.321823320201	-	4.10e-01	GO:0097264	self proteolysis	BP
1	8	0.321823320201	-	4.10e-01	GO:0006548	histidine catabolic process	BP
1	8	0.321823320201	-	4.10e-01	GO:0035865	cellular response to potassium ion	BP
1	8	0.321823320201	-	4.10e-01	GO:0071313	cellular response to caffeine	BP
9	72	0.321823320201	-	4.21e-01	GO:0031146	SCF-dependent proteasomal ubiquitin-dependent protein catabolic process	BP
1	8	0.321823320201	-	4.69e-01	GO:0006704	glucocorticoid biosynthetic process	BP
1	8	0.321823320201	-	4.69e-01	GO:0001867	complement activation, lectin pathway	BP
1	8	0.321823320201	-	4.69e-01	GO:0040016	embryonic cleavage	BP
1	8	0.321823320201	-	4.69e-01	GO:0009743	response to carbohydrate	BP
1	8	0.321823320201	-	4.69e-01	GO:0048646	anatomical structure formation involved in morphogenesis	BP
1	8	0.321823320201	-	4.69e-01	GO:0033555	multicellular organismal response to stress	BP
1	8	0.321823320201	-	4.69e-01	GO:0008535	respiratory chain complex IV assembly	BP
1	8	0.321823320201	-	4.69e-01	GO:0060137	maternal process involved in parturition	BP
1	8	0.321823320201	-	4.69e-01	GO:0098915	membrane repolarization during ventricular cardiac muscle cell action potential	BP
1	8	0.321823320201	-	4.69e-01	GO:1900165	negative regulation of interleukin-6 secretion	BP
1	8	0.321823320201	-	4.69e-01	GO:0007494	midgut development	BP
1	8	0.321823320201	-	4.69e-01	GO:0060539	diaphragm development	BP
1	8	0.321823320201	-	4.69e-01	GO:0043129	surfactant homeostasis	BP
1	8	0.321823320201	-	4.69e-01	GO:0042987	amyloid precursor protein catabolic process	BP
1	8	0.321823320201	-	4.69e-01	GO:0035767	endothelial cell chemotaxis	BP
1	8	0.321823320201	-	5.22e-01	GO:0045654	positive regulation of megakaryocyte differentiation	BP
1	8	0.321823320201	-	5.22e-01	GO:0046039	GTP metabolic process	BP
1	8	0.321823320201	-	5.22e-01	GO:0000012	single strand break repair	BP
1	8	0.321823320201	-	5.22e-01	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	BP
1	8	0.321823320201	-	5.22e-01	GO:0051103	DNA ligation involved in DNA repair	BP
1	8	0.321823320201	-	5.22e-01	GO:0003139	secondary heart field specification	BP
1	8	0.321823320201	-	5.22e-01	GO:0040019	positive regulation of embryonic development	BP
1	8	0.321823320201	-	5.22e-01	GO:0060452	positive regulation of cardiac muscle contraction	BP
1	8	0.321823320201	-	5.22e-01	GO:0045416	positive regulation of interleukin-8 biosynthetic process	BP
1	8	0.321823320201	-	5.22e-01	GO:0097105	presynaptic membrane assembly	BP
1	8	0.321823320201	-	5.22e-01	GO:0048312	intracellular distribution of mitochondria	BP
1	8	0.321823320201	-	5.22e-01	GO:0033993	response to lipid	BP
1	8	0.321823320201	-	5.22e-01	GO:0038003	opioid receptor signaling pathway	BP
1	8	0.321823320201	-	5.22e-01	GO:0010470	regulation of gastrulation	BP
1	8	0.321823320201	-	5.22e-01	GO:0072091	regulation of stem cell proliferation	BP
1	8	0.321823320201	-	5.22e-01	GO:0030850	prostate gland development	BP
1	8	0.321823320201	-	5.22e-01	GO:0009651	response to salt stress	BP
1	8	0.321823320201	-	5.22e-01	GO:0015889	cobalamin transport	BP
1	8	0.321823320201	-	5.22e-01	GO:0060253	negative regulation of glial cell proliferation	BP
1	8	0.321823320201	-	5.22e-01	GO:0021799	cerebral cortex radially oriented cell migration	BP
1	8	0.321823320201	-	5.22e-01	GO:0001766	membrane raft polarization	BP
1	8	0.321823320201	-	5.22e-01	GO:0060059	embryonic retina morphogenesis in camera-type eye	BP
1	8	0.321823320201	-	5.22e-01	GO:0060054	positive regulation of epithelial cell proliferation involved in wound healing	BP
1	8	0.321823320201	-	5.22e-01	GO:0090150	establishment of protein localization to membrane	BP
1	8	0.321823320201	-	5.22e-01	GO:0035912	dorsal aorta morphogenesis	BP
1	8	0.321823320201	-	5.22e-01	GO:0051963	regulation of synapse assembly	BP
4	32	0.321823320201	-	5.36e-01	GO:0043967	histone H4 acetylation	BP
4	32	0.321823320201	-	5.45e-01	GO:0045773	positive regulation of axon extension	BP
1	8	0.321823320201	-	5.70e-01	GO:0060100	positive regulation of phagocytosis, engulfment	BP
1	8	0.321823320201	-	5.70e-01	GO:2000643	positive regulation of early endosome to late endosome transport	BP
1	8	0.321823320201	-	5.70e-01	GO:1900029	positive regulation of ruffle assembly	BP
1	8	0.321823320201	-	5.70e-01	GO:0050687	negative regulation of defense response to virus	BP
1	8	0.321823320201	-	5.70e-01	GO:0001825	blastocyst formation	BP
1	8	0.321823320201	-	5.70e-01	GO:0044387	negative regulation of protein kinase activity by regulation of protein phosphorylation	BP
1	8	0.321823320201	-	5.70e-01	GO:2000480	negative regulation of cAMP-dependent protein kinase activity	BP
1	8	0.321823320201	-	5.70e-01	GO:0030007	cellular potassium ion homeostasis	BP
1	8	0.321823320201	-	5.70e-01	GO:0006012	galactose metabolic process	BP
1	8	0.321823320201	-	5.70e-01	GO:0006782	protoporphyrinogen IX biosynthetic process	BP
1	8	0.321823320201	-	5.70e-01	GO:0042117	monocyte activation	BP
1	8	0.321823320201	-	5.70e-01	GO:0097345	mitochondrial outer membrane permeabilization	BP
1	8	0.321823320201	-	5.70e-01	GO:0010764	negative regulation of fibroblast migration	BP
1	8	0.321823320201	-	5.70e-01	GO:0045647	negative regulation of erythrocyte differentiation	BP
1	8	0.321823320201	-	5.70e-01	GO:0032463	negative regulation of protein homooligomerization	BP
1	8	0.321823320201	-	5.70e-01	GO:0006544	glycine metabolic process	BP
1	8	0.321823320201	-	5.70e-01	GO:0006264	mitochondrial DNA replication	BP
1	8	0.321823320201	-	5.70e-01	GO:0006268	DNA unwinding involved in DNA replication	BP
1	8	0.321823320201	-	5.70e-01	GO:0048227	plasma membrane to endosome transport	BP
1	8	0.321823320201	-	5.70e-01	GO:0045630	positive regulation of T-helper 2 cell differentiation	BP
1	8	0.321823320201	-	5.70e-01	GO:0070206	protein trimerization	BP
1	8	0.321823320201	-	5.70e-01	GO:0043297	apical junction assembly	BP
1	8	0.321823320201	-	5.70e-01	GO:0085020	protein K6-linked ubiquitination	BP
1	8	0.321823320201	-	5.70e-01	GO:0034720	histone H3-K4 demethylation	BP
1	8	0.321823320201	-	5.70e-01	GO:0035457	cellular response to interferon-alpha	BP
1	8	0.321823320201	-	5.70e-01	GO:2000020	positive regulation of male gonad development	BP
1	8	0.321823320201	-	5.70e-01	GO:0034379	very-low-density lipoprotein particle assembly	BP
1	8	0.321823320201	-	5.70e-01	GO:0010498	proteasomal protein catabolic process	BP
1	8	0.321823320201	-	5.70e-01	GO:0002011	morphogenesis of an epithelial sheet	BP
1	8	0.321823320201	-	5.70e-01	GO:0071312	cellular response to alkaloid	BP
1	8	0.321823320201	-	5.70e-01	GO:0051646	mitochondrion localization	BP
2	16	0.321823320201	-	6.44e-01	GO:0048255	mRNA stabilization	BP
2	16	0.321823320201	-	6.44e-01	GO:0061036	positive regulation of cartilage development	BP
2	16	0.321823320201	-	6.44e-01	GO:0001709	cell fate determination	BP
2	16	0.321823320201	-	6.44e-01	GO:0060216	definitive hemopoiesis	BP
2	16	0.321823320201	-	6.44e-01	GO:0048265	response to pain	BP
2	16	0.321823320201	-	6.44e-01	GO:0060292	long term synaptic depression	BP
2	16	0.321823320201	-	6.57e-01	GO:0048535	lymph node development	BP
2	16	0.321823320201	-	6.57e-01	GO:0061136	regulation of proteasomal protein catabolic process	BP
2	16	0.321823320201	-	6.57e-01	GO:2000179	positive regulation of neural precursor cell proliferation	BP
2	16	0.321823320201	-	6.57e-01	GO:0010259	multicellular organism aging	BP
2	16	0.321823320201	-	6.57e-01	GO:0010744	positive regulation of macrophage derived foam cell differentiation	BP
2	16	0.321823320201	-	6.71e-01	GO:0070507	regulation of microtubule cytoskeleton organization	BP
2	16	0.321823320201	-	6.71e-01	GO:0030518	intracellular steroid hormone receptor signaling pathway	BP
2	16	0.321823320201	-	6.71e-01	GO:0006275	regulation of DNA replication	BP
2	16	0.321823320201	-	6.71e-01	GO:0007020	microtubule nucleation	BP
1	8	0.321823320201	-	2.71e-01	GO:0001591	dopamine neurotransmitter receptor activity, coupled via Gi/Go	MF
1	8	0.321823320201	-	3.44e-01	GO:0042562	hormone binding	MF
1	8	0.321823320201	-	4.10e-01	GO:0004022	alcohol dehydrogenase (NAD) activity	MF
1	8	0.321823320201	-	4.69e-01	GO:0047498	calcium-dependent phospholipase A2 activity	MF
1	8	0.321823320201	-	4.69e-01	GO:0033130	acetylcholine receptor binding	MF
1	8	0.321823320201	-	4.69e-01	GO:0015232	heme transporter activity	MF
1	8	0.321823320201	-	4.69e-01	GO:0032052	bile acid binding	MF
1	8	0.321823320201	-	4.69e-01	GO:1902282	voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization	MF
1	8	0.321823320201	-	5.22e-01	GO:0008430	selenium binding	MF
1	8	0.321823320201	-	5.22e-01	GO:0016655	oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor	MF
1	8	0.321823320201	-	5.22e-01	GO:0005113	patched binding	MF
1	8	0.321823320201	-	5.22e-01	GO:0015450	P-P-bond-hydrolysis-driven protein transmembrane transporter activity	MF
1	8	0.321823320201	-	5.22e-01	GO:1901981	phosphatidylinositol phosphate binding	MF
1	8	0.321823320201	-	5.70e-01	GO:0003857	3-hydroxyacyl-CoA dehydrogenase activity	MF
1	8	0.321823320201	-	5.70e-01	GO:0032183	SUMO binding	MF
2	16	0.321823320201	-	6.44e-01	GO:0071949	FAD binding	MF
2	16	0.321823320201	-	6.71e-01	GO:0008266	poly(U) RNA binding	MF
12	97	0.306872978735	-	1.35e-01	GO:0030182	neuron differentiation	BP
11	89	0.305521507872	-	9.46e-02	GO:0007160	cell-matrix adhesion	BP
29	235	0.303287368764	-	4.83e-03	GO:0007166	cell surface receptor signaling pathway	BP
56	456	0.296288228094	-	2.83e-05	GO:0007155	cell adhesion	BP
7	57	0.296288228094	-	1.83e-01	GO:0007338	single fertilization	BP
6	49	0.292075976807	-	4.39e-01	GO:0006606	protein import into nucleus	BP
6	49	0.292075976807	-	6.30e-01	GO:0051865	protein autoubiquitination	BP
18	147	0.292075976807	-	3.49e-02	GO:0046983	protein dimerization activity	MF
5	41	0.28619941047	-	4.13e-01	GO:0030968	endoplasmic reticulum unfolded protein response	BP
5	41	0.28619941047	-	5.88e-01	GO:0031072	heat shock protein binding	MF
12	99	0.277429200843	-	1.35e-01	GO:0016310	phosphorylation	BP
8	66	0.277429200843	-	2.64e-01	GO:0072659	protein localization to plasma membrane	BP
8	66	0.277429200843	-	3.75e-01	GO:0030855	epithelial cell differentiation	BP
4	33	0.277429200843	-	5.20e-01	GO:0003007	heart morphogenesis	BP
4	33	0.277429200843	-	5.27e-01	GO:0072593	reactive oxygen species metabolic process	BP
33	273	0.27346029864	-	6.38e-02	GO:0003779	actin binding	MF
7	58	0.271197247131	-	3.41e-01	GO:0050839	cell adhesion molecule binding	MF
48	398	0.270161200379	-	1.27e-02	GO:0006357	regulation of transcription from RNA polymerase II promoter	BP
6	50	0.262929631148	-	1.46e-01	GO:0031338	regulation of vesicle fusion	BP
9	75	0.262929631148	-	1.74e-01	GO:0001503	ossification	BP
15	125	0.262929631148	-	2.70e-01	GO:0006897	endocytosis	BP
12	100	0.262929631148	-	2.78e-01	GO:0006979	response to oxidative stress	BP
3	25	0.262929631148	-	4.29e-01	GO:0045880	positive regulation of smoothened signaling pathway	BP
3	25	0.262929631148	-	4.29e-01	GO:0009966	regulation of signal transduction	BP
3	25	0.262929631148	-	4.61e-01	GO:0016573	histone acetylation	BP
3	25	0.262929631148	-	7.34e-01	GO:0006891	intra-Golgi vesicle-mediated transport	BP
6	50	0.262929631148	-	4.58e-01	GO:0008092	cytoskeletal protein binding	MF
8	67	0.255734129743	-	4.05e-01	GO:0042147	retrograde transport, endosome to Golgi	BP
8	67	0.255734129743	-	5.36e-01	GO:0038061	NIK/NF-kappaB signaling	BP
29	243	0.254991811723	-	2.29e-01	GO:0003713	transcription coactivator activity	MF
20	168	0.25143399231	-	2.29e-02	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	MF
9	76	0.2438208082	-	1.09e-01	GO:0008233	peptidase activity	MF
11	93	0.24209612773	-	3.67e-01	GO:0060071	Wnt signaling pathway, planar cell polarity pathway	BP
2	17	0.234360478951	-	1.87e-01	GO:0050909	sensory perception of taste	BP
8	68	0.234360478951	-	2.73e-01	GO:0006310	DNA recombination	BP
4	34	0.234360478951	-	2.94e-01	GO:0030282	bone mineralization	BP
2	17	0.234360478951	-	3.79e-01	GO:0043171	peptide catabolic process	BP
2	17	0.234360478951	-	3.79e-01	GO:0006895	Golgi to endosome transport	BP
2	17	0.234360478951	-	6.44e-01	GO:0043651	linoleic acid metabolic process	BP
2	17	0.234360478951	-	6.44e-01	GO:0030902	hindbrain development	BP
2	17	0.234360478951	-	6.44e-01	GO:0050804	modulation of synaptic transmission	BP
2	17	0.234360478951	-	6.44e-01	GO:0010592	positive regulation of lamellipodium assembly	BP
2	17	0.234360478951	-	6.44e-01	GO:0045582	positive regulation of T cell differentiation	BP
2	17	0.234360478951	-	6.44e-01	GO:2000377	regulation of reactive oxygen species metabolic process	BP
2	17	0.234360478951	-	6.57e-01	GO:0045956	positive regulation of calcium ion-dependent exocytosis	BP
2	17	0.234360478951	-	6.57e-01	GO:0051497	negative regulation of stress fiber assembly	BP
2	17	0.234360478951	-	6.57e-01	GO:0034199	activation of protein kinase A activity	BP
2	17	0.234360478951	-	6.57e-01	GO:1901800	positive regulation of proteasomal protein catabolic process	BP
2	17	0.234360478951	-	6.71e-01	GO:0033189	response to vitamin A	BP
2	17	0.234360478951	-	6.71e-01	GO:0031589	cell-substrate adhesion	BP
2	17	0.234360478951	-	6.71e-01	GO:0021772	olfactory bulb development	BP
2	17	0.234360478951	-	6.71e-01	GO:0045638	negative regulation of myeloid cell differentiation	BP
2	17	0.234360478951	-	6.71e-01	GO:0048814	regulation of dendrite morphogenesis	BP
2	17	0.234360478951	-	6.85e-01	GO:0070266	necroptotic process	BP
2	17	0.234360478951	-	6.85e-01	GO:0044257	cellular protein catabolic process	BP
2	17	0.234360478951	-	3.79e-01	GO:0017049	GTP-Rho binding	MF
10	85	0.234360478951	-	4.49e-01	GO:0051087	chaperone binding	MF
2	17	0.234360478951	-	6.44e-01	GO:0046933	proton-transporting ATP synthase activity, rotational mechanism	MF
2	17	0.234360478951	-	6.71e-01	GO:0003746	translation elongation factor activity	MF
2	17	0.234360478951	-	6.71e-01	GO:0034237	protein kinase A regulatory subunit binding	MF
2	17	0.234360478951	-	6.85e-01	GO:0071837	HMG box domain binding	MF
23	196	0.230675432143	-	3.86e-02	GO:0004872	receptor activity	MF
22	188	0.226666087161	-	4.96e-02	GO:0030198	extracellular matrix organization	BP
9	77	0.224961780949	-	3.10e-01	GO:0009952	anterior/posterior pattern specification	BP
1038	8884	0.224420371012	-	4.79e-10	GO:0005515	protein binding	MF
7	60	0.22228764665	-	4.87e-01	GO:0048306	calcium-dependent protein binding	MF
17	146	0.219461602571	-	1.77e-01	GO:0016887	ATPase activity	MF
5	43	0.217486660386	-	4.25e-01	GO:0032755	positive regulation of interleukin-6 production	BP
11	95	0.211399330508	-	5.02e-02	GO:0004867	serine-type endopeptidase inhibitor activity	MF
3	26	0.206346102781	-	1.58e-01	GO:0016339	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	BP
3	26	0.206346102781	-	2.11e-01	GO:0035025	positive regulation of Rho protein signal transduction	BP
9	78	0.206346102781	-	4.27e-01	GO:0046718	viral entry into host cell	BP
3	26	0.206346102781	-	4.78e-01	GO:0051930	regulation of sensory perception of pain	BP
3	26	0.206346102781	-	7.41e-01	GO:0032728	positive regulation of interferon-beta production	BP
7	61	0.198440904696	-	1.95e-01	GO:0051965	positive regulation of synapse assembly	BP
7	61	0.198440904696	-	3.48e-01	GO:0007613	memory	BP
21	183	0.198440904696	-	3.70e-01	GO:0061630	ubiquitin protein ligase activity	MF
8	70	0.192540303256	-	6.06e-02	GO:0042391	regulation of membrane potential	BP
4	35	0.192540303256	-	2.94e-01	GO:0045494	photoreceptor cell maintenance	BP
4	35	0.192540303256	-	3.40e-01	GO:0051321	meiotic cell cycle	BP
4	35	0.192540303256	-	7.71e-01	GO:0019985	translesion synthesis	BP
62	545	0.185907210924	-	3.71e-02	GO:0006366	transcription from RNA polymerase II promoter	BP
5	44	0.184319796451	-	2.46e-01	GO:0061337	cardiac conduction	BP
5	44	0.184319796451	-	3.74e-01	GO:0006879	cellular iron ion homeostasis	BP
5	44	0.184319796451	-	3.82e-01	GO:0048666	neuron development	BP
6	53	0.178865366359	-	4.44e-01	GO:0007612	learning	BP
6	53	0.178865366359	-	6.30e-01	GO:0003707	steroid hormone receptor activity	MF
20	177	0.176145865006	-	1.74e-01	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	MF
15	134	0.162624725352	-	5.12e-02	GO:0010951	negative regulation of endopeptidase activity	BP
5	45	0.151898318759	-	6.20e-02	GO:0045596	negative regulation of cell differentiation	BP
2	18	0.151898318759	-	2.64e-01	GO:0023019	signal transduction involved in regulation of gene expression	BP
1	9	0.151898318759	-	2.71e-01	GO:0006688	glycosphingolipid biosynthetic process	BP
22	198	0.151898318759	-	3.21e-01	GO:0006281	DNA repair	BP
1	9	0.151898318759	-	3.44e-01	GO:0006278	RNA-dependent DNA biosynthetic process	BP
1	9	0.151898318759	-	3.44e-01	GO:0043266	regulation of potassium ion transport	BP
1	9	0.151898318759	-	3.44e-01	GO:0036444	mitochondrial calcium uptake	BP
1	9	0.151898318759	-	4.10e-01	GO:0009247	glycolipid biosynthetic process	BP
1	9	0.151898318759	-	4.10e-01	GO:0050778	positive regulation of immune response	BP
1	9	0.151898318759	-	4.10e-01	GO:0051205	protein insertion into membrane	BP
1	9	0.151898318759	-	4.10e-01	GO:0001973	adenosine receptor signaling pathway	BP
1	9	0.151898318759	-	4.10e-01	GO:0033619	membrane protein proteolysis	BP
3	27	0.151898318759	-	4.44e-01	GO:0045746	negative regulation of Notch signaling pathway	BP
3	27	0.151898318759	-	4.61e-01	GO:0030534	adult behavior	BP
1	9	0.151898318759	-	4.69e-01	GO:0097267	omega-hydroxylase P450 pathway	BP
1	9	0.151898318759	-	4.69e-01	GO:0043117	positive regulation of vascular permeability	BP
1	9	0.151898318759	-	4.69e-01	GO:0071435	potassium ion export	BP
1	9	0.151898318759	-	4.69e-01	GO:0046887	positive regulation of hormone secretion	BP
1	9	0.151898318759	-	4.69e-01	GO:0015866	ADP transport	BP
1	9	0.151898318759	-	4.69e-01	GO:0007143	female meiotic division	BP
3	27	0.151898318759	-	4.78e-01	GO:0042476	odontogenesis	BP
3	27	0.151898318759	-	4.78e-01	GO:0006612	protein targeting to membrane	BP
1	9	0.151898318759	-	5.22e-01	GO:0046548	retinal rod cell development	BP
1	9	0.151898318759	-	5.22e-01	GO:0030903	notochord development	BP
1	9	0.151898318759	-	5.22e-01	GO:0070072	vacuolar proton-transporting V-type ATPase complex assembly	BP
1	9	0.151898318759	-	5.22e-01	GO:0015886	heme transport	BP
1	9	0.151898318759	-	5.22e-01	GO:0003143	embryonic heart tube morphogenesis	BP
1	9	0.151898318759	-	5.22e-01	GO:0010917	negative regulation of mitochondrial membrane potential	BP
1	9	0.151898318759	-	5.22e-01	GO:0030643	cellular phosphate ion homeostasis	BP
1	9	0.151898318759	-	5.22e-01	GO:0061351	neural precursor cell proliferation	BP
1	9	0.151898318759	-	5.22e-01	GO:0035721	intraciliary retrograde transport	BP
1	9	0.151898318759	-	5.22e-01	GO:0046339	diacylglycerol metabolic process	BP
4	36	0.151898318759	-	5.36e-01	GO:0006479	protein methylation	BP
1	9	0.151898318759	-	5.70e-01	GO:2001224	positive regulation of neuron migration	BP
1	9	0.151898318759	-	5.70e-01	GO:0090197	positive regulation of chemokine secretion	BP
1	9	0.151898318759	-	5.70e-01	GO:0006515	misfolded or incompletely synthesized protein catabolic process	BP
1	9	0.151898318759	-	5.70e-01	GO:1900027	regulation of ruffle assembly	BP
1	9	0.151898318759	-	5.70e-01	GO:0060340	positive regulation of type I interferon-mediated signaling pathway	BP
1	9	0.151898318759	-	5.70e-01	GO:1904153	negative regulation of retrograde protein transport, ER to cytosol	BP
1	9	0.151898318759	-	5.70e-01	GO:0048193	Golgi vesicle transport	BP
1	9	0.151898318759	-	5.70e-01	GO:0090394	negative regulation of excitatory postsynaptic potential	BP
1	9	0.151898318759	-	5.70e-01	GO:0016126	sterol biosynthetic process	BP
1	9	0.151898318759	-	5.70e-01	GO:0007019	microtubule depolymerization	BP
1	9	0.151898318759	-	5.70e-01	GO:0021675	nerve development	BP
1	9	0.151898318759	-	5.70e-01	GO:0002544	chronic inflammatory response	BP
1	9	0.151898318759	-	5.70e-01	GO:1990403	embryonic brain development	BP
1	9	0.151898318759	-	5.70e-01	GO:0034101	erythrocyte homeostasis	BP
1	9	0.151898318759	-	5.70e-01	GO:1902857	positive regulation of non-motile cilium assembly	BP
1	9	0.151898318759	-	5.70e-01	GO:0051983	regulation of chromosome segregation	BP
1	9	0.151898318759	-	5.70e-01	GO:0000733	DNA strand renaturation	BP
1	9	0.151898318759	-	5.70e-01	GO:0046653	tetrahydrofolate metabolic process	BP
1	9	0.151898318759	-	5.70e-01	GO:0071243	cellular response to arsenic-containing substance	BP
1	9	0.151898318759	-	5.70e-01	GO:0031915	positive regulation of synaptic plasticity	BP
1	9	0.151898318759	-	5.70e-01	GO:0042908	xenobiotic transport	BP
1	9	0.151898318759	-	5.70e-01	GO:0007034	vacuolar transport	BP
1	9	0.151898318759	-	5.70e-01	GO:2000059	negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
1	9	0.151898318759	-	5.70e-01	GO:0072089	stem cell proliferation	BP
1	9	0.151898318759	-	5.70e-01	GO:0010950	positive regulation of endopeptidase activity	BP
1	9	0.151898318759	-	5.70e-01	GO:0003254	regulation of membrane depolarization	BP
1	9	0.151898318759	-	5.70e-01	GO:0046855	inositol phosphate dephosphorylation	BP
1	9	0.151898318759	-	5.70e-01	GO:0032836	glomerular basement membrane development	BP
1	9	0.151898318759	-	5.70e-01	GO:0097484	dendrite extension	BP
1	9	0.151898318759	-	5.70e-01	GO:0039694	viral RNA genome replication	BP
9	81	0.151898318759	-	5.73e-01	GO:0006338	chromatin remodeling	BP
6	54	0.151898318759	-	6.34e-01	GO:0043401	steroid hormone mediated signaling pathway	BP
2	18	0.151898318759	-	6.44e-01	GO:1903861	positive regulation of dendrite extension	BP
2	18	0.151898318759	-	6.57e-01	GO:0016079	synaptic vesicle exocytosis	BP
2	18	0.151898318759	-	6.57e-01	GO:0007413	axonal fasciculation	BP
2	18	0.151898318759	-	6.57e-01	GO:0030318	melanocyte differentiation	BP
2	18	0.151898318759	-	7.00e-01	GO:0042098	T cell proliferation	BP
2	18	0.151898318759	-	7.00e-01	GO:0006913	nucleocytoplasmic transport	BP
2	18	0.151898318759	-	7.00e-01	GO:1901741	positive regulation of myoblast fusion	BP
2	18	0.151898318759	-	7.00e-01	GO:0045807	positive regulation of endocytosis	BP
2	18	0.151898318759	-	7.00e-01	GO:0010824	regulation of centrosome duplication	BP
3	27	0.151898318759	-	7.41e-01	GO:0090314	positive regulation of protein targeting to membrane	BP
3	27	0.151898318759	-	7.48e-01	GO:0070979	protein K11-linked ubiquitination	BP
1	9	0.151898318759	-	1.00e+00	GO:0008090	retrograde axonal transport	BP
1	9	0.151898318759	-	1.00e+00	GO:0043653	mitochondrial fragmentation involved in apoptotic process	BP
1	9	0.151898318759	-	1.00e+00	GO:0048489	synaptic vesicle transport	BP
1	9	0.151898318759	-	1.00e+00	GO:0022417	protein maturation by protein folding	BP
1	9	0.151898318759	-	1.00e+00	GO:0016558	protein import into peroxisome matrix	BP
1	9	0.151898318759	-	1.00e+00	GO:0034063	stress granule assembly	BP
1	9	0.151898318759	-	1.00e+00	GO:0050774	negative regulation of dendrite morphogenesis	BP
1	9	0.151898318759	-	1.00e+00	GO:0031115	negative regulation of microtubule polymerization	BP
1	9	0.151898318759	-	1.00e+00	GO:0008228	opsonization	BP
1	9	0.151898318759	-	1.00e+00	GO:0032464	positive regulation of protein homooligomerization	BP
1	9	0.151898318759	-	1.00e+00	GO:0032780	negative regulation of ATPase activity	BP
1	9	0.151898318759	-	1.00e+00	GO:0008635	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	BP
1	9	0.151898318759	-	1.00e+00	GO:0006265	DNA topological change	BP
1	9	0.151898318759	-	1.00e+00	GO:0051593	response to folic acid	BP
1	9	0.151898318759	-	1.00e+00	GO:0048245	eosinophil chemotaxis	BP
1	9	0.151898318759	-	1.00e+00	GO:2000300	regulation of synaptic vesicle exocytosis	BP
1	9	0.151898318759	-	1.00e+00	GO:0090557	establishment of endothelial intestinal barrier	BP
1	9	0.151898318759	-	1.00e+00	GO:1902902	negative regulation of autophagosome assembly	BP
1	9	0.151898318759	-	1.00e+00	GO:0032688	negative regulation of interferon-beta production	BP
1	9	0.151898318759	-	1.00e+00	GO:0035067	negative regulation of histone acetylation	BP
1	9	0.151898318759	-	1.00e+00	GO:2000188	regulation of cholesterol homeostasis	BP
2	18	0.151898318759	-	3.03e-01	GO:0046914	transition metal ion binding	MF
1	9	0.151898318759	-	3.44e-01	GO:0003810	protein-glutamine gamma-glutamyltransferase activity	MF
1	9	0.151898318759	-	3.44e-01	GO:0005243	gap junction channel activity	MF
1	9	0.151898318759	-	3.44e-01	GO:0033691	sialic acid binding	MF
1	9	0.151898318759	-	4.10e-01	GO:0015267	channel activity	MF
1	9	0.151898318759	-	4.10e-01	GO:0055056	D-glucose transmembrane transporter activity	MF
1	9	0.151898318759	-	4.10e-01	GO:0052650	NADP-retinol dehydrogenase activity	MF
1	9	0.151898318759	-	4.69e-01	GO:0036122	BMP binding	MF
1	9	0.151898318759	-	4.69e-01	GO:0005126	cytokine receptor binding	MF
1	9	0.151898318759	-	4.69e-01	GO:0046703	natural killer cell lectin-like receptor binding	MF
1	9	0.151898318759	-	5.22e-01	GO:0016176	superoxide-generating NADPH oxidase activator activity	MF
1	9	0.151898318759	-	5.22e-01	GO:0008239	dipeptidyl-peptidase activity	MF
1	9	0.151898318759	-	5.22e-01	GO:0016918	retinal binding	MF
1	9	0.151898318759	-	5.22e-01	GO:0031419	cobalamin binding	MF
1	9	0.151898318759	-	5.70e-01	GO:0045499	chemorepellent activity	MF
1	9	0.151898318759	-	5.70e-01	GO:0052659	inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity	MF
1	9	0.151898318759	-	5.70e-01	GO:0070679	inositol 1,4,5 trisphosphate binding	MF
1	9	0.151898318759	-	5.70e-01	GO:0046790	virion binding	MF
2	18	0.151898318759	-	6.85e-01	GO:0051371	muscle alpha-actinin binding	MF
3	27	0.151898318759	-	7.28e-01	GO:0001106	RNA polymerase II transcription corepressor activity	MF
3	27	0.151898318759	-	7.34e-01	GO:0001968	fibronectin binding	MF
3	27	0.151898318759	-	7.41e-01	GO:0001205	transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding	MF
3	27	0.151898318759	-	7.48e-01	GO:0046966	thyroid hormone receptor binding	MF
1	9	0.151898318759	-	1.00e+00	GO:0004862	cAMP-dependent protein kinase inhibitor activity	MF
1	9	0.151898318759	-	1.00e+00	GO:0003691	double-stranded telomeric DNA binding	MF
1	9	0.151898318759	-	1.00e+00	GO:0030957	Tat protein binding	MF
1	9	0.151898318759	-	1.00e+00	GO:0017081	chloride channel regulator activity	MF
1	9	0.151898318759	-	1.00e+00	GO:0032357	oxidized purine DNA binding	MF
15	136	0.141251074559	-	1.98e-01	GO:0001501	skeletal system development	BP
37	337	0.134671904648	-	1.41e-01	GO:0004842	ubiquitin-protein transferase activity	MF
11	101	0.123043456087	-	6.14e-01	GO:0007062	sister chromatid cohesion	BP
8	74	0.112369954572	-	3.85e-01	GO:0022617	extracellular matrix disassembly	BP
7	65	0.10681042923	-	3.57e-01	GO:0050830	defense response to Gram-positive bacterium	BP
7	65	0.10681042923	-	6.64e-01	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
3	28	0.0994308988647	-	4.16e-01	GO:0086010	membrane depolarization during action potential	BP
9	84	0.0994308988647	-	4.32e-01	GO:0001822	kidney development	BP
3	28	0.0994308988647	-	4.61e-01	GO:0030449	regulation of complement activation	BP
3	28	0.0994308988647	-	4.97e-01	GO:0035116	embryonic hindlimb morphogenesis	BP
6	56	0.0994308988647	-	6.49e-01	GO:0036498	IRE1-mediated unfolded protein response	BP
3	28	0.0994308988647	-	4.97e-01	GO:0008139	nuclear localization sequence binding	MF
3	28	0.0994308988647	-	7.41e-01	GO:0004003	ATP-dependent DNA helicase activity	MF
3	28	0.0994308988647	-	7.56e-01	GO:0043021	ribonucleoprotein complex binding	MF
3	28	0.0994308988647	-	7.56e-01	GO:0017048	Rho GTPase binding	MF
8	75	0.0930046297053	-	6.91e-01	GO:0016925	protein sumoylation	BP
5	47	0.0891625634109	-	6.07e-01	GO:0003774	motor activity	MF
9	85	0.0823573855058	-	4.27e-01	GO:0006874	cellular calcium ion homeostasis	BP
19	180	0.0778977373151	-	3.54e-03	GO:0031424	keratinization	BP
6	57	0.0738958067576	-	3.07e-01	GO:0006959	humoral immune response	BP
2	19	0.0738958067576	-	3.03e-01	GO:2000649	regulation of sodium ion transmembrane transporter activity	BP
2	19	0.0738958067576	-	3.03e-01	GO:0015711	organic anion transport	BP
2	19	0.0738958067576	-	3.79e-01	GO:0033280	response to vitamin D	BP
8	76	0.0738958067576	-	4.05e-01	GO:0007018	microtubule-based movement	BP
2	19	0.0738958067576	-	6.44e-01	GO:0048148	behavioral response to cocaine	BP
2	19	0.0738958067576	-	6.57e-01	GO:0048545	response to steroid hormone	BP
2	19	0.0738958067576	-	6.57e-01	GO:0060384	innervation	BP
2	19	0.0738958067576	-	6.71e-01	GO:0032502	developmental process	BP
2	19	0.0738958067576	-	6.85e-01	GO:0031290	retinal ganglion cell axon guidance	BP
2	19	0.0738958067576	-	6.85e-01	GO:0071385	cellular response to glucocorticoid stimulus	BP
2	19	0.0738958067576	-	6.85e-01	GO:0042832	defense response to protozoan	BP
2	19	0.0738958067576	-	7.00e-01	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	BP
2	19	0.0738958067576	-	7.00e-01	GO:0072583	clathrin-dependent endocytosis	BP
4	38	0.0738958067576	-	7.71e-01	GO:0045214	sarcomere organization	BP
2	19	0.0738958067576	-	1.00e+00	GO:0006509	membrane protein ectodomain proteolysis	BP
2	19	0.0738958067576	-	3.03e-01	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	MF
8	76	0.0738958067576	-	6.85e-01	GO:0051117	ATPase binding	MF
31	295	0.0714484863388	-	2.56e-02	GO:0007267	cell-cell signaling	BP
22	210	0.0670094211723	-	7.89e-02	GO:0007268	chemical synaptic transmission	BP
5	48	0.0587889143674	-	5.93e-01	GO:0035176	social behavior	BP
8	77	0.0550367795063	-	6.85e-01	GO:0030674	protein binding, bridging	MF
3	29	0.0488048257948	-	4.16e-01	GO:0019228	neuronal action potential	BP
3	29	0.0488048257948	-	4.44e-01	GO:0055072	iron ion homeostasis	BP
6	58	0.0488048257948	-	4.51e-01	GO:0002244	hematopoietic progenitor cell differentiation	BP
3	29	0.0488048257948	-	4.61e-01	GO:0048706	embryonic skeletal system development	BP
3	29	0.0488048257948	-	4.97e-01	GO:0044344	cellular response to fibroblast growth factor stimulus	BP
3	29	0.0488048257948	-	7.34e-01	GO:0051881	regulation of mitochondrial membrane potential	BP
3	29	0.0488048257948	-	1.00e+00	GO:0000281	mitotic cytokinesis	BP
3	29	0.0488048257948	-	1.00e+00	GO:0006294	nucleotide-excision repair, preincision complex assembly	BP
3	29	0.0488048257948	-	1.00e+00	GO:0090307	mitotic spindle assembly	BP
4	39	0.0364211013389	-	5.67e-01	GO:0045071	negative regulation of viral genome replication	BP
8	78	0.0364211013389	-	6.88e-01	GO:0000724	double-strand break repair via homologous recombination	BP
4	39	0.0364211013389	-	7.79e-01	GO:0009411	response to UV	BP
4	39	0.0364211013389	-	2.94e-01	GO:0022857	transmembrane transporter activity	MF
4	39	0.0364211013389	-	5.27e-01	GO:0042626	ATPase activity, coupled to transmembrane movement of substances	MF
9	88	0.0323167030062	-	7.09e-01	GO:0003697	single-stranded DNA binding	MF
5	49	0.0290415709733	-	8.08e-01	GO:0010212	response to ionizing radiation	BP
6	59	0.0241427715605	-	2.63e-01	GO:0016266	O-glycan processing	BP
19	187	0.0228563737571	-	3.50e-01	GO:0007420	brain development	BP
7	69	0.0206537854806	-	6.68e-01	GO:0006887	exocytosis	BP
14	138	0.0206537854806	-	4.31e-01	GO:0017137	Rab GTPase binding	MF
22	217	0.019703706394	-	7.24e-01	GO:0000209	protein polyubiquitination	BP
